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Background: Dementia is a national priority and this research addresses the Prime Minister’s commitment
to dementia research as demonstrated by his 2020 challenge and the new UK Dementia Research Institute.
In the UK > 800,000 older people have dementia. It has a major impact on the lives of people with
dementia themselves, on the lives of their family carers and on services, and costs the nation £26B per
year. Pharmacological cures for dementias such as Alzheimer’s disease are not expected before 2025. If no
cure can be found, the ageing demographic will result in 2 million people living with dementia by 2050.
People with dementia lose much more than just their memory and their daily living skills; they can also lose
their independence, their dignity and status, their confidence and morale, and their roles both within the
family and beyond. They can be seen as a burden by society, by their families and even by themselves, and
may feel unable to contribute to society. This programme of research aims to find useful interventions to
improve the quality of life of people with dementia and their carers, and to better understand how people
with dementia can be supported at home and avoid being admitted to hospital.
Objectives: (1) To develop and evaluate the maintenance cognitive stimulation therapy (MCST) for people
with dementia; (2) to develop the Carer Supporter Programme (CSP), and to evaluate the CSP and
Remembering Yesterday, Caring Today (RYCT) for people with dementia both separately and together in
comparison with usual care; and (3) to develop a home treatment package (HTP) for dementia, to field test
the HTP in practice and to conduct an exploratory trial.
Methods: (1) The MCST programme was developed for people with dementia based on evidence and
qualitative work. A randomised controlled trial (RCT) [with a pilot study of MCST plus acetylcholinesterase
inhibitors (AChEIs)] compared MCST with cognitive stimulation therapy (CST) only. The MCST implementation
study conducted a trial of outreach compared with usual care, and assessed implementation in practice.
(2) The CSP was developed based on existing evidence and the engagement of carers of people with
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dementia. The RCT (with internal pilot) compared the CSP and reminiscence (RYCT), both separately and
in combination, with usual care. (3) A HTP for dementia, including the most promising interventions and
components, was developed by systematically reviewing the literature and qualitative studies including
consensus approaches. The HTP for dementia was evaluated in practice by conducting in-depth field testing.
Results: (1) Continuing MCST improved quality of life and improved cognition for those taking AChEIs.
It was also cost-effective. The CST implementation studies indicated that many staff will run CST groups
following a 1-day training course, but that outreach support helps staff go on to run maintenance groups
and may also improve staff sense of competence in dementia care. The study of CST in practice found no
change in cognition or quality of life at 8-month follow-up. (2) The CSP/RYCT study found no benefits for
family carers but improved quality of life for people with dementia. RYCT appeared beneficial for the
quality of life of people with dementia but at an excessively high cost. (3) Case management for people
with dementia reduces admissions to long-term care and reduces behavioural problems. In terms of
managing crises, staff suggested more costly interventions, carers liked education and support, and people
with dementia wanted family support, home adaptations and technology. The easy-to-use home treatment
manual was feasible in practice to help staff working in crisis teams to prevent hospital admissions for
people with dementia.
Limitations: Given constraints on time and funding, we were unable to compete the exploratory trial of
the HTP package or to conduct an economic evaluation.
Future research: To improve the care of people with dementia experiencing crises, a large-scale clinical
trial of the home treatment manual is needed.
Conclusion: There is an urgent need for effective psychosocial interventions for dementia. MCST improved
quality of life and was cost-effective, with benefits to cognition for those on AChEIs. MCST was feasible in
practice. Both CSP and RYCT improved the quality of life of people with dementia, but the overall costs
may be too high. The HTP was useful in practice but requires evaluation in a full trial. Dementia care
research may improve the lives of millions of people across the world.
Trial registrations: Current Controlled Trials ISRCTN26286067 (MCST), ISRCTN28793457 (MCST
implementation) and ISRCTN37956201 (CSP/RYCT).
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants
for Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 5, No. 5. See the NIHR Journals Library website for further project information.
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Care Excellence
NIHR National Institute for Health
Research
NPI Neuropsychiatric Inventory
NWORTH North Wales Organisation for
Randomised Trials in Health
PCA person-centred approach
PCS-12 physical component summary
PhD Doctor of Philosophy
QALY quality-adjusted life-year
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R&D research and development
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REMCARE REMiniscence groups for people
with dementia and their family
CAREgivers
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Caring Today
SAE serious adverse event
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SHIELD Support At Home – Interventions
to Enhance Life in Dementia
SMD standardised mean difference
SPSS Statistical Product and Service
Solutions
STANDOUT Staff Training and Outreach
TAU treatment as usual
VAS visual analogue scale
WTP willingness to pay
LIST OF ABBREVIATIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xx
Plain English summary
Dementia has an enormous social and economic impact and there is an urgent need to improve care.This research programme aims to improve the quality of life of people with dementia and their carers,
and to help support people at home. Cognitive stimulation therapy (CST), which involves people with
dementia participating in mentally simulating games and other activities in groups, is beneficial for
cognition and quality of life as well as being good value for money. Our 6-month clinical trial of continued
weekly CST found that it improved quality of life and was good value. Many staff will run CST groups
following a 1-day training course. The Carer Supporter Programme (CSP) involves ex-carers of people
with dementia helping new carers with support and information. In a large clinical trial for people with
dementia and their carers, we evaluated the CSP and a reminiscence programme. Both the CSP and the
reminiscence programme helped to improve the quality of life of people with dementia but no benefits
were noted for family carers. The reminiscence programme groups were very costly to run and may not be
value for money. Home treatment teams may reduce hospital admissions for people with dementia. Based
on reviewing the research evidence and consultations with people with dementia, family carers and staff,
we have developed and field-tested a home treatment protocol to help clinical teams manage crises and
support people with dementia at home. Our results suggest that care for people with dementia and their
carers can be improved.
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Scientific summary
Background
In the UK > 850,000 older people have dementia resulting in progressive cognitive deterioration, increasing
disability and social exclusion. There are many psychosocial interventions for dementia but often these have
not been standardised, adequately evaluated or systematically implemented. Cognitive stimulation therapy
(CST) has been shown to be beneficial for cognition and quality of life, and is cost-effective. There is less
evidence for the effects of CST over an extended period. A recent pilot study found that one-third of people
who attend CST training go on to run CST groups, but staff identified a lack of support as a key reason for
the lack of implementation of CST in practice. The evidence for the potential benefits of reminiscence is
limited, but involving people with dementia and their carers may be more effective than working with
carers only.
Our experience from the Befriending and Costs of Caring (BECCA) programme showed that many ex-carers
are motivated to support others in family carer roles through mentoring and teaching. There is growing
evidence that carer well-being may be enhanced through interventions that engage both the primary
carer and the person with dementia. A recent review observed a lack of evidence for alternative interventions
to acute psychiatric admissions for older people. There is some evidence that home treatment teams (HTTs)
may reduce hospital admissions for people with dementia; local data suggest that admissions reduced by
30% and that early discharge can be facilitated. This research programme aims to help to support people at
home and improve the quality of life of people with dementia and their carers.
Objectives
1. To develop the maintenance CST (MCST) programme for people with dementia, to conduct a
randomised controlled trial (RCT) [with a pilot study of the effectiveness of MCST with
acetylcholinesterase inhibitors (AChEIs)] and to conduct an implementation study of MCST.
2. To develop the Carer Supporter Programme (CSP) for the carers of people with dementia and conduct a
RCT (with an internal pilot) of the CSP and the Remembering Yesterday, Caring Today (RYCT) reminiscence
intervention, separately and in combination, compared with usual care.
3. To develop a model including the most promising interventions and components for an effective home
treatment package (HTP) for dementia by systematically reviewing the literature and qualitative studies,
using consensus approaches to develop a feasible HTP and conducting in-depth field testing of the HTP
for dementia in practice.
Methods
1. MCST study (two projects).
MCST trial The MCST programme was developed by a systematic review of the literature including a
Cochrane Review; adaptation of the CST programme and the original maintenance programme; and
qualitative work including focus groups with people with dementia, carers and staff to tailor the sessions
to people’s preferences and interests. The multicentre, pragmatic RCT assessed the effectiveness and
cost-effectiveness of MCST groups for dementia. All participants were initially included in CST groups for
7 weeks and were then randomised either to continue in the intervention group with 24 weekly MCST
sessions or to continue with treatment as usual (TAU). Data were collected at baseline and at 12 and
24 weeks (primary end point). The primary outcome measures were quality of life of people with dementia
and cognition. The secondary outcomes included the person with dementia’s mood, behaviour, activities
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of daily living (ADLs), ability to communicate and costs, and carer health-related quality of life. The
cost-effectiveness analysis is from a public sector perspective.
MCST implementation study This comprised three projects: (i) a pragmatic multicentre RCT of staff
training, comparing CST training and outreach support with CST training only; (ii) a phase IV monitoring
and outreach trial that evaluates the implementation of CST in practice by staff members who have
previously had the CST manual or attended training; and (iii) implementation in practice study
monitoring centres running groups in their usual practice and looking at basic outcomes of cognition
and quality of life of the person with dementia. For studies (i) and (ii), centres were randomised to
receive outreach support or usual care, with the primary outcome being the number of CST and MCST
sessions run for people with dementia. The secondary outcomes included the number of attenders at
sessions, staff job satisfaction, dementia knowledge and attitudes, competency, barriers to change,
approach to learning and a controllability of beliefs and the level of adherence. Focus groups assessed
staff members’ perceptions of running CST groups and receiving outreach support.
2. CSP/RYCT study.
The trial was a factorial, single-blind, four-arm RCT, comparing CSP alone, RYCT alone, CSP and
RYCT combined, and usual care, in community settings, addressing both clinical effectiveness and
cost-effectiveness. The CSP intervention and supporting related documentation was developed in
consultation with service users and carers. Former family carers also had involvement as direct providers
of the CSP element of the trial. The carer supporter co-ordinators for each centre recruited and
screened the carer supporter. Before being matched with a family carer participant, carer supporter
volunteers attended a mandatory ‘Being a Carer Supporter’ orientation and awareness course and were
supported by a carer supporter co-ordinator throughout the study.
The RYCT group intervention followed the RYCT programme for people with dementia and their family
carers with 12 weekly sessions. Each group session was led by two experienced facilitators, supported
by a team of volunteers and staff. All members of the RYCT team attended a training day. After the
12 initial sessions, monthly reunion sessions took place over a further 7 months. To ensure enough
participants to run viable RYCT groups, we randomised between TAU, RYCT, CSP and CSP/RYCT
combined in the proportions 1 : 2 : 1 : 2. Data were collected at baseline, 5 and 12 months (primary end
point). After randomisation, all participants also continued to receive usual care from services in their
locality. We conducted a feasibility study before the full RCT in accordance with Medical Research
Council guidance on complex interventions guidance. All participants were adult English-speaking
carers for a relative or close friend with dementia living at home in the community.
3. HTP.
The first phase of this study comprised systematic reviews on case management in dementia, risk
factors for admission in dementia and crisis resolution approaches aimed at maintaining people with
dementia at home. The second phase involved focus groups, consensus approaches and a scoping
exercise, using the evidence from the literature reviews to develop the HTP. This process involved
professionals, academics, care workers, the voluntary sector, carers and people with dementia, and was
used to identify and understand risk factors for admission, factors helping to maintain people with
dementia at home, optimal approaches to managing crises, and key structural and organisational
features associated with good outcomes.
The consensus conference worked through a range of ‘high-risk’ case examples using a draft of the
HTP to articulate best practice care packages. The HTP functioned as an advisory protocol/care pathway
and included a combined risk assessment/care-planning tool, a manual and a training package. The
manual was based on a needs assessment using the Camberwell Assessment of Need for the Elderly
and included a glossary of preferred interventions in relation to various problems (e.g. challenging
behaviour). HTTs for older people benchtested the home treatment manual by working through a
number of example cases. People with dementia living in the community were referred for home
treatment because of a high or very high risk of requiring institutional or hospital admission. Field
testing of the home treatment manual was carried out with 21 clinical cases in practice using HTTs in
Lancashire and London. The implementation of the HTP for each person with dementia was managed
by an identified HTT key worker. After feedback, the home treatment manual was further revised to
produce the final definitive version.
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Results
1. MCST study (two projects).
MCST trial The Cochrane review of cognitive stimulation for dementia meta-analysis provided strong
evidence of the benefits on cognitive function and quality of life, over and above any benefits of
antidementia medication. The focus group work found agreement for 14 themes and suggestions for
improvement for the five remaining themes. These results were used to revise the manual for the MCST
programme. The RCT results showed that at 6 months there were significant benefits for self-rated
quality of life for the MCST group, and at 3 months there were improvements for proxy-rated quality of
life and ADLs. The MCST subgroup taking AChEIs showed cognitive benefits at 3 and 6 months.
Although outcome gains were modest, MCST appeared cost-effective for self-rated quality of life,
cognition measured on the Mini-Mental State Examination and proxy-rated quality-adjusted life-years
(QALYs). MCST plus AChEIs offered cost-effectiveness gains for cognition.
MCST implementation study Outreach support was rarely accessed. There was no difference in the
delivery of the CST programme between the outreach support intervention and the usual care group,
but centres with outreach support were more likely to go on to run MCST. More groups were run in
the staff recruited for the phase IV study and these staff had prior experience in delivering CST groups.
At follow-up, staff in the outreach support group felt more competent in dementia care. For the
observational study there was no deterioration in scores for quality of life or cognition at final follow-up.
2. CSP/RYCT study.
Developing the CSP package, we followed consensus methods involving principles of good practice and
meaningful involvement. People with dementia and their family carers were involved in the development
via a modified Delphi process and consensus conference to develop the content of the intervention, and
in a consultation to develop and refine information and consent documents. In the RCT there was no
evidence of effectiveness for family carers for either CSP or RYCT, and no indication of a significant
interaction between the interventions. For people with dementia allocated to CSP or RYCT there were
significant benefits to quality of life. For the person with dementia, significant interactions between
RYCT/CSP for quality of life, anxiety and ADLs indicated that the interventions were not independent.
The health economic analysis suggested that, for quality of life, RYCT may be cost-effective for people
with dementia.
3. HTP.
The systematic review of risk factors found that falls/fractures and infections were more common causes
of general admission for people with dementia than for other older people. For people with dementia,
behaviour problems were likely to precipitate a psychiatric admission. The Cochrane review found
evidence for the benefits of case management in terms of reduced admissions to long-term care and
hospital length of stay, reduced behaviour disturbance and reduced carer burden. Although case
management involved higher use of community services, this was offset by a lower use of acute services
and hospitalisations. There was limited evidence that home treatment reduced admissions. In terms of
crises, people with dementia focused on risks and hazards in their home, family carers emphasised
carer stress and staff were concerned about problems with service co-ordination. In developing the
HTP, we that found health-care professionals often emphasised more costly and intensive interventions
(extended-hours services and multidisciplinary interventions), whereas carers valued education and support,
and people with dementia preferred family support, technology and home adaptations to reduce risks.
Five case review workshops were held with 45 staff using the HTP package. Following further revision,
17 staff from crisis teams used the HTP, with 21 cases finding it to be feasible and useful in practice.
Conclusion
There is an urgent need for useful and effective interventions to help to reduce the impact of dementia
on patients, carers and society. Continuing MCST improved quality of life, improved cognition for those
taking AChEIs and was cost-effective. Moreover, our results support other work indicating that drug and
psychosocial interventions may potentially work better together than either alone. Our CST implementation
DOI: 10.3310/pgfar05050 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 5
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Orrell et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
xxv
studies indicated that many staff will run CST groups following a 1-day training course, but that outreach
support helps staff go on to run maintenance groups and may also improve staff sense of competence in
dementia care. Although the observational study of CST in practice did not find a noticeable improvement
in cognition or quality of life at follow-up 8 months later, it is encouraging that neither declined over time.
The CSP/RYCT study did not find any particular benefits for family carers. However, both CSP and RYCT
appeared to improve the quality of life of people with dementia. RYCT has the potential to be both
effective and cost-effective in maintaining the quality of life of people with dementia, but the cost per
QALY would be far beyond the National Institute for Health and Care Excellence-accepted price window.
Using a factorial design assumes that interventions are independent of each other but for people with
dementia we found there were significant interactions. The finding that case management for people with
dementia reduces admission to long-term care is consistent with related literature. Case management also
reduced behavioural problems in people with dementia. On the evidence available it is not clear how it
may affect overall health-care costs. People with dementia and family carers have much to offer in their
understanding of the causes and best interventions in times of crisis. Staff suggested more costly and
intensive interventions, whereas carers liked education and support, and people with dementia appreciated
support from family, and home adaptations and technology to reduce risks. The consensus methods and
field testing enabled the production of an easy-to-use HTP to help staff working in crisis teams prevent
admissions for people with dementia. The HTP requires evaluation in a full-scale multicentre trial.
The new wave of complex interventions shows great potential for benefit for people with dementia.
Alongside this research into psychosocial interventions, further advances in methodology will be required,
particularly in relation to process evaluations and implementation. Recent funding rounds by the National
Institute for Health Research (NIHR) and the Economic and Social Research Council should help the UK to
remain at the forefront of dementia care research with the potential to improve the lives of millions of
people with dementia across the world.
Trial registrations
These trials are registered as ISRCTN26286067 (MCST), ISRCTN28793457 (MCST implementation) and
ISRCTN37956201 (CSP/RYCT).
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of
the NIHR.
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Chapter 1 Introduction
Background
Dementia is very common in old age and the frequency of dementia increases with age, from around 5% in
those aged > 65 years to around 20% in those aged > 85 years.1,2 In the UK there are 850,000 people living
with dementia3 which leads to progressive intellectual deterioration, increasing disability and social exclusion.4
This has an enormous social and economic impact on health and social care services, and on family carers.
There is little high-quality research on the effectiveness of psychological and social interventions, and there is
an urgent need to find more useful interventions to help reduce the impact of dementia on people with
dementia, carers and society. Drug treatments have an important role in dementia care, but in the UK they
are limited to people with Alzheimer’s disease, with mild to moderately severe dementia, have a limited
impact on the illness, are not suitable for all patients and cost approximately £1000 per year.5 There is
increasing recognition that psychological and social interventions may have comparable value6 and may be
preferable (e.g. when medication may have intolerable side effects).7
In the UK there is recognition that psychological therapies for older people should be more widely
available, and the National Service Framework for Older People4 states that ‘treatment for dementia always
involves using non-pharmacological management strategies such as mental stimulation’ (contains public
sector information licensed under the Open Government Licence v3.0). However, the delivery of such
therapies has been generally unstandardised, and many evaluations of psychological treatments have been
either small or of poor methodological quality, or both. A number of systematic reviews of psychosocial
interventions are now available,8–10 as well as a number of Cochrane reviews on interventions with a
cognitive focus.11,12 Cognitive stimulation therapy (CST) is an evidence-based approach which has been
shown to be beneficial to cognitive function and quality of life, and also cost-effective.6,13 Indeed, the
recent draft National Institute for Health and Care Excellence (NICE) guidelines on dementia14 recommend
that all people with mild to moderate dementia should be ‘given the opportunity to participate in a
structured group cognitive stimulation programme’.
In the UK, reminiscence work with people with dementia has an extensive history;15,16 it involves enjoyable
activities that tap into early memories and encourage communication and well-being. However, its
popularity has not led to a corresponding body of evidence on its effects. The Remembering Yesterday,
Caring Today (RYCT) trial platform suggested that it was useful to involve family carers in reminiscence
groups with people with dementia, and a recent meta-analysis of outcomes for family caregivers confirms
that involving people with dementia and their carers together is more effective than working with carers
only.10 Over the last decade, the needs of carers have remained a high priority, with a national strategy
published in 1999.17 Being a family carer is stressful and a recent study showed that one in three carers
had a mental illness.18 The carers of people with dementia experience greater strain and distress than the
carers of other older people.19 The Expert Patients Programme for people with long-term conditions aims
to increase their confidence, improve their quality of life and better manage their conditions.20 In a 2006
White Paper21 the government pledged funding for the creation of an Expert Carer Programme, which
would include training to develop carers’ skills in addition to self-care skills of people with dementia. The
progressive decline and the changing nature of dementia over time mean that family carers’ needs will
change.22 There is an evidence base for cognitive–behavioural packages being the predominant approach
for psychoeducation, stress and behaviour management, with principles and basic components that could
be disseminated for use by non-therapists. For example, in caring for a person with dementia, sessions may
include coping with the psychological and behavioural symptoms of dementia.
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In the last few years there has also been an increasing emphasis on maintaining older people with
dementia at home, rather than admitting them to hospital, to help to maintain their independence and
quality of life. The document Everybody’s Business: Integrated Mental Health Services for Older Adults23
advised that community mental health teams (CMHTs) for older people needed to have some provision for
24-hour home-based crisis support, and Raising the Standard: Specialist Services for Older People with
Mental Illness24 highlighted the need for alternatives to inpatient care. A 2005 review25 noted the lack of
evidence for alternatives to acute psychiatric admissions for older people and another study from the same
year indicated that home treatment teams (HTTs)/crisis teams are effective at reducing admissions for those
aged < 65 years.26 There are suggestions that this approach may also reduce admissions for those aged
> 65 years with mental health problems,27,28 including people with dementia.
Aims and objectives
The aim of this research programme is to prevent excess disability, promote social inclusion, improve health
outcomes and enhance the quality of life of people with dementia and their carers. The aim was achieved
by a rigorous 5-year programme of psychosocial research building on our existing work in cognitive
stimulation, reminiscence work and carer support, and also by a new initiative developing intensive home
support to manage crises at home and prevent admission to hospital for people with dementia.
Cognitive stimulation therapy is an evidence-based approach which has been shown to be beneficial to
cognitive function and quality of life, and also cost-effective. As the degree of cognitive benefit from CST
is similar to that from cholinesterase inhibitors, longer-term CST may have an impact on long-term care.
Reminiscence work with people with dementia taps into early memories and encourages communication
and well-being, and a recent meta-analysis indicated that involving people with dementia and their carers
is more effective than working with carers only. Our trial platform successfully developed a manual for
joint reminiscence, RYCT, and suggests that RYCT improves the caring relationship and benefits both
people with dementia and carers. Our experience from the Befriending and Costs of Caring (BECCA)
programme29 showed that many ex-carers are motivated to support others at an earlier stage in their role
as a family carer, through mentoring and teaching.
There is some evidence that HTTs may reduce admissions for people with dementia; however, better
evidence for their effectiveness is required before wider implementation is considered.
This research programme provides essential evidence to clarify the role of each of these interventions in
helping to support people at home, reducing hospital and care home admissions, and improving the
quality of life of people with dementia and their carers.
The three projects are (1) cognitive stimulation groups for people with dementia to improve their cognition
and quality of life, (2) a new initiative called the Expert Carer Programme, which trains ex-carers to help
new carers of people with dementia and was undertaken alongside reminiscence groups for people with
dementia and their carers which help to maintain quality of life and improve their relationships, and (3) the
development of intensive home support to help manage crises at home and prevent admission to hospital
for people with dementia.
Each of the three projects completed a number of components of the pathway through development of
theory, modelling, feasibility and evaluation to dissemination and implementation, as illustrated in the
Medical Research Council (MRC) framework for complex interventions.30
All of these approaches were carefully evaluated to look at their potential benefits to people with
dementia and their carers. We have also produced training manuals which will be made widely available to
help other services implement the same approaches.
INTRODUCTION
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Objectives
1. To develop a model to identify the most promising interventions and components for an effective
home treatment package (HTP) for dementia.
2. To carry out systematic reviews in the areas of home treatment for dementia and to update the
Cochrane review on reality orientation/CST for dementia.
3. To develop a HTP for dementia and a package for carer supporters.
4. To carry out a pilot study for (a) the reminiscence and carer programmes separately and in
combination, and (b) the effectiveness of maintenance CST (MCST) with donepezil.
5. To provide definitive randomised controlled trials (RCTs) for MCST, RYCT and the Carer Supporter
Programme (CSP).
6. To conduct in-depth field testing of the HTP for dementia.
7. To conduct a post-RCT surveillance study of MCST in practice, including minimal outcome measures
and qualitative approaches.
8. To provide economic evaluations for the MCST and CSP/RYCT interventions.
9. To involve users, carers and the voluntary sector, and to develop a model of user/carer involvement
that can be widely used.
10. To develop training and manuals for all three interventions.
11. To disseminate service models, training programmes, tools and outcomes.
This report outlines the work undertaken for each project and individual aims and objectives for each study
are given in their respective chapters. The development of the interventions focuses on the involvement of
service users and key stakeholders.
User and carer involvement
User and carer involvement is now central to research and development (R&D) strategy in health and
social care nationally, and their involvement is required as a condition of funding.31 User involvement and
collaboration has been found to improve the quality, depth and utility of research.32,33 We developed a
strategy for user and carer involvement as part of the SHIELD (Support At Home – Interventions to Enhance
Life in Dementia) research programme.34 The strategy encompassed principles of good involvement practice
(i.e. clarity and transparency, respect, diversity, flexibility and accessibility) and meaningful involvement.35
Service users and carers were involved in consensus workshops, focus groups and consultation processes
for developing interventions to ensure their relevance and acceptability. User involvement can help develop
more theoretically coherent and evidence-based interventions, which are more likely to be practical,
generalisable and meaningful for potential users.36 Carers were also involved in the recruitment of staff and
provision of training and as part of the SHIELD research programme steering and monitoring committees.
Ethics arrangements and research governance for the SHIELD
research programme
All projects obtained ethics approval from a NHS Research Ethics Committee and local R&D approvals for all
sites involved in the research. Amendments to protocols were made and approvals were sought from ethics
committees as needed throughout the research programme. The trial was sponsored by University College
London and North East London Foundation Trust (NELFT). Our Programme Steering Committee consisted of
an independent chairperson and external committee members comprised interested clinicians, academics,
voluntary sector staff and service users, as well as the grantholders and key individuals from the research
programme (see Acknowledgements).37 A Data Monitoring and Ethics Committee was created as a
subcommittee of the Programme Steering Committee. This group consisted of an independent academic
as chairperson, an independent statistician and a family carer37 (see Acknowledgements).
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Consent
Informed consent was sought whenever appropriate. Participants were at various stages of dementia
ranging from mild to moderate, to severe. Some participants were competent to give informed consent for
participation, provided that appropriate care was taken in explaining the research and sufficient time was
allowed for them to reach a decision. However, those people with more advanced dementia were also
included and, in these situations, the provisions of the Mental Capacity Act were followed.38,39 It was
helpful for a family member or other supporter to be involved, and we aimed to ensure that this was done
whenever possible. It was made clear to all that no disadvantage would accrue if they chose not to
participate. In seeking consent, we followed current guidance from the British Psychological Society40 on
the evaluation of capacity; thus, consent was regarded as a continuing process rather than a definitive,
and willingness to participate was continually checked through discussion with participants during the
assessments. When a participant’s level of impairment was more severe or increased so that they were no
longer able to provide informed consent, the provisions of the Mental Capacity Act were followed.38,39
The initial giving of informed consent provided a clear indication of the person’s likely perspective on
continuing at this point, and the family caregiver was consulted in this regard. If a participant with
dementia became distressed during the assessments, the assessments were discontinued.
Adverse events
Prospective participants were fully informed of the potential risks and benefits of the projects they were
recruited to. A reporting procedure was in place to ensure that serious adverse events (SAEs) were
reported to the chief investigator (MO).41 On becoming aware of an adverse event involving a participant
or carer, the research programme co-ordinator (JH) assessed its seriousness. A SAE was defined in the trial
as an untoward occurrence experienced by either a participant or a carer which resulted in death; was
life-threatening; required hospitalisation or prolongation of existing hospitalisation; resulted in persistent or
significant disability or incapacity; was otherwise considered medically significant by the investigator; or
was within the scope of the Protection of Vulnerable Adults protocol.41 A reporting form was submitted to
the chief investigator, who assessed whether or not the SAE was related to the conduct of the trial and
was unexpected. If SAEs were judged to be related and unexpected, they were reported to the Multicentre
Research Ethics Committee and the trial Data Monitoring and Ethics Committee.
Changes from the planned protocol
National Institute for Health Research (NIHR) funding for SHIELD was received in August 2007 and the
research programme commenced in February 2008. The original scope of the programme was to
undertake four trials examining the effectiveness of MCST programmes, the implementation of MCST in
practice, RYCT and the CSP, and a HTP for dementia. Time and budgetary constraints meant that we were
advised by the NIHR review team not to complete a trial of the home treatment intervention. This will now
be tested in a further NIHR-funded trial. All studies followed the MRC guidance for developing and
evaluating complex interventions.30
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Chapter 2 Maintenance cognitive stimulation
therapy
Background
Cognitive ‘training’, cognitive ‘stimulation’ and cognitive ‘rehabilitation’ have on occasion been used
almost interchangeably, but Clare and Woods42 have proposed clear definitions for all of these terms.
Cognitive stimulation has been defined as the engagement in a range of activities and discussions (usually
in a group) aimed at the general enhancement of cognitive and social functioning.42 CST6 is a therapeutic
non-pharmacological treatment for dementia that aims to optimise cognitive function based on the notion
of cerebral plasticity. A large multicentre RCT of CST found that it improved cognition and quality of life,6
and was cost-effective.13 Indeed, the 2007 draft NICE/Social Care Institute for Excellence guideline on
dementia14 recommended that all people with mild-to-moderate dementia should have the opportunity to
take part in a structured programme of cognitive stimulation groups.
As CST is only a brief intervention (a 14-session programme over 7 weeks), it is necessary to investigate if
its benefits can be extended over a longer period of time. This has been investigated as a pilot study43 in
which the 16 additional weekly sessions led to a significant improvement in cognitive function for those
receiving MCST, compared with those receiving CST only. The programme grant funded a full-scale trial of
MCST over 24 weeks.
The MSCT programme included an update of the Cochrane review on reality orientation/cognitive
stimulation, explored the long-term effects of a MCST programme versus CST for dementia and compared
the effectiveness of two different training approaches with care staff from a range of dementia care
settings. The cognitive stimulation groups for people with dementia aimed to improve cognition and quality
of life. The training package comprises a workbook, a digital versatile disc (DVD) and training seminars.
Work package 1: update of the Cochrane review on cognitive
stimulation therapy
A systematic review and meta-analysis evaluating the effectiveness and
impact of cognitive stimulation in dementia
A systematic review and meta-analysis evaluating the effectiveness and impact of cognitive stimulation in
dementia was conducted with the Cochrane Dementia and Cognitive Improvement Group (CDCIG), based
in Oxford, UK.44 The review followed the Specialised Register of the CDCIG, called ALOIS (Action in
Language, Organisations and Information Systems). This yielded 94 studies, of which 15 were RCTs
meeting the inclusion criteria. The analysis included 718 participants (407 receiving cognitive stimulation
and 311 in control groups).
Objectives
l To evaluate the effectiveness and impact of cognitive stimulation interventions aimed at improving
cognition for people with dementia, including any negative effects.
l To indicate the nature and quality of the evidence available on this topic.
l To assist in establishing the appropriateness of offering cognitive stimulation interventions to people
with dementia and identifying the factors associated with their efficacy.
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Review methods
Protocol and registration
The protocol was registered with The Cochrane Library and can be found online at http://onlinelibrary.
wiley.com/doi/10.1002/14651858.CD005562.pub2/pdf.
Criteria for considering studies for this review
We selected RCTs examining the effect of cognitive stimulation for dementia if they had been published
and written in English, peer reviewed and presented in a journal article. Authors were contacted for
missing data, such as details of randomisation, means and standard deviations (SDs).
Search methods for identification of studies
The search methods included a combination of the search terms cognitive stimulation, reality orientation,
memory therapy, memory groups, memory support, memory stimulation, global stimulation and cognitive
psychostimulation, which were used to search ALOIS on 6 December 2011. The studies were identified
from the following databases:
l health-care databases: MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature
(CINAHL), PsycINFO and Latin American and Caribbean Health Sciences Literature (LILACS)
l trial registers: metaRegister of Controlled Trials, Umin (University Hospital Medical Information Network)
Japan Trial Register and World Health Organization portal [which covers ClinicalTrials.gov, International
Standard Randomised Controlled Trial Number (ISRCTN), Chinese Clinical Trials Register, German
Clinical Trials Register, Iranian Registry of Clinical Trials and the Netherlands National Trials Register,
plus others]
l The Cochrane Library’s Central Register of Controlled Trials
l a number of grey literature sources: ISI Web of Knowledge Conference Proceedings, Index to Theses,
Australasian Digital Theses.
Additional searches in each of the sources listed above to cover the time frame from the last searches
performed for the Specialised Register to December 2011 were run to ensure that the search for the
review was as up to date as possible. A total of 670 references were retrieved from the December 2011
update search. After deduplication and a first assessment, authors were left with 94 references to further
assess for inclusion, exclusion or discarding.
Participants
Participants were any age with a diagnosis of dementia (Alzheimer’s disease, vascular dementia or mixed
Alzheimer’s and vascular dementia, other types of dementia), including all severity levels of dementia,
indicated through group mean scores, range of scores or individual scores on a standardised scale, such
as the Mini-Mental State Examination (MMSE)45 or Clinical Dementia Rating (CDR).46 The participants
could receive the intervention in a variety of settings (own home, outpatient setting, day care setting
or residential setting). We documented when participants were receiving concurrent treatment with
acetylcholinesterase inhibitors (AChEIs).
Interventions
Participants attended regular therapy sessions (involving a group or family caregiver) for a minimum period
of 4 weeks. The intervention needed to describe a cognitive stimulation intervention targeting cognitive
and social functioning, offering generalised cognitive practice. These may also be described as reality
orientation groups, sessions or classes. The intervention needed to be compared with ‘no treatment’,
‘standard treatment’ or placebo.
MAINTENANCE COGNITIVE STIMULATION THERAPY
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Outcome measures
These assessed the short- (immediately after the intervention) and medium-term (follow-up 1 month to
1 year after the intervention finished) impact on the intervention on the person with dementia, the family
caregiver or both. For the person with dementia, outcome measures needed to evaluate performance on
at least one cognitive measure and/or include the assessment of any of the following variables: mood,
well-being, activities of daily living (ADLs), behaviour, neuropsychiatric symptoms and social engagement.
Rates of attrition and reasons for withdrawal were noted. Family caregiver outcomes, such as self-reported
well-being, depression and anxiety, burden, strain and coping, and satisfaction with the intervention,
were considered.
Data collection and analysis
Searches were conducted as detailed above to identify all relevant published studies. The date and time
of each search, together with details of the version of the database used, were recorded. Additional
information was sought, as outlined above, and hard copies of articles were obtained.
Quality assessment
Two reviewers independently screened the identified RCTs for inclusion and the final list of included
studies was reached by consensus. Trials not meeting the criteria were excluded. The studies were assessed
against a checklist of quality requirements using the Cochrane approach:
l grade A – ‘low risk’: adequate concealment (randomisation; concealed allocation)
l grade B – ‘unclear risk’: ‘randomised’, but methods uncertain
l grade C – ‘high risk’: inadequate concealment of allocation or no randomisation, or both.
Only trials with a grade A or B ranking were included in the review. Again, the reviewers worked
independently to ascertain which studies met the quality criteria, and consensus was reached through
discussion. Attempts were made to obtain additional information from the study authors when needed.
Data extraction
Descriptive characteristics (such as quality of randomisation and blinding) and study results were extracted,
recorded and entered into RevMan 5.1 (The Cochrane Collaboration, The Nordic Cochrane Centre,
Copenhagen, Denmark). Additionally, letters and e-mails were sent to some authors of controlled trials
asking for essential and additional information (statistics, sources of bias and details of randomisation).
The summary statistics required for each trial and each outcome for continuous data were the mean
change from baseline, the standard error (SE) of the mean change and the number of patients for each
treatment group at each assessment. When changes from baseline were not reported, we extracted the
mean, SD and number of patients for each treatment group at each time point, if available. We calculated
the required summary statistics from the baseline and assessment time treatment group means and SDs,
assuming in this case a zero correlation between the measurements at baseline and assessment time. This
conservative approach was chosen, as it is preferable in a meta-analysis. For binary data, the numbers in
each treatment group and the numbers experiencing the outcome of interest were sought. The baseline
assessment was defined as the latest available assessment prior to randomisation, but no longer than
2 months prior. For each outcome measure, data were sought on every patient randomised. To allow an
intention-to-treat analysis, the data were sought irrespective of compliance, or whether or not the patient
was subsequently deemed ineligible or otherwise excluded from treatment or follow-up. Discussion
between the two reviewers and the other authors was used to resolve any queries.
Data analyses
RevMan 5.1 was used for the meta-analysis. Analyses were adjusted to the random-effects model, owing
to the heterogeneity of trials. Because trials used different tests to measure the same outcomes, the
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measure of the treatment difference for any outcome that we used was the weighted mean difference
when the pooled trials used the same rating scale or test, and the standardised mean difference (SMD)
(the absolute mean difference divided by the SD) when different rating scales or tests were used. For
binary outcomes, such as clinical improvement or no clinical improvement, the odds ratio was used to
measure treatment effect. A weighted estimate of the typical treatment effect across trials was calculated.
Overall estimates of the treatment difference were employed, presenting the overall estimate from a
fixed-effects model and performing a test for heterogeneity using a standard chi-squared statistic. The
reviewers achieved consensus on the interpretation of the statistical analyses, seeking specialist statistical
advice from the CDCIG as required. Non-randomised studies were described in tabular form and the reviewers
discussed and reached consensus on the presentation of the findings in the background to the review.
Results
Studies included in the review
Ninety-four studies were identified since the last review through the literature search.47 Two reviewers
independently assessed eligibility. Of the 94 references, nine studies met the inclusion criteria48–55 and were
included in the analysis. Three recent studies were left awaiting classification.56–58 Our previous review47
included eight studies in the meta-analysis and six of these met the criteria for inclusion in this updated
review.59–64 Two studies from our previous review were excluded this time, as the data needed for the
meta analysis were not available.65,66 Therefore, a total of 15 studies was included in the analysis (Figure 1).
Quality of included studies
The quality of each study was assessed according to the four criteria outlined in the Cochrane
Collaboration Handbook:67 selection bias, performance bias, attrition bias and detection bias. The details
of biases and descriptions of studies can be seen in Table 1. Performance bias was difficult to evaluate.
With psychological interventions, unlike drug trials, it is impossible to totally blind patients and staff to
treatment. Patients are often aware that they are being treated preferentially, staff involved may have
different expectations of treatment groups and independent assessors may be given clues from patients
during the assessments. There may also be ‘contamination’ between groups, in terms of groups not being
held in separate rooms and staff bringing ideas from one group to another.
The latter effect would be reduced with clear therapeutic protocols, the existence of which was not
mentioned in any of the studies, although during a face-to-face meeting with Professor Woods he stated
that ‘Checks were made to ensure compliance with the therapeutic protocol’ (Bangor University, 2008,
personal communication).
In relation to contamination, Wallis et al.63 and Baines et al.59 both stated that staff were unaware of the
allocation of patients to groups, as they were removed from the setting for treatment, and several other
studies described the groups being run in a separate or specific room.6,55,62,64 Most studies took steps to
ensure that at least part of the assessment of outcomes was carried out by assessors blinded to treatment
allocation. Only three studies48,60,62 did not report the blinding of assessors. Of course, even independent
assessors may be given clues from participants during the assessments, but this was not reported as an
issue in the studies reviewed here. Using independent assessors works well for evaluating change in
cognition or self-reported mood, well-being and quality of life. Ratings of day-to-day behaviour and
function are typically carried out by care staff, who may be more difficult to keep blind to group allocation,
unless the group sessions are carried out in a separate location to which all participants are taken.
Whether or not the patients were blind to treatment is a controversial issue, depending on how much
information was given to them and their level of comprehension.
Several studies reported48,62–64 that the reality orientation groups were held in separate areas, reducing
the chance of contamination. Spector et al.6,55 said that the groups were run in a separate and specific
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FIGURE 1 The Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart of the review and
selection process of studies.
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room for the programme. The other studies did not provide information regarding where groups
were held.49,51,53
All of the studies reported on attrition to the programme, although the intention-to-treat analysis plan
was described in only two.6,51 Given the nature of the condition and the age of the participants, attrition
in several studies was remarkably small, with zero attrition recorded in six studies48–50,52,59,60 out of
180 participants. The largest attrition rate was reported in the study by Wallis et al.,63 in which there was
39% attrition in the group of participants with dementia. In this study, patients who attended < 20% of
the group sessions were eliminated from the study. Requena et al.54 reported 32% attrition, but this
was over a 2-year period. The two largest studies had rates of 19%59 and 17%6 over periods of 6 and
2 months, respectively.
Detailed treatment protocols were hard to find from the authors of the included studies, so the extent to
which the cognitive stimulation was delivered as intended could be questioned. Some recent studies
described that staff received training and/or supervision in running the groups. Chapman et al.51 described
weekly meetings held to ensure that their treatment programme was implemented as designed:
Sub-groups were led by a licensed speech-language pathologist and three masters level speech-
language pathology students; all underwent two hour training before the groups started; weekly
meetings to ensure the programme was implemented as designed.
Onder et al.53 described how family caregivers were trained by a multidisciplinary team and given a
manual and specific schedule for each session. No records were made, however, of how often caregivers
delivered the sessions or how closely the manual was followed. The only available data from an early study
came from Professor Woods, who stated during a face-to-face meeting that ‘A sample of sessions were
tape-recorded and rated to ensure compliance with the therapeutic protocol’ (Bangor University, 2008,
personal communication).
Meta-analysis
Data from the included studies were entered into ‘Metaview’ (the Cochrane term for meta-analysis). Data
were identified, included and pooled from the 15 included RCTs,6,48–55,59–64 with a total of 718 participants
(407 in experimental groups and 311 in control groups). Analyses were adjusted to the random-effects
model, owing to the heterogeneity of trials, and SMDs, because trials used different measures to assess
the same outcomes.
In order to evaluate the effect of cognitive stimulation on cognitive function, 14 RCTs that included
useable data were included in the analysis (n = 658; 377 received treatment and 281 received no
treatment or placebo). In comparison with the control groups at the post-treatment assessment, cognitive
stimulation was associated with significant improvements on all measures of cognition. The overall results
in the cognitive section were significantly in favour of treatment (Figure 2). The overall effect size (SMD)
was 0.41 [95% confidence interval (CI) 0.25 to 0.57]. The results were strongly weighted by Breuil et al.61
(n = 61), Onder et al.53 (n = 137) and Spector et al.6 (n = 201), the largest studies. The largest effect sizes
can be seen at the 12-month point in Requena’s et al.54 study [SMD 0.70 on the Alzheimer’s Disease
Assessment Scale – Cognitive Subscale (ADAS-Cog)] and the Baldelli et al.60 study (SMD 0.99 on the
MMSE), both of which offered above-average duration of exposure to cognitive stimulation. Other studies
with longer exposure62 had below-average effect size and other studies which offer only 10 hours of
exposure had above-average effect size (0.63), showing that these effects require replication, as the CIs are
broad and cross zero.
To evaluate the effectiveness of cognitive stimulation on behaviour, three separate meta-analyses were
conducted. One focused on outcome measures seen as a problem, the second focused on ADLs and the
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third focused on general behaviour outcomes. Three studies used behavioural outcome measures seen
as a problem (Figure 3) including 166 participants, showing that no difference was apparent related to
cognitive stimulation (SMD –0.14, 95% CI –0.44 to 0.17; z = 0.86; p = 0.39). The ADL measure results also
did not achieve significance (Figure 4), including four studies, involving 260 participants. There was no
benefit identified associated with cognitive stimulation (SMD 0.21, 95% CI –0.05 to 0.47; z = 1.56;
p = 0.12). The third behaviour analysis (Figure 5) (general behaviour) showed a similar picture, with no
difference emerging. Eight studies reported data on relevant scales, including 416 participants (SMD 0.13,
95% CI –0.07 to 0.32; z = 1.30; p = 0.20).
Five studies, involving 201 participants, used a self-report measure of mood (the Geriatric Depression Scale
or the Montgomery–Åsberg Depression Rating Scale) (Figure 6). Cognitive stimulation is not associated
with a clear improvement in mood (SMD 0.22, 95% CI –0.09 to 0.53; z = 1.42; p = 0.16). This is of similar
magnitude to the finding of proxy report of mood and anxiety, where the SMD is close to zero (SMD 0.05,
95% CI –0.21 to 0.31) (Figure 7).
Study or subgroup
CS
Mean SD
Control SMD
IV, fixed, 95% CIMean Total
ADAS-Cog
Bottino 200549
Buschert 201150
Coen 201152
Onder 200553
Requena 200654
Spector 200155
Spector 20036
Subtotal (95% CI)
Heterogeneity: χ2 = 4.88, df = 6 (p = 0.56); I2 = 0%
Test for overall effect: z = 3.74 (p = 0.0002)
2.17
0.7
0.2
0.4
6.4
4.3
1.9
8.33
8
7.2
6.69
14.06
17.33
6.2
Total
6
8
13
70
20
17
97
231
0.28 (–0.82 to 1.38)
0.09 (–0.93 to 1.10)
–0.34 (–1.13 to 0.45)
0.44 (0.10 to 0.77)
0.70 (0.12 to 1.29)
0.28 (–0.51 to 1.06)
0.37 (0.06 to 0.68)
0.37 (0.17 to 0.56)
–0.43
0
2.3
–2.5
–6.6
–1
–0.3
7
7
12
67
30
10
70
203
SD
8.92
6.93
4.1
6.55
20.48
20.5
5.5
Weight
2.1%
2.5%
4.1%
22.5%
7.6%
4.2%
26.9%
70.0%
Wechsler Memory Scale
Woods 197964
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.73 (p = 0.47)
4.7 12.02 5
5
SMD
IV, fixed, 95% CI
0.47 (–0.80 to 1.74)
0.47 (–0.80 to 1.74)
–0.6 5
5
7.85 1.6%
1.6%
Global cognitive score (includes MMSE and CERAD)
Breuil 199461
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 2.29 (p = 0.02)
5.8 7.3 29
29
0.63 (0.09 to 1.17)
0.63 (0.09 to 1.17)
1 27
27
7.8 8.9%
8.9%
MMSE
Baldelli 199360
Baldelli 200248
Subtotal (95% CI)
Heterogeneity: χ2 = 0.83, df = 1 (p = 0.36); I2 = 0%
Test for overall effect: z = 2.69 (p = 0.007)
3
2.34
5.32
4.78
13
71
84
0.99 (0.11 to 1.87)
0.50 (–0.04 to 1.05)
0.64 (0.17 to 1.10)
–4.4
–0.12
10
16
26
9.15
5.06
3.3%
8.6%
11.9%
CAPE-I/O
Baines 198759
Ferrario 199162
Subtotal (95% CI)
Heterogeneity: χ2 = 0.03, df = 1 (p = 0.87); I2 = 0%
Test for overall effect: z = 0.74 (p = 0.46)
1.4
1.23
4.59
3.64
5
13
18
0.21 (–1.03 to 1.46)
0.34 (–0.63 to 1.32)
0.29 (–0.48 to 1.06)
0.1
0
5
6
11
6.4
2.93
1.7%
2.7%
4.4%
RCP Cognition
Wallis 198363
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.27 (p = 0.78)
5.9 35.5 10
10
0.13 (–0.78 to 1.03)
0.13 (–0.78 to 1.03)
1.7 9
9
27.04 3.2%
3.2%
Total (95% CI)
Heterogeneity: χ2 = 7.98, df = 13 (p = 0.84); I2 = 0%
Test for overall effect: z = 5.04 (p < 0.00001)
Test for subgroup differences: χ2 = 2.24, df = 5 (p = 0.82); I2 = 0%
377 0.41 (0.25 to 0.57)281 100.0%
–4 –2
Favours control Favours CS
0 2 4
FIGURE 2 Forest plot of comparison for CS vs. no CS: outcome – cognition. ADAS-Cog, Alzheimer’s Disease
Co-Operative Study–Cognitive Subscale; CAPE I/O, Clifton Assessment Procedures for the Elderly – Information/
Orientation scale; CERAD, Consortium to Establish a Registry for Alzheimer's Disease; CI, confidence interval;
CS, cognitive stimulation; df, degrees of freedom; IV, inverse variance; RCP, Royal College of Physicians.
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Four studies included self report well-being and quality-of-life measures (n = 219) (Figure 8). The analysis
showed a significant improvement on this outcome measures following treatment, compared with control
groups. The SMD was 0.38 (95% CI 0.11 to 0.65; z = 2.76; p = 0.006).
Follow-up
Owing to the great variety in follow-up data, the analyses were divided in two sections: short- and
long-term follow-up. Short-term follow-up analysis included Baines et al.59 and Wallis et al.,63 who had a
1-month follow-up, and Baldelli et al.,60 who reported data from a 3-month follow-up. Long-term follow-up
data included Chapman et al.,51 who reported useable data only from a 10-month follow-up, a much
longer period in the context of the progression of dementia. For cognitive measures (Figure 9), the three
studies with short-term follow-up reported data for 52 participants. The significant advantage for cognitive
stimulation on cognitive measures seen immediately post treatment remained at this point (SMD 0.57,
95% CI 0.01 to 1.14; z = 2.00; p = 0.05). For the 54 participants included by Chapman et al.51 (Figure 10),
Study or subgroup
CS
Mean SD
Control Mean difference
IV, fixed, 95% CI
Mean difference
IV, fixed, 95% CIMean Total
1–12 months of CS
Baldelli 199360
Baldelli 200248
Bottino 200549
Breuil 199461
Buschert 201150
Coen 201152
Onder 200553
Requena 200654
Spector 200155
Spector 20036
Subtotal (95% CI)
Heterogeneity: χ2 = 7.48, df = 9 (p = 0.59); I2 = 0%
Test for overall effect: z = 5.57 (p < 0.00001)
3
2.34
0.83
1.4
0.5
0.8
0.2
1.5
3.1
0.9
5.32
4.78
4.53
2.7
3.14
3.6
3.35
7.38
7.04
3.5
Total
13
71
6
29
8
14
70
20
17
97
345
7.40 (1.03 to 13.77)
2.46 (–0.26 to 5.18)
2.26 (–3.08 to 7.60)
2.10 (0.57 to 3.63)
1.40 (–1.62 to 4.42)
5.30 (0.50 to 5.30)
1.30 (0.19 to 2.41)
4.87 (–0.14 to 9.88)
3.10 (–2.40 to 8.60)
1.30 (0.22 to 2.38)
1.74 (1.13 to 2.36)
–4.4
–0.12
–1.43
–0.7
–0.9
–2.1
–1.1
–3.37
0
–0.4
10
16
7
27
7
11
67
30
10
70
255
SD
9.15
5.06
5.3
3.1
2.83
2.5
3.27
10.71
7.04
3.5
Weight
0.9%
5.1%
1.3%
16.1%
4.1%
6.6%
30.6%
1.5%
1.2%
32.5%
100.0%
24 months of CS
Requena 200654
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 1.55 (p = 0.12)
–1.31 10.3 14
14
5.99 (–1.58 to 13.56)
5.99 (–1.58 to 13.56)
–7.3 15
15
10.5 100.0%
100.0%
Test for subgroup differences: χ2 = 1.20, df = 1 (p = 0.27); I2 = 16.7% –20 –10
Favours control Favours CS
0 10 20
FIGURE 4 Forest plot of comparison for CS vs. no CS: outcome – MMSE. CS, cognitive stimulation; df, degrees of
freedom; IV, inverse variance.
Study or subgroup
CS
Mean SD
Control Mean difference
IV, fixed, 95% CIMean Total
1–12 months of CS
Bottino 200549
Buschert 201150
Coen 201152
Onder 200553
Requena 200654
Spector 200155
Spector 20036
Subtotal (95% CI)
Heterogeneity: χ2 = 9.01, df = 6 (p = 0.17); I2 = 33%
Test for overall effect: z = 3.48 (p = 0.0005)
2.17
0.7
0.2
0.4
6.4
4.3
1.9
8.33
8
7.2
6.69
14.06
17.33
6.2
Total
6
8
13
70
20
17
97
231
Mean difference
IV, fixed, 95% CI
2.60 (–6.79 to 11.99)
0.70 (–6.86 to 8.26)
–2.10 (–6.65 to 2.45)
2.90 (0.68 to 5.12)
13.00 (3.43 to 22.57)
5.30 (–9.84 to 20.44)
2.20 (0.42 to 3.98)
2.27 (0.99 to 3.55)
–0.43
0
2.3
–2.5
–6.6
–1
–0.3
7
7
12
67
30
10
70
203
SD
8.92
6.93
4.1
6.55
20.48
20.5
5.5
Weight
1.9%
2.9%
7.9%
33.3%
1.8%
0.7%
51.5%
100.0%
24 months of CS
Requena 200654
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 1.81 (p = 0.07)
3.38 18.26 14
14
11.94 (–0.97 to 24.85)
11.94 (–0.97 to 24.85)
–8.56 15
15
17.13 100.0%
100.0%
Test for subgroup differences: χ2 = 2.13, df = 1 (p = 0.14); I2 = 53.1%
–20 –10
Favours control Favours CS
0 10 20
FIGURE 3 Forest plot of comparison for CS vs. no CS: outcome – ADAS-Cog. CS, cognitive stimulation; df, degrees
of freedom; IV, inverse variance.
MAINTENANCE COGNITIVE STIMULATION THERAPY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
14
there was no significant effect on either the MMSE (SMD 0.18) or the ADAS-Cog (SMD 0.12) at the
10-month follow-up. No other significant results were found in the other outcome measures at either the
short- or the long-term follow-up analysis.
Discussion
The results of this updated meta-analysis of 15 studies with a total of 718 participants (407 receiving
treatment and 311 controls) provide strong evidence of the benefits of cognitive stimulation for dementia
on cognitive function. Moreover, they provide positive evidence that benefits can be extended to quality of
Study or subgroup
CS
Mean SD
Control SMD
IV, fixed, 95% CI
SMD
IV, fixed, 95% CIMean TotalTotal SD Weight
Holden Communication Scale
Baines 198759
Spector 200155
Spector 20036
Subtotal (95% CI)
Heterogeneity: χ2 = 1.75, df = 2 (p = 0.42); I2 = 0%
Test for overall effect: z = 3.22 (p = 0.001)
2
–0.7
0.2
7.56
10.5
6.1
5
17
97
119
0.40 (–0.86 to 1.66)
–0.02 (–0.80 to 0.76)
0.55 (0.23 to 0.86)
0.47 (0.18 to 0.75)
–2.6
–0.5
–3.2
5
10
70
85
12.5
9.4
6.3
4.7%
12.1%
75.4%
92.1%
MOSES: withdrawn behaviour
Ferrario 199162
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.21 (p = 0.83)
1.31 6.31 13
13
0.10 (–0.86 to 1.07)
0.10 (–0.86 to 1.07)
0.5 6
6
9.44 7.9%
7.9%
Total (95% CI)
Heterogeneity: χ2 = 2.24, df = 3 (p = 0.52); I2 = 0%
Test for overall effect: z = 3.15 (p = 0.002)
Test for subgroup differences: χ2 = 0.49, df = 1 (p = 0.48); I2 = 0%
132 0.44 (0.17 to 0.71)91 100.0%
–10 –5
Favours control Favours CS
0 5 10
FIGURE 6 Forest plot of comparison for CS vs. no CS: post treatment, outcome – communication and social
interaction. CS, cognitive stimulation; df, degrees of freedom; IV, inverse variance; MOSES, Multidimensional
Observation Scale for Elderly Subjects.
Study or subgroup
CS
Mean SD
Control SMD
IV, fixed, 95% CI
SMD
IV, fixed, 95% CIMean TotalTotal SD Weight
CAPE-I/O
Baines 198759
Ferrario 199162
Subtotal (95% CI)
Heterogeneity: χ2 = 0.03, df = 1 (p = 0.87); I2 = 0%
Test for overall effect: z = 0.74 (p = 0.46)
1.4
1.23
4.59
3.64
5
13
18
0.21 (–1.03 to 1.46)
0.34 (–0.63 to 1.32)
0.29 (–0.48 to 1.06)
0.1
0
5
6
11
6.4
2.93
13.3%
21.7%
35.0%
RCP cognition
Wallis 198363
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.27 (p = 0.78)
5.9 35.5 10
10
0.13 (–0.78 to 1.03)
0.13 (–0.78 to 1.03)
1.7 9
9
27.04 25.3%
25.3%
Berg Orientation Scale
Baldelli 199360
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 1.97 (p = 0.05)
2.6 3.47 13
13
0.87 (0.00 to 1.74)
0.87 (0.00 to 1.74)
–0.8 10
10
4.1 27.2%
27.2%
Information/orientation
Woods 197964
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.92 (p = 0.36)
4 6.11 5
5
0.60 (–0.68 to 1.89)
0.60 (–0.68 to 1.74)
0.1 5
5
5.52 12.5%
12.5%
Total (95% CI)
Heterogeneity: χ2 = 1.65, df = 4 (p = 0.80); I2 = 0%
Test for overall effect: z = 1.93 (p = 0.05)
Test for subgroup differences: χ2 = 1.62, df = 3 (p = 0.65); I2 = 0%
46 0.45 (–0.01 to 0.90)35 100.0%
–4 –2
Favours control Favours CS
0 2 4
FIGURE 5 Forest plot of comparison for CS vs. no CS: outcome – other cognitive measure (information/orientation).
CAPE-I/O, Clifton Assessment Procedures for the Elderly – Information/Orientation scale; CS, cognitive stimulation;
df, degrees of freedom; IV, inverse variance; RCP, Royal College of Physicians.
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life and self-reported well-being outcome measures. This review did not show a clear relationship between
either the amount/frequency or the length of intervention and benefits to cognition, and the studies
that showed most benefit were both shorter (Spector et al.6 and Breuil et al.61 having 7 and 5 weeks,
respectively) and longer (Onder et al.,53 with 25 weeks). The MMSE was of a similar size to the SMD (1.30)
of the Spector et al.6 and Onder et al.53 studies. Because MMSE scores decline, on average, by 2 to
4 points per year on the MMSE for dementia,68 the benefits of cognitive stimulation might equate to a
6-month delay in the usual cognitive deterioration.
Recent reviews of psychosocial interventions for dementia are in line with the findings of this review and
give strong recommendation for the use of cognitive stimulation for dementia.8,69 Moreover, the 2011
World Alzheimer’s Report1 offered some evidence in relation to the benefits of AChEI medication and
cognitive stimulation. This review also offered some evidence in relation to AChEI medication. Five out of
the 15 included studies report data whereby all of the participants were prescribed AChEI medication in
combination with cognitive stimulation. The additional effect of cognitive stimulation, over and above the
medication (in four studies providing post-treatment data), was 3.18 points on the ADAS-Cog, compared
Study or subgroup
CS
Mean SD
Control SMD
IV, fixed, 95% CI
SMD
IV, fixed, 95% CIMean Total
Geriatric Depression Scale (GDS-30) 1–12 months of CS
Baldelli 199360
Baldelli 200248
Requena 200654
Subtotal (95% CI)
Heterogeneity: χ2 = 2.48, df = 2 (p = 0.29); I2 = 19%
Test for overall effect: z = 1.88 (p = 0.06)
2.1
3.21
5.6
4.61
7.98
7.87
Total
13
71
20
104
0.89 (0.02 to 1.76)
0.08 (–0.47 to 0.62)
0.41 (–0.16 to 0.98)
0.34 (–0.01 to 0.70)
–2.3
2.57
2.03
10
16
30
56
SD
4.99
10
9.07
Weight
12.7%
32.7%
29.4%
74.8%
Geriatric Depression Scale (14 item) 1–12 months of CS
Coen 201152
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.97 (p = 0.33)
–0.9 3 13
13
–0.39 (–1.16 to 0.39)
–0.39 (–1.16 to 0.39)
0.1 13
13
1.9 15.9%
15.9%
Montgomery–Åsberg Depression Rating Scale (MADRS) 1–12 months of CS
Buschert 201150
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.59 (p = 0.56)
1.5 5.33 8
8
0.31 (–0.72 to 1.33)
0.31 (–0.72 to 1.33)
–0.4 7
7
6.4 9.2%
9.2%
Total (95% CI)
Heterogeneity: χ2 = 5.30, df = 4 (p = 0.26); I2 = 25%
Test for overall effect: z = 1.42 (p = 0.16)
Test for subgroup differences: χ2 = 2.82, df = 2 (p = 0.24); I2 = 29.1%
125 0.22 (–0.09 to 0.53)76 100.0%
–2 –1
Favours control Favours CS
0 1 2
FIGURE 7 Forest plot of comparison for CS vs. no CS: outcome – GDS. CS, cognitive stimulation; df, degrees of
freedom; IV, inverse variance.
Study or subgroup
CS
Mean SD
Control SMD
IV, fixed, 95% CI
SMD
IV, fixed, 95% CIMean Total
Life Satisfaction Index
Baines 198759
Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.37 (p = 0.71)
–1.2 6.09
Total
5
5
–0.23 (–1.48 to 1.01)
–0.23 (–1.48 to 1.01)
0.2 5
5
SD
4.64
Weight
4.7%
4.7%
QOL-AD
Buschert 201150
Coen 201152
Spector 20036
Subtotal (95% CI)
Heterogeneity: χ2 = 1.17, df = 2 (p = 0.56); I2 = 0%
Test for overall effect: z = 2.91 (p = 0.004)
–0.4
3.6
1.3
10.61
3.7
5.1
8
14
97
119
0.05 (–0.96 to 1.07)
0.74 (–0.04 to 1.53)
0.39 (0.08 to 0.70)
0.41 (0.13 to 0.69)
–0.9
0.5
–0.8
7
13
70
90
5.52
4.4
5.6
7.1%
11.9%
76.2%
95.3%
Total (95% CI)
Heterogeneity: χ2 = 2.15, df = 3 (p = 0.54); I2 = 0%
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FIGURE 8 Forest plot of comparison for CS vs. no CS: outcome – quality of life. CS, cognitive stimulation;
df, degrees of freedom; IV, inverse variance; QOL-AD, Quality of Life – Alzheimer’s Disease.
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with the overall finding (from seven RCTs) of 2.27 points. This supports the proposition that cognitive
stimulation is effective irrespective of whether or not AChEIs are prescribed, and any effects are in addition
to those associated with the medication.
Conclusions
Our review consolidates the growing evidence that cognitive stimulation improves cognitive function in
people with dementia. It also indicates that cognitive stimulation benefits not only cognition but also
self-reported well-being and quality of life, as has been reported by qualitative studies and people with
dementia for a long time.70 These benefits are over and above any antidementia medication effects.
Work package 2: development of the maintenance cognitive
stimulation therapy programme
This section reports the development of the MCST programme manual. We followed the MRC guidelines for
the development and evaluation of complex interventions30 using a systematic review of the literature44 and
the original CST trial programme6 to produce a full draft of a manual for a MCST programme. As in the main
CST programme, maintenance sessions focus on ‘themes’, with a primary emphasis on cognitive stimulation,
while incorporating the process of reminiscence therapy and multisensory stimulation. Group names and
songs, a ‘reality orientation board’ and introductory exercises provided continuity between sessions.
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FIGURE 9 Forest plot of comparison for CS vs. no CS: post treatment, outcome – mood, staff-reported. CS, cognitive
stimulation; df, degrees of freedom; IV, inverse variance; RAID, Rating of Anxiety in Dementia.
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FIGURE 10 Forest plot of comparison for CS vs. no CS: outcome – ADLs. CS, cognitive stimulation; df, degrees of
freedom; IV, inverse variance.
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Objectives
l To identify, from the Cochrane review studies, the interventions that have shown to be effective and
have had an impact at improving cognition and quality of life of people with dementia, including any
negative effects.
l To indicate the nature and quality of the interventions and identify key themes and elements.
l To develop, from the analysed interventions and current CST training manual, 24 weekly sessions of MCST.
l To develop a MCST training package for care staff based on the existing CST manual. This comprised a
manual workbook, a DVD and training seminars.
Development of maintenance cognitive stimulation therapy sessions and workbook
We selected all relevant and effective interventions from the CST Cochrane review. We contacted study
authors with the aim of obtaining additional information, hard copies of the intervention programme
manuals and the manuals translated into English. The research team developed a database identifying
key themes from the initial CST manual71 guiding principles and sessions, and included the 16 sessions
developed for the MCST pilot project. A draft manual (version I) was produced based on the results.
The results from the analysis of the cognitive stimulation manuals, including the original papers, manuals
and table database, were presented in a consensus workshop (comprising key academics, research staff
and clinical staff involved in CST practice) and used to validate and review a subsequent draft of the MCST
manual (version II), which included 24 maintenance sessions and was produced using the results of the
consensus workshop. The MCST manual (version II) was discussed in focus groups with care staff (three
groups), carers (three groups) and people with dementia (three groups) to review key themes, feasibility
and potential modifications. The revised MCST manual was further modified in consultation with the
attendees of the consensus workshop and key contributors to other aspects of process (e.g. a sample of
care staff, carers, clinical staff and leading experts on CST).
The next draft of the MCST manual (version III) was produced to publication quality and was used in the
development of a revised version of the CST training package compromising the revised manual, a CST/
DVD including extra maintenance sessions, a PowerPoint® 2003 (Microsoft Corporation, Redmond, WA,
USA) presentation, methods of evaluation and adherence. We developed the training package in
consultation with trainers from Dementia UK.
Focus groups: a comparison of the views of people with dementia, staff and family
carers
We included qualitative testing of the intervention through focus groups, developing a consultation
process with people with dementia, family carers and staff. The aim was to identify improvements for
the draft version of the MCST manual. Focus groups were the natural choice, as the aim was to gain
comprehensive views of the key stakeholders with regard to the MCST programme. A key strength of
focus groups is their ability to ‘tune in’ to the attitudes and perceptions of users regarding services.
Method
Sample
Focus groups were undertaken separately with three user groups that consisted of key stakeholders in
the project. Three focus groups were carried out with people with dementia, three groups were carried
out with staff and three groups were carried out with family carers of people with dementia. In total,
17 people with dementia, 13 staff and 18 family carers took part in separate focus groups. In the people
with dementia groups, there were eight men (47%) and nine women (53%). Their mean age was 78 years,
they all scored mild to moderate on the CDR scale46 and were able and willing to consent to participate in
the focus groups. The staff groups consisted of three men (23%) and 10 women (77%), with a mean age
of 36 years. All were permanent, paid staff, with at least 1 month’s employment, from residential homes,
day centres or day hospitals. Their main duties involved caring for people with dementia. The family carers
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consisted of six men (33%) and 12 women (67%), with a mean age of 53 years. All were former or current
carers of a person with dementia and had at least monthly contact during their time as a family carer.
Purposive sampling, for example sex, length of caring experience and dementia type, was used to ensure
a wide range of participants. The centres selected were typical in size, organisational structure and
management of others in the area. When people were recruited via local carers’ organisations (Uniting
Carers for Dementia and Alzheimer’s Society), permission was also obtained from the management
committees of these groups.
Procedure
We used the Noticeable Problems Checklist72 to screen potential participants who were then approached
for their consent and further screening using the CDR scale. Participants with a CDR score of mild to
moderate were included, provided that they did not meet the exclusion criteria (diagnosis of severe
learning disability and/or diagnosis of depression, anxiety or other mental or physical illness adversely
affecting their ability to participate in focus groups) and were willing to take part in the discussion groups.
Seventeen participants met the inclusion criteria and agreed to take part. Members of staff who were
working directly with people with dementia in the different centres approached were invited to take part
in the groups. Eighteen family caregivers were recruited through Uniting Carers, Dementia UK and the
Alzheimer’s Society. Participants were reminded that they could leave the group at any time.
Two researchers conducted self-contained, hourly focus groups. The sessions included a brief presentation
about the overall project. One facilitator led the interview, with the second person actively listening and
seeking clarification, to ensure the adequacy and accuracy of content as appropriate.73 The second
facilitator also took substantive and methodological field notes during and immediately after the focus
groups, as recommended by Burgess.74 A semistructured interview schedule based on the CST empirical
literature was used as cues for open questions. The groups focused on the 24 themes developed for the
MCST programme and the cognitive stimulation definition by Clare et al.11
Design
Focus groups were chosen in preference to individual interviews, as they are useful for stimulating
discussion, generating ideas to explore topics in depth, gaining insight and obtaining rich data.75 A focus
group interview schedule was constructed and developed to provide a framework for the discussions,
which was piloted and adapted. The participants were encouraged to express their opinions and discuss
issues through a series of open questions, which covered various aspects of mental stimulation activities,
beginning with a presentation of the programme on a DVD and followed by open questions designed to
elicit the activities and themes that participants particularly enjoyed and factors that contributed to the
programme activities being stimulating and meaningful. Questions included ‘what do you think about use
it or lose it/mental stimulation?’ and ‘could you tell us a bit about what sort of things you do that you
find as being mental stimulating for you and you enjoy doing them?’. Pictures and materials used in the
different themes and activities were used to help stimulate discussion in the participant groups. All groups
used the same schedule, and participants were asked their opinions of what activities/themes they thought
would be successful among people with dementia.
Analyses
The focus group interviews were tape-recorded and transcribed. The facilitators then reviewed the
transcripts. The notes taken by the second facilitator were consulted to clarify the context of the discussion
(e.g. benefits of being part of a group that was expressed by people with dementia focus groups). We used
an inductive (data driven) thematic analysis approach76 to code and analyse the data. Inductive analysis
allows themes to emerge from the data and is useful when the intent is exploratory and descriptive, as in
our case. Consistent with various qualitative research methods, the focus group inquiry allows participants
the freedom to provide information that does not necessarily fit with any expectation/hypotheses going into
the research. This openness to new and unexpected information allows measurement designers to more
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fully ‘ground’ the content of new patient-reported outcomes in the concerns and issues that participants
think are relevant.77
To develop a thematic codebook, researchers immersed themselves in the transcripts and rereading to gain
deeper understanding of and familiarity with the content. One transcript was revisited and analysed into
exclusive in vivo categories; that is, one theme was applied to one unit of meaning and the words used by
the participant were adopted as the label of the theme. These themes were then applied to the remaining
transcripts using a method of constant comparison to refine themes within the coding manual. During this
process themes became more conceptual, with some original themes split into subthemes and others
linked under one category depending on the emphasis placed on each theme within the transcripts. The
resulting coding manual provided a meaningful way of understanding the views of the participants and
assessing similarities and differences across the different groups (people with dementia, staff and family
caregivers). Using the final codebook, all transcripts were coded independently by both researchers and
then compared to reach 100% consensus.
Results
Thematic analysis revealed themes relating to perceptions and opinions of ‘mental stimulation/use it or
lose it’, ‘examples of mental stimulating activities of daily life‘, ‘factors influencing successfulness and
unsuccessfulness of a mental stimulation activity’ and ‘opinions and perceptions of specific themes of the
presented maintenance CST programme’. Patterns of themes were found among the different groups
(people with dementia, family caregivers and members of staff).
In the quotations below, PWD refers to the group ‘people with dementia’, FC refers to the group ‘family
caregivers’, SC refers to the group ‘staff caregivers’, FG1 and FG2 refer to the focus group numbers and
the digits refer to the line numbers in the transcript.
Mental stimulation: ‘use it or lose it’
This included discussing their opinions regarding mentally stimulating activities, ‘use it or lose it’, in terms
of their views and beliefs about the effects of keeping the brain active. All participants showed general
agreement about the usefulness of keeping the brain active.
People with dementia expressed the view that keeping the brain active was very important and a way
of relieving frustration. They thought that it was essential for a healthy life and preserving their mental
abilities, and that engaging in activities would keep the brain going. Some family carers expressed the view
that the need for mental stimulation was universal and could bring neurological (building connections in
the brain) and mental (helping with mood, anxiety, depression) benefits to everyone, and was important
for promoting a healthy lifestyle and well-being. Staff and family carers also thought that there were
added benefits to people with dementia in terms of increasing confidence, giving a sense of achievement,
satisfaction, retaining skills and enjoyment.
No participants with dementia expressed negative views about the value of ‘use it or lose it’; however,
there were concerns about the importance of keeping the brain active from members of staff and family
carers groups who gave examples of individuals for whom the idea of ‘use it or lose it’ did not apply.
Famous writers and politicians were given as examples of people who maintained a mentally stimulating,
active lifestyle but nevertheless developed dementia. Some family caregivers expressed concerns that
mental stimulation programmes may result in people with dementia losing confidence, experiencing
anxiety or a sense of inferiority if confronted with their own cognitive deficits and difficulties as a result of
undertaking a challenging mental activity.
Perceived stimulation in everyday life
Listening to music, singing and dancing, reading, painting, drawing, cooking and knitting were highlighted as
being important for people with dementia. Factors that made an activity important included being interesting,
being enjoyable, having a relaxing effect and helping to pass the time. Reading was a popular activity for
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most people with dementia as it raised their confidence and helped to increase interaction and participation
when part of a group. In particular, talking and listening to others appeared enjoyable and were highly valued
among people with dementia. They thought that talking to another person, to a pet or to the TV maintained
their links with important current and past relationships and helped to reduce feelings of isolation.
Being part of a group helps considerably. I think being left on your own is not as effective as being
part of a group. I belong to an African Caribbean group and I find that very stimulating. We talk on a
number of things what we have done and why we did it. I think talking is very important.
PWD: FG1; 175–179
Family caregivers perceived that activities involving music (e.g. listening to music, singing, tapping and
clapping) were those that people with dementia enjoyed the most.
Sounds and music are very important to stimulate something that’s there already so they recognise . . .
FC: FG2; 183–184
Those in the family caregivers group also spoke of having the opportunity to enjoy dinner together and to
reminisce together by looking at photographs or sharing memories.
They learned a lot about others, everyone was telling their old past stories of how they went to school in
shared shoes and things like this as a family. And we got so much information and it really stimulated them.
FC: FG2; 232–238
Staff caregivers thought that their planned activities were the most valuable stimulating activities for
people with dementia. Staff participants identified reminiscence as an activity people with dementia
enjoyed and often engaged in. However, there appeared to be little understanding of its value, and
concern that it did not relate to the present.
I think we have to be careful with reminiscence, for me one of the best bits of this therapy is the
variety of activities that you are going to do, otherwise it can get very repetitive as you tend to do
things that you know work well, like reminiscence. You have to set goals within every session . . .
SC: FG1; 60–66
Factors influencing success of a cognitive stimulation programme
The perceptions of what made a CST programme successful were based on the person’s values and
beliefs, with their interests and routines reinforcing a sense of identity and sense of belonging. Staff and
family caregivers appreciated that the philosophy of the programme should be person centred and that
enjoyment was a measure of what made programme activities successful.
People with dementia stated that basic human courtesies were important: being kind, trying to make
others happy and not underestimating participants’ abilities.
Nothing that involves cruelty. As long as there’s kindness you can’t fault it.
PWD: FG1; 366
Being able to discuss, learn and make contributions was also mentioned.
I think it is very important to learn new things, you don’t stop learning ‘till you die.
PWD; FG1; 669–672
Other factors highly valued in the groups were activities that included reminiscence as an aid to orientation
and activities that were provided in a multisensory way. Activities involving discussion and sharing opinions
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among the group were highly valued, as were challenging activities and quizzes requiring right or
wrong answers.
Some people will remember more things than others you know. But it’s good for the brain . . .
PWD: FG1; 576–579
In contrast, family caregivers and staff participant groups stated that activities in the programme should
not be based on right or wrong answers, so that people with dementia did not feel under pressure.
‘Playing it safe’ was perceived as being very important and this helped people feel more secure.
You have to adapt to the person and never ask them to do anything they can’t do because they have
a sense of self and it will give them a sense of inferiority or inadequacy.
FC: FG2; 90–94
Most staff acknowledged that it was important to identify participants’ individual preferences, skills and
abilities, as this affected their level of engagement in activities, whereas some recognised the need to
adapt activities to a participant’s capabilities as a way of providing choice and contributing to their
well-being. Some family carers stressed the importance of providing this programme to people only in the
mild-to-moderate stages of dementia, as they thought that it would not be appropriate for people in more
advanced stages.
The group participants should be of [a] similar level of dementia.
SC; FG2; 176
They also thought that group participants should be chosen based on having similar abilities and interests
so that the group could run successfully and be stimulating and enjoyable. Both staff and family carer
groups noted that attention needed to be paid to each participant’s level of hearing and vision, as they
thought that high levels of impairment in either would limit a person’s participation.
You have to think about the personality dynamics within each group.
SC: FG2; 109
Staff and family caregivers also indicated that the group facilitator’s skills, knowledge, understanding of
dementia and attitudes towards participants was also key to running the group effectively. The need
for several facilitators was mentioned, as was limiting the number of group participants. Appropriate
equipment was identified as another key factor to the success of this programme.
I think the size of the group has to be pretty small as an important factor.
FC: FG2; 388–391
Presented themes
A total of 19 themes was presented to the focus groups of people with dementia, family caregivers and
staff. Fourteen themes were from the existing CST programme. Five new themes were developed from the
literature review and the pilot MCST study (Table 2).
The five new themes
People with dementia rated useful tips, thinking cards and using objects as very positive themes. They stated
that these themes were good for learning, hearing other people’s opinions and giving their own opinions in
the group. They thought that the themes could help the group cohesiveness and would trigger conversation.
Family caregivers and staff groups also thought that useful tips and using objects were good themes for the
session and highly valued the involvement of reminiscence in the activities as an aid to orientation. Some
staff expressed concern that the thinking cards theme would not work but others challenged that it would.
Some family caregivers thought that the proposed activities for this theme would not be appropriate,
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TABLE 2 Maintenance themes
Maintenance
session Version 2 Version 3
People with
dementia Staff Family carers
New session themes
Useful tips 11 24 11 24 Excellent: discussion
(learn and teach) and
reminiscence
Excellent: discussion
(learn and teach) and
reminiscence
Good: some concerns
about healthy tips
Visual clips 13 13 Not interested Good theme Very good, discussion,
reminiscence and
multisensorial
Thinking cards 12 22 12 Very good Mixed opinions, down on
list
Mixed opinions
Art discussion 14 14 Mixed emotions Mixed emotions: will
generate discussion
Very good, discussion
Using objects 10 10 22 Very good Excellent theme:
discussion and
reminiscence
Excellent theme:
discussion and
reminiscence
CST session themes
Physical games 8 8 Very good Very good Very good
Sounds 7 7 Very good Very good, music and
multisensorial
Very good, music and
multisensorial
Childhood 1 23 1 23 Good, enjoyable Very good: multisensorial
and reminiscence
Very good: multisensorial
and reminiscence
Food 3 17 3 17 Very good Very good: multisensorial Very good: multisensorial
Current affairs 2 21 2 Very interesting Mixed emotions: needs to
include reminiscence
Mixed emotions, not for
everyone. Needs to
include reminiscence
Faces/scenes 15 15 Very successful
(discussion and
reminisce)
Very good theme:
discussion
Very good theme:
discussion, recognition
Associated
words
18 18 Very good Very good at the right
level
Very good
Being creative 4 4 Fun Good theme, some
dangers (not for everyone)
Very good: multisensorial
Categorising
objects
9 9 Mixed emotions Very successful (discussion
and reminisce)
Very successful
(discussion and
reminisce) group
cohesiveness
Orientation 19 19 Very good Very good: discussion and
reminiscence
Very good: discussion
and reminiscence
Using money 20 20 Very good Mixed emotions, sensitive
topic
No good topic
Number games 5 5 Not popular Mixed opinions, some
dangers (not for everyone)
Mixed emotions
Word games 16 16 21 Excellent activities Very popular, good Good activity, pay
attention to presentation
Quiz 6 6 Excellent theme Very popular, good Good
Note
The two sets of numbers refer to the session numbers that included this theme and the changes that were made between
different drafts of the manual. For example, Word games was included as session 16 in version 2 of the manual, and as
session 16 and 21 in version 3 in the final draft of the manual.
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as some people did not like ‘closing your eyes and imagining’ and might feel uncomfortable with this. Other
carers liked this theme and thought that the questions were a good way of stimulating conversation and
possibly helping group cohesion.
People with dementia rated visual clips discussion and art discussion as neutral. Although they liked the
idea of group discussion, they did not feel enthusiastic about the topics presented. Staff and family
caregivers groups rated these themes positively, as visual prompts were highly valued and they liked the
idea of promoting discussion. Some staff had successfully run these types of activities previously with
people with dementia and advised that materials be chosen appropriately.
Existing cognitive stimulation therapy themes
Participants were asked to rate and organise the presented themes as very positive, neutral or negative,
and to rank them in order of those themes perceived as most and least successful. My life (childhood
and occupations), food and orientation were perceived as positive themes; they were applicable to
everyone, helped people to keep in touch with themselves and were multisensorial. Quizzes and word
games were rated highly among people with dementia, who thought that they were very stimulating
and helped the brain to keep working and ‘ticking together’. Family caregivers and staff also rated
these two themes very highly. Physical games, sounds, faces and scenes, categorising objects, associated
words and being creative were also rated positively by all groups, as these were good for stimulating
recognition, reminiscence and discussion, offered multisensorial stimulation and promoted keeping
healthy and active.
Number games was the only theme rated very low by people with dementia, who said that, as numbers
were not something they related to very well and were a bit meaningless to them, this was not their
preferred choice of activity. Family caregivers and staff shared similar views, as their previous experience
indicated that number games required more one-to-one work with people with dementia, and were
frustrating and pointless unless the numbers were related to pricing.
Using money and current affairs were rated very low by the family caregivers and staff groups but rated
highly by people with dementia. Some family caregiver and staff participants stated that people with
dementia did not often relate to current affairs (owing to the disease) and it would be meaningless to
present topics about news unless reminiscence was used as a context for the information. However,
people with dementia expressed a great interest in current affairs and stated that they loved reading
newspapers. People with dementia also stated that they would enjoy talking about the value of money,
and there were spontaneous comments about the value of money and the cost of bus journeys in the past
and the present. In contrast, family caregivers and staff thought that money was too complicated and not
a good theme, as it could be a very sensitive topic for some people with dementia.
Discussion
We used a novel approach to refine an existing psychological intervention programme that investigated
the opinions, types of activities and qualities which make a cognitive stimulation programme more
successful for people with dementia. An advantage of using focus groups with people with dementia
is that sharing experiences may trigger recall. A possible disadvantage is that they rely on verbal
communication and short-term memory, both of which are often impaired in people with the condition.78
Opinions about mental stimulation programme and key factors for success
People with dementia thought that keeping the brain active was essential and they acknowledged that
this helped with their memory losses and difficulties. This finding supports Barnett’s79 statement that
bereavement with memory losses is a major theme for people with dementia, who value the opportunity
to be listened to. They also value being in a group. As indicated in other studies, socialising is an important
activity for older people in care.80–82 People with dementia valued quality social interactions, especially
when being part of a group, and feeling a sense of belonging, reflecting Kitwood’s83 theory, which claims
that positive interactions reinforce the personhood of those with dementia.
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Conversely, staff and family carers expressed mixed opinions about the effectiveness of keeping the brain
active; they cited examples of public figures who had developed dementia and said that the focus should be
on the factors that would make a programme successful or unsuccessful for people with dementia. The main
factors to consider when planning a CST group were grouped into participant characteristics (level of
dementia, sensory impairments, personality, interests, life history), facilitator characteristics (knowledge about
dementia, group skill and personality), group size and materials (multisensorial prompts, age appropriate).
Limitations
Staff focus groups included managers or senior carers, the presence of whom may have affected the
opinions expressed by other staff members. Participants sometimes appeared reluctant to give personal
examples, perhaps inhibited by the stigma of sharing information in a group, and this may be a
disadvantage of using focus groups. We selected a thematic analysis, as it is a method for identifying,
analysing and reporting patterns (themes) within data. Although thematic analysis is used widely, there is
a lack of consensus regarding its precise methodology.84
Conclusion
Findings from the user focus groups regarding MCST programmes support the 2006 NICE guidelines on
dementia85 that state that all people with mild to moderate dementia should be ‘given the opportunity to
participate in a structured group cognitive stimulation programme’. Positive agreement was found among
14 themes and suggestions were made for the five remaining themes. These results were used to revise
the manual for the MCST programme.
Work package 3: maintenance cognitive stimulation therapy for
dementia – a single-blind, multicentre, randomised controlled trial
of maintenance cognitive stimulation therapy versus cognitive
stimulation therapy for dementia
Introduction
This section describes the study protocol for a pragmatic RCT of CST versus CST followed by a 24-week
MCST programme undertaken with people experiencing mild to moderate dementia. This research
programme aims to provide essential evidence to clarify the role of long-term CST interventions alone and
in combination with cholinesterase inhibitors, and to assess the cost-effectiveness of this long-term vision.
Methods
Design
The design was a single-blind, multicentre RCT of CST groups for dementia versus MCST groups (Figure 11).
After the completion of the initial CST programme (twice-weekly 45-minute sessions for 7 weeks),
participants were randomly allocated to the treatment group (maintenance sessions weekly for 24 weeks)
or the control group (usual care). Data were collected at baseline (baseline 0), after completion of the
7-week CST programme (baseline 1), and at 3- (follow-up 1) and 6-month follow-ups (follow-up 2). It was
calculated that a sample size of 230 participants was needed at baseline 1 to detect an effect size of 0.39
on the ADAS-Cog,86 with power of 80% using a 5% significance level. Ethics approval was obtained
through the Multicentre Research Ethics Committee (reference number 08/H0702/68). The clinical trial was
registered as ISRCTN26286067.
Participants
The participants were people meeting the Diagnostic and Statistical Manual of Mental Disorders-Fourth
Edition (DSM-IV)87 criteria for dementia graded as mild to moderate on the CDR scale,46 with the ability to
communicate, hear and see well enough to participate in the group, with no major physical illness or
disability, and without a learning disability. Half of the sample was recruited from care homes and half was
recruited from community settings, including CMHTs, day centres and voluntary organisations in London,
Essex and Bedfordshire. Of the 21 centres initially contacted, one refused to participate and two were
excluded owing to a lack of participants.
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Randomisation
The randomisation process in this trial was undertaken in two stages: randomisation 1 and randomisation 2.
Figure 11 sets out the two-stage randomisation process. The allocation ratio at randomisation 1 stage was
1 : 1; into either group A or group B, with both groups receiving 7 weeks of CST.
The allocation ratio at randomisation 2 stage was 1 : 1; into either the control group or the treatment group.
The sample was stratified to ensure that equal numbers of participants taking cholinesterase inhibitors
were randomised into either the MCST or the control group. The North Wales Organisation for
Randomised Trials in Health (NWORTH) was responsible for undertaking the remote randomisation.
NWORTH is accredited as a Clinical Trials Unit by the UK Clinical Research Collaboration and funded as
part of the Clinical Research Collaboration Cymru, notably for Health Technology Assessment trials.
Blinding
The participants could not be blinded to group allocation owing to the nature of the intervention.
The researchers involved in collecting participant consent and in the interviews were not involved in the
randomisation process and were blinded to treatment group allocation at follow-up. Our experience in
the previous CST trial, as shared by those conducting similar projects, is that participants may occasionally
and inadvertently inform researchers of the treatment they are receiving. We aimed to reduce this effect
by giving explicit reminders to participants before the assessment visit and by the use of self-report
measures whenever feasible. On completion of the two follow-up assessments, the assessors recorded
their impression of which arm of the trial each participant belonged to and their confidence in that
People with dementia meeting inclusion criteria for CST groups 
Screened and randomised (first stage) into CST groups
Subtype of dementia identified
Commence CST groups
IF (1) continue with AChEIs
Randomisation (second stage) to either 
MCST plus AChEIs OR control plus AChEIs
Randomisation (second stage) 
to either MCST OR control group
IF (2) contact local clinical 
team suggest suitability for AChEIs
Clinical team 
starts AChEIs
Clinical team does 
not start AChEIs
Alzheimer’s disease plus 
1. Currently on AChEIs OR
2. Willing and suitable for cholinesterase
    inhibitors
1. Non-Alzheimer’s dementia OR
2. Alzheimer’s but unwilling
    or unsuitable to take AChEIs
CST groups finish
FIGURE 11 Flow diagram of the trial: trial and randomisation stages.
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prediction. This enabled us to test whether or not the inadvertent loss of blinding leads to bias, and to
adjust for any bias that was detected.
Intervention
Cognitive stimulation therapy is an intervention for people with mild to moderate dementia, designed
following extensive evaluation of the available research, and is an evidence-based treatment.55 The
programme consists of 14 45-minute sessions that are run twice-weekly. Each session incorporates the use
of a ‘reality orientation board’, displaying both personal and orientation information, including the group
name (as chosen by participants). The guiding principles of CST involve using new ideas, thoughts and
associations; using orientation (but sensitively and implicitly); a focus on opinions rather than facts; using
reminiscence as an aid to the here-and-now; providing triggers to aid recall; the creation of continuity and
consistency between sessions; focus on implicit (rather than explicit) learning; stimulating language;
stimulating executive functioning; and being person centred (treating people as unique individuals with
their own personalities and preferences). The CST programme aims to create an environment in which
people have fun, learn, strengthen their abilities and improve their relationships to other group members,
thus maintaining their social and cognitive skills at their optimum ability.
The MCST programme is an evidence-based maintenance group therapy programme for people with
dementia. It comprises 24 sessions of MCST, based on the theoretical concepts of reality orientation/
cognitive stimulation and grounded in the original CST programme. The aim is to create an evidence-based
maintenance group therapy programme for people with dementia, based on the same principles as those
of the CST programme. A summary of the CST and MCST programme can be found in Table 3.
TABLE 3 The CST and MCST themes development
CST session Main activity MCST session
1 Physical games 8
2 Sound 7
3 My life 1 and 23
4 Food 3 and 17
5 Current affairs 2
6 Faces/scenes 15
7 Associated words, discussion 18
8 Being creative 4
9 Categorising objects 9
10 Orientation 19
11 Using money (clip adverts II) 20
12 Number game 5
13 Word game 16 and 21
14 Team games, quiz 6
NEW Useful tips 11 and 24
NEW ‘Golden Expression’ cards 12
NEW Art discussion 14
NEW Visual clips discussion 13
NEW Using objects 10 and 22
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Recruitment and training of facilitators
Each CST and MCST group had two facilitators, one from the research team and a cofacilitator who was
a member of staff from the recruited centre (e.g. a care home). The facilitators had at least 1 year of
experience in dementia care. The main facilitators often had a background in mental health nursing,
occupational therapy or clinical psychology, as well as experience in dementia care and group facilitation
skills. The use of two facilitators for each group enabled effective debriefing and reflection to occur at the
end of each session. All facilitators attended 1-day CST training developed by one of the CST pioneers (AS)
as part of the dissemination strategy. The training provided detailed background and description of CST,
and used learning methods including group observation, role-playing and small group exercises.
Usual care
The participants allocated to the control group received treatment as usual (TAU). This can vary between
and within centres, and may change over time but, in principle, the interventions offered to this group were
also available to those in the active treatment groups. Therefore, the trial examined the additional effects
of MCST. Our approach to costing the services and interventions received allowed us to monitor whether
or not the TAU group had been receiving similar therapeutic interventions. The use of antidementia
medication was recorded as part of the costing information collected. It was possible that participants in the
TAU group were involved in some form of cognitive stimulation work during the 24 weeks of the study
period. However, it is very unlikely that such a structured approach to CST was offered in any of the centres.
It is this systematic group-based approach that was the focus of this evaluation.
Ethics arrangements
Risks and anticipated benefits for trial participants
There appears to be no documented harmful side effects of participating in CST groups, and no serious
adverse reactions were apparent in the CST study. The participants in the groups consistently reported
benefits, including enjoyment and feelings of validation and self-worth.88 Participants’ inclination to
continue meeting following the sessions gave an indication of how valuable they found these benefits.
All adverse events were recorded and reports as per the SHIELD adverse events policy.41
Consent
All recruited participants were in the mild-to-moderate stages of dementia, and were able to give informed
consent for participation. Whenever possible, a family member or other supporter was included. It was
made clear to participants and family caregivers that no disadvantage would occur if they chose not to
participate. In seeking consent, we followed current guidance from the British Psychological Society40 on
evaluation of capacity. If a participant’s level of impairment increased, so that they were no longer able to
provide informed consent, the provisions of the Mental Capacity Act 200538,39 were followed.
Outcome measures
Primary and secondary measures were completed at baseline (time 0), after the 7 weeks of the CST
programme (first follow-up, time 1), 3 months after beginning of the maintenance groups (second
follow-up, time 2) and 6 months after the beginning of the maintenance groups (third follow-up and
primary end point, time 3).
Primary outcome measures
(a) Cognition was measured using the ADAS-Cog.86 The ADAS-Cog consists of 11 tasks measuring the
disturbances of memory, language, praxis, attention and other cognitive abilities, which are often
referred to as the core symptoms of Alzheimer’s disease.
(b) Quality of life was measured using the Quality of Life – Alzheimer’s disease (QOL-AD) scale.89 The
QOL-AD covers 13 domains of quality of life. It has good internal consistency, validity and reliability,
and its use is recommended by the European consensus on outcome measures for psychosocial
interventions in dementia.90
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Secondary outcomes
(a) Cognition was measured using the MMSE,45 a brief, widely used test of cognitive function that has
good reliability and validity.
(b) Communication was assessed using the Holden Communication Scale.91 This scale is completed by
staff or family caregivers and covers a range of social behaviour and communication variables.
(c) Depression was assessed using the Cornell Scale for Depression in Dementia.92 This scale rates
depression in five broad categories using information from interviews with staff and participants.
Good reliability and validity have been demonstrated.
(d) Anxiety is assessed using the Rating Anxiety in Dementia scale.93 This rates anxiety in four main
categories and uses information from interviews with staff and participants. It has good validity
and reliability.
(e) Behaviour was assessed using the Neuropsychiatric Inventory (NPI).94 The NPI assesses 10 behavioural
disturbances occurring in dementia patients. It has good validity and reliability.
(f) Activities of daily living were assessed using the Alzheimer’s Disease Co-operative Study – Activities of
Daily Living Inventory (ADCS-ADL).95 The ADCS-ADL is a structured questionnaire originally created to
assess functional capacity over the range of dementia severity. The sensitivity and reliability of the
scale have been established.95
(g) Family caregiver health was assessed using the Short Form-12 Health Survey (SF-12).96 This scale
measures generic health concepts relevant across age, disease and treatment groups. The SF-1296
comprises eight concepts commonly represented in health surveys. It is a self-administered measure
that provides a comprehensive, psychometrically sound and efficient way to measure health from the
patient’s point of view by scoring standardised responses to standard questions. This measure was
used only when a family caregiver was available from the community sample participants.
(h) Costs were assessed using the validated Client Services Receipt Inventory (CSRI),97 adapted for this study.
Used extensively in studies of mental health and dementia,13 the CSRI gathers comprehensive data on
accommodation, medication and services received. In this trial the data covered the previous 3 months
(at baseline and after treatment) or the 3 and 6 months’ follow-up points. Unit costs were then attached
to services and support received, based on nationally relevant estimates of long-run marginal opportunity
costs. Two quality-of-life measures were also included for cost–utility analyses. The EuroQol-5 Dimensions
(EQ-5D)98 is a standardised instrument for use as a measure of health-related quality of life. It contains a
three-level coding system for five dimensions. The instrument includes a global rating of current health
using a visual analogue scale (VAS). The Dementia Quality of Life (DEMQOL)99 uses self-rated reports of
quality of life administered by a trained interviewer; there is also a separate scale for family caregiver
or members of staff reports, called the DEMQOL-Proxy. It covers five domains of quality of life. The
DEMQOL has high internal consistency and acceptable inter-rater reliability, and indicates concurrent
validity through moderate associations with the QOL-AD and DEMQOL.99
Analyses
The assessments were scored and data were entered into MACRO™ (version 3.0.84, Infermed, Elsevier,
London, UK), Infermed’s electronic data capture system that produces a fully auditable trail for data from
input to extraction for analysis. For cleaning and analysis purposes, SPSS (Statistical Product and Service
Solutions; version 20, IBM Corporation, Armonk, NY, USA) syntax was written to extract the relevant data
from MACRO. No changes were made to the SPSS files. The randomisation was stratified according to use of
AChEIs and living situation (i.e. living in the community or in care homes). A paired t-test was applied to the
data to establish if there was a difference between the pre and post scores on the various outcome measures.
This analysis was then followed by a repeated measure linear model to allow various variables to be taken
into account. The model was fitted using post score as the dependent variable, with living situation, marital
status, sex and AChEI medication as factors and age as a covariate. Finally, a two-sample independent
t-test was conducted to compare the Spector et al.6 control group results with the results seen in this group.
Complete-case data analysis was used initially to establish the results, followed by the analysis with
imputations. When individual data points were missing within a scale, data were imputed by using scale/
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subscale means according to the validated rules for the measures. When an outcome measure total score
was missing, it was imputed using a multiple imputation regression model comprising treatment group
allocation, marital status, ethnicity, centre, age, sex, AChEIs, living situation (i.e. care home or community)
and other outcome measures scores. The model used was a forward step model; that is, baseline outcome
scores (baseline 0 and baseline 1) were used to help predict follow-up 1 scores, and then both of these
were used to predict follow-up 2 scores. No data were imputed for those cases in which all assessments
were missing. There were no participants missing for follow-up 1 who returned for follow-up 2.
Primary analyses used an intention-to-treat basis, analysing participants according to the group to which
they were randomised and using all data. Multilevel modelling was used to address clustering within
randomised groups. An analysis of covariance (ANCOVA) adjusted for baseline differences in outcome
variables. Analyses considered the evaluation 6 months after the second randomisation as the primary end
point. Secondary analyses considered the effects at 3 months. Age, sex, AChEI use and baseline scale
scores were entered as covariates, and ‘centre’ was entered as a random factor. A secondary analysis
included a trial platform for the MCST/AChEIs effectiveness that used the same model as for the complete
analysis including an interaction term between AChEIs and the treatment group to identify any effect
between the two factors for cognition (MMSE and ADAS-Cog) and quality of life (QOL-AD).
Results
Eighteen centres took part in the study trial (nine care homes and nine community), comprising 354
participants who were screened and 272 who participated in the CST groups. The reasons for exclusion
included failure to meet the inclusion criteria (n = 42) or refusal to participate (n = 37). A total of 36
participants were lost between first and second randomisation (baseline 0 and baseline 1), leaving 236
participants randomised to the MCST or usual care group. The reasons for withdrawal can be found in the
Consolidated Standards of Reporting Trials (CONSORT) diagram (Figure 12). Overall retention was good.
At 6-month follow-up (follow-up 2) (primary end point), 199 participants (84%) remained in the study and
there were 218 (92%) at 3-month follow-up (follow-up 1). The withdrawal rate was similar in both arms
of the trial and the response rate, excluding deaths, was 89% at follow-up 2 and 96% at follow-up 1.
During phase 1 trial CST mean attendance was 10 sessions and during phase 2 trial MCST mean
attendance was 18 sessions.
A total of 82 (31%) participants were receiving AChEIs, only 16 (14%) of whom resided in care homes. Table 4
compares community and care home participant characteristics in terms of age, sex and AChEIs, and provides
information about the total participant group. Most of the sample had moderate dementia, with a mean
MMSE score of 16.8 (SD 5.5) and a mean ADAS-Cog score of 34.3 (SD 12.9). The community group were less
cognitively impaired at baseline (MMSE 18.9, SD 5.7) and had a higher mean ADAS-Cog of 30.5 (SD 13.1); this
compared with a mean MMSE of 16.2 (SD 5.1) and ADAS-Cog of 40.6 (SD 11.4) for the care home sample.
The total sample scored in the mid-range on the QOL-AD (mean 36.3, SD 12.9) and DEMQOL (mean 93.4,
SD 11.4). Mean scores were in the mid-range on the measures of dependency (ADCS-ADL 42.3, SD 17.7) and
behavioural symptoms (NPI 16.0, SD 12.9). The average attendance for the CST programme was 10.3 sessions
(range 0–14 sessions) and 81% of participants attended seven or more sessions of the programme.
Of the 236 participants randomised into the trial at second randomisation, 123 were allocated to the
intervention MCST group and 113 were allocated to usual care. Table 5 shows that the groups appeared
well matched in terms of demographic and clinical measures. The mean age was 83 years and most
participants were white and female. A total of 135 participants (57.2%) were living in the community and
101 (42.8%) were living in care homes. One-third was taking AChEI medication (32%).
Predictors of change in cognition and quality of life between baseline and follow-up
A repeated measure linear model explored the impact of other variables. The model was fitted for age,
living situation (community/care home), sex, marital status and taking AChEIs, and using post score as the
dependent variable. As a result of fitting the models in this way, the results showed that both age and
sex were important factors for the effectiveness of CST. For MMSE, age was a significant predictor of
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effectiveness of CST, with older participants appearing to benefit more. At the mean age of 82 years there
was little difference between the pre and post score, but participants older than this appeared to benefit
more, with a possible increase in MMSE score. For ADAS-Cog, age again was a significant predictor of the
effectiveness of CST, with older participants benefiting more, in the same way as with the MMSE. Sex
proved to be a significant variable in the complete-case study analysis, and showed a strong correlation
with cognitive improvement, with female ADAS-Cog scores improving more than male scores.
Completed CST groups
Baseline 1
(n = 236)
Randomised
(n = 236)
Allocated to control
(n = 113)
Assessed at follow-up 1
(n = 104)
Assessed at follow-up 2
(n = 93)
Lost to follow-up 1
(n = 9)
• Death, n = 3
• Health problems, n = 2
• Declined to continue, n = 4
Lost to follow-up 2
(n = 11)
• Death, n = 3
• Health problems, n = 3
• Declined to continue, n = 3
• Other, n = 2
Enrolment
Allocated to intervention
(n = 123)
Allocation
Follow-up 1
Follow-up 2
Assessed at follow-up 1
(n = 114)
Assessed at follow-up 2
(n = 106)
Lost to follow-up 1
(n = 9)
• Death, n = 3
• Health problems, n = 2
• Declined to continue, n = 4
Lost to follow-up 2
(n = 8)
• Death, n = 2
• Health problems, n = 2
• Declined to continue, n = 4
FIGURE 12 The CONSORT diagram of participants through the trial. At phase 1, the mean CST attendance was
10 sessions and at phase 2 the mean MCST attendance was 18 sessions.
TABLE 4 Baseline characteristics (before CST groups) according to living condition
Characteristic Community Residential All
Number of participants 159 113 272
Number (%) of prescribed AChEIs 67 (42) 16 (14) 82 (31)
Age (years), mean (SD) 81.6 (7.6) 85.7 (8.5) 82.6 (8.1)
Sex (female), n (%) 96 (80) 81 (72) 177 (61)
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Living situation was also shown to be an important variable for some of the staff-completed outcome
measures (Table 6). For the NPI, a decrease in score was seen for the community sample [18.08 (SE 2.25)
to 13.89 (SE 2.24)], while there was a small increase in NPI score for the care-home-based participants
[11.35 (SE 2.48) to 13.42 (SE 2.48)]. This indicates a benefit for the community sample.
For the DEMQOL (proxy), both community- and care-home-based participants saw a mean increase.
However, the care home increase [94.2 (SE 3.61) to 100.87 (SE 3.39)] was larger than the community
increase [99.32 (SE 3.47) to 100.26 (SE 3.26)]. In fact, this can be viewed as the community sample
remaining steady while the care home sample were brought into alignment with what was observed in
the community.
For the imputed proxy EQ-5D utility values, age was seen as a significant factor, with older participants
appearing to benefit more. For the proxy EQ-5D VAS, the community sample showed a mean increase
from 60.19 (SE 3.63) to 67.52 (SE 3.36), while, conversely, the care home sample showed a small mean
decrease from 65.47 (SE 3.29) to 62.72 (SE 3.04). In summary, we have identified benefits for the
community sample on NPI scores and proxy EQ-5D VAS, and there is a benefit for care home sample for
the DEMQOL-Proxy.
Change when comparing the results with those of a similar control group
Independent sample t-tests were used to compare the complete-case data set results with the Spector et al.6
control group, which had a mean age of 84.7 years and a 3 : 1 ratio of female to male. For the ADAS-Cog,
the Spector et al.6 control group showed a mean reduction of 0.3, while the CST group showed a mean
reduction of 2.72. This gives a mean difference of 2.42 [t = 2.27, degrees of freedom (df) = 240; p = 0.024],
with CIs of 0.33 to 4.51. For the MMSE, the Spector et al.6 control group reduced by an average of 0.4
points, while the CST group saw a mean increase of 0.9 points. This gave a mean difference of 1.3 points
TABLE 5 Baseline 2 characteristics (after attending CST groups) of 236 participants randomised to intervention
and control
Characteristic Intervention (N= 123) Control (N= 113)
Age (years), mean (SD) 82.66 (7.9) 83.47 (7.2)
Sex (female), n (%) 80 (65) 70 (62)
Ethnicity (white), n (%) 111 (90) 104 (92)
Marital status (widow), n (%) 54 (44) 57 (50)
Dementia diagnosis (Alzheimer’s disease), n (%) 38 (31) 35 (31)
On AChEIs (yes), n (%) 42 (34) 34 (30)
Accommodation (care home), n (%) 51 (41) 50 (44)
ADAS-Cog score, mean (SD) 31.12 (14.6) 33.21 (13)
QOL-AD score, mean (SD) 36.12 (4.8) 36.51 (5.7)
MMSE score, mean (SD) 17.79 (5.6) 17.79 (5.4)
DEMQOL score, mean (SD) 94.81 (10.9) 95.08 (11.7)
NPI score, mean (SD) 13.84 (12.9) 11.34 (9.1)
ADCS-ADL score, mean (SD) 42.67 (17.2) 41.51 (18.1)
QOL-AD-Proxy score, mean (SD) 33.69 (5.9) 33.33 (4.9)
DEMQOL-Proxy score, mean (SD) 102.19 (13.5) 102.25 (11.2)
Cornell score, mean (SD) 4.40 (4.2) 3.78 (3.6)
RAID score, mean (SD) 4.59 (3.8) 4.49 (3.7)
RAID, Rating Anxiety In Dementia.
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(t = 2.76, df = 293; p = 0.006), with a CI of 0.38 to 2.22 points (Table 7). At follow-up, the CST group had
demonstrated significantly better results than the Spector et al.6 control group on both MMSE and ADAS-Cog.
There was no difference between the CST group and the Spector et al.6 control group on the QOL-AD.
Using an adjusted ANCOVA comparing groups (treatment and controls), Table 8 shows the analysis of
the primary end point (follow-up 2) and secondary end point (follow-up 1). At 6-month follow-up the
treatment group had significantly higher scores on self-rated quality of life measured by the QOL-AD than
the usual care group (p = 0.04).
Cognition on the MMSE also favoured the MCST group but this was not significant. Centre emerged
as a significant covariate in relation to the ADAS-Cog, Cornell and Rating Anxiety In Dementia scales.
At 3 months’ follow-up, the MCST group had significantly higher scores than the usual care group on
proxy-rated quality of life on both the QOL-AD (p = 0.008) and the DEMQOL (p = 0.04), as well as ADLs
as measured by the ADCS-ADL (p = 0.05).
The MCST-AChEIs platform adjusted results at 6- and 3-month follow-up showed that the group receiving
MCST plus AChEIs scored highest on the MMSE (see Table 3), than those receiving MCST only, those not
receiving MCST and those not taking AChEIs. There is a significant interaction term between treatment
group and taking AChEIs. Post hoc testing indicated that there was a significant difference between the
MCST plus AChEIs group and the usual care and AChEIs group (p = 0.025). No significant interactions
were found on any of the other outcome measures.
Numbers needed to treat
The number needed to treat is the calculation of the number of people who need to be treated in a
particular intervention for one favourable outcome to be achieved. The number needed to treat calculation
uses the proportion of participants who benefit in each treatment group. A number needed to treat analysis
using QOL-AD change was used between baseline and follow-up 2, as this was the primary end point.
TABLE 6 Differences before and after CST (people with dementia completed measures)
Measure
Estimated mean
before CST (SE)
Estimated marginal
mean after CST (SE) F-value p-value
Other variable
significant in the model
MMSE 15.8 (0.99) 18.5 (0.89) 20.7 < 0.001 Age F= 5.5; p= 0.019
ADAS-Cog 35.0 (2.0) 30.6 (2.3) 16.8 < 0.001 Age F= 12.5; p < 0.001
QOL-AD 35.7 (0.9) 36.3 (0.9) 0.001 0.97 None
DEMQOL 93.4 (2.0) 92.4 (1.9) 8.38 0.004 None
ADCS-ADL 44.0 (2.8) 44.6 (2.8) 0.24 0.32 Age F= 8.64; p = 0.004
NPI 14.7 (2.2) 13.6 (2.2) 4.11 0.044 Type F= 6.25; p= 0.013
QOL-AD-Proxy 33.3 (1.0) 32.8 (1.0) 2.91 0.089 None
DEMQOL-Proxy 96.7 (3.4) 100.6 (3.2) 27.24 < 0.001 Type F= 8.39; p= 0.004
TABLE 7 Meta-analysis comparison of mean change in CST groups vs. control group of the Spector et al.6 study
Measure
Spector et al.6 control group,
mean change (SD) [n]
Current study, mean
change (SD) [n] Values
MMSE –0.4 (3.5) [70] 0.93 (3.3) [225] t = 2.76; p= 0.006
ADAS-Cog –0.3 (5.5) [70] –2.72 (8.3) [172] t = 2.26; p= 0.024
QOL-AD –0.8 (5.6) [70] –0.08 (4.9) [225] t = 0.92; p= 0.357
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An improvement of one SD on the QOL-AD (large effect size) was taken to indicate major clinical benefit,
and 0.5 of a SD change (moderate effect size) was taken to indicate moderate clinical benefit. When
calculating a large size effect (1 SD), the proportion benefiting was 0.18 (17/96) for the treatment group
compared with 0.07 (6/81) for the control group and, therefore, 9.7 people needed to be treated for 1 to
benefit (95% CI 5.0 to 129.9 people). When calculating a moderate size effect (0.5 SD), the proportion
benefiting was 42 out of 96 (0.44) for the treatment group compared with 16 out of 81 (0.20) of the
control group and, therefore, 4.2 people needed to be treated for 1 to benefit (95% CI 2.7 to 9.2 people).
Health economics
Methods
The main economic analysis compared MCST with usual care from a health and social care perspective.
Secondary analyses also included the costs of unpaid carer time (societal perspective) and the cost of
MCST as if it had been provided by health-care assistants rather than by the research team (‘in-practice’
implementation). A subgroup analysis also compared individuals receiving only MCST with individuals using
an AChEI in addition. Health and social care services used by participants and inputs from unpaid carers
were captured by the CSRI97 and completed with family carers or centre care workers. When possible, unit
costs for the services were drawn from the Personal Social Services Research Unit compendium for 2011.100
We used a 3.5% discount rate (recommended by Her Majesty’s Treasury) for items providing benefit for
more than 1 year, such as equipment or adaptations. Medication costs were obtained from the British
National Formulary.101
The economic analysis estimated incremental costs and incremental effects and their CIs with seemingly
unrelated regression methods with 1000 bootstrap replications. The information obtained through the
economic analysis has led to the calculation of incremental cost-effectiveness ratios (ICERs) and to plotting
cost-effectiveness acceptability curves (CEACs), showing the probability that MCST is a cost-effective
addition to usual care against a series of hypothetical willingness-to-pay (WTP) values.
TABLE 8 Primary and secondary end-point results: adjusted analysis model
Outcome
measure
Primary end point follow-up 2 (6-month
follow-up)
Secondary end point follow-up 1 (3-month
follow-up)
Treatment,
mean (SE)
Control,
mean
(SE)
Group
difference,
mean (SE)
Between-
group
difference
(p-value)
Treatment,
mean (SE)
Control,
mean
(SE)
Group
difference,
mean (SE)
Between-
group
difference
(p-value)
ADAS-Cog
score
35.94
(2.79)
35.29
(2.85)
0.19
(1.61)
0.91 35.32
(2.56)
34.47
(2.59)
–0.85
(1.29)
0.16
QOL-AD
score
35.62
(1.43)
33.84
(1.53)
–1.78
(0.91)
0.04 34.29
(1.03)
33.97
(1.04)
–0.32
(0.61)
0.70
MMSE
score
16.34
(1.21)
15.49
(1.25)
–0.85
(0.58)
0.17 16.09
(0.88)
15.79
(0.91)
–0.30
(0.52)
0.52
DEMQOL
score
89.13
(3.55)
88.83
(3.56)
–0.30
(1.52)
0.86 89.85
(2.34)
90.71
(2.38)
0.86
(1.31)
0.55
NPI score 18.76
(3.78)
20.35
(3.94)
1.58
(2.16)
0.44 14.71
(2.84)
16.18
(2.76)
1.47
(1.55)
0.25
ADCS-ADL
score
43.29
(2.88)
42.35
(2.87)
–0.94
(1.51)
0.48 43.58
(2.32)
40.94
(2.32)
–2.64
(1.30)
0.05
QOL-AD-
Proxy
34.12
(1.41)
34.05
(1.41)
–0.07
(0.74)
0.93 33.93
(1.05)
32.40
(1.07)
–1.53
(0.59)
0.008
DEMQOL-
Proxy
97.75
(3.23)
96.61
(3.21)
–1.13
(1.71)
0.47 101.36
(2.67)
98.12
(2.67)
–3.24
(1.50)
0.04
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Results
Looking at the primary outcomes in the health and social care perspective (Table 9), the mean cost for
each 1-point difference on QOL-AD was £266. Looking at the CEAC for this outcome, the probability that
MCST would be seen as more cost-effective than usual care alone would be 90% at a WTP of about
£1400 (Figure 13). There are no established WTP thresholds for QOL-AD against which to compare this
finding, but a cost of only £1400 for a 1-point difference on a 40-point scale is modest. Based on previous
studies,44 the effect size of ‘standard’ CST on the QOL-AD scale is around 0.4 SD, which represents a
modest increment. In the current study the difference at follow-up for MCST was estimated to be 1.78
points (SD 0.34 points). A 2-point difference in QOL-AD can be considered to be clinically significant and
a cost of £2800 to achieve such a result may be attractive to decision-makers. When the outcome was
measured in terms of ADAS-Cog, the probability that MCST would be seen as cost-effective was low
across all values of WTP (Figure 14).
Secondary economic analyses indicated that MCST was more cost-effective than usual care over the
shorter period of 3 months when outcomes were measured in terms of proxy-rated quality of life
TABLE 9 Incremental cost-effectiveness ratios from health and social care perspective, over periods of 1–6 months
and 1–3 months
Outcome measure
Incremental cost (£ 2010/11),
mean (95% bootstrap CI)
Incremental effect, mean
(95% bootstrap CI) ICER
1–6 months
ADAS-Cog 473.89 (–315.45 to 1263.23) –0.65 (–4.08 to 2.77) Usual care dominant
QOL-AD 473.46 (–315.61 to 1262.53) 1.78 (–0.39 to 3.95) 266
MMSE 474.01 (–316.15 to 1264.17) 0.85 (–0.48 to 2.18) 558
ADCS-ADL 471.57 (–317.67 to 1260.81) 0.95 (–2.50 to 4.39) 498
QOL-AD-Proxy 472.70 (–314.60 to 1260.01) 0.07 (–1.63 to 1.76) 7050
DEMQOL-Proxy 472.31 (–338.46 to 1283.07) 1.13 (–2.48 to 4.74) 419
QALY (EQ-5D) 474.81 (–314.38 to 1263.99) 0.0013 (–0.0200 to 0.0223) 365,276
QALY (Proxy EQ-5D) 473.60 (–315.48 to 1262.68) 0.0176 (–0.0050 to 0.0403) 26,835
QALY (DEMQOL) 518.39 (–346.60 to 1383.39) 0.0039 (–0.0092 to 0.0170) 132,539
QALY (DEMQOL-Proxy) 401.52 (–441.99 to 1245.04) 0.0062 (–0.0049 to 0.0173) 64,785
1–3 months
ADAS-Cog 366.38 (–150.51 to 883.26) –0.86 (–4.14 to 2.43) Usual care dominant
QOL-AD 366.22 (–150.20 to 882.63) 0.32 (–1.17 to 1.81) 1139
MMSE 366.30 (–150.22 to 882.81) 0.30 (–0.80 to 1.40) 1223
ADCS-ADL 366.35 (–150.38 to 883.08) 2.64 (–0.36 to 5.65) 139
QOL-AD-Proxy 365.85 (–150.07 to 881.76) 1.53 (0.27 to 2.79) 240
DEMQOL-Proxy 367.96 (–151.88 to 887.81) 3.24 (–0.02 to 6.50) 114
QALY (EQ-5D) 366.40 (–150.80 to 883.59) –0.0037 (–0.0117 to 0.0043) Usual care dominant
QALY (Proxy EQ-5D) 365.74 (–150.45 to 881.92) 0.0077 (–2.94 × 10–6 to 0.0155) 47,339
QALY (DEMQOL) 387.08 (–192.12 to 966.27) 0.0014 (–0.0030 to 0.0058) 276,791
QALY (DEMQOL-Proxy) 358.43 (–169.61 to 886.45) 0.0034 (–0.0003 to 0.0070) 105,904
QALY, quality-adjusted life-year.
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FIGURE 13 Cost-effectiveness acceptability curve: MCST vs. usual care – 6 months, health and social care
perspective, with effectiveness measured on the QOL-AD scale.
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FIGURE 14 Cost-effectiveness acceptability curve: MCST vs. usual care – 6 months, health and social care
perspective, with effectiveness measured on the ADAS-Cog.
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(using QOL-AD and DEMQOL) and ADLs (using ADCS-ADL), but less cost-effective than usual care on all
other outcomes, including quality-adjusted life-years (QALYs).
In sensitivity analyses we broadened the cost measure to include unpaid care and support, conducting the
evaluation from a societal perspective. The cost-effectiveness case for adding MCST to usual care was,
again, mixed. Subgroup analyses found that the combination of MCST and AChEI was more cost-effective
than AChEI and usual care by reference to a number of outcomes, including cost per QALY.
Discussion
The benefits of CST on cognitive function are now well documented and the results of this study provide
additional evidence for the effectiveness of the programme developed by Spector et al.6 The study showed
that CST has a generalised cognitive benefit for people with dementia evident in comparisons of change
scores, and in comparisons with the changes shown by the control group from the previous trial. Unlike the
Spector et al.6 study and the recent Cochrane review,44 this study found a positive change in behaviour
following the CST intervention as measured by the NPI. There was also a significant improvement in quality
of life as measured by the DEMQOL and EQ-5D (VAS) (for both participant and proxy-rated versions), but no
significant change was found using the QOL-AD. Previous studies have identified the need for quality-of-life
measures in dementia that are able to detect any changes in quality of life in response to both interventions
and the progression of the disease,102 so that they can be used to establish the benefits of treatment for
people with dementia. In this analysis, the DEMQOL seemed to be a more sensitive instrument than the
QOL-AD for measuring change in quality of life in dementia.103 Conversely, the two measures may be
measuring different aspects of quality of life. These findings need to be explored further in future trials.
Predictors of success: who benefits most?
The benefits of CST were found to be independent of the use of AChEIs, which is in line with the
Cochrane review findings and other studies.44,49,51,53 In line with the earlier study,6,104 greater improvements
in cognition were associated with female sex. Men might be more reluctant to communicate as they are
usually in the minority in most groups, with women outnumbering men in the groups by a ratio of
4 : 1.6,104 It may be that the sex majority dictates the style in which the groups are run, for example more
‘talking’ in female-dominated groups and more ‘doing’ in male-dominated groups. Further work is needed
to explore these sex differences in response to CST and to develop interventions more geared towards the
attributes of men.
The greater effect for the older people in this study is an unexpected finding. It may suggest that these
older residents are experiencing more excess disability, showing impairment beyond that resulting directly
from the dementia. It may be that they receive less stimulation in general than the slightly younger
participants, and so benefit more from the new intervention. The findings of differences in outcomes
between those living in the community and those living in care homes relate to all measures completed by
a proxy: a family member or a member of staff. Their ratings may be affected systematically by different
factors (e.g. family carer ratings are typically influenced by their level of strain; staff in care homes may
change or have limited contact with residents on which to base their judgements). Further work is needed
to explore these differences in perspectives and in the changes reported.
Maintenance cognitive stimulation therapy
This is the first major investigation to compare the short- and long-term impacts of CST for people with
dementia. The investigation indicates that after standard CST (7 weeks, twice weekly), 24 weeks of MCST
sessions both improves quality of life for people with dementia at 6-month follow-up and benefits quality
of life and ADLs at 3-month follow-up, in comparison with the usual care control group. Cognitive
stimulation programmes for dementia have a significant positive effect on cognition;44,105 however, there
are concerns that the benefits may only persist for a limited period of time.44 These results indicate that a
lower intensity input of once-weekly CST sessions can continue to be effective after the initial twice-weekly
CST programme is completed. In comparison with the first baseline before CST, cognitive function in the
MCST group had decreased by only 0.35 points on the MMSE, whereas cognitive function in the usual
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care (CST) group had decreased by 1.65 points at follow-up 2. The ADAS-Cog showed a similar pattern
of results. On the basis that MMSE scores in mild-to-moderate dementia are expected to decrease by
2–4 points per year,106 these results suggest that, relative to no treatment, the MCST programme continues
to have a protective effect on cognition. Other studies have also found that a longer-term cognitive
stimulation intervention can be effective in reducing cognitive decline in dementia.107,108
However, benefits to cognition alone may not be sufficient to justify an extensive programme of
intervention unless they are accompanied by other benefits, and a few studies have explored the long-term
impact of psychosocial interventions on quality of life.109 This study indicates that the MCST programme
improves quality of life and ADLs. As CST alone improves both cognition and quality of life,6,105 this provides
a strong case for an ongoing programme of CST being supported in health and social care settings.
The MCST-AChEIs subanalysis results confirm the results of similar studies,6 suggesting that the additional
effects of cognitive stimulation on cognition are over and above those of medication alone. In addition,
the Cochrane review showed that type of control condition (e.g. usual care or social activities) made
no difference to outcome, demonstrating that cognitive stimulation, rather than social activities, was
responsible for the improvements in outcome.
Previous studies have shown that CST is effective in improving cognition and quality of life,6 and is
cost-effective.13 CST is endorsed in NICE clinical guidelines.14
Findings from this new trial suggest that, although outcome gains were modest over 6 months, the
continuation of CST appeared cost-effective in terms of self-rated quality of life, cognition measured on
the MMSE and proxy-rated QALYs. MCST in combination with AChEIs offered cost-effectiveness gains
when cognition was measured as the outcome.
The external validity of this pragmatic trial is high, as the sample came from a wide variety of settings.
However, participants were almost exclusively white British and, therefore, solid conclusions on the
applicability or effectiveness of this intervention to people of other ethnic or cultural groups cannot be
made. Having said this, we recently successfully adapted and ran a local CST group in Hindi, and CST
programmes have been run successfully in 20 countries.
Limitations of study
The SDs for the cognitive measures were higher than those in the original Spector study,6 suggesting that a
larger sample may be needed to achieve significance differences in cognition after MCST relative to
CST alone. Proxy measures (e.g. the ADCS-ADL and NPI) were rated by the family carer or staff members
who were aware of participant group allocation, and so this might have introduced detection bias into the
ratings. The subgroup of people on AChEIs might also have received extra psychiatric services during the
trial. However, comparisons of the AChEIs-only group and MCST plus AChEIs group data confirm that
the effects of the MCST programme are above and beyond those of medication alone.
Conclusion
This project provides further evidence that CST benefits cognition and quality of life for people with
dementia, and suggests that the benefits are in addition to the effects of antidementia medication. CST
appears to be more beneficial for women and people older than the average age of those in the study.
This provides good evidence for the clinical effectiveness and cost-effectiveness of continuing CST beyond
the initial programme and shows that quality of life and ADLs continue to benefit from extended CST.
Work package 4: maintenance cognitive stimulation therapy in practice
Cognitive stimulation therapy has been shown to improve cognition and quality of life, but little is known
about the best way of ensuring implementation of CST in care settings. A recent pilot study found that
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one-third of people who attended CST training went on to run CST in practice, but staff identified a lack
of support as a key reason for the lack of implementation.110
The research project was divided into three studies. The Staff Training and Outreach (STANDOUT) and
Monitoring and Outreach (MONOU) studies assessed the effects of outreach support on uptake of CST in
practice, as well as looking at staff outcome measures and adherence to the programme. The observational
study recruited people with dementia to complete minimal outcome measures before and after CST, and
after the delivery of the MCST programme.
Methods
Design
The STANDOUT and MONOU studies differed in how staff members were recruited into the research
and in their previous exposure to CST. Staff members in the STANDOUT study were new to CST, having
had no prior experience of the programme, whereas staff recruited into the MONOU study had either
previously attended CST training or purchased the CST ‘Making a difference’ manual. The observational
study looked at the effects of CST and MCST on people with dementia in the practice context delivered by
staff members. The three studies together provided evidence on both the most effective way of facilitating
the implementation of CST, and uptake and effectiveness of the approach in a clinical context (Table 10).
Ethics approval was obtained for the project through the Multi-centre Research Ethics Committee
(reference number RP-PG-0606-1083). The clinical trial was registered as ISRCTN28793457.
STANDOUT trial
The design was a pragmatic, multicentre, single-blind, two-treatment-arm RCT. The STANDOUT trial
sample comprised dementia care staff from specialist and non-specialist dementia care settings. All
participants received the training package as TAU, consisting of a CST training day, a training DVD, the
CST ‘Making a difference’ manual and the MCST ‘Making a difference 2′ manual, and cluster randomised
by centre prior to the training day into the intervention group or to TAU. The intervention group consisted
of a local co-ordinator, e-mail support and an online forum. Each staff member was expected to complete
three questionnaires, the first before the training day and the others at 6 and 12 months thereafter
(Figure 15).
TABLE 10 Project overview
Title STANDOUT trial MONOU trial Observational study
Aim To assess the effectiveness of staff
training and outreach support
To assess the implementation in
practice of CST and outreach support
To assess the effectiveness
of CST in practice
Participants Dementia care staff Dementia care staff People with dementia
Experience No previous CST experience or
training
Previously received CST manual/training Staff have varying levels of
experience
Number 175 66 89
Resources CST manual, MCST manual and
DVD
CST manual, MCST manual and DVD CST manual, MCST manual
and DVD
Training Yes Variable Variable
Outreach 50% 50% Variable
Assessment
time frame
Baseline, 6 and 12 months Baseline, 6 and 12 months Before and after CST
(0–7 weeks or 0–14 weeks)
and MCST (31 or 38 weeks)
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Recruitment
Those recruited to the trial included staff from care homes, day centres and NHS trusts from various
locations across the UK. The trial was advertised through the Journal of Dementia Care, the National Care
Forum and the UK Clinical Research Network study portfolio, and referrals were made through the
commercial CST training day. The researcher also followed up individuals who, prior to the start of the
research, had expressed an interest in CST or in attending a CST training day. Using the inclusion criteria,
the researcher was then able to assess all expressions of interest from individuals, centres and trusts.
Participants
Staff members were screened to ensure that they met the inclusion criteria: (1) having adequate written
and spoken English; (2) being able to complete online assessments at three time points; (3) having at least
two other team members to run groups with; (4) reaching agreement with management to have 2 hours
per week set aside to run the CST groups, and 1 hour following on from this for the 24-week MCST
programme; and (5) being able to provide between five and eight people with mild-to-moderate dementia
who were willing to participate and met the inclusion criteria (described in the observational study). Attempts
were made to recruit a minimum of three staff members per centre for the logistical reason of being able to
consistently run the groups. Originally, 40 centres were considered feasible to recruit the 120 staff members
required for the STANDOUT trial; however, in total 173 staff members across 50 centres were recruited into
the study. This was because there was a higher demand for receiving the CST training than for entering the
MONOU study and, as the analyses for the STANDOUT and MONOU studies were combined, statisticians on
the SHIELD programme advised that this would not compromise the integrity of the trial, as there had always
been the intention to analyse the results from both the STANDOUT and MONOU trials together. Working on
Recruitment
Screening
Consent
Baseline assessment (0/12 months)
Randomisation
Training day and CST and maintenance CST manual and DVD
Outreach supportNo outreach support
Follow-up 1 assessment (6/12 months)
Follow-up 2 assessment (12/12 months)
FIGURE 15 Flow diagram of the STANDOUT trial and assessment schedule.
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the premise of a 15% attritition rate, the sample size provided sufficient numbers for (1) the staff training
outreach support versus no outreach support, and (2) monitoring and outreach versus no outreach support
to estimate effect size and the feasibility of the trial. The attrition rate was an estimation based on previous
research conducted in CST.111
Training package
The CST ‘Making a difference’ and MCST ‘Making a difference 2′ manuals, along with the staff training
DVD, were distributed to all staff members participating in the study. The staff training DVD comprises
an introduction by Dr Aimee Spector, a table listing the order of the CST and MCST sessions, and key
principles. There is also video footage of each CST and MCST session run with people with dementia for
staff to observe and questions after each clip to encourage reflective learning and discussion. All staff
members attended a CST training day. The training comprised different perspectives of dementia, main
psychosocial approaches for dementia, development and evaluation of CST, session themes and examples
of activities for sessions, key principles, planning of sessions and the setting up of a group and reflective
learning of issues that arise when implementing and running groups. The training used learning methods,
such as role-play, and small group exercises and the DVD was used when time was spent reflecting on
the sessions and critically appraising how the session had been run. At the end of the training day, time
was taken to emphasise the importance of completing the attendance and adherence forms after each
completed session; these forms would then be collected by the researcher at the end of the research time.
Randomisation
Cluster randomisation occurred prior to staff attending the CST training day to ensure that staff members
from the same centre received the same level of support. The allocation ratio for randomisation was 1 : 1,
into either the intervention or TAU. NWORTH was responsible for undertaking the remote randomisation.
Treatment as usual
Staff members within centres randomised to the control group attempted to deliver the CST as usual without
the additional outreach support. The training package offered to the intervention group was also available to
those in the control group. Therefore, the trial examined the additional effects of the outreach support.
Intervention
A pilot study conducted, prior to this research being undertaken, identified that outreach support should
consist of (1) an online forum, (2) e-mail support and (3) local supervision.110 The online forum was an
online discussion site. It was accessible using a username and password. The first time a person attempted
to enter the site, an e-mail was sent to the researcher for their approval to ensure that the person in
question had been randomised to the intervention group. The use of login details allowed a record to be
kept of the number of people accessing the service and how many times they did so. Staff members were
able to write up a variety of messages, such as comments on sessions, asking questions and asking for
advice. The same researcher who had extensive experience of CST and experience of running groups
delivered the e-mail support and local supervision, unless the centre was able to provide their own person
to deliver the supervision. Both services were made available as often as was needed. The role of the local
supervisor was to help to resolve practical issues that were encountered in attempting to run CST groups.
The supervisors recorded all the support given.
Primary outcome measure
The primary outcome measure was the total number of sessions attended over the duration of the CST
and MCST programme. This was determined by the total number of sessions run multiplied by the average
number of people at each. This was recorded by staff using the monitoring progress form located in the
‘Making a difference’ manual112 that included recording who was in attendance, and rating level of
interest, communication, enjoyment and mood on a scale of 1–5 (i.e. 1 = no interest, 2 = little interest
shown, 3 = some interest shown, 4 = interest shown and 5 = great interest shown). This measure was
completed at the end of each session from the start of the CST programme to the end of intervention
delivery, until the MCST groups had been completed or the groups had been discontinued.
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Secondary outcome measures
(a) Adherence to the CST and MCST programme was measured using an adherence list designed for the
trial and was based on 18 key principles developed as part of the MCST programme.112 The adherence
records were reviewed by a member of administration to mark whether or not staff adhered to the
key principles as laid out in the ‘Making a difference 2′ manual and to highlight any similar issues that
were arising across centres. Any ambuiguity in participants’ responses was discussed with a researcher
until consensus was reached regarding whether or not the participant was adhering to the key
principles. Job satisfaction was measured using the Minnesota Satisfaction Questionnaire.113 This
consists of 100 questions and comprises 20 dimensions with five items per scale, using a 5-point Likert
rating scale. The measure has adequate internal reliability.
(b) Staff members’ approach to dementia was measured using the Approaches to Dementia
Questionnaire (ADQ).114 The ADQ has 19 statements about the person with dementia and the care
that they receive. The scale has high validity and good reliability using Cronbach’s α for its
person-centeredness and hopefulness subscales.
(c) Knowledge was measured using the Dementia Knowledge – 20 scale.115 This consists of 20 questions
for which there are five possible answers. The scale has sufficient reliability and was administered at
baseline and final follow-up only.
(d) Perceived sense of competence was measured using the Sense of Competence in Dementia care –
Staff questionnaire.116 It comprises 17 items categorised into four subscales: professionalism, building
relationships, care challenges and sustaining personhood. The scale has good internal consistency.
(e) Learning characteristics of staff were measured using the brief version of the Learning Transfer System
Inventory (LTSI).117 The constructs of the LTSI are validated using common factor analysis.118 The brief
form comprises 16 questions that are categorised into four major groups: trainee characteristics,
motivation, work environment and ability. All of the items use 5-point Likert-type scales from 1
(strongly disagree) to 5 (strongly agree).110
(f) Barriers to change in the workplace were measured using the Barriers to Change Questionnaire.119 It
comprises 19 questions focusing on institutional constraints, support from colleagues, philosophical
opposition, client dissatisfaction, interference and positive factors, and allows the addition of any
further comments.
(g) The emotional and behavioural responses relating to challenging behaviour presented by the person
with dementia were measured by the Controllability Beliefs Scale.120 The scale has 15 items based on
a 5-point scale. Higher scores indicate higher staff member belief in the level of control demonstrated
by the person with dementia. The scale has good internal reliability.
Consent
Ethics and local R&D approvals were obtained and all staff members provided informed consent to
participate in the trial. Consent was also sought from a manager in each centre recruited.
Blinding
Although staff members could not be blinded to their allocation, the majority of the assessment data
was completed online and independently of the research team. To maintain anonymity throughout the
trial, an administrator on the SHIELD programme team assigned an identification number to all participants
who completed the survey. The researcher administering the outreach support had the contact details
of the staff members but was unaware of their individual code, and hence they were blinded to identifying
the staff members. The staff members were aware of their code and it was emphasised that it was not
to be discussed with the research team member. A reminder was also included in the e-mail that the
administrator sent to the participants asking them to complete the follow-up assessments.
MONOU trial
The design was a pragmatic, multicentre, single-blind Phase IV trial. The participants were staff members
from centres that had previously purchased the CST ‘Making a difference’ manual or had attended a CST
training course. Once enrolled in the research, all staff received the free MCST ‘Making a difference 2′
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manual and DVD. It was recorded whether participants had the manual only or manual and training
before centres were cluster randomised into outreach support or TAU (Figure 16). The time points for
completing the questionnaire were the same as for the STANDOUT trial. However, the participants also
completed a retrospective questionnaire on their use of CST in practice prior to the research.
Recruitment
Recruitment of staff members for the MONOU study was created from records of purchased CST manuals
via Hawker publications and a database of attendees generated from previously run CST training days.
Staff members were then contacted to determine if they were interested in participating in the study.
A CST poster also advertised the research on the CST website (www.cstdementia.com), on the SHIELD
website (www.ucl.ac.uk/shield) and through the Journal of Dementia Care. In addition to this, as the
project was a UK Clinical Research Network portfolio-adopted study, NHS trusts nationwide could
approach the research team for their eligibility to participate in the research to be assessed.
Participants
The participants were dementia care staff who had the CST manual or had attended the CST training day
and were able to implement the CST programme once or twice weekly followed by the MCST programme.
The screening and inclusion criteria matched those for the STANDOUT study, except a minimum of one staff
member could be recruited per centre; because of this it was estimated that between 40 and 120 centres
Recruitment
Screening
Consent
Baseline assessment (0/12 months)
Randomisation
Provision of maintenance CST manual and DVD
Outreach supportNo outreach support
Previous CST manualPrevious CST training and manual
Follow-up 1 assessment (6/12 months)
Follow-up 2 assessment (12/12 months)
FIGURE 16 Flow diagram of the MONOU trial and assessment schedule.
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were required to recruit 120 staff members. This figure also accounts for a 15% (240 × 0.75 = 180) attrition
rate. However, in total 68 staff members were recruited across 13 centres. This was due to difficulty in
identifying and recruiting suitable participants.
Randomisation
Once staff had completed their baseline assessment, it was recorded who had the manual or training,
and randomisation occurred. This was created by dividing into two clusters, taking into consideration
centre size and type of previous training (manual vs. manual and training); staff were then independently
randomised to receive the intervention or TAU by remote e-mail service to NWORTH. Owing to differing
numbers in each centre, an effort was made to keep similar numbers in the control and experimental
groups, with an allocation ratio for randomisation of 1 : 1, into either the intervention or the TAU group.
Treatment as usual
Sites randomised to the control group were expected to deliver the CST as usual. Each centre randomised
into TAU received a monthly telephone call from a member of administration to see what stage they were
at in the delivery of the programme, but they were not given any advice. The trial examined the additional
effects of the outreach support and long-term effect in practice.
Intervention
The outreach support options were identical to those in the STANDOUT study, with one difference: to
emulate CST in practice, staff members identified the local supervisor, and, if this was not possible, it was
recorded and the staff members were then offered the researcher’s services. All of the staff members
randomised to receive outreach support were encouraged to use all options available to them, but this was
not compulsory. Staff members were monitored to measure their usage of the outreach support options.
A monthly telephone call was also made by the researcher to each centre in receipt of outreach to determine
what stage of the programme they were at and, if advice was sought, this was recorded accordingly.
Primary outcome measure
Attendance as the primary outcome was identical to that in the STANDOUT trial. If the response to a
person attending the session was left blank and no reason was given for this, the researcher assumed that
the person had not attended the session. If a person was introduced part way through the programme,
the sessions that had not been offered to them were excluded from the total number of sessions
considered, as the person’s non-attendance at these sessions had not been because of a refusal to attend
but because the sessions had been unavailable by the time they joined.
Secondary outcome measures
The secondary outcome measures were identical to those in the STANDOUT trial.
Consent
Informed consent was gained from each staff member and a member of management, and this was
identical to the STANDOUT trial. Ethics and local R&D approvals were obtained.
Blinding
The procedure for blinding was identical to that in the STANDOUT trial.
Analyses
Demographics In total, 300 individuals, 28 centres and 12 trusts expressed interest or were approached
to participate in the research. Overall, 241 staff members were recruited across 63 centres in both the
STANDOUT and MONOU trials. All of the staff members consented and completed the baseline
assessment before randomisation. Four people were randomised by association, after randomisation had
occurred but before the centre was aware of whether or not they were in receipt of the intervention. In
total there were 115 (48%) people not in receipt of the intervention across 28 centres and 126 (52%)
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who were in receipt of intervention across 35 centres. The majority of staff members were female (88%)
and white (71%). Generally, staff had between 1 and 10 years of experience (43%), with 41% having a
qualification up to diploma/degree level. Most sites were dementia specialist settings (64%), with 33%
being care home settings (Table 11).
Attendance in STANDOUT and MONOU trials A combined analysis of the results from the STANDOUT
trial (175 participants) and the MONOU trial (66 participants) was carried out. The primary outcome was
the total number of sessions attended for each centre (total number of sessions run × average number of
people at each) per centre, assuming an intracluster correlation of p < 0.05.
For the group receiving the intervention of outreach support, 18 (51%) out of 35 centres went on to deliver
the CST programme, whereas in the TAU group 12 (43%) out of 28 centres delivered the programme
(Table 12).
A chi-squared statistic suggests that there is not a statistically significant difference in the proportion of CST
groups run in the intervention group and the number of CST groups run in the TAU group (p = 0.458).
Leading on from the CST programme, 12 (67%) out of the 18 centres in the intervention group went on
to deliver the MCST and 8 (67%) out of 12 centres in the TAU group delivered the MCST programme
(Table 13).
TABLE 11 Staff demographics
Staff demographics Frequency, n (%)
Sex (female) 212 (88)
Ethnicity (white) 170 (71)
Age (45–54 years) 56 (23)
Level of experience (1–10 years) 103 (43)
Qualification (diploma/degree) 99 (41)
Dementia setting (care home) 80 (33)
Specialist dementia setting (yes) 155 (64)
TABLE 13 Number of MCST programmes delivered based on the intervention
Intervention No CST (n)
Number of CST
programmes only, n (%)
Number of MCST
programmes run, n (%)
Outreach support 17 6 (33) 12 (67)
No outreach support 16 4 (33) 8 (67)
TABLE 12 Number of CST programmes delivered based on intervention
Intervention Number of centres (n) No CST, n (%)
Number of CST
programmes run, n (%)
Outreach support 35 17 (49) 18 (51)
No outreach support 28 16 (57) 12 (43)
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A chi-squared statistic suggests there is a statistically significant difference, with more MCST groups run in
the intervention group than in the TAU group (p = 0.011).
Attendance Staff at each centre running the CST and MCST programmes marked the attendance of the
people with dementia after each session was completed. This information was then collected at the end of
the programme and the researcher entered it into a Microsoft Excel® 2003 spreadsheet (Microsoft Corporation,
Redmond, WA, USA). By calculating the primary outcome of total number of sessions attended for each
centre, the researcher was able to group the centres by the average number of people attending during
the programme. Centres unable to run the programme scored zero, centres considered to have delivered
CST poorly scored < 41 overall (and so had, on average, fewer than three group members) and centres
considered to have delivered CST OK scored between 42 and 69, reflecting that, on average, there were
three or four group members. Finally, CST was considered good if a centre scored ≥ 70, demonstrating
that, on average, in these centres there were ≥ 5 group members over the duration of the programme
(Table 14).
A chi-squared statistic suggests that there is no statistical significance between the centres that were in
receipt of the intervention and those that were not, and the delivery of the programme as determined by
the number of average attendees across the CST programme (p = 0.87; 2 df). However, Table 14 does not
reflect one centre that ran the programme in the intervention group, as the attendance and adherence
booklet was mislaid, so for the purposes of this table the centre has been included in the intervention
‘no groups’ column.
From the centres that followed the CST programme with the MCST programme, the primary outcome of
total number of sessions attended enabled the researcher to group the centres according to the average
number of people who attended across the delivery of the programme (24 sessions). A score of 0 was
assigned to centres in which groups were not run; centres in which MCST was considered to have been
delivered poorly (a score of < 71 indicating fewer than three group members) were assigned a score of 1.
Centres with between 3 and fewer than 5 people, on average scoring between 72 and 119, were given
a score of 2 and those centres with ≥ 5 group members, as demonstrated by a score of > 120, were
assigned a score of 3 (Table 15).
TABLE 15 Whether or not in receipt of intervention and rating of MCST delivery
Intervention and rating of MCST No MCST groups MCST poor MCST OK MCST good Total
Intervention
No 21 0 5 2 28
Yes 22 2 5 6 35
Total 43 2 10 8 63
TABLE 14 Whether or not in receipt of intervention and rating of CST delivery
Intervention and rating of CST No groups CST poor CST OK CST good Total
Intervention
No 16 0 3 9 28
Yes 18 0 5 12 35
Total 34 (33)a 0 8 21 63
a One centre mislaid the attendance and adherence booklet.
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A chi-squared statistic suggests that there is no statistically significant difference between the centres in
receipt of the intervention and the average number of attendees in the delivery of the MCST programme
(p = 0.35; 3 df).
A comparison was also carried out to look at the different pathways by which participants entered the
trial, either ‘new’ to CST (STANDOUT) or with previous experience (MONOU). Of the centres recruited into
the STANDOUT trial, 17 out of 50 went on to deliver the CST programme. The MONOU trial had a total of
13 centres and, of these, 12 went on to deliver the CST programme (Table 16).
A chi-squared statistic suggests that there is a statistically significant difference, in that more CST groups
were run in the MONOU group than in the STANDOUT group (p = 0.001; 1 df).
This comparison was also considered for the centres within the two strands of the trial that went on to
deliver the MCST programme. Within the STANDOUT trial, 9 of the 17 centres continued with the MCST
programme, whereas in the MONOU trial 11 of the 13 centres went on to deliver the MCST programme
(Table 17).
A chi-squared statistic suggests there is a statistically significant difference, in that more MCST groups
were run in the centres recruited into the MONOU trial than in those recruited into the STANDOUT trial
(p = 0.000; 3 df).
Access of outreach support The researcher recorded outreach support each time it was accessed by a
staff member in the intervention group. In total, three centres signed up to the online forum, the e-mail
support was accessed twice and local supervision in the form of a telephone call was used 15 times.
However, within this staff members initiated three of the telephone calls, whereas the remaining 12 were
the monthly follow-up support telephone calls in which staff members were asked if they needed support.
It was also noted that within the MONOU trial two of the trusts (Kent and North Staffordshire) had a
support network already set up that they accessed in monthly meetings across the duration of their
involvement in the research.
Secondary outcome measures
Adherence To determine if the centres running the CST programme were adhering to the key principles,
one-third of the CST adherence records were randomly chosen. The adherence questions were devised
with the CST key principles in mind (Table 18). There were five CST records chosen from the centres in
TABLE 16 Strand of trial and success of CST
Trial No CST groups CST poor CST OK CST good Total
STANDOUT 33 0 4 13 50
MONOU 1 0 4 8 13
Total 34 0 8 21 63
TABLE 17 Strand of trial and success of MCST
Trial No groups MCST poor MCST OK MCST good Total
STANDOUT 41 1 4 4 50
MONOU 2 1 6 4 13
Total 43 2 10 8 63
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receipt of the intervention and five records from centres in the TAU group; these comprised six centres in
the STANDOUT trial and four centres in the MONOU trial.
When the responses were recorded, any adherence questions left blank were considered incorrect and
for any adherence sheets missing these were deducted from the overall score that the centre obtained.
The self-reported adherence score of not adhering to the key principle across the delivery of the CST
programme ranged from 11% to 24%. The three main key principles that were not adhered to were:
(14) were group members given the choice of activities for the session, (9) did anyone struggle to join in
with the session and (7) were indirect questions used during the session. However, when key principle 17
was reviewed by the researcher there was either no comment or it was stated that they were following the
session structure. So, it was considered that the question was ambiguous and needs further clarification in
the future. With regard to key principle 9, when the centre highlighted that people were struggling within
the centre it generally was a result of one or two group members being more impaired than the others or
being unwell on the day of the session. It was expected that people’s participation over the time frame of
the programme might vary and it is arguably a positive sign that the staff were able reflect on the session
and identify participants struggling during the session, as one would hope that this would enable the staff
to then cater to the individual needs of each participant and to keep the group as inclusive as possible.
Key principle 7 identified that there was a lack of indirect questions used when delivering the programme.
The use of indirect questions is important to ensure that people do not feel put on the spot, so it is useful
to understand that this is a principle that staff find difficult to adhere to.
TABLE 18 Adherence and related key principles
Number Adherence question Key principle
1 Was the session pitched at the right level for all group members? Mental stimulation
2 Were people encouraged to think of new ideas during the
session?
New ideas, thoughts and associations
3 Was time spent on the date, time, weather and feelings of
group members?
Using orientation, but sensitively and
implicitly
4 Did the discussion focus on opinion over fact? Opinion rather than facts
5 Were past experiences used to bring people in to the here and
now?
Using reminiscence as an aid to the here
and now
6 Did you follow the session structure? Continuity and consistency between sessions
7 Were indirect questions used during the session? Implicit (rather than explicit) learning
8 Was everyone encouraged to participate in the session? Stimulating language
9 Did anyone struggle to join in with the session? Stimulating executive functioning
10 Were the individual needs of each group member met? Person centred
11 Was respect shown between group members and the
facilitators?
Respect
12 Did everyone equally contribute to the session? Involvement
13 Was every opinion valued within the group? Inclusion
14 Were group members given the choice of activities for the
session?
Choice
15 Did people seem to enjoy the session? Fun
16 Was everyone given enough time to contribute to the session? Maximising potential
17 Is there a good relationship between group members? Building/strengthening relationships
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Staff outcome measures An ANCOVA was applied to the secondary outcomes measures including job
satisfaction, approaches to dementia, dementia knowledge, responses relating to challenging behaviour,
perceived sense of competence and learning characteristics, as well as barriers to change. Each measure
was calculated factoring in sex, age, frequency in the delivery of CST, type of centre, whether or not it was
a specialist dementia setting, how the participant was recruited into the project (MONOU/STANDOUT) and,
finally, if they were in receipt of the intervention.
A one-way between-group ANCOVA was conducted to compare the effectiveness of outreach support
as the intervention versus TAU on participants’ job satisfaction, approaches to dementia, dementia
knowledge, responses relating to challenging behaviour, perceived sense of competence and learning
characteristics, as well as barriers to change. The independent variable was the type of intervention
(outreach support or no outreach support) and the dependent variables consisted of scores on the
secondary outcomes at 6 and 12 months. Participants’ scores at baseline in these measures were used as
the covariate in the analysis. Preliminary checks were carried out to ensure that there was no violation of
the assumptions of normality, linearity, homogeneity of variances, homogeneity of regression slopes and
reliable measurement of the covariates.
Job satisfaction as measured by the Minnesota Satisfaction Questionnaire113 evaluated job satisfaction
using a score ranging from 100 to 500, with a higher score indicating a higher sense of satisfaction.
In general, job satisfaction increased for both the control and intervention groups at follow-up 1, but
decreased at follow-up 2 to lower than the baseline score. After adjusting for baseline scores, job
satisfaction showed no statistical difference at follow-up 1 (p = 0.72) or follow-up 2 (p = 0.99).
Approach to dementia was measured using the ADQ114 and looked at the attitude of the staff members,
with a low score suggesting a negative attitude and a higher score indicating a positive attitude (19–95).
The score in both the control and intervention groups increased slightly over the duration of the research.
However, there was no significant difference for approaches to dementia on the hope subscale at follow-up
1 (p = 0.82) or follow-up 2 (p = 0.97), or person-centred subscale at follow-up 1 (p = 0.18) or follow-up
2 (p = 0.95).
Perceived barriers to change, including institutional constraints, support from colleagues, philosophical
opposition, interference and additional factors, were measured using the Barriers to Change Questionnaire,119
with a higher score indicating more perceived barriers (0–80). Overall, the score decreased at follow-up 1, but
then increased at follow-up 2. For barriers to change there was no significant difference at either time point,
follow-up 1 (p = 0.54) or follow-up 2 (p = 0.96).
To look at training transfer, the brief LTSI117 was used looking at learning characteristics, motivation, work
environment and ability/enabling, with a higher score (16–80) indicating a more positive transfer of learning.
The scores improved at follow-up 1 compared with baseline and, although they decreased at follow-up 2,
still remained higher than the baseline score. For transfer of learning there was no significant difference at
follow-up 1 (p = 0.1) or follow-up 2 (p = 0.34) when comparing the intervention and control groups.
To determine the level of control that the staff member considered the person with dementia to have over
their own behaviour, the Controllability Beliefs Scale120 was used, with a higher score indicating a higher
level of control (15–75). The challenging behaviour scale was split into two subscales: high control and low
control. Over the duration of the study, both the intervention and the control groups attributed a lower
controllability rating, although neither follow-up 1 (p = 0.56) nor follow-up 2 (p = 0.84) showed a
significant difference. In addition, although the lower controllability score increased at follow-up 1 and
decreased at follow-up 2 but remained higher than baseline, the low control score was not statistically
significant at follow-up 1 (p = 0.20) or at follow-up 2 (p = 0.65).
To understand the level of dementia knowledge, the Dementia Knowledge – 20 scale115 was used at
baseline and follow-up 2 only. Within the scale there are two subdomains, dementia core knowledge and
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dementia care knowledge, with a higher score demonstrating a higher level of dementia knowledge
(0–20); however, this was low at baseline, it remained low at final follow-up and there was no significant
difference at this time point (p = 0.72).
Sense of competence was measured using the Sense of Competence in Dementia care – Staff
questionnaire,116 with a higher score demonstrating a higher perceived rating of competence (17–68).
Sense of competence continually increased at follow-up 1 and follow-up 2 and, although not reaching
significance at follow-up 1 (p = 0.61), showed statistical difference at follow-up 2 (p = 0.05), indicating
that sense of competence significantly increased at final follow-up compared with the control group
(Table 19).
Observational study of cognitive stimulation therapy in practice
The design was a multicentre, longitudinal observational study with people with dementia. Sites that were
running or in the process of setting up CST groups completed minimal outcome measures at three time
points with people with dementia participating in the CST and MCST programme (Figure 17). The measures
were completed before the group started (baseline), at 7 or 14 weeks depending on how they implemented
the CST programme (once or twice weekly) and after the MCST at 31 or 38 weeks. However, this end
time point did differ when taking into consideration staff and group member availability and holidays. The
intervention of CST was routinely offered in the care setting. The aim of this study was to determine whether
or not groups were running in practice and to determine if the positive findings for cognition and quality of
life for the person with dementia found in previous CST research5 could be demonstrated in practice.
TABLE 19 Secondary outcome measures and statistical significance
Measure Subscale Intervention
Baseline
mean score
(SE)
Follow-up 1
mean score
(SE) Significance
Follow-up 2
mean score
(SE) Significance
ADQ Hope Y 31.5 (4.20) 31.3 (1.51) 0.82 32.2 (1.68) 0.97
N 30.8 (5.30) 31.1 (1.26) 32.2 (1.40)
Person
centred
Y 18.3 (3.64) 19.8 (1.54) 0.18 19.1 (1.55) 0.95
N 17.6 (3.28) 18.5 (1.30) 19 (1.30)
BARCQ Y 33.9 (17.25) 26.6 (4.79) 0.54 31.9 (6.92) 0.96
N 35.5 (17.32) 28.5 (3.96) 32.1 (5.68)
LTSI Y 56 (7.20) 61 (2.76) 0.1 57.8 (3.21) 0.34
N 55.6 (6.58) 58.1 (2.29) 59.8 (2.65)
CBS High
control
Y 42.1 (7.48) 40.4 (2.37) 0.56 26.7 (1.45) 0.84
N 41.4 (6.82) 41.3 (1.97) 26.5 (1.19)
Low
control
Y 11.6 (4.05) 16.6 (1.90) 0.2 14.5 (0.67) 0.65
N 11.9 (3.96) 15 (1.56) 14.3 (0.54)
DK-20 Y 3.30 (0.12) N/A N/A 2.97 (0.23) 0.82
N 3.15 (0.10) N/A 2.89 (0.26)
MSQ Y 374.7 (53.07) 395.6 (12.93) 0.72 362.7 (22.48) 0.99
N 373.2 (49.04) 392.2 (15.66) 362.5 (19.20)
SCID-S Y 54.5 (7.81) 58.3 (2.27) 0.61 61.4 (2.44) 0.05
N 55.4 (7.92) 57.6 (1.87) 58.2 (2.00)
BARCQ, Barriers to Change Questionnaire; CBS, Controllability Beliefs Scale; DK-20, Dementia Knowledge – 20;
MSQ, Minnesota Satisfaction Questionnaire; N, no; N/A, not applicable; SCID-S, Sense of Competence in Dementia care –
Staff questionnaire; Y, yes.
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Recruitment
Centres that were starting or running CST groups were approached and the staff were asked to complete
measures of cognition and quality of life with the people with dementia taking part in the groups. If the
staff were unfamiliar with the measures then the researcher agreed to complete the follow-up time points
with the people with dementia. The centre type, level of staff experience and training were all recorded.
The centres were given the MCST manual and staff training DVD. The recruited participants had a
confirmed diagnosis of mild to moderate dementia.
Participants
Centres that were currently running or setting up CST groups were approached to participate in the
observational study. It was explained that they would be expected to run the CST and MCST programme.
Eleven centres were recruited, with some running more than one programme, providing us with 89 people
with dementia. To participate, the people with dementia had to have a score of between 0.5 and 2 on the
CDR scale,121 a diagnosis of dementia, adequate spoken and written English, the ability to participate in a
‘meaningful’ conversation and the ability to remain in a group for 45 minutes. The participants also needed
to have adequate eyesight and hearing, be able and willing to give informed consent and have the ability to
complete a cognitive and quality-of-life measure at three intervals over 1 year. Once between five and eight
people with dementia in a centre gave informed consent to complete the minimal outcome measures with a
staff member or researcher, the centre was recruited in to the study and a letter explaining their participation
in the research was sent to the people with dementia’s general practitioners (GPs). The interviews with
people with dementia were carried out by a researcher or staff member who was trained to undertake the
assessment and had training in Good Clinical Practice and taking informed consent.
Training package
The staff members in the centres had the CST manual or had previously attended CST training which
included the CST manual. To participate in the research programme, in addition to the resources they
already had the staff at the centre received the MCST manual and DVD.
Randomisation
No randomisation was necessary, as this was a naturalistic study of CST in practice, so people with
dementia who were about to start the CST programme were approached and informed, and their consent
was obtained.
Recruitment
Screening
Consent
Baseline assessment (prior to CST)
Follow-up 1 assessment (after CST programme)
Follow-up 2 assessment (after maintenance CST programme)
FIGURE 17 Flow diagram of observational study and assessment schedule.
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Outcome measures
The primary and secondary outcome measures for people with dementia were completed at baseline (time 0)
prior to the CST programme starting, and then post CST groups (time 1) (at 7 or 14 weeks depending on
whether groups were implemented once or twice weekly). The final follow-up was completed after the
MCST had been completed or the programme had ceased running (time 2). Sociodemographic information
was collected about the person with dementia, including age, sex, ethnicity, diagnosis of dementia,
type of diagnosis and medication. Medication was recorded at each follow-up to mark any differences for
the duration of their participation in the trial.
l The primary outcome was cognition as measured by the MMSE.45 The MMSE has a score of up to
30 points and is widely used as a brief indicator of level of cognitive impairment. It has good reliability
and validity.
l The secondary outcome measure was quality of life as measured by the QOL-AD.89 The QOL-AD is a
13-item scale measuring different aspects of life. The scale totals 52 points and higher scores indicate
better quality of life. It has good internal consistency, validity and reliability.122
Consent
Ethics and local R&D approvals were obtained and all participants provided informed consent to participate
in the trial. The British Psychological Society’s guidance on the evaluation of capacity was adhered to, as it
was in the MCST trial.111
Blinding
Blinding was unnecessary for the staff members and researchers, as each person with dementia had the
opportunity to participate in the CST and MCST programme and the staff members or researcher were
completing the assessment at each time point.
Analyses
Analysis was a pre–post analysis based on intention to treat, in that all collected data made available by the
person with dementia were included, regardless of whether or not that person completed the programme.
Imputation methods such as last observation carried forward are of limited use in dementia, as there is the
expectation of gradual decline and that participants will be lost through illness or death. A linear regression
model was used when there were missing data to predict the missing value and impute the total when
possible. The sample size calculation accounted for the number of people expected to be available at the
study end point. All participants were in receipt of the CST and MCST programme. Analysis took into
account the evaluation at 24 weeks after CST as the primary end point. The secondary analysis considered
the effects immediately following the CST programme. Age, sex, AChEI and baseline scores on the two
scales being measured were entered as covariates, together with ‘centre’ entered as a random factor.
Ethics arrangements
Risks and anticipated benefits for trial participants
As per the previous study, no documented harmful side effects from participating in either CST training
or the running of the CST and MCST programme were apparent and any SAEs were reported to the
chief investigator.
Results
Demographics The majority of the sample was female (57%) and white (94%), with a mean age of
80 years. Just over half were diagnosed with Alzheimer’s disease (51%), with 17% diagnosed with
Alzheimer’s and vascular dementia, 16% diagnosed with vascular only and the remaining 16% diagnosed
with another type of dementia or unknown. Approximately two-thirds were on dementia medication
(62%), with 35% accessing the CST groups through a memory clinic (35%), although overall 91% were in
a specialist dementia setting (Table 20).
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If the CST programme was adhered to twice weekly and followed up immediately with the MCST
programme, a person would be expected to participate for 7 months and 21 days. For the centres that
delivered the CST twice weekly, the amount of time spent in the trial (from baseline to final follow-up
assessment) ranged from 7 months and 23 days to 9 months and 6 days. When the CST programme was
run once weekly and followed up with the MCST programme, a person would be expected to participate
for 9 months and 14 days. The amount of time participants spent in the trial ranged from 8 months and
27 days to 12 months and 29 days. The variation in time was accounted for by practical issues such as
time constraints, lack of staffing, transport difficulties or lack of group members.
Cognition
Cognition as measured by the MMSE45 remained stable over the time frame of the CST and MCST programme.
At baseline, 89 participants ranged in score from 7 to 30, with a mean score of 21.2. At follow-up 1, 62
participants ranged in score from 10 to 29, with a mean score of 22. At follow-up 2, 55 participants ranged in
score from 4 to 30, with a mean score of 21.4 (Table 21).
TABLE 20 People with dementia demographics (n= 89)
Demographic Frequency
Sex, n (%)
Female 51 (57)
Ethnicity, n (%)
White 84 (94)
Age in years (mean)
48–92 80
Type of dementia, n (%)
Alzheimer’s 45 (51)
Alzheimer’s and vascular 15 (17)
Vascular 14 (16)
AChEIs, n (%)
Yes 55 (62)
Type of centre, n (%)
Memory clinic 31 (35)
Specialist dementia setting, n (%)
Yes 81 (91)
TABLE 21 Details of participants’ cognition
Time point
MMSE score
Range
Mean SDLower Upper
Baseline 7 30 21.2 4.6
Follow-up 1 10 29 22 4.8
Follow-up 2 4 30 21.4 5.6
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A paired sample t-test was conducted to evaluate the impact of CST on cognition at baseline and final follow-up
scores. There was no statistical significance difference in MMSE scores from baseline (mean= 21.36, SD 4.9) to
final follow up (mean= 21.42, SD 5.68) [t= –0.138, p= 0.891 (two-tailed)]. The mean increase in the MMSE
scores was 0.06 with a 95% CI ranging from –0.85 to 0.74. The eta-squared statistic (–0.14) indicated no effect
size (Table 22). A paired sample t-test was also conducted between baseline and follow-up 1; however, there
was no statistical significance between time points (p= 0.16).
Quality of life
Quality of life as measured by the QOL-AD 89 increased slightly over the time frame of the CST and MCST
programme. At baseline, 89 participants ranged in score from 0 to 49, with a mean score of 35.7. At
follow-up 1, 62 participants ranged in score from 24 to 49, with a mean score of 36.8. At follow-up 2,
56 participants ranged in score from 25 to 47, with a mean score of 36.7 (Table 23).
A paired sample t-test was conducted to evaluate the impact of CST on quality of life at baseline and final
follow-up score. There was no statistical significance difference in QOL-AD scores from baseline (mean
36.34, SD 7.63) to final follow-up (mean 36.7, SD 5.3) [t = –0.43, p = 0.667 (two-tailed)]. The mean
increase in the QOL-AD scores was 0.39 with a 95% CI ranging from –2.21 to 1.43. The eta-squared
statistic (–0.00) indicated no effect size (Table 24).
Discussion
This project pragmatically evaluated the effectiveness of staff training and outreach support by increasing
the delivery of CST in practice by outreach support intervention in both new (STANDOUT trial) and
experienced (MONOU trial) CST practitioners. The MONOU trial provided a naturalistic evaluation of the
benefits of manual only versus manual and training in CST implementation, and both the STANDOUT and
MONOU trial identified staff and situational factors that impeded or facilitated CST implementation. It also
allowed the research to demonstrate, on a large scale, the knowledge, views and understanding, and
TABLE 22 Paired t-test of participants’ cognition
Paired sample statistics Mean SD SE
MMSE baseline 21.36 4.9 0.66
MMSE follow-up 2 21.42 5.68 0.77
TABLE 23 Details of participants’ quality of life
Time point
QOL-AD score
Range
Mean SDLower Upper
Baseline 0 49 35.7 7.7
Follow-up 1 24 49 36.8 5.6
Follow-up 2 25 47 36.7 5.3
TABLE 24 Paired t-test participants’ quality of life
Paired sample statistics Mean SD SE
QOL-AD baseline 36.34 7.64 1.02
QOL-AD follow-up 2 36.73 5.30 0.71
MAINTENANCE COGNITIVE STIMULATION THERAPY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
54
approach of staff members to dementia in a variety of care settings nationwide with the secondary
outcome measures.
As outreach support was rarely accessed, it may seem unsurprising that there was no statistical difference
in the delivery of the CST programme between the intervention and TAU groups. However, this study
shows similar uptake of CST (one in three) to that in the previously conducted pilot study110 after 1-day
training for the STANDOUT trial. There was an increase in both the intervention group (51%) and the TAU
group (43%), compared with the 33% reported in the pilot study. This indicated that the outreach support
increases the uptake of CST; however, it may be that research involvement inflated this figure also, as
when the centre enrolled in the study they agreed to intend to implement the programme. One might
expect this initial effort to have dwindled by the time of implementing the MCST programme but this
study demonstrates that, with the additional outreach support, the centres were more likely to run MCST
following on from the original programme.
The secondary outcome measures provided a useful overview of staff perceptions and knowledge before,
during and after the research study, and there was an indication that the intervention improved staff sense
of competence. However, it is important to consider the situational factors that impeded the running of
the CST and MCST programme. In particular, staff left posts because of restructuring, left their current
post or retired, or there was a lack of staff or a lack of suitable participants when considering the inclusion
criteria or the time frame of the study. There was a higher than expected dropout rate that could be
attributed to these reasons; however, another reason was that staff who did not run the programme felt
that it was unnecessary to complete the questionnaire or staff did not have enough time to complete it.
On reflection the questionnaire could have been shortened in attempt to maintain a higher retention rate.
In relation to the observational study, it provided an evaluation of long-term cognitive and quality-of-life
benefits of CST and MCST in practice. It is the first study to measure outcome measures with people with
dementia when only staff members are delivering CST and MCST as part of usual care. Although there
were no statistically significant differences from baseline to final follow-up in either cognition or quality of
life, the scores remained stable over the time frame of the programme. This is useful as previous research
has suggested a decrease of 2–4 points on the MMSE over time frame of a year and a half.123
Although this study looks at groups in practice, and this was reflected in the time frame of the follow-ups,
it would be useful to conduct a trial in which staff members in centres emulated the time frame the
researchers followed in previous work111 so that it would be possible to make a direct comparison.
Conclusions
In conclusion, the project has attempted to demonstrate the potential benefits of offering outreach support
to dementia care staff across a variety of settings. There is no statistical difference between the intervention
and TAU groups in running CST. However, those in the intervention group were more likely than those in
TAU to go on to run MCST. Positively, in the delivery of CST no groups were considered poor, with all in the
OK–good range (≥ 3 group members) and the majority in the latter category. However, this rating did
diminish slightly for the MCST programme, for which the majority were in the OK range. There were more
groups run among the staff recruited as part of the MONOU trial, and this could be attributed to the staff’s
prior experience in delivering CST making them more adept at running the programme.
There was no significant difference in secondary outcome measures when comparing the intervention group
with TAU, apart from the staff members in the intervention group at final follow-up considering themselves
more competent. It is a positive finding that staff in receipt of outreach support consider themselves more
competent, although it would also be useful to develop a measure to determine if this is evident in practice.
With regard to the observational study, there may not have been an improvement in cognition and quality of
life over the duration of the programme; however, maybe just as importantly, there was no deterioration in
scores either. This is important as the CST originally designed to be run twice weekly was also implemented
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once weekly and this did not affect the cognition and quality-of-life scores. A future trial would be useful to
control the frequency in delivery of the CST, the time frame of completing the assessment time points and
the rigorousness of the inclusion criteria required to participate in the programme.
Overall, this study has made a positive step towards demonstrating the benefits of offering outreach
support to staff in delivering CST as part of their usual practice. Although the support may not be able
to overcome the wider factors that might impede the successful delivery of the programme, such as
organisational change, it does appear to build on the staff members’ perceived levels of competence and
increase the delivery of the MCST programme following on from the original programme.
Focus groups about the experience and effect of maintenance cognitive
stimulation therapy
Three focus groups were undertaken with people with dementia taking part in the observational study and
the staff facilitating these sessions. The results were originally written up by Priyanka Chauhan, a BSc
(Bachelor of Science) psychology student supervised by Professor Martin Orrell, entitled ‘The experience
and effect of Maintenance Cognitive Stimulation Therapy (maintenance CST): The perspective of people
with dementia and maintenance CST group facilitators’. However, the focus groups were co-run and
supported by a researcher (Amy Streater) as part of the SHIELD programme.
Aim
The study explored the experiences and effects of participating in the MCST programme by conducting
semistructured interviews with people with dementia and CST facilitators. It also aimed to explore the
mechanisms of change and compare the findings with those of a previously conducted study110 on the
experiences of CST to determine if the MCST continued the perceived benefits identified from the original
programme.
Sample
Ten people with dementia who had completed the CST programme and were part way through the MCST
programme were recruited from an East London community day centre for older people. The mean age
was 84 years and the sample was made up of four male and six female participants. There was a mean
baseline MMSE45 score of 16, indicating a moderate level of impairment. All had completed the CST
programme and were up to the sixth MCST session.
Five staff members were recruited that had previously acted as a cofacilitator or main facilitator in running
the CST programme and were in the process of running the MCST programme with the people with
dementia recruited into the study. The day centre was purposefully chosen as it had previously been
enrolled in the MCST research project111 and staff had gone on to run their own groups following on from
the research, it was considered that the staff were experienced enough to provide an in-depth experience
of the MCST programme. The staff members either had attended the CST training day or had the CST
‘Making a difference’ manual. All staff members were female and between them they had an average of
11 years of dementia care experience.
Inclusion criteria
People with dementia were initially approached if they had completed the CST programme and regularly
attended the MCST programme that was currently under way at the centre. However, they also needed
to (1) have met the DSM-IV124 criteria for dementia, (2) have scored between 10 and 24 on the MMSE,45
(3) be able to adequately communicate, (4) see and hear well enough to participate in the group, (5) not
present behaviour or have a physical illness that could limit their participation, and (6) not have a diagnosis
of a learning disability. These inclusion criteria were used to ensure that people could adequately
participate and provide useful information in the focus group.
The staff members were considered eligible to participate in the focus group if they had participated in
the running of the CST and MCST programme and met with the service users accessing CST at least
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twice weekly; this was considered sufficient time for staff to be familiar enough with the service users that
they could comment on everyday effects that might arise from the MCST programme.
Procedure
Managers were approached 1 month before the focus groups were undertaken to gauge their level of
interest and identify potential participants from both staff and people with dementia. A week prior to the
focus groups being undertaken, a researcher approached the staff and people with dementia and went
through the information and consent form, allowing any questions to be asked. The researcher went
through the information sheet and consent form again on the day of the focus group and discussed this
with the participant for a second time before informed consent was obtained. Consent was obtained in
accordance with the British Psychological Society40 guidelines and ongoing consent was adhered to;
participants were reminded that they could withdraw at any time and no adverse consequences would
result from this.
Materials
A discussion guide was devised, based on the findings from a previous study,110 to guide the conversation.
This allowed a reliable comparison to be made between the person’s MCST experience and the original CST
programme. Questions were created with the aim of understanding any mechanisms of change that might
be occurring; this was in relation to a person-centred approach (PCA).125 Swaab’s theory of stimulating
underused cognitive ability126 and the biopsychosocial model127 were explored. All focus groups were
audio-taped and field notes were taken by a cofacilitator to document any useful non-verbal communication
and interaction of group members that might have been lost in the transcription stage of the data analysis.
Data analysis
The data analysis followed the stages of framework analysis128 and followed the principles of thematic
content analysis.129 Each focus group transcript was analysed with the following steps: (1) immersion in the
data; (2) categorising the data to identify a thematic framework; (3) coding; and (4) interpretation and
association. In the first stage it consisted of the researcher familiarising himself or herself with the general
ideas generated from the focus group discussion that were identified from reading the transcripts. In stage 2,
‘open coding’130 was used to categorise the data into general themes, followed by themes more representative
of the data. To ensure the validity of the themes, a second researcher also analysed the transcripts so that a
final set of themes was agreed by both researchers. The third stage involved the coding of the transcripts in
accordance with the thematic framework and this was then followed by the final stage of interpreting the
findings in accordance with the existing literature.
Results
After the data were analysed, two main themes emerged across the three focus groups. The first was
‘positive experiences of being in the group’ including the subthemes ‘enjoyable company’, ‘positive
feelings’ and ‘benefits of a smaller group’. The second theme identified was ‘cognitive stimulation and
cognitive benefits’, with the subthemes ‘importance of and improvement in communication’, ‘importance
of variety’ and ‘improvements in memory’.
In the following quotations, to clarify who was speaking, P will be used to identify a person with dementia
and S will be used to identify a staff member.
Positive experiences of being in the group
Enjoyable company People with dementia emphasised the building of relations resulting from their
participation in the programme and time spent with others as key reasons that they enjoyed the sessions.
They openly expressed their enjoyment and appreciation of interacting with others, including the staff.
It’s nice to have a group, it feels like you’ve got friends.
P
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Current affairs was discussed as being the most enjoyable activity (see Importance of conversation);
however, people with dementia were receptive to all of the activities in the programme and emphasised
that the company of others was the primary reason that the sessions were enjoyable.
I’m never bothered about what they are going to discuss, I can be a listener as well as a talker . . .
when I’m with people the atmosphere does me.
P
Positive feeling People with dementia often reported feelings of happiness and feeling lifted and more
relaxed. Some also mentioned that they could recall the MCST session later when they were at home,
demonstrating lasting effects beyond the group itself.
It’s nice, when you get indoors you’re relaxed and in your mind you can see it all over again. You’re
doing it all over again in your mind, you relive it.
P
Another repeated positive feeling was that of being valued and comfortable.
Nobody’s taking the quiet mick out of anybody.
P
Staff members also noted that the group members felt a sense of inclusion and that the attendees
highlighted the group they attended as ‘theirs’.
They ask each other ‘Which group are you going?’ and he says ‘No, no, no, I’m going to my own
group, this is my own group’.
S
Benefits of a smaller group Staff members felt that the larger group size usually used for activities in the
day centre (group size of 12) would not generate the positive feelings demonstrated by the CST group
members. Having a group size of between five and eight people facilitated the positive feelings. People
with dementia were also aware of the difference in numbers.
She’s allowed to say what she wants to say. I think because it’s a smaller and it’s a happy group as
we say.
S
When we amongst a lot of others (common areas), it’s not the same.
P
However, the point was made that a balance had to be struck in terms of group size so that groups did
not get too small with the potential to bring in new members.
We’ve been so small we haven’t diversified a lot. I’d like to see us know get more people in here so
discussions become more broad and diversify.
P
Cognitive stimulation and cognitive benefits
Importance of and improvement in communication Both staff members and people with dementia
believed that cognitive stimulation occurred through discussion. Discussion is one form of cognitive
stimulation with the MCST programme, as it helps to facilitate the learning of new information and allows
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people to express their opinions. All participants rated a session theme entitled ‘Current affairs’ the
most enjoyable.
It is nice to hear other people’s opinion, you think to yourself, ‘Oh I never thought of that’. It livens
you up.
P
You can develop some sort of discussion and people will join in it, irrespective whether they like it or
not, and that gives a feeling that they appreciate you and don’t want to decline what you’re saying.
P
Staff members noticed improvements in people with dementia’s ways of expressing themselves and
identified an increase in their willingness to communicate and participate in the MCST group.
She never used to say much, but in the group she’s got loads to say, I just have to sit back and listen
to her, just going on and on and she won’t stop you know.
S
She’s thinking about things and more confident about expressing her opinions.
S
Importance of variety The staff members clearly felt that cognitive stimulation occurred owing to the
range of activities and discussion topics available and raised the idea that the variety of sessions would be
key to the continuing success of the MCST programme. The service users also emphasised the importance
of flexibility and choice within the programme that would not be possible without there being a variety
of sessions.
You’ve got different sections to it, you’ve got the reminiscence you know, you’ve got the newspapers,
you’ve got the activities so even if there is something that they are not interested in the activities,
but you might find that they would have a lovely discussion during the newspaper reading. There is
always something for someone.
S
They [staff] allow a free discussion . . . it creates a good atmosphere, it gives people confidence then
to talk.
P
Improvement in memory Both service users and staff reported that the sessions aided recall and led to
specific improvements in memory, such as the repetition of the group song or orientation to the current
time and place.
They didn’t even know the road that the day centre was on . . . now as soon as we sit down . . . they
can tell you the resource centre, [road name], even the postcode now.
S
I’m using it more . . . I was becoming really as if I had no memory at all. Since coming here it’s revived
it all.
P
Discussion
This study aimed to explore the experiences and effects of the MCST programme for people with dementia
and the perceptions of the facilitators. It also looked to identify possible mechanisms for change and to see
if the findings of this study were comparable with the themes identified in the CST programme,110 to see if
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the MCST programme sustains the positive experiences and effects when it follows on from CST. The
identified themes indicate that there is a similarity between the experiences and effects of CST and those of
the MCST programme, and each theme ties into at least one of the mechanisms of change explored: Kitwood’s
PCA,125 Swaab’s theory of stimulating underused cognitive abilities126 and the biopsychosocial model.127
Comparison with Spector et al.110 CST findings
The first theme identified was ‘positive experience of being in the group’, which was identified in the
previous study. Within this theme, ‘positive feeling’ was also found in the 2011 study and within this were
feelings of enjoyment, relaxation and something to look forward to. The second subtheme, ‘enjoyable
company’, corresponds to the identified subtheme in the previous study of ‘supportive and non-threatening
environment’, as both recognise the positive effects of relationship building between group members and
with the facilitators. A difference in the main theme between this study and that by Spector et al.110 is that
the latter did not find the subtheme of ‘benefits of a smaller group’ and this study did not report the service
users gaining and remaining confident for the remainder of the day after CST. However, the increase in
confidence for people with dementia had been identified through their family caregivers and, as this
demographic was not used in this study, it cannot be assumed that this is different for the MCST
programme. However, it is important to note that staff members noticed that for some people with
dementia their increased confidence outside the group could be considered evidence of their enhanced
confidence (see Importance of and improvement in communication).
Two of the subthemes, ‘cognitive stimulation and cognitive benefits’ and ‘importance of and improvement
in communication’, tally with the subtheme ‘positive experience of being in the group’ as identified in the
2010 study. Within this were the subthemes ‘finding it easier to talk’ and ‘sharing a diagnosis’, which can
be considered reasons for improvement in communication. An increase of confidence in communication
ties in with the first theme of ‘positive experience of being in the group’, as comfort in a smaller group
size, valued contributions and friendship can lead to a heightened confidence in expressing oneself. The
corresponding subthemes demonstrate that the opportunity that is created in CST to discuss, give and
receive opinions is a factor in the perceived success of the CST and MCST programme. It would seem
unlikely that conversation would have been an important element without having ‘positive feelings’ and
the ‘benefits of a smaller group’. The importance placed on opinion links into the CST key principles of
opinion over fact and implicit learning, both of which fall under ‘positive person work’ (PCA). Placing
value on what people say rather than on the factual content or accuracy of what they say increases their
confidence in expressing their opinion. The subtheme ‘importance of variety’, under the main theme of
‘cognitive stimulation and cognitive benefits’, did not correspond to the Spector et al.110 study, yet it was a
key point of agreement in this study (see Mechanisms of change); however, this might be have been
emphasised owing to the extended duration of the MCST programme.
Both a general and a specific improvement in memory were identified in Spector et al.110 and in this study.
It could be argued that ‘improvement in memory’ resulted from the use of reality orientation,131 as a result
of the reality orientation board used for every CST and MCST session and the repetitiveness of the implicit
information processing (group name, song, location) as well as the session structure as presented in both
the CST and MCST manual. This can be related to the subtheme of ‘positive experience of being in the
group’, as one might expect that, without an environment conducive to participation and enjoyment,
the likelihood of someone becoming actively involved in the discussion and activities might decrease and,
in turn, lead to a negative impact on their memory and cognition.
Mechanisms of change
An analysis of the mechanisms of change was necessary to develop an understanding of what is effective
in relation to CST. Two of the themes emerged in this study, ‘benefits of a smaller group’ and ‘importance
of variety’, that can be considered mechanisms of change. As both the Spector et al.110 and this study
identified ‘positive experience of being in a group’ as a theme, it is apparent that both the CST and MCST
programmes created an environment that facilitated ‘positive feelings’ of value and inclusion as well as the
building of relationships. This theme is evidence of the benefits of using a PCA.125 A PCA places emphasis
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on seeing the person with dementia as a person and an individual, rather than defining them according to
their diagnosis.
The ‘benefits of a smaller group’ subtheme appears to fit well as part of a PCA125 as it encourages more
in-depth relationships, something one might expect to be harder with a larger group . The possibility of
developing friendships in a small group might encourage the active participation of each group member
and increase the cognitive benefits of CST.126 So, although a larger group might adhere to the same
principles, it may not demonstrate the same benefits for the group members.
The variety of activities and current affairs to be discussed at the beginning of each session follows another
key principle of CST: choice. Allowing choice reiterates that the group belongs to the group members and
increases the chance of catering to each person’s needs and interests, further facilitating the use of a PCA.
The flexibility of variety is in keeping with the biopsychosocial model,127 which states that treatment should
consider the fixed biological factors as well as the changeable psychological and social factors when working
with a person with dementia. This model works with CST as it identifies the fixed factors that are reflected
in the inclusion criteria of the therapy of scoring 10–24 on the MMSE,45 as well as the tractable factors such
as sensory impairment when it is necessary for the person with dementia to see and hear well enough to
participate in the programme.6 The biopsychosocial model does link in with the inclusion criteria used for
participation in the programme but it is more strongly related to the psychological factors as recognised in
the model. CST as a psychosocial intervention creates a social support network through the group format of
the therapy leading to improvements in social relations and uses a multisensory stimulation through the
session themes and materials to encourage implicit mental stimulation (psychological tractable factor). An
understanding of the person’s history, personality and beliefs before starting CST emphasises a PCA as this
can be considered when running discussion or activities. The variety offered by CST also allows for personal
psychology and individual differences to be taken into account when creating sessions that can cater for a
range of interests.
Limitations
The study focused on the opinions generated from the people with dementia participating in the
programme as well as those of the staff members facilitating the groups. As the staff members were
familiar with the service users, it was not considered necessary to include family members. However, when
conducting the focus group, staff did not feel comfortable commenting on the possible after-effects of
MCST. Staff might also be unaware of the person with dementia’s feelings about the group, whereas the
service user might be more open with a family member about their experiences. So, focus groups run with
family members might be useful when considering the after-effects and a more in-depth understanding of
the perceptions of the MCST programme.
Owing to the limited time frame of the study the focus groups were conducted after the sixth session
of MCST. The full maintenance programme is run over 24 weeks so the opinions expressed were after
one-third of the programme had been delivered. It could be considered that focus groups conducted at
the end of the MCST programme would be more beneficial in getting a truer account of the experience
of the programme, as in the study the people with dementia could discuss the experience of the first six
sessions only. This point might not be as relevant to the staff as they were able to draw on their previous
experience of the MCST programme, having delivered it prior to the current group.
As there was a time constraint on collecting the data, only one centre could be recruited into the study.
This might have biased the results as the feedback on the MCST programme was specific to the delivery of
it in that particular centre. There was also a small number of participants (10 people with dementia and
five staff members) and so the amount of feedback was limited to a small sample size. However, the same
thoughts about the programme were mentioned across the three groups, so it might be that more
participants would not necessarily generate any additional themes but rather would strengthen those
already identified in this study.
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Conclusion
This study used focus groups to explore the experience and effect of MCST with people with dementia and
staff members, and in addition looked at the mechanisms of change and compared the findings with those
of a previously conducted study on service users’, family members’ and staff members’ experience of CST.110
This study identified that the experience of MCST closely matched the experience of CST and that MCST
appears to preserve the perceived benefits across the duration of the programme. The main themes identified
were ‘positive experience of being in the group’ and ‘cognitive stimulation and cognitive benefits’, and both
of these can be indirectly related to one of the mechanisms of change (PCA and benefits of a small group).
Further research is required to look further at the mechanisms of change identified in both quantitative and
qualitative methods and relate this to CST and MCST to determine what is most important in attempting to
further understand and increase the benefits for people with dementia.
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Chapter 3 Peer support and joint reminiscence for
people with dementia and their carers
Work package 1: development of a Carer Supporter Programme
training package
The CSP (RYCT) trains experienced carers to support newer carers of people with dementia; reminiscence
groups are also held jointly for people with dementia and their carers to maintain quality of life and
improve relationships.
Our intervention was developed from the BECCA trial29 of a carer support intervention in which trained
volunteer lay workers befriended family carers of people with dementia for companionship and
conversation.29 Supporters did not necessarily have personal experience of caring for a relative with
dementia, but the most successful volunteers were those who were ex-carers. Building on the BECCA
work, we focused on the involvement of family carers in the development of a peer-support programme in
which newer family carers are matched with and then supported by current or former family carers of
people with dementia who provide a listening ear, conversation and companionship, moral support and
signposting to useful organisations and services.
In developing the CSP package, we followed consensus methods involving principles of good practice
(i.e. clarity and transparency, respect, diversity, flexibility and accessibility) and meaningful involvement.35
Service users (people with dementia and their family carers) were involved in the development of the
intervention using two consultation methods, which are not commonly participated in by service users.33
As shown in Figure 18, these were a modified Delphi process and consensus conference to develop the
content of the intervention (study 1) and a consultation to develop and refine information and consent
documents (study 2).
Study 1: modified Delphi and consensus conference
Aim
To develop a peer-support intervention from the carer perspective in consultation with service users.
Design
A combination of a modified Delphi process132,133 and consensus conference134 was used to explore the
details of the peer-support programme from the carer and volunteer perspective. A combination was used
to allow participants to respond personally and privately, but also to provide an opportunity to discuss their
ideas and concerns.
Participants
Service users and stakeholders were approached through organisations with an interest in dementia, family
carers, peer support/voluntary work, NHS organisations and universities. Twenty-five people expressed
interest in taking part and completed round 1 of the modified Delphi process. Of these, 21 attended the
consensus conference. The delegates comprised eight current and former carers, seven members of
voluntary organisations supporting carers and people with dementia or representing volunteers, three
clinical health professionals, an academic specialising in the area and two others (did not specify). Round 2
was sent to the original 25 stakeholders as well as to an additional eight who had become involved as the
project progressed. In round 2 five questionnaires were returned from three former family carers (one of
whom had also worked with carers), one current family carer and one representative of a charity for
people with dementia and their carers.
DOI: 10.3310/pgfar05050 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 5
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Orrell et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
63
Aims and model of intervention 
protocol adapted by SHIELD 
research team to create basis 
of SHIELD CSP
Modified Delphi process and 
Consensus Conference conducted
to develop the SHIELD CSP 
intervention model
• Carers
• Volunteers
• Representatives of carer and/or
   voluntary organisations
• Local academics
Returned to research team by
post or e-mail prior to the 
conference
Selection of delegates:
Delphi round 1
Consultation on informed 
consent documents conducted 
to improve the suitability and 
readability of recruitment and 
consent materials
• Carers (from Dementia 
   UK panel)
• Persons with dementia
   (from Norfolk and North 
   Thames DeNDRoN panels)
Consultation packs sent to 
Dementia UK and DeNDRoN and 
distributed to interested members
of the panel
Returned directly to the research 
team by post
Selection of delegates:
Consultations
Comprising presentations 
concerning previous research 
and facilitated group discussions
Conference
Pre-funding development
Results incorporated into the SHIELD CSP intervention
 protocol and materials
Recruitment and consent 
materials adapted by SHIELD 
research team to suit SHIELD CSP
Discussion feedback and 
round 1 responses summarised
and sent to delegates along 
with an amended round 2 
questionnaire
Delphi round 2
BECCA intervention
(HTA 99/34/07;
ISRCTN08130075)
FIGURE 18 Model of consensus methods used in the development of SHIELD CSP (study 1, modified Delphi and
consensus conference). DeNDRon, Dementias and Neurodegenerative Diseases Network.
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Method
Three weeks before the conference, a round 1 Delphi questionnaire was sent along with copies of the
raft participant information sheets and related recruitment materials to provide context to the proposed
peer-support intervention. Delegates were required to complete the questionnaire before attending the
conference and either post it back to the research team or hand it to the team on the day. The questions
concerned the intervention name, the role of the peer supporter, the content and duration of training,
desirable peer-supporter characteristics, the criteria to be used to match peer supporters with family carers
(matching criteria), support for peer supporters and monitoring the matches for research purposes. These
items were developed by the research team with reference to the service user feedback for BECCA, along
with ideas and concepts trialled by other research groups in their work with peer supporters.135–137
During the conference, round 1 data were analysed and the results were presented for discussion. The
delegates were split into smaller groups, with careful consideration given to creating heterogeneous
groups, as these can be the most productive when aiming to explore uncertainties and develop ideas.133
Each group was given a question from round 1 to focus on, facilitated by a member of the research team
who made notes on a flip-chart. These notes were used to feed back to the larger group and were also a
record of the discussions held.
After the conference, the round 1 results were analysed in more detail with particular focus on identifying
areas in which consensus had not been reached. Each question was scored on a six-point Likert-type scale
measuring strength of consensus (where 1 = unimportant/unsuitable/unfeasible and 6 = important/suitable/
feasible). The delegates were also asked to rate their most preferred and least preferred options. The
responses to the question items were summarised as medians, with higher medians indicating higher
importance/suitability, as these are more robust than means and provide a better indication of distribution
of consensus as opposed to central tendency.133 Percentages were also calculated for most preferred and
least preferred options. By using these two response formats, it was possible both to understand the
extent of overall consensus (through most and least preferred options) and to assess the strength of
consensus by analysing the medians for each item. The scores from all of the delegates were given equal
weighting, regardless of perceived ‘expertise’, meaning that the responses of service users were equal to
those of other delegates working professionally in the area.
Items with the lowest medians (1 and 2) were excluded from round 2. Items with highest medians (5 and 6)
were also excluded because consensus was that these items should clearly be incorporated. Items with
median scores of between 3 and 4 were included in the round 2 questionnaire along with clarifying
information. This information was based on identified areas of confusion and disagreement from notes taken
during the conference. For instance, the difference between ‘giving advice’ and ‘sharing experiences’ was
raised as an issue during the conference as it was not clear as to how they differed in reality. An item had
been included on ‘giving advice’ to raise debate. ‘Advice giving’ had been explicitly placed outside the remit
of the BECCA befriending volunteers, given the potential legal ramifications of providing advice. However,
carers would often state that they would ‘value the advice’ of a more experienced peer. Definitions and
further information were provided in round 2 to set out some distinction. A summary of the consensus
conference discussions held were incorporated into round 2 and more space for open-ended responses
allowed delegates to clearly outline their views, reducing the need for a third round. Thematic analysis was
carried out for all open-ended responses. The analysis was inductive (data driven) with themes defined as
specific patterns of interest within the participants’ responses.138 A third round was found to be unnecessary
as disparate views had been resolved at the end of round 2. The results from rounds 1 and 2 (including the
thematic analysis of round 2 comments) are presented together to illustrate the delegates’ contribution to the
programme through the consensus process.
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Results
Name of intervention and intervention providers
The peer-support programme was planned at a time when the Expert Patient Programme was being
evaluated, and the parallel initiative for ‘Expert Carers’ was in development. The term ‘expert carer’ has
been used in different ways,139 but preliminary conversations with stakeholders made it clear that even the
most experienced family carers were uncomfortable with the ‘expert’ label. The programme was given the
working title ‘Experienced Carer Programme’, in which peers would be referred to as ‘experienced carers’.
As carers provide support to other carers, it was essential that service users were involved in naming the
intervention. The delegates were presented with a number of alternative names to describe the peer
supporters and were asked for further suggestions. The options included expert carer, mentor, buddy,
experienced carer and carer supporter. Round 1 indicated that delegates thought that peers providing the
intervention preferred the terms experienced carer and carer supporter (both medians = 5). Experienced
carer was the most preferred option (n = 7 of 12 responses; 58.3%), whereas buddy was the least
preferred option (n = 8 of 13 responses; 61.5%). The conference delegates also thought that experienced
carer and carer supporter would be the preferred terms for people receiving the intervention and both
received a median of 5, with experienced carer ranked as most preferred (n = 6 of 10 responses; 60%),
followed by carer supporter (n = 4 of 10 responses; 40%).
To reach an effective consensus (and allow time for discussion of the content of the intervention), a
nominal group technique was used.140 The delegates were asked to vote on potential names, including
those presented in the round 1 questionnaire and a series of names suggested by the delegates during the
nominal group. Two rounds of voting took place. In the second round carer supporter was most popular
with 15 votes, whereas experienced carer received eight votes. Carer supporter was preferred, as it more
accurately described the role of the volunteer, and former carers objected to the term experienced carer, as
‘experienced’ was a difficult term to define. On this basis, the intervention was renamed the SHIELD CSP.
The role of the carer supporter
The delegates were also consulted on the types of support the carer supporters should provide to help
to build the newer carers’ confidence in their caring role. The median scores were ≥ 5 for all items other
than specific training (median = 4) (Table 25). In round 1, ‘providing encouragement and moral support’
was rated as most important (n = 4 of 8 responses; 50%). The delegates were less certain about the
TABLE 25 Median scores for role of carer supporter (Delphi round 1; n= 19)
Role of carer supporter Median Interquartile range
Providing encouragement and moral supporta 6 0
Listening to carers’ experiences 6 0
Signposting to services and/or resources 6 1
Encouraging carer self-care 6 1
Talking about common challenges of caring for a person with dementia 5 2
Supporting problem-solving 5 2
Chatting about life outside/beyond caring 5 2
Meeting with both the carer and person with dementia 5 2
Specific training tasks/exercises to compete with newer carerb 4 1
a Most important option (n= 4 of 8 responses; 50%).
b Least important option (n= 4 of 7 responses; 57.1%).
Note
Six-point Likert-type scale (1 = unimportant; 6= essential).
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importance of carer supporters providing specific training or completing exercises from a ‘toolkit’ with the
new carer. This was echoed in discussions during the conference focusing on the importance of building
an open and flexible relationship based on trust, companionship and encouragement.
In round 2, respondents were asked more specifically about the use of a ‘toolkit’ consisting of optional
exercises that carer supporters could use during their meetings with carers to aid communication,136 such
as asking newer carers to talk about their role as carer and the obligations they may feel, the history of
their relationship with the person they care for, their social circle to identify ‘helpful others’ and any future
concerns. The results indicated that a toolkit was not popular (median= 2). Thematic analysis of open-ended
responses from former family carers revealed that that the role of the carer supporters should be to meet
the needs of the carer. This could be as simple as being there to listen, which was actually seen as being the
most important aspect of the role:
Not having someone to talk to is one of worst aspects of caring for someone with dementia. To have
opportunity to talk with someone else who is caring, or has cared, is very valuable.
ID [identification data] 2
As such, a toolkit would not help to build the relationship and, for this reason, specific tasks were not
incorporated into the SHIELD CSP intervention model at this stage but were discussed further with family
carers during the pilot training for carer supporters once the trial had started.
Training content, duration and techniques
The carer supporter training intended to provide a mix of good practice guidelines and support skills.
The research team suggested specific training topics to achieve this, such as information about dementia,
services and resources, supporting self-care, problem-solving and the use of ‘standard scripts’ to introduce
specific topics or tasks. In round 1 all items but one received a median score of > 5, and were seen as being
important aspects of training (Table 26). Responses from both the round 1 questionnaire and the consensus
conference discussions indicated that, although it was important to be an emotionally supportive peer, carer
supporters should also have a strong knowledge base about dementia and dementia services/resources.
TABLE 26 Median scores for training: content, duration and techniques (Delphi round 1)
Training Median Interquartile range
Topics for volunteer training (n= 20)
Information about dementiaa 6 0
Information about services and resourcesb 6 0
Supporting self-careb 6 1
Supporting problem-solvingb 5 1
Standard scripts to introduce specified topics or tasks/exercises (n = 19)c 4 3
Training techniques (n= 19)
Telling one’s own story of caringd 6 2
Additional readinge 5 2
Video/DVD examples of recommended discussion topics/exercisesf 6 1
a Most important option (n= 5 of 9 responses, 55.6%).
b Six-point Likert-type scale (1 = unimportant; 6= essential).
c Least important option (n= 7 of 7 responses, 100%).
d Most suitable option (n = 5 of 8 responses, 62.5%).
e Least suitable option (n = 5 of 7 responses, 71.4%).
f Six-point Likert-type scale (1 = unsuitable; 6 = suitable).
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In addition, delegates thought it was very important for carer supporters to be are aware of the boundaries
of their role and to be trained to be able to say no to inappropriate requests. The use of ‘standard scripts’ to
introduce specified topics or to help carer supporters ‘break the ice’ at initial meetings received a median of 4.
Comments on the questionnaires, along with discussion during the conference itself, revealed that delegates
were unsure of what standard scripts were.
Round 2 provided more explanation for this term ‘standard scripts’ and opinions were sought on whether
or not they would be useful. Opinion remained divided, with a range of scores between 1 and 4
(median = 1). Some thought that standard scripts could be a very valuable tool, particularly one former
carer who had also worked with family carers:
A standard script is extremely useful as a prompt to gaining all the required information. It is very easy
to miss something important when listening to a carer’s issues that may prove useful in working with
that person.
ID4
Others had concerns, such as one former carer who wrote:
If needing to resort to using standard scripts it could send out message about the lack of volunteers’
skills, confidence and above all sincerity. It is the sincerity and empathy that are so important.
ID2
Again, owing to the lack of consensus, it was decided that the use of standard scripts would be raised as a
topic for discussion during pilot training sessions.
Regarding the duration of the training programme, 19 (of 20) valid responses were received, of which
14 (73.7%) confirmed that six 2-hour modules were adequate; delegates also highlighted the need for
ongoing support and training. A range of techniques was planned for the training sessions, including short
lectures, discussions, illustrative examples and role-play, all of which had all worked effectively in the
BECCA training module. For the SHIELD CSP, other training techniques suggested for inclusion were telling
one’s own story of caring, additional reading and video/DVD examples. Only these three techniques were
included in round 1 because they had not been used in BECCA. Telling one’s own story and video/DVD
examples were both seen as very suitable (both medians = 6), whereas additional reading received a
median score of 5. After discussions during the conference it was seen as least suitable, as delegates raised
queries regarding its feasibility. This item was, therefore, retained for round 2 but opinions continued to
differ with scores ranging from 2 to 6 (median = 4), indicating that participants thought that it had limited
feasibility. As a former carer wrote in round 2:
Some [carer supporters] may be interested in becoming more knowledgeable by additional reading,
some may lose confidence if they feel they require and are required to have additional knowledge
before being considered as a supporter . . . For example, I am a book and research-oriented person;
I know other former carers who are excellent carers but not interested in serious study.
ID1
Another round 2 question asked, if additional reading was not feasible, whether or not it would be
appropriate for other material to be requested. It was unanimously agreed that this was the case.
A current carer summarised:
. . . not all carer supporters would like to do all recommended tasks. The information should be
available with details of resources and no compulsion.
ID3
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Carer supporter characteristics
To identify the type of carer supporter who could be most helpful to the newer carer, a list of characteristics
was presented for evaluation (Table 27). All delegates agreed that the ability to listen was absolutely essential
and this prompted the strongest response received from all items on the questionnaire, with all 19 responses
giving this a score of 6. A tolerant attitude (median 6) and being knowledgeable about dementia (median 6)
were also found to be essential. Advice-giving continued to be out of favour (median 4) but, surprisingly,
the sharing of experiences during meetings was also unpopular (median 4), even though one of the perceived
values of an experienced carer is that they have common or shared experiences. Delegates thought that
some carers may feel that the carer supporter was ‘taking over’, with the envisaged worst consequence being
that experiences may result in the carer supporter ‘off-loading’, thus adding to the family carers’ burdens.
Conference discussions revealed that delegates were unclear about the difference between using experience to
guide discussion and sharing personal experiences. Therefore, in round 2, the concepts of using and sharing
experience were defined more clearly. Using personal experiences was described as carer supporters using
their experiences to assist carers in problem-solving or signposting to useful resources but not to give advice
on courses of action. Sharing personal experiences was described as carer supporters talking about their own
personal caregiving journey. It was also made clear that training would explicitly cover the importance of
not ‘off-loading’. However, consensus was not reached as both approaches received a range of scores
(median= 4), perhaps indicating that the difference was not so clear. Thematic analysis revealed that, despite
the varying scores, all delegates thought that sharing experiences was vital as the basis of the SHIELD CSP
regardless of whether the question concerned sharing or using experience. As one former carer wrote:
Sharing experiences, exchanging information evoke a spirit of kinship among fellow carers and begins
the learning curve of dementia care and coping strategies and other life experiences of living
with dementia.
ID3
However, all had concerns about the risks associated with allowing carer supporters to share their
experiences, perhaps leading to these mixed views. In particular, a representative of a dementia
charity wrote:
After 17 years working with carers of people with dementia it is my experience that very few are able
to be objective about their own experience. If some time has passed . . . they may offer out of date
information, or allow a bad personal experience to colour the conversation.
ID5
TABLE 27 Median scores for carer supporter characteristics (Delphi round 1; n= 19)
Carer supporter characteristics Median Interquartile range
Ability to listena 6 0
Tolerant attitude 6 0
Keen to give advice 4 2
Keen to share their experienceb 4 2
Keen to use their experienceb 5 2
Knowledgeable about dementia 6 0
a Most important option (n= 5 of 8 responses; 62.5%).
b Least important option (n= 2 of 5 responses each; 40% for both).
Note
Six-point Likert-type scale (1 = unimportant; 6= essential).
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Comments from delegates stated that they thought that giving advice should be avoided. Although
delegates emphasised that using and sharing experiences could be useful in terms of signposting carers
to useful resources or simply conveying empathy, all thought that this would need to be very carefully
considered before being implemented. This discussion was taken forward to the pilot training.
Matching criteria
For the SHIELD CSP intervention to reach its full potential, newer carers needed to feel some warm and
genuine connection with the carer supporters. Previous research suggests peers and those they support be
matched on a set of criteria associated with personal constructs and characteristics.8 However, experience
from the BECCA programme29 highlighted the need for flexibility in making matches. To ensure balance
between theory and practice, and to generate ideas concerning the most important characteristics for
people to have in common, potential matching criteria were explored in round 1. Psychological health
(i.e. feelings of burden or mood state) was considered to be essential (median 5), along with view of
caregiving (i.e. as burden, challenge to face, problems to solve) (median 5). Being matched on marital
status (median 2) or employment status (median 1) were considered unimportant (Table 28), although
during the conference discussions the former was seen as an important criterion. Other matching criteria
such as sex, age, relationship to care recipient and geographical location did not result in a firm consensus.
One reason for this, suggested during the conference, was that certain criteria may be important to some
but not to all (e.g. matching according to sex). Further discussion during the conference led to the
proposal of hobbies, religious or ethnic origin, and type of dementia and age of onset as matching criteria.
TABLE 28 Median scores for matching criteria (Delphi round 1, n= 19; round 2, n= 5)
Matching
Delphi round
1 2
Median
Interquartile
range Median
Interquartile
range
Sex 4 2 5 2
Marital status 2 2
Employment status (including retirement)a 1 3
Age 4 1 4 1.5
Education 3 3
View of caregiving (e.g. as burden, challenge to face,
problems to solve)
5 3
Psychological health (e.g. sense of burden, mood state)b 5 3
Relationship to care recipient 4 2
Geographical location 4 2 3 4.5
Religious/spiritual views 5 3
Cultural/ethnic background 6 1
Interests/hobbies 2 3.5
Relationship to care recipient 3 4
Type of dementia 2 4
Age of onset 6 3
a Least important option (n= 2 of 7 responses; 28.6%) (round 1 only).
b Most important option (n= 2 of 6 responses; 33.3%) (round 1 only).
Note
Six-point Likert-type scale (1 = unimportant; 6= essential).
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In round 2, these criteria were explored further and consensus was reached that, where possible, carers
and supporters should have the option to be matched according to sex, religious/spiritual views, cultural or
ethnic background and, to a greater extent, relative’s age at onset of dementia. How sensitively such
differences in experience could be viewed was highlighted by a former carer:
If you have cared for someone with young onset, as I did, you are apt to get a bit irritated with
someone who cared for someone in their 80s. It’s not the same, as we share that sense of loss yes,
but not that of an ‘out of turn’ experience which is so distressing where young family and all the other
related issues come into play.
ID2
Delegates thought that matching according to interests and hobbies and type of dementia was not
important. Indeed, some thought that different interests could stimulate conversation and interest, and,
with good training, type of dementia would not be important. As one former carer wrote:
Supporter is providing companionship and moral support to someone who is tired, worn out and
isolated. The support is for the carer, not the patient.
ID1
There was less agreement on geographical location and relationship to relative. Despite consensus for the
majority of criteria, the decision was made to ask participants and carer supporters about the characteristics
that they would like to be matched on, as the point of matching was to achieve a warm and supportive
relationship. Indeed, this was found to be the most practical approach during the subsequent pilot trial of
the SHIELD CSP. Feedback from the organisers of the scheme indicated that matches were not made
according to a list of objective criteria, but on a judgement made by the managers as to whether or not a
pair would get on well. Thus, the criteria were seen to be useful in identifying and avoiding potential areas
of conflict, but were not used as the basis for making matches.
Ongoing support for carer supporters
Carer supporters needed to feel supported in their role, and delegates were consulted on the best methods to
achieve this. The research team suggested group meetings, individual face-to-face contact and additional
training, which were all approved by the delegates (median 6 for all). Additional comments from both round 1
and conference discussions confirmed that local co-ordinators should provide ongoing support, with more
frequent contact encouraged during the first 3 months of the 10-month intervention. In terms of the
frequency of contact, once per month was thought to be most appropriate (n = 10 of 19; 52.6%), although
during the discussions some suggested an ‘open door’ policy of support, which has since been adopted.
Monitoring matches for research purposes
The frequency and nature of contact between carer supporters and carers needed to be monitored to
assess how much intervention time the participants received. In round 1, delegates were consulted on the
best ways of accurately monitoring contacts while avoiding burdening the carer supporters. Methods such
as checklists, telephone contacts and diaries were suggested. Of these, regular telephone calls from the
local co-ordinator to the volunteer were judged as most feasible (median 6), whereas checklists were
second (median 5). Comments during the conference warned against time-consuming and burdensome
procedures, which may explain the lack of consensus on completing a diary (median 4). The decision was
made for carer supporters to complete a checklist of items, suggested during the conference, which would
be administered by a co-ordinator during regular telephone meetings.
Study 2: informed consent document consultation
Aim
These documents were necessary to enable participants to decide whether or not to take part in the
research trial with valid informed consent. The aim of the consultation was to ensure the appropriateness
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and suitability of the consent documents (recruitment leaflet and information booklets for carers and their
relatives with dementia) and improve readability of the documents.
Design
To manage time constraints and reduce the potential burden on readers, postal consultations were used.
The materials for consultation had been adapted from the BECCA study,29 so some materials were able
to be reused whereas others had to be newly developed. This is a novel approach to developing informed
consent documents, which has logistical and practical advantages over existing methods.
Participants
As carers and their relatives with dementia were involved in the SHIELD CSP, both groups took part in the
reader consultations. The consultations were anonymous and the packs were sent to readers by post. Family
carers were contacted through the Uniting Carers network of the charity Dementia UK. People with dementia
were contacted through the East Anglia and North Thames hubs of the Dementias and Neurodegenerative
Diseases Network (DeNDRoN), and were members of the Patient and Public Involvement Forum. In both
cases, the research team sent consultation packs to identified gatekeepers at each organisation who then
forwarded the packs to interested members of their participant involvement panels.
Method
Before beginning consultations, the research team incorporated the outcomes of the modified Delphi
process and consensus conference into the draft materials. Although the focus of the reader consultations
was on the recruitment leaflet and information booklets, draft consent forms were also included in the
consultation to show respondents what participants would be expected to decide on and, therefore,
the type of information the booklets should contain. Carers were asked to read the recruitment leaflet, the
information booklet for family carers and the consent form. People with dementia were asked to read
the information booklet for people with memory problems and the corresponding consent form. The
respondents were then asked to complete feedback forms that asked about the clarity of information about
the research study, what commitment would be required for taking part, information about right to
withdraw from the research study and the layout of the booklet. The respondents rated the clarity of
information on a 5-point Likert-type scale (where 1 = no/not clear, 3 = partially clear and 5 = yes/very clear).
The respondents were also asked about the overall quality of each document on a similar scale (where
1 = low, 3 =moderate and 5 = high). Space was also provided for respondents to write other suggestions
and comments. In total, 12 carer consultation packs and 12 person with dementia consultations packs were
distributed, with 6 and 11 packs returned, respectively.
Results
Median scores and interquartile ranges were calculated. Responses with median scores of 1–4 were taken
as being unclear or not as clear as possible, and actions were taken to amend these areas of concern.
Ease of readability and grade level of the leaflet and information booklets were also assessed using the
Flesch–Kincaid tests available in Microsoft Word® 2003 (Microsoft Corporation, Redmond, WA, USA).141
The Flesch–Kincaid Reading Ease test is based on the average number of words per sentence and the
number of syllables, taking into account the number of words about people in the passage, and the
number of sentences addressed to an audience. A score of 90–100 is considered easily understandable by
an 11-year-old, a score of 60–70 is considered easily understandable by 13- to 15-year-olds and a score of
≤ 30 is considered easily understandable by graduates.142 The Flesch–Kincaid Grade Level score rates text in
terms of US school years: a score of 8.0 means that an eighth-grade student (aged about 13 years) would
be able to understand the information, which is the recommended level of readability for standard
documents for the general population.143
Recruitment leaflet
Readers thought that the recruitment leaflet was very clear and that the layout was easy to read (median 5),
and they understood what the study was about (median 5). The details of the study were clear (median 5).
Readers were less certain about the type of participants the study aimed to recruit (median 4.5).
PEER SUPPORT AND JOINT REMINISCENCE FOR PEOPLE WITH DEMENTIA AND THEIR CARERS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
72
The overall quality score reflected these issues. The leaflet was rated as being high quality, but with some
potential shortcomings and room for improvement (median 4.5). Written comments helped to develop the
accessibility of the leaflet. For example, feedback indicated that there was too much white/blank space;
headings could be larger for more impact and enhance the leaflet’s readability. Finally, it was suggested that
black-and-white printing can be harsh on the eye and that glossy paper might soften the initial starkness. To
address these concerns, the text font was increased in size to reduce the amount of white space and increase
the impact of the headings, and glossy paper was used. Through the consultation process, the readability of
the leaflet increased slightly from 58.7 to 58.9 post consultation, whereas the grade level dropped from 9.2
to 9.1.
Family carer information booklet
Several elements of the booklet were rated very highly, and overall it was seen as being very clear and
detailed (Table 29). Importantly, the information concerning withdrawal and implications for participating
in the intervention were also clear. However, comments focused on layout and design rather than on
content, with some readers referring to the booklets as having a ‘daunting format’ and ‘rather clinical’.
The panel suggested more breaks between sections to make the booklet more user-friendly, and the
research team also added pictures to make the booklet less formal and more inviting. Before the
consultation, the information booklet had a Flesch–Kincaid score of 58.8 and a grade level of 10.4. After
the suggested changes were made, the Flesch–Kincaid score increased to 61.5 and grade level to 9.7.
Information booklet for people with memory problems
The booklet was rated ‘clear’ (median 4) but only the information regarding withdrawal from the study
was rated ‘very clear’ (median 5). Comments to improve the layout included presenting the booklet as an
invitation to participate rather than an extension of the family carer booklet, and to use the word
‘informal’ wherever possible to reduce the anxiety associated with official documents. It was also
highlighted that, in a booklet for people with dementia, the purpose of the study should appear at the
beginning of the booklet to help people retain the information. Comments indicated that the purpose and
role of carer supporters were not clear enough, and further clarification was required about what would
happen if the person with memory problems did not want to take part, and whether or not the carer
could still have access to the planned interventions (Table 30).
TABLE 29 Median scores for reader consultation: family carer information booklet (n= 6)
Question Median Interquartile range
Is the layout of the booklet easy to read? 4.5 3
Is it clear what the study is about? 5 1.25
Does it provide enough detail about the study to make an informed decision
about whether or not to participate?
5 1.25
Is it clear as to what will happen to the participant at each stage of research? 5 1.25
Does it provide enough information about what the participant is committing to
by consenting to take part?
5 0.50
Is it clear that the participants can withdraw from the study at any point without
affecting the care they receive from health or social services or their legal rights?
5 0.25
Is it clear that if the participant does withdraw from the research interviews, they
will no longer be able to receive any of the interventions?
5 0.50
How would you rate the overall quality of the booklet?a 4.5 3.25
a Five-point Likert-type scale (1 = low – serious or extensive shortcomings, 5= high – minimal shortcomings).
Note
Five-point Likert-type scale (1 = no, 3= partially, 5 = yes).
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As a result, the information booklet was made less formal and was styled more as an invitation. The
interviews were described as informal and the purpose of the study was presented first. A larger font was
used, and the role of a carer supporter was clarified along with reassurance that the carer could still be
involved in the study even if the person with dementia declined involvement. Before the consultation,
the Flesch–Kincaid score for the information booklet was 60.8, which increased to 63.7. In addition, grade
level decreased from 9.2 to 8.5.
Using the documents in practice
These documents were used in the pilot trial of SHIELD CSP resulting in a further round of amendments in
response to comments and concerns raised by participants during the pilot. Tables 31 and 32 show the
improvements made as a result of the reader consultations, but also show that there was very little
additional improvement made as a result of participant feedback during the pilot.
TABLE 30 Median scores for reader consultation: person with dementia information booklet (n= 11)
Question Median Interquartile range
Is the layout of the booklet easy to read? 4 2
Is it clear what the study is about? 4 2
Does it provide enough detail about the study to make an informed decision
about whether or not to participate?
4 1
Is it clear as to what will happen to the participant at each stage of research? 4 2
Does it provide enough information about what the participant is committing to
by consenting to take part?
4 2
Is it clear that the participants can withdraw from the study at any point without
affecting the care they receive from health or social services or their legal rights?
5 0
How would you rate the overall quality of the booklet?a 4 1.25
a Five-point Likert-type scale (1 = low – serious or extensive shortcomings, 5= high – minimal shortcomings).
Note
Five-point Likert-type scale (1 = no, 3= partially, 5 = yes).
TABLE 31 Flesch–Kincaid scores for consent documents
Type of document Original Post reader consultation Post pilot
Recruitment leaflet 58.7 58.9 58.5
Family carer information booklet 58.8 61.5 61.6
Information booklet for people with memory problems 60.8 63.7 63.7
Higher scores indicate that documents are more readable.
TABLE 32 Grade level for consent documents
Type of document Original Post reader consultation Post pilot
Recruitment leaflet 9.2 9.1 9.2
Family carer information booklet 10.4 9.7 9.6
Information booklet for people with memory problems 9.2 8.5 8.5
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It was noted that readers in the consultation reviewed the documents at an abstract level for meaning, flow
and format, whereas participants in the pilot trial reviewed the documents at the practical level to clarify the
information and weigh up the personal implications of participating. Both types of consultation are important
in developing consent documents, although the latter has little impact on the readability of documents.
Service users contributed to the development of the intervention in a unique way. Not only was the name
of the intervention changed as a result of their input, but their personal experiences provided insight
into the important elements of role of the carer supporter and identified important issues about carer
supporters adding burden to the carers participating in the trial. The service users went on to also propose
practical ways to manage the matches to reduce the likelihood of this happening. This contribution was
vital, and highlights the importance of involving service users in the development of complex interventions,
particularly when the intervention itself relies on peer support.
Limitations and implications for service user involvement
The consultation methods proved fruitful for developing the SHIELD CSP. The research team strove to
create an environment in which service users would feel empowered, which seemed to be the case for
study 1 but less the case for study 2. Anonymised methods of contributing, which may assume a level of
expertise or even comfort with the research process, are adequate and suitable ways to involve service
users in research when service users will have varying access to different levels of education and other
resources. Service users met face to face in study 1 but not in study 2, and it may be that they value
methods more that allow them to debate ideas with others. This may also serve to empower them and to
ensure that their contribution is experienced as, and seen to be, meaningful.
Conclusions
Often service users are consulted so as to improve a research grant, research methodology or therapeutic
intervention, but rarely have the opportunity to help determine specific research topics. Constraints on
research processes and resources may explain why much service user involvement is consultative.143 The
current report highlights ways in which service users can still be involved meaningfully while also highlighting
the negative impact that some methods can have on power relationships between researchers and
service users.
The contribution made by service users makes it more likely that the finally developed intervention will
have high levels of acceptability. This is likely to increase adherence and enhance uptake, both of which
are important in psychosocial intervention trials, and have been a challenge for many trials evaluating
interventions for family carers of people with dementia.
Work packages 2 and 3: exploratory trial and randomised controlled
trial of peer support and joint reminiscence for people with dementia
and their family carers – a factorial randomised controlled trial
Introduction
The peer-support intervention, namely the CSP, was based on self-efficacy theory and developed through a
review of the existing evidence base and consultation with key stakeholders (work package 1). Self-efficacy
is a person’s belief in their ability to perform competently and capably in given situations.144 A previous trial
of befriending for family carers of people with dementia (the BECCA trial)29 found no significant benefit
of listening support by trained volunteer lay workers, compared with TAU. However, the most ‘successful’
volunteer supporters were former family carers, which raises the possibility that peer supporters may have
advantages over general befriending volunteers.
Joint reminiscence has recently been evaluated in the REMCARE (REMiniscence groups for people with
dementia and their family CAREgivers) trial145 and did not identify any significant benefits for people with
dementia or their carers. Indeed, there was evidence of increased anxiety for the family carers. In the
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REMCARE trial, the main focus was on the person with dementia. In contrast, the current study includes
a greater carer focus. Furthermore, it was hoped that the combination of one-to-one peer support and
reminiscence would enhance the RYCT intervention by both encouraging the use of reminiscence and
improving communication techniques in the home.
The 2 × 2 factorial multisite RCT assessed both effectiveness and cost-effectiveness of (1) one-to-one peer
support for carers and (2) group reminiscence (alone and in combination) for people with dementia and
their carers, compared with usual care. Factorial design allows for the combination of treatments, and a
2 × 2 factorial design is in effect ‘two trials in one’. There is an assumption that there will be no interaction
between the interventions such that two main effects and one interaction term form the main analysis.
The three null hypotheses are:
1. there is no effect of CSP compared with TAU
2. there is no effect of RYCT compared with TAU
3. there is no interaction between RYCT and CSP.
Methods
Design
A 2 × 2 factorial, pragmatic, multisite RCT design was used. Participant carers were randomised individually
to carer support (CSP) or TAU after consent and baseline data collection, and then rerandomised on a
group basis to joint reminiscence therapy (RYCT) or TAU. This gave the four ‘cells’ of CSP, RYCT, combined
CSP-RYCT and TAU only. All participants continued to receive usual care. To ensure enough participants to
run viable RYCT groups, randomisations between TAU, RYCT, CSP and combined CSP/RYCT were in
the proportions 1 : 2 : 1 : 2. Stratification variables were used for each stage of randomisation. At first
randomisation, kinship within the dyad (spouses vs. offspring) and locality were used as stratification
variables. At second randomisation (2 : 1 reminiscence vs. no reminiscence), the first allocation was added
as a stratification variable to keep the four arms in balance. Follow-up data were collected 5 and 12 months
after the first randomisation, with the main end point at 12 months.
In accordance with MRC guidance on complex interventions,32 there was a feasibility phase prior to
expansion to full trial. The pilot trial ran in two London boroughs with the focus of the first site directed
towards appropriateness and acceptability of procedures, the second site focusing on logistics and timing
of the interventions in relation to the timetable for recruitment and research interviewing procedures.
Monitoring methods were developed in accordance with the draft checklist, and the outcomes of these
were systematically recorded alongside the recording of the implications for the main trial. Examples of the
monitoring methods used, outcomes of the monitoring process, and decisions made on the potential
pooling of pilot and full trial data have been described by Charlesworth et al.146 As the changes between
the feasibility and full trial were minimal, the feasibility phase was considered an internal pilot and data
were carried forward to the full trial.
Randomisation procedure
Figure 19 shows the flow diagram for the SHIELD CSP-RYCT trial. Administrators at each site entered
participants’ variables into a remote web-based randomisation, which then allocated them in equal
proportions between CSP and TAU on an individual basis. Once adequate dyads had been randomised
within each site (target 24, range 16–30), they were entered on a group basis into a second randomisation
between RYCT and TAU. The (unblinded) administrator at each site then informed carers of their allocation
by letter and liaised with the RYCT facilitator and/or CSP co-ordinator, as appropriate.
Blinding
Owing to the nature of the interventions, it was not possible to blind participants or providers to their
allocated intervention. In this trial, for example, both the CSP co-ordinator and the RYCT facilitator needed
to know which carers were allocated to the combined interventions. However, the research interviewers
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who assessed outcomes were blinded, mainly by their being denied access to the web-based management
system. The research interviewers recorded their perception of participants’ allocations for use as a
covariate in statistical analysis.
Ethics arrangements and research governance
Ethics approval was given by the Outer North East London Research Ethics Committee (09/H0701/54). The
clinical trial was registered as ISRCTN37956201. As per the previous studies, a reporting procedure was in
place to ensure that SAEs were reported to the chief investigator. The consent procedures were described in
the trial protocol.147 Three formal groups met regularly to manage the trial within the SHIELD programme:
the Project Management Group, the Programme Steering Committee and the Data Monitoring and
Ethics Committee.
Setting
The trial ran in community settings in England (four boroughs in North East London plus sites in Norfolk,
Northamptonshire and Berkshire).
Expressions of interest received
Screening for eligibility
Individual randomisation of dyads
Informed consent taken from 
family carers and persons with dementia
Baseline assessments conducted
Follow-up 2: at end of RYCT monthly reunions in area
 (approximately 12 months after randomisation)
TAU
RYCT TAU
CSP
CSP/RYCTCSP
Group randomisation of dyads
Follow-up 1: at end of RYCT weekly sessions 
(approximately 5 months after randomisation)
FIGURE 19 Flow diagram of the SHIELD CSP-RYCT trial.
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Participants
Eligibility criteria
All participants were adult (aged ≥ 18 years) carers for a relative or close friend living at home in the
community with dementia as defined by DSM-IV criteria.124 Carers were excluded if they or the person they
cared for had a learning disability or a non-progressive brain injury. Carers with a diagnosed terminal
illness were also excluded, as were those already taking part in another psychosocial intervention study.
Recruitment procedures
Recruitment took place in memory clinics, in outpatient clinics, with community psychiatric nurses,
admiral nurses, psychiatrists and GPs, and through carers’ registers, local media and online carer support
forums and websites. ‘Direct’ recruitment strategies included the use of leaflets, flyers, posters and oral
presentations at carer events. Strategies for newer and ‘hard-to-reach’ carers included invitations in local
papers and newsletters. Indirect recruitment strategies involved engaging with community health, social
services and voluntary sector staff who acted as ‘gatekeepers’ between the research team and potential
participants. Gatekeepers were briefed on eligibility criteria and provided with recruitment literature. The
contact details of potential participants were passed to the research team only with the consent of those
potential participants. At some sites, participants were recruited from research registers and research
network databases, where family carers and people with dementia had given their permission to be
approached about potentially relevant research. Interested carers were contacted by researchers who
provided further information about the trial and gave the opportunity for the carers to ask questions.
For those meeting the eligibility criteria, arrangements were made with them for a face-to-face interview,
with times and venues organised to accommodate the carer’s needs and preferences.
Sample size
Sample size calculations were based on the BECCA29 and REMCARE148 trials. These predicted effect sizes,
defined as average effect per participant divided by population SD, of 0.42 for CSP and 0.35 for RYCT.
In a 2 × 2 factorial design using a 2 : 1 allocation ratio in favour of groups receiving RYCT, a completed
sample of 240 dyads would yield power of > 90% to detect both main effects using a significance level of
5%. This design would also yield power of > 80% to detect interaction between CSP and RYCT equivalent
to an effect size of 0.4, using an analogous definition. As both the REMCARE trial platform and BECCA
retained some 80% of participants, the aim was to recruit 300 dyads in 13 rounds of 24 dyads to yield a
final sample of 240 dyads.
Interventions
Each intervention was organised and provided independently of the research assessments.
Peer support (SHIELD CSP) The focus of this intervention was on peer support for family carers by
family carers. The participant carers allocated to this intervention were contacted by a local carer supporter
co-ordinator who met to discuss the peer-support programme and to consider an appropriate match from a
pool of trained carer supporter volunteers with experience of caring for a relative with dementia. The carer
supporter co-ordinator then facilitated a first meeting between the supporter and supportee. The target
number of meetings for the carer support intervention was for 12 weekly meetings, each lasting 1 hour,
followed by fortnightly meetings for the next 5 months. The meetings took place in the carer’s own home or
in a public venue such as a café. Carer supporters were encouraged to provide a listening ear, encouragement
and morale support. They could also signpost the carer to resources and services but were explicitly requested
not to offer tangible support, ‘sitting’ for the person with dementia or direct advice. Meetings were arranged
to include or exclude the person with dementia according to the family carer’s preference.
Joint group reminiscence (RYCT) For dyads allocated to this intervention, both the family carer and
the person with dementia were invited to attend a local reminiscence group. Twelve weekly sessions,
each lasting 2 hours, covered themes ‘across the lifespan’, following Schweitzer and Bruce’s RYCT
programme.149 Each session explored its theme using multisensory triggers and activities, including group
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discussions, small group activity, handling objects, enacting or improvisation and singing songs. Each session
was led by two experienced facilitators, supported by a team, including volunteers, health and social care staff
and trainees, to facilitate small group discussion and activities, and engage the people with dementia. During
four of the sessions, the family carers met separately from the main group for approximately 45 minutes with
the aim of developing listening and communication skills, and considering how the activities and strategies
used in the sessions could be carried over into the home environment. The RYCT intervention ran in
community settings such as church halls, with transport provided if needed. After the 12 weekly sessions,
monthly reunion sessions took place over a further 7 months using previously successful themes or new
themes, depending on the preferences of the group. All members of the RYCT team attended a training day
led by one of the original RYCT programme authors.
Combined intervention (SHIELD CSP-RYCT) When participants were offered both contact with a carer
supporter and the opportunity to attend the RYCT programme, the carer supporter was asked to attend the
RYCT sessions ahead of individual meetings with the carer. These carer supporters were also invited to an
additional 2-hour training session on the topic of reminiscence at home, to enable them to better support
the family carer in implementing the strategies and advice provided during the RYCT carers’ sessions. The
aim of this intervention was to extend the benefits of RYCT through the carer supporters bringing
knowledge of the care dyad to the group, and encouraging reminiscence in the family carer’s home.
Treatment as usual
All participants continued to receive the usual care available in their area. All trial participants were given a
list of useful local resources, tailored to their area.
Intervention adherence and cost
The MRC Framework for Developing and Evaluating Complex Interventions32 recommends that researchers
monitor the extent to which interventions have been delivered to and received by the participants.150
Measures were designed specifically for this trial to capture:
l treatment delivery – the extent to which the intervention provider adhered to the treatment protocol,
the absence of any other intervention and the quality of the intervention
l treatment receipt – the extent to which the participant received the intervention, the intensity of the
intervention received and the satisfaction with that intervention.
To allow calculation of an estimation of the cost per dyad per session, the following information was
collected during the interventions. For CSP, information was collated by the carer supporter manager on
Microsoft Excel spreadsheets. These reported the time all carer supporters spent each month on travel and
training and on providing support to family carers. The spreadsheets for each site also included claims for the
volunteers’ expenses and time spent by the carer supporter co-ordinator on directly supporting each carer
supporter. The family carer’s identification data were recorded, as were the carer supporter’s identification
data. For RYCT groups the information recorded was team membership, including professional background
and grade (Agenda for Change band or similar), team members’ travel (mode and mileage) to the sessions,
team attendance at each session and the number of hours of staff time utilised per session including
travelling time. The external facilitator was usually allocated 1 day per session and other team members were
allocated between 3 and 5 hours per session. The programme ‘overheads’ which included the 1-day and
2-hour training sessions and attendance by the facilitator and team members, the overarching administrative
support, the costs for the venue, refreshments and other materials required for each programme such as a
camera, photographs and RYCT manuals.
Participant data-collection procedures
Once the carer and the person with dementia had consented to take part in the research, baseline data
were collected, with follow-up at 5 and 12 months post randomisation. For the family carer, psychometric
questionnaires were either completed with the researcher or self-completed, depending on the carer’s
preference. The questionnaire for the person with dementia was always completed with the researcher.
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To maximise data collection, variations in methods were made. For instance, some carers were interviewed
over several appointments and some carers completed the questionnaires by themselves and used the
included stamped addressed envelope to return them. Most carers were interviewed in their own homes;
however, neutral venues were organised for those who preferred an alternative location (e.g. NHS
settings). At follow-up, psychometric self-completion questionnaires were posted to participants along with
the covering letter confirming time and date of the follow-up interview to allow carers to complete the
questionnaire prior to the interview if they wished.
Measures
Demographic information was collected from family carers for both the carer and the person with
dementia, including age, sex, kinship, education and living situation. The nature of the carers’ social
network was assessed using the Practitioner Assessment of Network Type.151 The cognitive status of the
person with dementia was measured using the MMSE45 and an interviewer rating of the global functioning
of persons with dementia was made using the CDR scale.46 Information on use of health, social care,
voluntary sector and other relevant services for both the carer and person with dementia was collected
through interviews with carers, using the CSRI (see Resource use and cost measures).97
Primary outcomes
The primary outcome was the family carers’ health-related quality of life, measured by the validated and
widely used mental component summary (MCS-12) of the UK SF-12.152 The SF-12 measures general health
status from the perspective of the participant and, in addition to the MCS-12, also allows for the
generation of a second subscore, the physical component summary (PCS-12). The SF-12 includes eight
concepts commonly represented in health surveys: physical functioning, role functioning physical, bodily
pain, general health, vitality, social functioning, role functioning emotional and mental health. A higher
score is indicative of better mental and physical health. Reliability is 0.74 for the MCS-12 and 0.78 for the
PCS-12.152 Validity is 0.97 for the MCS-12 and 0.67 for the PCS-12.96
The primary outcome for the person with dementia was quality of life as measured by the QOL-AD.103
The measure assesses 13 items, namely physical health, energy, mood, living situation, memory, family,
marriage, friends, chores, fun, money, self and life as a whole. The 13 items are summed to generate a
total score of between 13 and 52. Responses range from poor (1), fair and good to excellent (4), with
higher scores indicative of better quality of life. It has good internal consistency, validity and reliability.89
The QOL-AD proxy was also completed by the carer, which is identical in structure and content to the
person with dementia version.
Secondary outcomes for family carers
l Health-related quality of life The EQ-5D98 comprises five items and a VAS. The measure includes five
dimensions of quality of life (mobility, self-care, usual activities, pain/discomfort and anxiety/depression),
with each dimension scored on a three-level scale ranging from 1, ‘no problem’, to 3, ‘extreme
problem’, and is used as the basis for calculating utility scores. It also includes a VAS on which
respondents are asked to rate their current health, ranging from 0 points (worst possible health state)
to 100 points (best possible health state).
l Anxiety and depression The Hospital Anxiety and Depression Scale (HADS)153 comprises 14 items, with
seven evaluating anxiety (e.g. ‘worrying thoughts go through my mind’) and seven assessing depression
(e.g. ‘I have lost interest in my appearance’). The HADS is scored on a 4-point scale ranging from 0 to 3,
with a higher score indicating higher levels of anxiety and depression. The scale also measures the severity
of anxiety and depression; the score for each subscale can range from 0 to 21. Cut-off points have been
used to indicate caseness, whereby a score of ≤ 7 indicates a non-case for both subscales, a score of
8–10 indicates a doubtful case and a score of ≥ 11 indicates a definite case. The HADS subscales have
been found to have good reliability and validity in a range of contexts and populations.153,154 Scores for
the entire scale (emotional distress) were also calculated, ranging from 0 to 42, with higher scores
indicating more distress.
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l Emotional loneliness This was measured using the 2-item Loneliness Scale.155 The questions used are
‘over the past 7 days, how much have you felt distressed by feeling lonely/feeling lonely even when
you are with people?’ Both items are rated on a 5-point scale from ‘not at all’ (0) to ‘extremely’ (4).
The scores of the items are summed to create a total loneliness score, with a range of between 0 and 8.
l Caregiver distress This was measured using the caregiver distress scale of the NPI.94 The NPI evaluates
the frequency and severity of 10 behavioural disturbances that can occur in dementia (delusions,
hallucinations, dysphoria, anxiety, agitation/aggression, euphoria, disinhibition, irritability/lability, apathy
and aberrant motor activity) and the associated distress experienced by the carer, rated from 0 (no
distress) to 5 (extreme or very severe distress) for each domain. The distress score total is calculated by
the sum of all the individual domain scores, with a range of between 0 and 60.
l Positive affect This was measured using the positive affect scale from the Positive and Negative Affect
Schedule.156 Participants rate the extent to which they have felt each of 10 positive mood states (e.g.
determined) within a specific time frame along a five-point scale ranging through ‘very slightly or not at
all’ (1), ‘a little’, ‘moderately’, ‘quite a bit’ and ‘extremely’ (5). Scores range between 10 and 50, with
higher scores indicative of greater positivity.
l Positive aspects of caring These were measured using the four-item positive aspects subscale from the
Carers of Older People in Europe (COPE) index.157 Responses are recorded from the categories never,
sometimes, often and always (or not applicable).
l Personal growth The 3-item version Personal Growth Index was used.158 Respondents report the
degree to which they agree or disagree with statements indicating feelings of personal growth on a
six-point scale from 1 (strongly disagree) to 6 (strongly agree). The Index score is obtained by summation of
the three item scores, ranging between 3 and 18. Higher scores are indicative of higher personal growth.
l Relationship quality The Quality of Caregiver–Patient Relationship (QCPR)159 comprises 14 items
measuring expressed emotion along two dimensions: level of absence of criticism and conflict, and
level of warmth. Responses are scored on five-point Likert scales ranging from ‘totally disagree’ to
‘totally agree’, with the criticism and conflict subscale items reverse coded so that a higher score
reflects a better relationship. Possible scores range between 14 and 70 and scores are dichotomised,
with scores of > 42 denoting a good relationship and those of ≤ 42 denoting a poor relationship.
Secondary outcomes for people with dementia
Secondary outcomes for people with dementia included the HADS, QCPR and EQ-5D, as also used with the
family carers. In addition, family carers gave a rating of the person with dementia’s functional capacity in
ADLs using the ADCS-ADL.95 The inventory comprises 23 items covering physical and mental functioning and
independence in self-care within the last 4 weeks. Each item consists of a series of hierarchical questions
designed to determine a person’s ability to perform one of the ADLs, ranging from total independence to
total inability. The total score is calculated by summation of item scores, ranging between 0 and 78. Lower
values are indicative of greater disability. The inventory has good reliability.95
Quality of life was also assessed using the DEMQOL,99 both the person with dementia version and the
carer-completed proxy version. The DEMQOL covers the domains of health, well-being, cognitive functioning,
social relationships and self-concept. Items are rated on a 4-point scale ranging from 1 (a lot) to 4 (not at all)
and summed to produce a total score. A higher score is indicative of better quality of life. The DEMQOL
comprises 28 items and scores range between 28 and 112, whereas the DEMQOL-Proxy comprises 31 items
and scores range between 31 and 124. It has high internal consistency (0.87) and acceptable inter-rater
reliability (intraclass correlation coefficient 0.84).
Measuring potential mechanisms action
Modelling of the stress process in family carers of people with dementia has indicated the value of
psychological and social resources in influencing carer outcomes. We therefore included measures of
coping,160,161 self-efficacy (Revised Scale for Caregiving Self-Efficacy),162 self-efficacy in responding to
challenging behaviours163 and social support.164
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Identifying resource use
The CSRI97 adapted for use in this study gathered information on health and social care services used by
participants with dementia and by their family carers. For the purposes of the trial the CSRI was completed
three times, on each occasion asking about service use retrospectively over the previous 3 months: at
randomisation to the trial (baseline), at 5 months after the first randomisation (after 3 months of weekly
intervention) and at 12-month follow-up. Carers identified services used by participants with dementia
covering the categories of accommodation, hospital services, community services, equipment and
adaptations, day services and medication use. Carers also provided records of their own medication use
and identified any other services used which fell in one of the other aforementioned categories. Unpaid
family carer inputs were also collected.
Data management and statistical analysis
Data were entered into MACRO for clinical trials. Data audits were carried out throughout the trial to check
ongoing data integrity. These audits were performed on a randomly selected 10% sample of data for each
site at each time point, to ensure that the data entered into the MACRO database were consistent with the
hard-copy paper questionnaires. Once data had been entered into the MACRO database and had been
screened and cleaned for any inconsistencies or errors, they were then transferred into SPSS. Further
accuracy checks were then carried out, such as manually checking for out-of-range values and scoring.
Handling missing data
When individual items were missing within scales or subscales, data were imputed before the calculation
of the scale or subscale score. Pro-rating within measures was undertaken at the 20% missing item level
(e.g. for a 5-item score if there was one item missing this was completed with the mean of the other
items). Multiple imputations at time points were conducted; however, no imputation was completed for
a dyad if all measures were missing at a time point.
Effectiveness analysis
As recommended for the analysis of a factorial design, an ‘at the margins’ analysis was carried out for the
two main effects of CSP versus not CSP (alone or in combination with RYCT) and RYCT versus not RYCT
(alone or in combination with CSP). The interaction term was also included in the analysis. A multilevel
ANCOVA was used with 12 months’ follow-up data as the dependent variable and with baseline score as
the covariable. Group allocation was treated as fixed effects, together with sex and dyad relationship. The
effects of locality (including personnel) and time were treated as random effects and the covariance structure
of this was assessed. A sensitivity analysis was performed to test whether or not plausible changes in key
variables, such as carers’ ages and relationships to their relatives with dementia, affected findings.
Intervention costs
Costs of the CSP intervention included staff costs and training for the volunteer carer supporters, plus
volunteers’ time and expenses. Each site employed a carer supporter co-ordinator for 1 day per week who
was part of either a NHS or a voluntary sector organisation. CSP intervention costs were allocated to each
family carer/dyad according to the amount of time the carer supporter spent supporting each family carer/
dyad, plus the costs of reimbursing volunteers’ travel. The unit cost for providing the carer supporter
training included trainer costs, costs of the venue, materials and refreshments, and cost of producing a
specially developed DVD. A manual (a 70-page spiral-bound book) was posted to each trainee carer
supporter and its development was undertaken during the staff time already identified. Time and expenses
data were sorted so that entries for each family carer/dyad were listed together and three ‘time’ totals
calculated over the period they received the intervention: (1) carer supporter time spent training, including
travel; (2) time spent by the carer supporter supporting the family carer, including travel; and (3) ‘other’
time, mainly when the carer supporter was in contact with the carer supporter co-ordinator (direct
support). Expenses and time were also totalled by family carer/dyad over the period they received the
intervention. Three values were used for volunteer time: £0 when a public sector cost perspective was
taken and two values for when a societal perspective was employed – a replacement cost (health-care
assistant) and an opportunity cost (minimum wage). Public sector costs based on the service-level
PEER SUPPORT AND JOINT REMINISCENCE FOR PEOPLE WITH DEMENTIA AND THEIR CARERS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
82
agreements constituted the ‘overarching’ costs associated with activities that allowed the intervention
(carer support) to be implemented: recruiting, organising, training and supporting the carer supporter.
For the RYCT intervention, staff costs were the major component and a unit cost (per hour) was estimated
for each team member employed by a health or social care agency or voluntary organisation. This included
the mean/median salary for that professional group/grade, additional salary on-costs such as employers’
National Insurance and superannuation contributions, and a proportion of the salary to cover direct and
indirect overheads. Using this cost per hour, a cost per session for each staff member was estimated and
their travel costs were added. Each time a particular member of staff was present at one of the sessions,
their unique staff ‘cost per session’ was included, allowing a total cost for any given session to be
calculated. Dyad transport costs were calculated separately and included the reimbursed transport costs for
each dyad attending at each session. The cost per dyad per session was calculated by dividing the total
cost per session by the number of dyads attending that session. The cost per session per dyad is mainly
driven by the number of dyads attending each session, but also by the number of team members present.
In turn, these figures were totalled for each participating dyad to arrive at a cost per programme per dyad
that varied depending on which sessions they attended. Thus, a unique cost for each dyad was calculated
which reflected how much of the intervention they received.
Costs of resource use
Unit costs were obtained so as to reflect long-run marginal opportunity costs, drawn where possible
from the Personal Social Services Research Unit compendium for 2011.100 We used a 3.5% discount rate
(as recommended by Her Majesty’s Treasury) for items that provide a benefit for > 1 year, such as equipment
or adaptations. Medication costs were obtained from the British National Formulary database.101 Costs for
equipment and adaptations to homes were obtained from market sources. Although it was possible to find
unit costs in 2011 prices for most items, for a very small number of services we used the Consumer Price
Index inflation rate to adjust costs to 2011 price levels.
The costs of unpaid family carer inputs were calculated in three ways, following the approach used for
volunteers. For the public sector perspective, a value of £0 per hour was employed. For the societal perspective,
the opportunity cost approach assumed that the unpaid carer would be able to find employment with a wage
rate equal to the national minimum wage (which was the hourly cost used in this calculation) and the
replacement cost was estimated as the hourly cost of a health-care assistant, under the assumption that a care
worker would need to be hired to provide care if the unpaid family carer was unable to do so.
Cost-effectiveness analyses
The primary economic evaluation estimated the incremental cost-effectiveness of:
l those in the sample receiving CSP compared with those who did not
l those in the sample receiving RYCT compared with those who did not
l CSP and RYCT combined compared with TAU.
For the primary analysis we adopted a societal perspective, with the main outcome measures being the
MCS-12 score of the SF-12 for the carer and QOL-AD for the person with dementia. The secondary
analyses adopted both a health and social care perspective and a societal perspective, with effectiveness
measured by the carer PCS-12 and QALYs estimated using EQ-5D for carers, and both DEMQOL- and
DEMQOL-Proxy-based QALYs for the person with dementia. As these analyses have many possible
combinations of outcomes, we followed the standard economic evaluation approach of extended
dominance. There were four potential results from each intervention group comparison. For instance:
1. the intervention is less costly and more effective (has better outcomes) than usual care (TAU), in which
case the decision-maker would be likely to be attracted to the intervention
2. the intervention is more costly and less effective than usual care (TAU), in which case it would be
unlikely that the decision-maker would consider the intervention over TAU
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3. the intervention is less costly but less effective than TAU
4. the intervention is more costly and more effective than TAU.
Results (1) and (2) are scenarios that exhibit strong dominance, and the recommendations made to the
decision-maker are typically straightforward. For results (3) and (4), however, the decision is not as
straightforward and decision-makers will need to weigh the potential outcome differences against the cost
differences before deciding whether or not to implement the new intervention. For these instances, we
estimated ICERs, defined as ICER = ΔC/ΔE, where ΔC denotes the difference in mean cost between the
interventions being compared and ΔE denotes the difference in the outcome measure between the two
interventions. These assist in providing a cost per unit of outcome for the outcome measure of interest.
Incremental costs and effects, and their CIs, were estimated with seemingly unrelated regression methods
with 1000 bootstrap replications. We plotted CEACs when necessary to show the probability that an
intervention is cost-effective relative to its comparator against a series of hypothetical WTP values.
One sensitivity analysis recalculated carer costs (used under the societal perspective) by adopting a
replacement cost approach. In this case the hourly cost of providing care was set to be equal to the
hourly cost of hiring a health-care assistant to provide care for the person with dementia: a replacement
cost approach.
Results
Participant flow
A summary of participant flow throughout the trial is provided in the CONSORT diagram (Figure 20).
In total, the research team received 640 expressions of interest from carers and 639 were screened for
eligibility. Of these, 292 family carers consented into the trial, with the remaining 347 carers excluded from
the trial. Of these, 177 carers were excluded for primary eligibility reasons, with the most frequent reasons
including that researchers were unable to contact the family carer (n = 66), time constraints (n = 33) and
that the person with dementia had recently passed away (n = 12). It is not possible to determine whether
or not those 170 who declined involvement would have been eligible for the trial. The reasons for
exclusion are shown in Figure 20. No demographic or psychosocial information was collected about
potential participants prior to their giving written informed consent. As a result, it is not possible to
determine whether or not those who decided to take part in the research differ from those carers who
decided not to take part in the research or were excluded from the trial.
Of the 292 family carers who gave informed consent to take part in the research, one withdrew before
randomisation. A total of 291 carers completed the baseline assessment and were randomised between
January 2010 and March 2012. Of the 291 dyads randomised, only 289 were included in the final analysis.
Two dyads were removed as there were no data recorded at any time point throughout the trial.
Follow-up interviews were carried out as soon as could be arranged after the interview due date, this
being 5 and 12 months post randomisation. A total of 253 family carers completed the first follow-up
(5 months post randomisation), whereas 36 dyads withdrew before the first follow-up, mainly as a result
of stress, poor health and time constraints. Two of the dyads were not available to complete the first
follow-up assessment, but were available to complete the second follow-up assessment. In total, 241 family
carers completed the final follow-up (12 months post randomisation) giving an overall 12-month retention
rate of 83%. However, loss to follow-up was slightly greater in the TAU group than in the intervention
groups (Table 33).
Baseline characteristics
Demographic information
Demographic information for family carers and people with dementia, for the total sample and by
allocated group, can be seen in Tables 34 and 35. Of the 289 family carers who took part in the research,
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Referred
(n = 640)
Screened
(n = 639)
Informed consent
(n = 292)
Randomised
(n = 291)
Completed follow-up 1
(n = 253)
Available for follow-up 2
(n = 255)
Completed follow-up 2
(n = 241)
Lost prior to randomisation
Excluded
(n = 347)
Primary eligibility reason
(n = 177)
Primary consent reason
(n = 170)
• Participant with dementia 
   deceased, n = 12
• Participant with dementia in care, n = 11
• Not caring for participant with 
   dementia, n = 2
• Paid carer, n = 3
• DSM-IV criteria not met, n = 4
• Time constraints, n = 33
• Out of area, n = 6
• Carer (physical) ill health, n = 7
• Carer cognitive impairment, n = 2
• Carer stress, n = 4
• Participant with dementia ill health, n = 5
• Involved in other research, n = 7
• Dementia not primary diagnosis, n = 4
• Carer does not want participant with
   dementia involved, n = 10
• Unable to contact, n = 66
• Missed recruitment deadline, n = 1
• Carer declined involvement, n = 170
Withdrawals
(n = 36)
• Carer stress, n = 8
• Carer stress and too busy, n = 3
• Carer stress and poor health, n = 1
• Declined further involvement, n = 12
• Too busy, n = 3
• Poor health, n = 3
• No benefit from the research, n = 3
• No benefit and too busy, n = 2
• Unable to contact, n = 1
Withdrawals
(n = 14)
• Carer stress, n = 7
• Too busy and not interested, n = 1
• No longer interested, n = 1
• No reason given, n = 1
• Unable to contact, n = 3
• Poor health, n = 1
Missed follow-up 1
(n = 2)
• Unable to contact, n = 1
• Carer poor health, n = 1
FIGURE 20 The CONSORT summary of participant flow.
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TABLE 33 Breakdown of participant retention by allocated group
Group Baseline (n) Follow-up 1 (n) Follow-up 2, n (%)
CSP 48 42 42 (88)
CSP/RYCT 97 84 80 (83)
TAU 47 39 36 (77)
RYCT 97 90 83 (86)
Total 289 255 241
TABLE 34 Baseline characteristics for family carers by allocated group
Characteristic Level
Total
(N= 289),
n (%)
CSP
(N= 48),
n (%)
CSP/RYCT
(N= 97),
n (%)
TAU
(N= 47),
n (%)
RYCT
(N= 97),
n (%) p-value
Sex Female 197
(68.17)
29
(60.42)
66
(68.04)
30
(63.83)
72
(74.23)
0.34
Ethnicity White British 258
(89.27)
45
(93.75)
84
(86.60)
39
(82.98)
90
(92.78)
0.18
Other 31 (10.73) 3 (6.25) 13
(13.40)
8 (17.02) 7 (7.22)
Marital status Married/cohabiting/
civil partnership
248
(85.81)
44
(91.67)
85
(87.63)
37
(78.72)
82
(84.54)
0.31
Relationship to
relative with
dementia
Spouse/partner 183
(63.32)
32
(66.67)
60
(61.86)
29
(61.70)
62
(63.92)
0.96
Live with relative Yes 230
(79.58)
39
(81.25)
78
(80.41)
40
(85.11)
73
(75.26)
0.55
Highest level of
education
School leaver (aged
14–16 years)
179
(61.94)
37
(77.08)
60
(61.86)
18
(38.30)
64
(65.98)
0.002
Further/higher
education
100
(34.60)
10
(20.83)
33
(34.02)
26
(55.32)
31
(31.96)
Age (years), mean
(SD)
66.68
(12.30)
69.04
(10.54)
65.84
(12.43)
66.81
(14.66)
66.30
(11.76)
0.48
Months since
diagnosis, mean
(SD)
31.25
(26.31)
29.64
(29.64)
20.65
(30.85)
25.53
(29.83)
26.08
(33.21)
0.94
Months of caring,
mean (SD)
52.52
(38.00)
58.81
(58.81)
38.08
(51.24)
42.28
(52.04)
36.17
(50.94)
0.43
PANT social
network
assignment
Family dependent 10
(20.83)
34
(35.41)
9
(19.15)
30
(31.58)
0.06
Locally integrated 13
(27.10)
32
(33.33)
16
(34.04)
29
(30.53)
Local self-contained 11
(22.72)
19
(19.79)
12
(25.53)
21
(22.11)
Wider community
focused
4
(8.33)
4
(4.17)
8
(17.02)
8
(8.42)
Private 10
(20.83)
7
(7.29)
2
(4.26)
7
(7.37)
PANT, Practitioner Assessment of Network Type.
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over two-thirds (68%) were female (68%) and their mean age was 67 years. Family carers were
predominantly white British (89%) and married or cohabiting (86%). Approximately two-thirds were
spousal carers and had school-only education. The mean duration of caring was > 4 years, with > 2 years
since diagnosis. The people with dementia had a mean age of 80 years. Just over half of the people with
dementia were female (54%). The majority were white British (89%) and married or cohabiting (69%),
and 8 out of 10 were residing with their carer. Only 2 out of 10 (21%) people with dementia had
completed further education. Alzheimer’s disease was the most common dementia diagnosis, followed
by vascular dementia, although a significant proportion had no specific diagnosis.
There were no significant differences between allocated groups in terms of demographics with the
exception of education for family carers, as those in the TAU group had achieved higher levels of
education. There was an indication that ethnicity varied between the groups, but there was greater
variation between localities, with the proportion of white British carers ranging between 71.7% in the
London Borough of Waltham Forest and 100% in areas such as Norfolk. These differences reflected the
ethnic differences of the local populations from which the participants were drawn.
Baseline psychometric measures
Scores on psychometric measures at baseline are shown in Tables 36 and 37. The groups are mainly
equivalent for people with dementia, with the exception of MMSE score where the TAU group was less
impaired than other groups. For the family carers, the groups were also equivalent at baseline, with the
TABLE 35 Baseline characteristics of persons with dementia by allocated group
Characteristic Level
Total
(N= 289),
n (%)
CSP
(N= 48),
n (%)
CSP/RYCT
(N= 97),
n (%)
TAU
(N= 47),
n (%)
RYCT
(N= 97),
n (%)
Sex Female 153 (53.68) 27 (56.25) 49 (50.52) 29 (61.70) 48 (49.48)
Ethnicity White British 253 (87.54) 46 (95.83) 81 (92.05) 37 (78.72) 89 (91.75)
Marital status Married/cohabiting/
civil partnership
196 (69.01) 34 (70.83) 68 (70.10) 29 (61.70) 65 (67.01)
Living situation Living alone 45 (15.57) 6 (12.50) 11 (11.34) 8 (17.02) 20 (20.62)
Cohabiting with
partner
194 (68.31) 35 (72.92) 65 (67.01) 29 (61.70) 65 (67.01)
Living in the community
with relatives, friends/
other people
45 (15.57) 7 (14.58) 21 (21.65) 7 (14.89) 10 (10.31)
Highest level of
education
School leaver (aged
14–16 years)
216 (77.98) 36 (75.0) 72 (74.23) 33 (70.21) 75 (77.32)
Further/higher
education
61 (21.11) 10 (20.83) 22 (22.68) 11 (23.40) 18 (18.56)
Type of dementia Alzheimer’s disease 134 (46.37) 28 (58.33) 40 (41.24) 20 (42.55) 46 (47.42)
Vascular dementia 49 (16.96) 7 (14.58) 20 (20.62) 5 (10.64) 17 (17.53)
Other/not known 106 (36.70) 13 (27.08) 37 (38.14) 22 (46.81) 34 (35.05)
Age (years),
mean (SD)
79.59 (7.87) 79.79 (8.19) 79.34 (7.54) 79.49 (7.31) 79.77 (8.36)
CDR 0.5 2 (4.17) 8 (8.25) 6 (12.77) 13 (13.40)
1 24 (50.0) 49 (50.52) 26 (55.32) 48 (49.48)
2 15 (31.25) 31 (31.96) 10 (21.28) 19 (19.59)
3 5 (10.42) 7 (7.22) 2 (4.26) 4 (4.12)
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exception of EQ-5D utility scores (higher in the RYCT/CSP group), positive affectivity score (higher in the
TAU group) and personal growth (higher in the TAU group).
Completers versus non-completers
A comparison of baseline characteristics using Fisher’s exact test and Mann–Whitney U-test of those dyads
who completed final follow-up with those who withdrew before final follow-up did not indicate any
significant differences. The baseline characteristics that were considered included carer sex (p = 0.74), age
(p = 0.12), ethnicity (p = 0.67), marital status (p = 0.62), carer/care recipient relationship type (p = 0.37),
living situation (p = 0.12), level of education (p = 0.76), type of dementia (p = 0.53), length of time spent
caring (p = 0.75) and length of time since the person with dementia was diagnosed (p = 0.56).
Intervention uptake and adherence
In the 49 dyads allocated to the CSP intervention there was a 76% uptake of the intervention, in the 97
dyads allocated to the RYCT intervention there was a 61% uptake of the intervention and in the 97 dyads
allocated to the combined intervention there was a 82% uptake of at least one of the interventions.
TABLE 36 Baseline measures of 289 family carers by allocated group
Outcome measure
CSP (n= 48),
mean (SD)
CSP/RYCT (n= 97),
mean (SD)
TAU (n= 47),
mean (SD)
RYCT (n= 97),
mean (SD)
SF-12 version 1 (UK)
MCS-12 38.42 (4.54) 38.28 (4.24) 39.90 (6.01) 39.12 (5.27)
PCS-12 30.33 (6.51) 30.07 (6.32) 32.24 (7.15) 31.59 (6.71)
EQ-5D
Your own health state today 74.44 (20.99) 74.27 (19.82) 63.64 (19.89) 68.1 (20.9)
Utility 0.76 (0.19) 0.83 (0.18) 0.73 (0.26) 0.75 (0.25)
HADS
Anxiety 6.86 (4.09) 6.29 (4.41) 6.51 (5.09) 6.68 (4.31)
Depression 5.13 (3.71) 5.41 (3.71) 5.15 (4.46) 6.48 (4.72)
Total (20%) 11.99 (7.06) 11.70 (7.67) 11.66 (8.81) 13.17 (8.28)
PANAS
Affectivity (20%) 31.77 (7.69) 30.53 (6.81) 34.05 (7.96) 29.43 (7.36)
COPE index
Positive aspects of caring (20%) 12.74 (2.16) 12.57 (2.42) 12.72 (2.30) 12.63 (2.20)
NPI
Carer distress 13.46 (8.91) 10.98 (8.63) 11.52 (8.64) 13.37 (13.46)
PGI
Personal growth 14.46 (3.14) 13.47 (3.36) 15.02 (3.10) 13.98 (2.91)
QCPR
Warmth (20%) 32.40 (4.94) 31.34 (5.60) 33.50 (5.00) 31.57 (5.39)
Lack of criticism and conflict (20%) 21.17 (5.05) 20.67 (4.61) 21.42 (4.27) 21.36 (4.82)
QCPR total (20%) 53.56 (9.22) 52.01 (9.56) 54.92 (8.43) 52.93 (9.28)
Loneliness 2.21 (2.04) 2.41 (2.49) 1.89 (2.36) 2.41 (2.40)
PANAS, Positive and Negative Affect Schedule; PGI, Personal Growth Index.
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Effectiveness results
The results of the primary intention-to-treat analysis for family carers (SF-12 MCS-12 at 12 months) and all
secondary outcome analyses are shown in Tables 38 and 39. There was no indication of benefit of either
peer support or reminiscence intervention over control on any of the outcome measures. There was no
indication of a significant interaction between the interventions.
There was some indication of impact on the person with dementia. There was a significant benefit to
quality of life as measured by the DEMQOL (p = 0.04) for those allocated to the CSP intervention. The
interaction term was significant for daily functioning (p = 0.02), quality of life as measured by the QOL-AD
proxy (p = 0.02) and anxiety (p = 0.05), indicating that the assumption of independence between the two
interventions was not valid.
Intervention
Costs
Table 40 reports the average costs per dyad for the CSP and RYCT interventions. The costs vary depending
on the perspective chosen, as there are carer inputs to the delivery of the interventions.
Costs of health and social care services
For the pre-baseline period, most of the health and social care-related costs were made up by community
care services, with an average of £1171 for a 3-month period, whereas (care-related) accommodation costs
TABLE 37 Person with dementia baseline outcome measures by allocated group
Outcome measure
CSP (n= 48),
mean (SD)
CSP/RYCT (n= 97),
mean (SD)
TAU (n= 47),
mean (SD)
RYCT (n= 97),
mean (SD)
QOL-AD
Self-report 37.07 (4.75) 35.60 (5.82) 37.55 (5.94) 36.72 (5.50)
Proxy 30.91 (6.01) 29.99 (5.89) 32.16 (6.81) 30.66 (5.35)
DEMQOL
Self-report 93.39 (12.37) 90.55 (13.38) 92.44 (11.19) 92.11 (12.33)
Proxy 89.29 (15.62) 94.38 (14.14) 93.50 (15.82) 93.75 (13.31)
EQ-5D
Utility value 0.74 (0.30) 0.73 (0.27) 0.82 (0.23) 0.72 (0.27)
Own health state today 76.22 (18.08) 70.41 (19.42) 76.42 (16.02) 69.60 (21.19)
HADS
Anxiety 3.76 (3.23) 5.01 (3.64) 4.27 (3.18) 4.52 (3.53)
Depression 4.73 (3.85) 5.62 (3.80) 4.74 (4.08) 5.37 (3.83)
Total 8.49 (6.27) 10.63 (6.32) 9.00 (6.28) 9.89 (6.27)
MMSE 16.34 (6.37) 17.53 (6.35) 19.74 (5.37) 16.32 (7.03)
ADCS-ADL total 42.00 (16.39) 41.16 (18.14) 44.25 (19.35) 42.17 (17.60)
NPI total 23.43 (17.70) 21.40 (16.94) 22.45 (17.17) 28.13 (22.34)
QCPR
Warmth 35.10 (3.12) 34.85 (3.46) 35.73 (2.84) 35.62 (3.22)
Criticism 23.42 (3.75) 22.58 (4.10) 22.90 (4.18) 22.74 (4.14)
Total 58.52 (6.11) 57.43 (6.56) 58.63 (5.96) 58.36 (6.41)
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contributed to a much smaller extent (£88). However, at final follow-up, the average quarterly expenditure
for residential care had increased to £1335. Hospital service use typically increased with time, with costs
averaging £301 at baseline and £410 at second follow-up. Costs of day-care services and medications barely
altered over time, averaging within the £200–300 range at both baseline and final follow-up. For the overall
12-month period, community services remained the highest contributor to total health and social care costs
(£4686), followed by accommodation costs (£3225) and hospital services (£1640). The smallest cost
component was adaptations and equipment (£269).
Comparing total health and social care expenditures for the person with dementia with those of the family
carer at baseline, the cost for the former was about 15 times higher (£2170 vs. £141). This gap was wider
at second follow-up (£3475 vs. £154: 23 times higher). For the total 12-month period, the average health
and social care costs were £12,497 for the person with dementia and £614 for the family carer.
The only adjusted differences in the distributions of costs between groups found to be significant at the
5% confidence level were residential and accommodation costs at first follow-up and for the whole
12-month period, for family carer at baseline and for some of the cost aggregates, which included
intervention-related costs.
Frequency of service use There was no difference in frequency of service use for either family carers or
people with dementia between intervention groups or TAU, although accommodation showed the most
variance between groups (p-values ranged between 0.10 and 0.15 depending on the time point). At baseline,
a small percentage of people with dementia used care accommodation and this percentage increased over
time, so that by final follow-up > 25% of some intervention groups generated accommodation costs. About
two-thirds of the people with dementia used hospital services at baseline, declining to around half at final
follow-up. At baseline, 95% of people with dementia made use of some sort of community service, this
percentage falling to 85% at final follow-up. At baseline, day services were used by half of the sample of
people with dementia, with this percentage remaining fairly stable between groups and time points. Every
person with dementia was receiving some form of unpaid family care at baseline, given the study design,
with this percentage remaining at ≥ 90% at final follow-up.
At baseline, the percentage of carers using health and social care services ranged between 38% and 46%,
depending on the treatment group, with this percentage declining slightly at final follow-up. About two-thirds
of carers reported using medication, whereas for the people with dementia the mean was about 90%.
TABLE 40 Cost per dyad for CSP and RYCT interventions from health and social care and societal perspectives
Intervention Perspective and cost assumption
Cost per dyad (£)
Mean Median Range
CSP Health and social care 2136 1143 32–12,249
Societal; replacement cost 2837 1817 36–14,489
Societal; opportunity cost 2339 1390 33–12,782
RYCT (12 week) Health and social care 1661 1704 0–5419
Societal; replacement cost 2165 2300 0–6382
Societal; opportunity cost 1785 1839 0–5652
RYCT reunion sessions Health and social care 551 454 0–1854
Societal; replacement cost 770 771 0–2146
Societal; opportunity cost 604 583 0–1924
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Cost-effectiveness analysis Table 41 displays the incremental costs, incremental effects (both measured
over 12 months) and ICERs for the two primary outcomes: MCS-12 for carers and QOL-AD for people with
dementia. Results are shown from three perspectives: two societal perspectives using (in turn) opportunity
cost and replacement cost approaches to value unpaid care, and a health and social care perspective,
which does not include unpaid care. This analytic strategy was repeated for the secondary outcomes:
PCS-12 for carers and QALYs for people with dementia derived in turn from the EQ-5D, DEMQOL and
DEMQOL-Proxy measures. These results are shown in Table 42.
Cost-effectiveness using carer outcomes For carers, none of CSP, RYCT or CSP/RYCT combined appears
to be cost-effective compared with its respective comparator, whatever the study perspective.
Looking at the primary outcome for carers (MCS-12) and taking the primary perspective (societal with
opportunity cost values), both RYCT and CSP/RYCT combined are dominated; that is, they are less effective
and have higher costs than their respective comparators. CSP alone had marginally better outcomes and
higher costs (although neither was significantly different), with the resultant ICER suggesting that the cost
for a 1-point improvement on the MCS-12 is £8601. There is no external threshold with which to compare
this ICER, but it looks high given that MCS-12 scores can range from 0 to 100.
The findings are the same under a health and social care perspective: RYCT and CSP/RYCT combined are
dominated – indeed, the combined intervention is significantly more costly than TAU – and CSP has a
high ICER.
Recalculating carer costs using a replacement cost approach, CSP still has a high ICER and CSP/RYCT
combined is dominated. RYCT significantly reduces costs but has worse outcomes than its comparator
(the ICER is £6914 for each 1-point worsening on the MCS-12). Given that neither the cost nor the
outcome difference in this case is significant – and that the ‘cost reduction’ is the imputed value of carer
time, and therefore not easily transferable as a ‘saving’ for use elsewhere in the system – it is unlikely that
the decision-maker would choose RYCT in these circumstances.
The two secondary outcomes for carers were PCS-12 and QALYs generated by the EQ-5D. Looking first
at PCS-12 and taking the primary perspective (societal, opportunity cost assumption), both RYCT and
CSP/RYCT combined are dominated by their comparators. CSP has higher costs but better outcomes than
not CSP (although neither achieves significance) and the ICER appears high at £4920, although there are
no established thresholds for PCS-12 against which to compare this figure.
The findings are similar under a health and social care perspective: RYCT and CSP/RYCT combined are
both dominated, and in fact each has significantly higher cost than its comparator, whereas CSP has an
ICER value (£3578) likely to be considered high.
Under a societal perspective with replacement cost values for carer time, CSP/RYCT combined is dominated
by its comparator (TAU). RYCT has lower costs but worse outcomes (although neither is significant). In a
similar vein to the earlier argument, this finding is unlikely to encourage the decision-maker to choose RYCT
over non-RYCT because the differences are not significant, and the ‘saving’ is in the ascribed value of carer
time that is not easily transferred to another use in the care system. CSP has slightly better effectiveness on
PCS-12 than not CSP but also higher costs (although neither is significant) and the ICER appears high.
Using QALY as an outcome measure, whether measured using EQ-5D (for carers) or DEMQOL or
DEMQOL-Proxy (for people with dementia), is helpful in cost-effectiveness analyses because it is then
possible to compare an estimated ICER value (when adopting a health and social care perspective)
with thresholds recommended by NICE, usually quoted as £20,000 per QALY gained.
From both a societal perspective (opportunity costs) and health and social care perspectives the findings
are the same: CSP has (non-significantly) higher costs and (non-significantly) lower costs than not CSP
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(with ICERs considerably greater than the NICE threshold) and both RYCT and CSP/RYCT combined are
dominated by their comparators. (The QALY difference for RYCT is small but statistically significant,
and under a health and social care perspective RYCT also has significantly higher costs.)
From a societal perspective (replacement costs), CSP is again unlikely to be seen as cost-effective given its
high ICER. RYCT generates significantly lower QALYs than not RYCT but also reduces costs, and for the
reasons noted earlier is unlikely to be seen as the preferred option. CSP/RYCT combined is dominated
by TAU.
Cost-effectiveness using outcomes for people with dementia The primary outcome measure for
people with dementia was QOL-AD. CSP is dominated by not CSP when adopting any of the perspectives
and costing approaches. RYCT had marginally but not significantly better effectiveness on this measure,
higher cost from the societal perspective with opportunity cost and also the health and social care perspective
(with cost difference being significant), and marginally but not significantly lower cost from the societal
perspective with replacement cost assumptions. There are no established thresholds against which to
compare ICER values for QOL-AD. The CEAC (Figure 21) suggests that RYCT is cost-effective across a wide
range of WTP values. For comparison, the CEAC in Figure 22 is for the same comparison but now from a
health and social care perspective: RYCT is not cost-effective. CSP/RYCT combined has high ICER values
under two perspectives and, under the other (societal with replacement costs), the estimated CEAC
(Figure 23) does not suggest that it would be seen as cost-effective.
The secondary outcomes for people with dementia were QALYs measured by DEMQOL and DEMQOL-Proxy.
From a societal perspective (opportunity costs), CSP is not cost-effective by reference to either measure,
as ICER values are all considerably above the NICE threshold. RYCT is dominated by its comparator using
DEMQOL, has a high ICER (£141,665 per QALY) using DEMQOL-Proxy and is not cost-effective. CSP/RYCT
combined is not cost-effective, as the ICERs are again considerably above the NICE threshold.
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FIGURE 21 Cost-effectiveness acceptability curve for RYCT, using QOL-AD as outcome, from a societal perspective
(replacement cost assumption).
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FIGURE 22 Cost-effectiveness acceptability curve for RYCT, using QOL-AD as outcome, from a health and social
care perspective.
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FIGURE 23 Cost-effectiveness acceptability curve for CSP-RYCT combined, using QOL-AD as outcome, from a
societal perspective (opportunity cost).
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From a societal perspective with replacement costs, CSP is not cost-effective. RYCT is not cost-effective
using DEMQOL, but dominates not RYCT using DEMQOL-Proxy and is cost-effective. CSP/RYCT combined
has a very ICER using DEMQOL and, although the ICER is much closer to the NICE threshold using
DEMQOL-Proxy (although the comparison is not so relevant given the perspective), the CEAC (Figure 24)
does not suggest cost-effectiveness as the curve barely gets above the 0.5 probability level, even at high
WTP values.
From a health and social care perspective, none of the interventions is cost-effective.
Bringing these cost-effectiveness results together:
l CSP is not cost-effective whether considering outcomes for carers or outcomes for people
with dementia.
l RYCT is not cost-effective when considering outcomes for carers or most outcomes for people with
dementia. It is cost-effective when looking at the QOL-AD measure and from a societal perspective
with replacement costs, but this was not the primary perspective chosen for the analysis before the
trial began.
l CSP-RYCT combined is not cost-effective when considering outcomes for carers or outcomes for
people with dementia.
Discussion
In this trial we had made some adaptations to both interventions to increase the awareness of intervention
providers to the needs of family carers. These changes led to greater acceptability of the one-to-one
support intervention, as 76% carers offered peer support took up this offer, much higher than in the
BECCA befriending intervention.
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FIGURE 24 Cost-effectiveness acceptability curve for CSP-RYCT combined, using QALYs from DEMQOL-Proxy as
outcome, from a societal perspective (replacement cost).
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Overall, the groups were well matched at baseline. However, given the significantly higher MMSE score for
the TAU group at baseline, a sensitivity analysis was carried out in which the MMSE score was taken into
account. The results continued to show a significant benefit to the person with dementia on quality of life
for those whose family carers had CSP.
The overall recruitment and retention met targets, and differences in group sizes were anticipated owing
to the 2 : 1 allocation ratio in favour of RYCT. The group sizes varied from those expected owing to
differential withdrawal rates between the groups. Although the overall retention rate was 83%, only 77%
of those allocated to usual care were available at follow-up.
The intention-to-treat analysis of primary and secondary outcomes at the primary end point (12 months
post randomisation) showed no benefit to family carers of either intervention. In contrast, people with
dementia whose family carers were in the CSP arm of the trial reported significantly higher quality of life
than those who were not in receipt of one-to-one peer support, and the interaction between CSP and RYCT
was significant for a number of outcome variables for the person with dementia. The finding of increased
anxiety for those carers receiving reminiscence was not replicated.
With one exception, the economic evaluation did not find CSP, RYCT or the combined intervention to be
cost-effective. The exception was that RYCT was more cost-effective than its comparator when looking at
the QOL-AD measure for people with dementia. But this was only when adopting a societal perspective
with replacement costs, an approach that attaches quite a high value to the unpaid time of family carers,
and which was not the primary perspective chosen a priori for the economic analysis. Overall, therefore,
we did not find evidence that the interventions were cost-effective.
The results of this trial should be considered generalisable within the UK as participants were drawn from a
wide range of community settings including those already well embedded in services and also new users of
health and social care services for people with dementia and family carers. There was a higher proportion of
non-white carers and people with dementia than was recruited to either BECCA or REMCARE.
The factorial trial design presents challenges to the interpretation of results for a number of reasons. First,
by allocating participants to carer support (CSP), reminiscence (RYCT), a combination of the two (CSP/RYCT)
or usual care, and by reporting the baseline characteristics of these four groups, we give the impression
of a four-arm trial in which three interventions (CSP, RYCT and CSP/RYCT) are each compared with TAU.
Reporting the baseline scores for each of these four groups highlights some potential differences between the
intervention groups and usual care (TAU). However, in the analysis, the only place in which the TAU group is
used is in the cost-effectiveness calculations, when CSP/RYCT is compared with TAU. In all other analyses the
four groups are collapsed into two. For the CSP analyses, those allocated to receive carer support either with
or without RYCT are compared with those who are not allocated to receive carer support (i.e. including those
in the RYCT arm) and, for the RYCT analyses, those allocated to receive RYCT either with or without carer
support are compared with those who are not allocated to receive RYCT (i.e. including those in the CSP arm).
Second, when carrying out the statistical analysis there is an assumption that the two interventions do not
interact. In this trial, however, we were anticipating added benefit to those carers and people with dementia
who were allocated to the combined CSP/RYCT intervention. Indeed, the interaction terms were significant
for a number of the outcome variables for the person with dementia, indicating that the main effects (in this
case non-significant) should be interpreted with caution.
The data collected in this trial include a comprehensive set of measures on coping and social support, the
secondary analysis of which will increase our understanding of the interplay of these variables. In particular,
by collecting information from both family carers and people with dementia we have the opportunity to
carry out analyses at the level of the dyad. This is something that has been long called for, but as yet rarely
executed in the field of dementia care. Multilevel analyses are becoming increasingly popular in other fields
in which interactions within the dyad influence the outcomes of each member of that dyad.
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Conclusions
There is no indication of benefit to carers of providing one-to-one peer support or group reminiscence
sessions. However, there is an indication that group reminiscence has the potential to be effective in
maintaining the quality of life of people with dementia, but not cost-effective as the cost per QALY is
considerably above the NICE threshold. Using a factorial design requires the assumption that interventions
are independent of each other, but the finding of significant interactions between the two main effects
meant that this assumption of independence was violated. However, the study was not adequately
powered for an analysis of each intervention with TAU.
For more information on the SHIELD carer supporter manual, please contact the R&D office at NELFT or
e-mail SHIELD@nelft.nhs.uk.
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Chapter 4 Home treatment programme:
development of a home treatment package for people
with dementia and their family caregivers
Background
There is growing recognition of the need to provide alternatives to hospital admission for older people in
both general and psychiatric settings, particularly for those with dementia,165 in whom crises often lead to
reduced quality of life and admission to either hospital or a care home. A recent study showed that 42%
of individuals aged > 70 years with unplanned admission into an acute hospital had dementia, rising to
48% in those aged > 80 years.166 People with dementia can be difficult to discharge from hospital and
often have longer stays than those without.166 Older people with mental health problems were generally
excluded by the home treatment services developed in the wake of the National Service Framework for
Mental Health,167 and those with mental illness by the intermediate care services established following the
recommendations of the National Service Framework for Older People.4 Studies of HTTs for physically ill
older people have shown that these services help to reduce the number of acute admissions and length of
hospital stay.168,169
Objective
The HTP will develop a model of intensive home support to help manage crises at home and prevent
admission to hospital for people with dementia.
Work package 1: Cochrane review/systematic reviews
A systematic review and meta-analysis evaluating the effectiveness and
impact of case/care management approaches to home support for people
with dementia
A systematic review and meta-analysis evaluating the effectiveness and impact of case/care management
approaches to home support for people with dementia was conducted with the Cochrane Collaboration
Cognitive Impairment and Dementia group, based in Oxford, UK.169,170 Case management can be defined
as a strategy for organising and co-ordinating care services at the level of the individual patient, with the
aim of providing long-term care for people with dementia as an alternative to admission to a care home or
hospital. The review followed the Specialised Register of the CDCIG, called ALOIS. This yielded 139 studies,
of which 11 were RCTs meeting the inclusion criteria. An updated search in February 2012 identified a
further two studies which were also included. The analysis comprised 9615 subjects.
Objectives
Primary objective
To evaluate the effectiveness of case management approaches to home support for people with dementia
from the perspective of the different people involved (patients, carers and staff), compared with other
forms of treatment including TAU, standard community treatment and other non-case management
interventions, on delaying institutionalisation, improving quality of life and/or reducing the number of
hospital admissions.
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Secondary objective
To study whether or not other potential mediating variables affect case management outcomes (e.g. key
structural and organisational features of case management interventions and also the methodological
characteristics of studies).
Review methods
Protocol and registration
The protocol was registered with The Cochrane Library (http://archie.cochrane.org).
Criteria for considering studies for this review
Randomised controlled trials of case management interventions for people with dementia who lived in
the community and their carers were included, if they had been published and written in English, peer
reviewed and presented in a journal article. Authors were contacted for missing data, such as details of
randomisation, means and SDs.
Search methods for identification of studies
The search methods included a combination of the search terms patient care management, case
management, intensive case management, care management, managed care programs, care co-ordination,
care pathway and managed care, which were used to search ALOIS, Specialised Register of the CDCIG and
EPOC (Effective Practice and Organisation of Care) register between November and December 2008, and
was updated in February 2012. The studies were identified from the Specialised Register of the CDCIG. This
register contains records from the following major health-care databases: The Cochrane Library, MEDLINE,
EMBASE, PsycINFO, CINAHL and LILACS, as well as ongoing clinical trial databases and other grey literature
sources for the most recent records. We contacted the first authors of important identified RCTs that were
potentially suitable for inclusion to request additional information on related new, unpublished or in-press
studies that had not been identified in the main search. We also cross-checked the reference lists and
citation reports of trials and relevant systematic reviews as identified by the above methods. Additional
searches were made of the following sources: Web of Science [including Science Citation Index Expanded
(SCI-EXPANDED) and Social Science Citation Index] and the Campbell Collaboration/SORO database. We
also searched the Specialized Register of the Cochrane Effective Practice of Care Group using the search
terms dementia OR demented OR Alzheimer in any fields. A total of 10,440 references were retrieved from
the November 2008 initial search. After deduplication and a first assessment, the authors were left with
145 references to further assess for inclusion and exclusion or discard.
Participants
Participants were any age and sex with a diagnosis of dementia (Alzheimer’s disease, vascular dementia or
mixed Alzheimer’s and vascular dementia, other types of dementia) who lived in the community (excluding
people in institutions receiving 24 hours of care), and their carers. Studies which focused on patients only
or both patient and carer dyads were included, whereas those which focused exclusively on carers were
not included.
Intervention
Participants received any case or care management intervention delivered in the community (not in
hospital/residential care settings). Interventions were screened to ensure that they predominantly focused
on the planning and co-ordination of services. The intervention needed to be compared with TAU,
standard community treatment, other non-case management or waiting list controls.
Outcome measures
Outcomes related to either patients or to patient–carer dyads and were grouped into short- (6 months),
medium- (10–18 months) and long-term (24–36 months) time points. For the person with dementia, the
outcome measures needed to record levels of institutionalisation (admissions to hospital or care homes and
length of stay), mortality, quality of life and assessment of any of the following variables: cognition,
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behaviour, mood, ADLs, service use and cost. Family caregiver outcomes such as self-reported quality of life,
burden or distress, depression and anxiety, social support and satisfaction with the intervention were
considered. Cost and attrition were recorded when available. Studies which focused exclusively on carer
outcomes were not included.
Data collection and analysis
Searches were conducted as detailed above to identify all relevant published studies. The date and time
of each search, together with details of the version of the database used, were recorded. Additional
information was sought, as outlined above, and hard copies of articles were obtained.
Quality assessment
Three reviewers independently screened the identified RCTs for inclusion and the final list of included
studies was reached by consensus. Trials not meeting the criteria were excluded. The studies were assessed
against a checklist of quality requirements using the Cochrane approach (see Figure 22), as follows.
l Grade A: ‘low risk’ – adequate concealment (randomisation; concealed allocation).
l Grade B: ‘unclear risk’ – ‘randomised’, but methods uncertain.
l Grade C: ‘high risk’ – inadequate concealment of allocation or no randomisation, or both.
No studies were excluded because of poor quality in the review. Again, the reviewers worked
independently to ascertain which studies met the quality criteria, and consensus was reached through
discussion. Attempts were made to obtain additional information from the study authors when needed.
Data extraction
Descriptive characteristics (such as quality of randomisation and blinding) and study results were extracted,
recorded and entered into RevMan 5.1. Additionally, letters and e-mails were sent to some authors of
controlled trials asking for essential and additional information (e.g. statistics, sources of bias and details of
randomisation). The summary statistics required for each trial and each outcome for continuous data were
the mean change from baseline (if reported), the SD of the mean change and the number of patients for
each treatment group at each assessment. The baseline assessment was defined as the latest available
assessment prior to randomisation, but no longer than 2 months to after randomisation. Categorical
responses were extracted for categorical outcome data (e.g. admitted to hospital/not admitted). For the
meta-analysis of follow-up data, the most frequently assessed time points were combined across trials
(3, 6, 12, 18 and 36 months). To allow an intention-to-treat analysis, the data were sought irrespective of
compliance, whether or not the patient was subsequently deemed ineligible or otherwise excluded from
treatment or follow-up. If intention-to-treat data were not available in the publication, ‘on-treatment’ data
were sought (i.e. the data of those who completed the trial). Discussion between the three reviewers and
the other authors was used to resolve any queries.
Data analysis
RevMan 5.1 was used for the meta-analysis. The meta-analysis required the combination of data from trials
using the same rating scale/test or a different rating scale/test to assess an outcome. The measure of the
treatment difference for any outcome was the weighted mean difference when the pooled trials used the
same scale and the SMD, the absolute mean difference divided by the SD, when different rating scales
were used. Summary statistics (n, mean and SD) were required for each rating scale at all assessment points,
for both treatment groups in each trial for change from baseline. For continuous data (or ordinal data
approximating a normal distribution), the mean change from baseline, the SD and the number of patients for
each treatment group at all assessments were analysed. For binary outcomes, such as clinical improvement or
no clinical improvement, the odds ratio was used to measure treatment effect. The treatment differences
from both fixed- and random-effects models were examined and a test for heterogeneity was performed
using a standard chi-squared statistic and an I2-statistic. When a significant degree of heterogeneity was
present, a random-effects model was preferred. The reviewers achieved consensus on the interpretation of
the statistical analyses, seeking specialist statistical advice from the CDCIG as required. Non-randomised
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studies were described in tabular form and the reviewers discussed and reached consensus on the
presentation of the findings in the background to the review.
Studies included in the review
One hundred and forty-five studies were identified through the literature search. Three reviewers
independently assessed eligibility. Of the 145 references, 11 studies met the inclusion criteria and were
included in the analysis. The trial search co-ordinator (AS) carried out the initial screening of these and
99 references were inspected by two reviewers. Two further trials were identified as eligible for inclusion
in the review. Therefore, a total of 13 studies was included in the analysis (Figure 25).
Quality of included studies
The quality of each study was assessed according to the four criteria outlined in the Cochrane
Collaboration Handbook:171 selection bias, performance bias, attrition bias and detection bias. Details of
biases and description of studies can be seen in Figure 26. Performance bias was difficult to evaluate.
With psychological interventions, unlike drug trials, it is impossible to totally blind patients and staff to
treatment. Patients are often aware that they are being treated preferentially, staff involved may have
different expectations of treatment groups and independent assessors may be given clues from patients
during the assessments. There may also be ‘contamination’ between groups, in terms of groups not being
held in separate rooms and staff bringing ideas from one group to another.
Results
We included 13 trials (9615 participants) in this review, although interventions varied somewhat. Four trials
provided data on admissions to either residential or nursing homes, and results significantly favoured the
case management group at 6 months (n = 5561, four RCTs; odds ratio 0.83, 95% CI 0.70 to 0.99;
I2 = 0%; p = 0.04) but not for other time points (Figure 27). We detected a reduction in hospital
Records after duplicates removed
(n = 9148)
Records screened
(n = 9148)
Records excluded
(n = 9003)
Full-text articles 
assessed for eligibility
(n = 145)
Studies included in the qualitative 
and quantitative synthesis
(n = 13)
Full-text articles excluded 
(not dementia/not RCT)
(n = 112)
Full-text articles excluded
 (reasons reported in 
excluded studies table)
(n = 33)
Update search
 (February 2012): records 
identified through 
database searching
(n = 1211)
Initial search: records 
identified through 
database searching
(n = 10,440)
Update search 
(February 2013): records 
identified through 
database searching
(n = 820)
Records identified 
through other sources
(n = 7)
FIGURE 25 The Preferred Reporting Items for Systematic Reviews and Meta-Analysis flow chart of the review and
selection process of studies.
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admissions (mean number of nights) in the intervention group at both 6 (n = 341, three RCTs; mean
difference 0.63, 95% CI 0.40 to 0.86; I2 = 40%; p = 0.00001) and 12 months (n = 575, six RCTs; mean
difference –1.94, 95% CI –3.68 to 0.60; I2 = 99%; p = 0.03). Ten trials recorded deaths but there were no
significant differences between groups at 4–6, 12, 18–24 or 36 months’ follow-up.
Eight trials assessed carer burden and benefit for the case management group was found at 6 months
(n = 4726, five RCTs; SMD –0.07, 95% CI –0.12 to –0.01; I2 = 2%; p = 0.02). Three of the trials measuring
carer depression at 18 months showed greater improvement in the case management group (n = 2888,
three RCTs; SMD –0.08, 95% CI –0.16 to –0.01; I2 = 0%; p = 0.03).
Three trials assessed quality of life of patients or carers with various scales at different time points. There
was no clear evidence that case management improved quality of life for either group. Data on carer
well-being and at 6 months found a significant improvement was shown in the case management group
(n = 203, one RCT; SMD –2.53, 95% CI –5.20 to 0.13; p = 0.03).
Six trials provided data on behaviour problems, which significantly favoured case management at 10–12
(n = 433, five RCTs; SMD –0.18, 95% CI –0.39 to 0.03; I2 = 18%; p = 0.05) and 18 months (n = 255,
three RCTs; SMD –0.29, 95% CI –0.53 to –0.04; I2 = 0%; p = 0.02) (Figure 28). There was no evidence of
benefit to patient depression (three trials), functional abilities (three trials), cognition (six trials), carer distress
(three trials) or carer mood (five trials) at any time point. The use of services varied, with the intervention
group receiving significantly more community services.
Study or subgroup
Control Odds ratio
M–H, fixed, 95% CI
Odds ratio
M–H, fixed, 95% CIEvents Total
At 6 months
Callahan – Indianapolis
Chu – Canada
Eloniemi Sulkava-Finland2
Newcomer – US
Subtotal (95% CI)
Total events
Heterogeneity: χ2 = 1.32, df = 3 (p = 0.72); I2 = 0%
Test for overall effect: Z = 2.08 (p = 0.04)
2.52 (0.26 to 24.77)
1.00 (0.06 to 16.61)
0.48 (0.08 to 2.70)
0.83 (0.70 to 0.99)
0.83 (0.70 to 0.99)
1
1
4
294
300
69
37
62
2527
2695
Case management
Events Total
3
1
2
264
270
84
37
63
2682
2866
Weight
0.4%
0.3%
1.4%
97.9%
100.0%
At 10–12 months
Callahan – Indianapolis
Chu – Canada
Eloniemi Sulkava-Finland1
Eloniemi Sulkava-Finland2
Jansen – Netherlands
Lam – Hong Kong
Newcomer – US
Subtotal (95% CI)
Total events
Heterogeneity: χ2 = 8.99, df = 6 (p = 0.17); I2 = 33%
Test for overall effect: Z = 0.43 (p = 0.67)
3.59 (0.39 to 32.99)
0.30 (0.06 to 1.57)
0.34 (0.10 to 1.21)
0.38 (0.11 to 1.31)
1.80 (0.16 to 20.73)
2.25 (0.23 to 22.40)
0.99 (0.87 to 1.14)
0.97 (0.85 to 1.11)
1
6
9
9
1
1
533
560
62
37
47
56
38
43
2527
2810
4
2
4
4
2
3
563
582
72
37
53
59
43
59
2682
3005
0.2%
1.2%
1.9%
1.9%
0.2%
0.2%
94.3%
100.0%
At 18 months
Callahan – Indianapolis
Chu – Canada
Eloniemi Sulkava-Finland2
Subtotal (95% CI)
Total events
Heterogeneity: χ2 = 1.83, df = 2 (p = 0.40); I2 = 0%
Test for overall effect: Z = 1.29 (p = 0.20)
0.13 (0.01 to 2.56)
0.31 (0.03 to 3.18)
0.89 (0.29 to 2.76)
0.55 (0.22 to 1.37)
3
3
7
13
62
37
48
147
0
1
7
8
65
37
53
155
27.7%
22.7%
49.6%
100.0%
At 24 months
Eloniemi Sulkava-Finland1
Eloniemi Sulkava-Finland2
Subtotal (95% CI)
Total events
Heterogeneity: χ2 = 0.40, df = 1 (p = 0.53); I2 = 0%
Test for overall effect: Z = 0.31 (p = 0.75)
Test for subgroup differences: χ2 = 3.19, df = 3 (p = 0.36); I2 = 6.1%
1.11 (0.48 to 2.61)
0.76 (0.34 to 1.70)
0.91 (0.51 to 1.63)
14
18
32
47
62
109
17
15
32
53
63
116
42.2%
57.8%
100.0%
0.1 0.5
Favours case management Favours control
0.2 1 2 105
FIGURE 27 Institutionalisation. Studies listed can be found in the Cochrane review. M–H, Mantel–Haenszel.
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Discussion
All but three of the RCTs had a duration of ≥ 12 months but only six trials lasted for ≥ 18 months.
The studies included in this review came from a variety of countries and contexts (from the USA, Canada,
Finland, the Netherlands, Hong Kong, India and the UK); were set in primary care practices, dementia
resource centres, memory clinics outpatient clinics, self-referrals, day centres and GP practices; and were
administered by case managers from a range of professional groups.
This review provides some evidence for the benefits of case management in terms of (1) reduced hospital
length of stay at 6 and 12 months, (2) reduced behaviour disturbance at 12 (five trials) and 18 months
(three trials), (3) reduced carer burden (three trials) and (4) improved carer well-being (only one trial). There
are signs that although case management, as intended, involves a higher use of community services, this may
be offset by a lower use of acute services and hospitalisations, but on the evidence available it is not clear
how it may affect overall health-care costs. In most of the studies, case management was just one aspect of
a broader programme of care, making it difficult to study the specific effects in detail. This review indicates
that there is evidence to show that case management is beneficial and effective for both the person with
dementia and their carer. However, there was heterogeneity of the interventions, outcomes measured and
time points across the 13 included trials. Further work is needed to identify what aspects of case management
(or service models) are associated with most improved outcomes.
The finding that case management for people with dementia reduces admission to long-term care in the
short term (< 12 months) appears to be one of the most consistent in the literature. Case management
reduced behavioural problems in people with dementia in both the short- and the long-term follow-up,
but did not appear to improve patient outcomes such as patient quality of life, cognition and depression.
In addition, hospital admissions and mortality were unaffected.
Case management also reduced carer burden in both the long and the short term. Interestingly, case
management did not benefit carer’s mood or distress. There was very limited evidence reported on use of
services and service use costs, and indications that case management leads to higher use of community-based
services. However, there was little indication that case management affected health-care use. Consequently,
service use costs appeared to be higher in the case management intervention groups.
In this review, case management focused on the planning and co-ordination of services required to meet
the identified needs of the person with dementia, although the forms of case management differed. The
core tasks of assessment, care planning and implementation/management were common to all but one
trial, but there was considerable variation in their delivery. Most studies used face-to-face contact to deliver
case management but one used solely telephone contact. Intensity of the case management varied,
frequency of contact between the case managers and the patients/carers varied from 1 to 2 or more
contacts per month, and caseload size ranged between 13 and 100 patients. Length of intervention varied
between 4 months and 2 years. However, given the limited data available for the long-term effects of
case management, it is difficult to conclude whether these observed effects are due to the duration or
frequency of the intervention or other mediating variables. This highlights the need for consistency in the
choice of outcome measures in the studies.
The case management interventions described across the studies had varying objectives and goals. In many
studies the case management interventions were specifically targeted at predetermined outcomes (e.g.
carer burden or institutionalisation), so it is possible that other beneficial effects of the interventions were
not measured. There was appreciable variability in the case management approaches, content of case
management interventions, target populations, degree of control and influence over allocation of care
resources, and intensity and duration. As the case management interventions varied considerably, this
made it difficult to link outcomes to the specific components of the interventions. The effect sizes may not
be independent and so a more powerful multilevel analysis might have assisted in the disentangling of
the effects.
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Only two of the studies reported data on use of prescribed medications, and there were not enough
data to draw reliable conclusions about whether or not certain prescribed medications have an influence
over the effectiveness of case management interventions. This could be considered in future research studies.
Access to forms of case management or other services were present in some of the control groups for
studies included in this review. The use of case management was measured among the control groups in
this study, and there was a reported significant difference in the numbers receiving case management in
the interventional and control arms, but there may be some degree of contamination in the results. One
study reported that the control group also had access to the standard home care programme. It was noted
in the Newcomer study that control group cases may have been exposed to comparable benefits, such as
case management and community care benefits, if they were participating in the Medicaid programmes.
For this reason, the demonstration programmes were encouraged not to seek or accept applications from
those receiving Medicaid. However, there were still around 7% of participants each in the treatment and
control groups who were Medicaid recipients. However, statistical controls were put in place to adjust for
the potential effect of Medicaid participation. Our results did not illuminate any particular effects of these
differences in control conditions on the outcomes.
The Newcomer trial172,173 was problematic during the analyses, as it used two models of case management,
with one that offered a higher community service reimbursement and more access to the case manager.
For most outcomes we used the results of the two models combined. In addition, this study had very large
sample sizes in comparison with the other studies and so heavily weighted the results in the meta analyses.
Consequently, we conducted the analyses with and without this study, and for some outcomes we found
that the results were no longer significant if this study was removed (e.g. institutionalisation).
The exclusion of studies for this review was usually because they were not RCTs, did not focus on people
with dementia or did not meet the criteria for a case management intervention. We defined case
management as any intervention delivered in the community predominantly focused on the planning and
co-ordination of services to meet the needs of the person with dementia.
The quality of the included studies is variable but most were free of selection bias owing to the use of
adequate methods for random sequence generation and allocation concealment. However, all of the studies
included in the review were subject to some level of performance bias, where either the participants or the
case managers or both were unblinded. However, 9 out of the 13 studies had blinded outcome assessors
and the others were either high risk or unclear but, overall, there was a low risk of detection bias. There
were huge variations in the sample sizes within studies. One study had 8095 participants and another study
had only 81 participants. Most studies had between 100 and 200 participants. Attrition bias was low overall
across the studies.
For each outcome measure, to allow an intention-to-treat analysis, the data were sought irrespective of
compliance, whether or not the patient was subsequently deemed ineligible or otherwise excluded from
treatment or follow-up. If intention-to-treat data were not available in the publication, ‘on-treatment’
data were sought (i.e. the data of those who completed the trial). Data on adverse effects of attrition
were noted. Reporting bias on the whole was classified as low risk in this review but four studies were
rated at high risk of reporting bias as they did not report data on all of the outcomes specified in
the study.
Future studies should use process measures to demonstrate the extent to which case management is
delivered and provided. Process evaluations are particularly important for interpreting outcomes and for
understanding how an intervention is implemented across multiple sites. Although 7 of the 13 studies
reported using standardised protocols, the use of well-developed manuals and protocols should be more
widespread, as they can help to ensure the transparency, replicability and integrity of this complex
intervention. This highlights the need for greater consistency in process level and quality-of-care indicators
(which systematically describe how the interventions are implemented). These could include the number of
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people with a care plan and how it is often monitored, reviewed and updated; the number of times the
person is visited, followed up or telephoned by the case manager; and the number of telephone calls or
contacts that the case manager makes contacts on behalf of the person with dementia or carer. Future
studies should consider including quality measures such as these to help to ascertain the active ingredients
of case management by relating these to outcomes. These process indicators are not necessarily good
outcomes, as the acid test of an outcome measure is the extent to which you can value it in its own right
(i.e. it is not a proxy). In general, however, the overall quality of the included studies is reasonable,
particularly in the more recent studies that have more detailed information on case management
components and delivery, participants’ information, inclusion/exclusion criteria, the use of consistent
outcome measures and increased sample sizes.
Case managers delivering the intervention were from a range of professional backgrounds (nurses,
social workers, occupational therapists and psychiatrists) and were based in a variety of settings including
primary care and dementia resource centres. The training that the case managers received to deliver case
management also ranged considerably between the trials in terms of both the mode of provision of training
and the content. Only three trials reported on provision of dementia training for their case managers and
several of the studies did not report any details on training for the case managers. The case manager was
responsible for the co-ordination of services and treatment between organisations and agencies. It would
appear that in only three of the studies the case managers were taking responsibility for managing the wider
care network. In many other studies they appeared to be more focused on co-ordinating the work of their
own service alone, which represents a narrower focus of case management responsibility. Such differences in
case manager involvement and range and breadth of responsibilities taken by case managers are likely to be
critical determinants of variations in outcome.
Studies included a high variability of patients and carers. This variability reflected the severity of dementia.
Five studies included both mild and moderate severity. Three studies included predominantly moderate and
four studies included mostly mild dementia. Within this review, there was no indication that the severity
of the dementia had any relationship to the efficacy of the intervention. However, further work may be
necessary to ascertain whether the severity of dementia or other subgroups are more or less likely to
benefit from case management.
A number of trials reported participants with significant comorbidities whereas others excluded those with
physical comorbidities. There was perhaps less variability in social characteristics and only one study
reported that a high proportion of patients were socioeconomically disadvantaged.
Two previous reviews have been completed in this area. Pimouguet et al.174 reviewed 12 trials, seven of
which we included. As in our review, Pimouguet et al.174 noted the effects of delaying institutionalisation
for people with dementia, but also concluded that there was not sufficient evidence to draw conclusions
about the effects of case management on costs and resource utilisation. The most recent review by
Somme et al.175 included six studies, five of which were included in this review. Somme et al.175 concluded
that more effective case management related to both better integration between the health and social
service organisations, and the intensity of the case management. Olazarán et al.69 reviewed 179 RCTs across
26 categories of non-pharmacological interventions. They concluded that there was grade B evidence for
multicomponent interventions for people with dementia and their carers in relation to cognition, ADLs,
behaviour, mood for person with dementia and carer, quality of life of person with dementia and carer,
and carer psychological well-being. Other systematic reviews on efficacy of non-pharmacological
interventions have also shown positive benefits for the person with dementia and the carer,8 although they
have not considered the efficacy of case management specifically within the reviews.
Finally, consideration should be given to the possibility of publication bias in this review. Trials that do not
produce positive findings appear less likely to be published and this can lead to a risk of a biased set of
studies included in systematic reviews. However, there is likely to be very low risk of publication bias for
this review, as our comprehensive search strategy did not restrict searches to peer-reviewed journals only;
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for example, the Jansen et al.176 study was a PhD (Doctor of Philosophy) conducted in the Netherlands and
was included as a trial in this review. We cannot rule out the possibility that we have missed unpublished
trials with negative results but, overall, the risk of publication bias in this review was low. In future, the
publishing of trials based on their results should be less of a problem as many trials are required to be
registered with a recognised clinical controlled trials register and many trial protocols are being published.
Managing crises for people with dementia: a systematic review
Introduction
People with dementia are at increased risk of acute admission to hospital and generally have poorer
outcomes than those without dementia. There is an increasing body of evidence reporting on physical
health problems among people with dementia, including falls, fractures, seizures, infections and
pneumonia, which are highly associated with hospital admissions. Psychiatric factors, particularly
behavioural problems, are also a key risk factor for hospital admissions and many people admitted to
hospital with dementia enter institutional care on discharge, rather than returning to their own homes.
Aims
To conduct a systematic review and meta analysis of literature of the factors leading to hospital admission
for people with dementia in comparison with (1) people without dementia acutely admitted and (2) people
with dementia remaining in the community.
Methods
Types of papers included in the review
Controlled comparison studies, which included cohort studies, epidemiological studies, case–control
studies, systematic literature reviews and descriptive studies, were eligible for inclusion in this review.
Types of risk factors
The following categories of risk factors for people with dementia associated with hospitalisation were
considered for inclusion in this review: physical problems, psychiatric problems, carer factors and
environmental factors.
Types of comparison groups
In this review we included two sets of group comparison data:
1. risk factor profiles in people admitted to hospital comparing those with dementia and those without
2. risk factor profiles in people with dementia comparing people admitted to hospital with people in
the community.
Types of outcome measures
The outcomes in this review included the following:
l number of patients admitted to hospital
l total number of admissions to hospital
l time to hospitalisation.
Types of participants
The inclusion criteria for the studies were that the samples contained:
l people aged ≥ 60 years
l people with a dementia diagnosis of any type.
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Search methods for identification of studies
Electronic searches The NHS electronic library records were searched, which contained records from the
following major health-care databases: MEDLINE, EMBASE, PsycINFO, CINAHL, Web of Science and
PubMed for the period 1999 to 30 June 2010.
The search terms were old, elder, aged, memory problems, memory disorders, cognition, cognitive
disorders, dementia, Alzheimer’s, vascular, fronto-temporal, predictors, causes, crisis, indicators, risk
profiles, risk factors, model, risk assessment, clinical indicators, prediction, trends, forecasting, probability,
prevalence, emergency, hospital, psychiatric, hospitalisation, patient admission, patient transfer, patient
readmission, institutionalisation, admissions, nursing home, care home, long term care.
Searching other resources Reference lists of key papers were checked and relevant systematic reviews
were identified by the above methods.
Data collection and analysis
Selection of studies
Titles and abstracts of citations obtained from the search were examined independently by two researchers
and any obviously irrelevant articles were discarded. The full texts of those studies deemed potentially
relevant were obtained. When it was not possible to accept or reject based on title and abstract alone,
the full text of the citation was obtained for further evaluation. The assessment of eligibility criteria was
undertaken from the full text by two reviewers (Sandeep Toot and Mike Devine). In addition, the third
reviewer (Martin Orrell) independently reviewed the selected studies and agreement was reached on which
papers should be included.
Assessment of validity
For all references, the studies were assigned a level of evidence according to the Centre for Evidence Based
Medicine (CEBM; www.cebm.net/levels_of_evidence.asp#levels) guidelines. Levels of evidence ranged from
1 to 5, with lower numbers indicating higher quality. Studies rated between levels 1 and 4 were included
in this review. Two reviewers (Sandeep Toot and Mike Devine) assigned levels of evidence to each study
independently and, in cases of disagreement, discussed the studies until a conclusion was agreed. Grades
of recommendation for risk factors across the studies were then assigned an overall grade of evidence
from A to D according to the CEBM criteria (grade A represents consistent level 1 studies, indicating
the best-quality evidence, and grade D is the lowest level of evidence, representing level 5 evidence or
troublingly inconsistent or inconclusive studies at any level). In addition, the third reviewer (MO)
independently reviewed the assigned levels of evidence and grades of recommendation for the studies and
agreement was reached on the assignments and gradings.
Results
Included studies
In total, 2938 references were identified through the searches, of which 2765 were excluded by reference
to title and abstract alone, as they did not cover risk factors associated with crisis. A further 69 papers
were excluded on the basis that (1) they did not include people with dementia aged > 60 years in their
sample, or (2) they did not explicitly report risk factors associated with crisis involving people with
dementia. Of the remaining 104 papers, four were systematic reviews, for which the reference lists were
checked. However, no new papers were identified. Ninety papers were excluded on the basis that they
reported risk factors associated with crisis for people with dementia leading to nursing home placement.
Ten studies were included in this review and assigned to level 2 or 4 according to the CEBM guidelines,
comprising nine prognostic cohort studies166,177–184 and one case–control study185 (Table 43).
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TABLE 43 Study descriptions
Study (year)
and country
Level of
evidence
CEBM
Description of study
sample Type of admission Study period Type of study
Nourhashémi
et al.,178 (2001)
France
4 Dementia group:
Alzheimer’s disease
Non-dementia group:
elderly controls
Dementia group:
Alzheimer’s acute
care unit
Non-dementia group:
emergency general
hospital admissions
4-month study
(January–April 1997)
Prognostic
cohort study
(prospective)
Malone et al.,183
(2009) USA
4 Dementia group:
Alzheimer’s disease
Non-dementia group:
matched elderly
controls
Acute hospital
admissions
6 years (retrospective
study 2000–6)
Information collected
via a health insurance
and pharmacy
database
Prognostic
cohort study
Natalwala et al.,182
(2008) UK
4 Dementia group:
unspecified dementia,
Alzheimer’s disease
and vascular dementia
Non-dementia group:
healthy elderly
controls
General hospital
admissions
(emergency, elective,
planned and day care
admissions)
5-year retrospective
study (2002–7)
Prognostic
cohort study
Tuppin et al.,184
(2009)a France
4 Dementia group: all
types of dementia
including Alzheimer’s
disease
Non-dementia group:
elderly controls aged
> 60 years
All types of general
hospital admissions
Retrospective
information extraction
from a national
health insurance
database (2007)
Prognostic
cohort study
Carter and
Porell,181 (2005)
USA
4 Dementia group:
Alzheimer’s disease
and related dementias
Non-dementia group:
elderly controls
Any type of acute
hospitalisation
(ambulatory
care-sensitive
conditions: preventable
hospital admissions)
Retrospective 3-year
prognostic cohort
study (1991–3)
Prognostic
cohort study
Sampson et al.,166
(2009) UK
2 Dementia group: any
type of dementia
diagnosis
Non-dementia group:
elderly controls aged
> 70 years
Unplanned acute
general hospital
admissions
Longitudinal study
over 6 months
(June–December
2007)
Prognostic
cohort study
(prospective)
Albert et al.,177
(1999) USA
4 Dementia group:
Alzheimer’s disease
Non-dementia group:
elderly controls
Acute general
hospital admissions
Retrospective study
over 21 months
(January 1996–
September 1997)
Prognostic
cohort study
Orrell and
Bebbington,185
(1995) UK
4 Dementia group: all
types of dementia
Day patients or
inpatients to a
psychogeriatric
assessment unit
6 months prior to
admission were
investigated but for
this review we will
only consider
3 months preceding
the index date
Case–control
study
continued
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Studies comparing hospital admissions for people with or without dementia
The risk factors reported below were all categorised into broader themes by the research team. The key
themes and risk factors can be found in Table 44.
Physical health-related factors For risk factors within the following four physical health-related themes,
relative risks (RRs) were either directly extracted or calculated by the research team from the relevant
studies. The data were then pooled in meta analyses and presented in forest plots for each theme.
TABLE 43 Study descriptions (continued )
Study (year)
and country
Level of
evidence
CEBM
Description of study
sample Type of admission Study period Type of study
Ibach et al.,180
(2004)
4 Dementia group:
dementia with
frontotemporal lobar
degeneration
Admissions to a
geriatric psychiatry
hospital
Not given Prognostic
cohort study
Andrieu et al.,179
(2002)
2 Dementia group:
Alzheimer’s disease
All types of acute
general hospital
admissions (general,
psychiatric,
specialised unit)
12-month study Prognostic
cohort study
(prospective)
a Paper quotes relative risks, so approximate numbers of admissions are calculated from these and other data in
the paper.
TABLE 44 Primary reason for admission for people with dementia vs. people without dementia
Primary
reason system
Subcategory
(where
specified) Study (year)
Level of
evidence
CEBM
Proportion of
all admissions
(dementia
group)
Proportion of
all admissions
(non-dementia
group)
RR (95% CI;
p-value) of given
factor being
primary cause of
admission
Orthopaedics Falls/injury Nourhashémi
et al.178 (2001)
4 22/118 698/6891 1.84 (1.25 to 2.70;
0.002)
Fractures (all) Malone et al.183
(2009)
4 955/5396 428/5396 2.23 (2.00 to 2.48;
< 0.001)a
Hip fracture Natalwala
et al.182 (2008)
4 167/2561 835/53,123 4.15 (3.53 to 4.87;
< 0.001)
General
(including
falls/fractures)
Tuppin et al.184
(2009)b
4 20,855/263,985 4595/63,985 1.10 (1.07 to 1.13;
< 0001)
Respiratory Infection Carter and
Porell181 (2005)
4 110/1782 123/2195 1.10 (0.86 to 1.41;
0.450)
Sampson
et al.166 (2009)
2 62/262 29/355 2.90 (1.92 to 4.37;
< 0.001)
Natalwala
et al.182 (2008)
4 331/2561 1614/53,123 4.25 (3.81 to 4.76;
< 0.001)
General
(including
infection)
Tuppin et al.184
(2009)b
4 16,103/263,985 2168/63,985 1.80 (1.72 to 1.88;
< 0.001)
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TABLE 44 Primary reason for admission for people with dementia vs. people without dementia (continued )
Primary
reason system
Subcategory
(where
specified) Study (year)
Level of
evidence
CEBM
Proportion of
all admissions
(dementia
group)
Proportion of
all admissions
(non-dementia
group)
RR (95% CI;
p-value) of given
factor being
primary cause of
admission
Urology/renal Infection Carter and
Porell181 (2005)
4 51/1782 47/2195 1.34 (0.90 to 1.98;
0.146)
Sampson
et al.166 (2009)
2 37/262 17/355 2.95 (1.70 to 5.12;
< 0.001)
Natalwala
et al.182 (2008)
4 116/2561 440/53,123 5.47 (4.47 to 6.68;
< 0.001)
General
(including
infection)
Tuppin et al.184
(2009)b
4 33,262/263,985 6718/63,985 1.20 (1.17 to 1.23;
< 0.001)
Gastrointestinal Infection Carter and
Porell181 (2005)
4 80/1782 66/2195 1.49 (1.08 to 2.06;
0.015)
General
(including
infection)
Nourhashémi
et al.178 (2001)
4 17/118 676/6891 1.47 (0.94 to 2.29;
0.090)
Tuppin
et al.184 (2009)b
4 17,951/263,985 4834/63,985 0.90 (0.87 to 0.93;
< 0.001)
Cardiology General Tuppin et al.184
(2009)b
4 15,839/263,985 3199/63,985 1.20 (1.16 to 1.25;
< 0.001)
Acute cardiac
syndrome
Sampson
et al.166 (2009)
2 12/262 43/355 0.38 (0.20 to 0.70;
0.002)
Cardiovascular Nourhashémi
et al.178 (2001)
4 11/118 1073/6891 0.60 (0.34 to 1.05;
0.076)
Neurology Tuppin et al.184
(2009)b
4 39,334/263,985 1799/63,985 5.30 (5.06 to 5.55;
< 0.001)
Nourhashémi
et al.178 (2001)
4 9/118 1072/6891 0.49 (0.26 to 0.92;
0.027)
Psychiatric General Tuppin et al.184
(2009)b
4 16,631/263,985 443/63,985 9.10 (8.28 to
10.00; < 0.001)
Behavioural
disturbance
Nourhashémi
et al.178 (2001)
4 31/118 93/6891 19.47 (13.53 to
28.00; < 0.001)
Other Syncope/collapse Natalwala
et al.182 (2008)
4 102/2561 777/53,123 2.72 (2.22 to 3.33;
< 0.001)
Fever Nourhashémi
et al.178 (2001)
4 13/118 951/6891 0.80 (0.48 to 1.34;
0.394)
Infection (general) Albert et al.177
(1999)
4 29/70 52/191 1.52 (1.06 to 2.19;
0.024)
Dehydration Natalwala
et al.182 (2008)
4 79/2561 147/53,123 11.15 (8.51 to
14.61; < 0.001)
RR, relative risk.
a Paper states the number of patients admitted at least once but not the total number of admissions, so the RR is
calculated in relation to community population rather than to admissions.
b Paper quotes RRs, so approximate numbers of admissions are calculated from these and other data in the paper.
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Orthopaedics Four prognostic cohort studies178,182–184 reported that people with dementia are at greater
risk of an orthopaedic crisis (e.g. falls and all types of fractures) resulting in hospital admission than people
without dementia. The RR for dementia inpatients versus non-dementia inpatients was 1.19 (95% CI 1.16
to 1.22; p < 0.001) (Figure 29).
Respiratory Four prognostic cohort studies166,181,182,184 investigated respiratory crises resulting in hospital
admission. All but one of these reported that people with dementia are at greater risk of respiratory crisis
resulting in hospitalisation than people without dementia (see Table 44). The RR for dementia inpatients
compared with non-dementia inpatients was 2.00 (95% CI 1.92 to 2.08; p < 0.001) (Figure 30).
Urology/renal Four prognostic cohort studies166,181,182,184 reported results on urological/renal factors
leading to hospital admission. All four reported that people with dementia are at greater risk than people
without dementia of experiencing a urological crisis resulting in hospital admission (see Table 44). All
except the Carter and Porell181 study reported statistically significant findings and, according to the
meta-analysis, the RR for dementia inpatients compared with non-dementia inpatients was 1.23 (95% CI
1.20 to 1.26; p < 0.001) (Figure 31).
Gastrointestinal Three prognostic cohort studies178,181,184 informed the meta-analysis for gastrointestinal
factors leading to hospitalisation, but there was no consistent pattern. Nourhashémi et al.178 and Carter
and Porell181 reported that people with dementia were more at risk of experiencing a gastrointestinal crisis
resulting in hospitalisation than people without dementia. However, the evidence in the Nourhashémi
et al.178 study was not statistically significant. In contrast, Tuppin et al.184 found that people with dementia
had a lower risk of experiencing a gastrointestinal crisis resulting in admission than those without dementia
(see Table 44). A meta-analysis gave a lower RR of 0.91 (95% CI 0.88 to 0.94; p < 0.001) for dementia
versus non-dementia inpatients (Figure 32).
For risk factors within the following physical health-related themes, RR were again either directly extracted
or calculated by the research team from the relevant studies. However, reported data were not pooled by
meta-analysis for these factors owing to potential heterogeneity between risk factors included within
these themes.
Cardiological factors Three prognostic cohort studies166,178,184 reported data on cardiological factors
leading to hospital admission (see Table 44). Tuppin et al.184 reported that people with dementia had a
significantly higher risk than those without dementia of acute hospitalisation because of general
cardiological factors (RR 1.20, 95% CI 1.16 to 1.25; p < 0.001). In contrast, Sampson et al.166 reported that
people with dementia had a significantly lower risk than those without dementia of experiencing a crisis
leading to hospitalisation due to acute cardiac syndrome (RR 0.38, 95% CI 0.20 to 0.70; p = 0.002).
Similarly, Nourhashémi et al.178 reported that people with dementia had a lower risk than those without
dementia of experiencing a cardiovascular crisis resulting in hospital admission (RR 0.60, 95% CI 0.34 to
1.05; p = 0.076).
Neurological Nourhashémi et al.178 and Tuppin et al.184 reported contrasting evidence on neurological
crises resulting in hospital admissions. Tuppin et al.184 found that people with dementia had a much higher
risk than those without of being hospitalised secondary to a neurological problem (RR 5.30, 95% CI 5.06
to 5.55; p < 0.001), whereas Nourhashémi et al.178 found that people with dementia had a significantly
lower risk of having a neurological crisis leading to hospital admission (RR 0.49, 95% CI 0.26 to 0.92;
p = 0.027).
All other physical health-related factors Several other physical health-related factors were reported
across the studies. Natalwala et al.182 reported a significantly higher risk of people with dementia being
admitted to hospital due to syncope/collapse (RR 2.72, 95% 2.22 to 3.33; p < 0.001) and due to
dehydration (RR 11.15, 95% CI 8.51 to 14.61; p < 0.001) compared with people without dementia.
Nourhashémi et al.178 found that people with dementia had a lower risk than people without dementia of
HOME TREATMENT PROGRAMME: DEVELOPMENT OF A HOME TREATMENT PACKAGE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
122
St
u
d
y 
n
am
e
St
at
is
ti
cs
 f
o
r 
ea
ch
 s
tu
d
y
R
is
k 
ra
ti
o
 a
n
d
 9
5%
 C
I
R
is
k
ra
ti
o
 
Lo
w
er
 
lim
it
U
p
p
er
 
lim
it
z-
va
lu
e
p
-v
al
u
e
N
o
u
ra
sh
ém
i e
t 
al
. 2
00
11
78
1.
84
0
1.
25
2
2.
70
4
3.
10
4
0.
00
2
M
al
o
n
e 
et
 a
l. 
20
09
18
3
2.
23
0
2.
00
3
2.
48
3
14
.6
15
0.
00
0
N
at
al
w
al
a 
et
 a
l. 
20
08
18
2
4.
15
0
3.
53
3
4.
87
4
17
.3
35
0.
00
0
Tu
p
p
in
 e
t 
al
. 2
00
91
84
1.
10
0
1.
07
0
1.
13
0
6.
84
8
0.
00
0
1.
19
0
1.
15
9
1.
22
1
13
.0
87
0.
00
0
0.
1
0.
2
0.
5
1
2
5
10
N
o
n
-d
em
en
ti
a 
p
at
ie
n
ts
D
em
en
ti
a 
p
at
ie
n
ts
FI
G
U
R
E
29
O
rt
h
o
p
ae
d
ic
s
m
et
a-
an
al
ys
is
an
d
su
m
m
ar
y
st
at
is
ti
cs
.
St
u
d
y 
n
am
e
St
at
is
ti
cs
 f
o
r 
ea
ch
 s
tu
d
y
R
is
k 
ra
ti
o
 a
n
d
 9
5%
 C
I
R
is
k
ra
ti
o
Lo
w
er
lim
it
U
p
p
er
lim
it
z-
va
lu
e
p
-v
al
u
e
C
ar
te
r 
an
d
 P
o
rr
el
l 2
00
51
81
1.
10
0
0.
85
9
1.
40
8
0.
75
6
0.
45
0
Sa
m
p
so
n
 e
t 
al
. 2
00
91
66
2.
90
0
1.
92
2
4.
37
5
5.
07
5
0.
00
0
N
at
al
w
al
a 
et
 a
l. 
20
08
18
2
4.
25
0
3.
80
2
4.
75
0
25
.4
78
0.
00
0
Tu
p
p
in
 e
t 
al
. 2
00
91
84
1.
80
0
1.
72
2
1.
88
2
25
.9
04
0.
00
0
2.
00
0
1.
92
0
2.
08
3
33
.5
13
0.
00
0
0.
1
0.
2
0.
5
1
2
5
10
N
o
n
-d
em
en
ti
a 
p
at
ie
n
ts
D
em
en
ti
a 
p
at
ie
n
ts
FI
G
U
R
E
30
R
es
p
ir
at
o
ry
m
et
a-
an
al
ys
is
an
d
su
m
m
ar
y
st
at
is
ti
cs
.
DOI: 10.3310/pgfar05050 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 5
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Orrell et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
123
St
u
d
y 
n
am
e
St
at
is
ti
cs
 f
o
r 
ea
ch
 s
tu
d
y
R
is
k 
ra
ti
o
 a
n
d
 9
5%
 C
I
R
is
k 
ra
ti
o
Lo
w
er
 
lim
it
U
p
p
er
 
lim
it
z-
va
lu
e
p
-v
al
u
e
C
ar
te
r 
an
d
 P
o
rr
el
l 2
00
51
81
1.
34
0
0.
90
3
1.
98
8
1.
45
5
0.
14
6
Sa
m
p
so
n
 e
t 
al
. 2
00
91
66
2.
95
0
1.
70
0
5.
12
0
3.
84
6
0.
00
0
N
at
al
w
al
a 
et
 a
l. 
20
08
18
2
5.
47
0
4.
47
5
6.
68
7
16
.5
81
0.
00
0
Tu
p
p
in
 e
t 
al
. 2
00
91
84
1.
20
0
1.
17
0
1.
23
0
14
.2
91
0.
00
0
1.
23
1
1.
20
1
1.
26
2
16
.4
45
0.
00
0
0.
1
0.
2
0.
5
1
2
5
10
N
o
n
-d
em
en
ti
a 
p
at
ie
n
ts
D
em
en
ti
a 
p
at
ie
n
ts
FI
G
U
R
E
31
U
ro
lo
g
y/
re
n
al
m
et
a-
an
al
ys
is
an
d
su
m
m
ar
y
ta
b
le
s.
St
u
d
y 
n
am
e
St
at
is
ti
cs
 f
o
r 
ea
ch
 s
tu
d
y
R
is
k 
ra
ti
o
 a
n
d
 9
5%
 C
I
R
is
k
ra
ti
o
 
Lo
w
er
 
lim
it
U
p
p
er
 
lim
it
z-
va
lu
e
p
-v
al
u
e
C
ar
te
r 
an
d
 P
o
re
ll 
20
05
18
1
1.
49
0
1.
07
9
2.
05
8
2.
42
1
0.
01
5
N
o
u
ra
sh
ém
i e
t 
al
. 2
00
11
78
1.
47
0
0.
94
2
2.
29
4
1.
69
6
0.
09
0
Tu
p
p
in
 e
t 
al
. 2
00
91
84
0.
90
0
0.
87
0
0.
93
1
–6
.0
95
0.
00
0
0.
90
7
0.
87
7
0.
93
8
–5
.6
64
0.
00
0
0.
1
0.
2
0.
5
1
2
5
10
N
o
n
-d
em
en
ti
a 
p
at
ie
n
ts
D
em
en
ti
a 
p
at
ie
n
ts
FI
G
U
R
E
32
G
as
tr
o
in
te
st
in
al
m
et
a-
an
al
ys
is
an
d
su
m
m
ar
y
st
at
is
ti
cs
.
HOME TREATMENT PROGRAMME: DEVELOPMENT OF A HOME TREATMENT PACKAGE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
124
experiencing fever leading to admission, but this finding was not statistically significant (RR 0.80, 95% CI
0.48 to 1.34; p = 0.394). Finally, Albert et al.177 reported that people with dementia had a significantly
higher risk than those without of being hospitalised due to infection (all types) (RR 1.52, 95% CI 1.06 to
2.19; p = 0.024).
Psychiatric factors Two prognostic cohort studies reported statistically significant findings relating to
hospital admissions caused by a psychiatric crisis. Tuppin et al.184 found that people with dementia had a
much higher risk than of those without psychiatric crisis resulting in hospitalisation (RR 9.10, 95% CI 8.28 to
10.00; p < 0.001). Similarly, Nourhashémi et al.178 found that people with dementia had a much higher risk
of behavioural disturbance resulting in hospital admission (RR 19.47, 95% CI 13.53 to 28.00; p < 0.001).
Comparing people with dementia admitted versus not admitted
In the following analyses of people with dementia, RR refers to the probability of being admitted with a
given risk factor relative to the probability of being admitted without this risk factor. In effect, this gives
an estimate of the ‘admission risk multiplier’ conferred by the given risk factor for people with dementia
(see Table 44). It was not possible to complete meta-analyses on these risk factors owing to either
potential heterogeneity between risk factors included within these themes or lack of studies.
Behavioural/psychological factors Three prognostic cohort studies177,179,180 reported data on behavioural
problems in people with dementia. Ibach et al.180 found that the presence of behavioural disturbance
placed people with fronto-temporal dementia at a slightly higher risk of being admitted to hospital, but
their finding was not statistically significant (RR 1.15, 95% CI 0.90 to 1.49; p = 0.277). They also reported
that neither depressive symptoms (RR 0.75, 95% CI 0.45 to 1.26; p = 0.273) nor speech disturbances
(RR 0.20, 95% CI 0.03 to 1.21; p = 0.088) were major precipitants of hospitalisation among people with
fronto-temporal dementia. Similarly, Albert et al.177 found that the presence of agitation placed people
with dementia at a slightly higher risk of admission, but again this was not statistically significant (RR 1.30,
95% CI 0.81 to 2.10; p = 0.280). Andrieu et al.179 reported specific behavioural problems which placed
people with dementia at greater risk of being hospitalised, namely night-time agitation (RR 1.45, 95% CI
0.61 to 3.44; p = 0.400), wandering (RR 1.36, 95% CI 0.74 to 2.52; p = 0.325) and sleep disorder
(RR 1.89, 95% CI 1.01 to 3.53; p = 0.046). Of these, sleep disorder was the only significant factor.
Social and environmental factors One case–control study185 considered the association of life events
(environmental and social factors) with risk of admission for people with dementia living in the community
and found that changes in both routine (RR 1.55, 95% CI 1.18 to 2.03; p = 0.002) and environment
(RR 1.57, 95% CI 1.20 to 2.11; p = 0.001) significantly increased their risk of hospital admission.
Activities of daily living Andrieu et al.179 reported that increased dependency problems in several ADLs
was associated with a higher risk of hospitalisation for people with dementia: bathing (RR 2.86, 95% CI
1.60 to 5.13; p < 0.001), dressing (RR 1.96, 95% CI 1.07 to 3.60; p = 0.030), toileting (RR 2.15, 95% CI
1.15 to 4.02; p = 0.017) and eating (RR 2.22, 95% CI 1.17 to 4.23; p = 0.015) all placed people with
dementia at a significantly higher risk of being admitted to hospital. Continence dependency in people
with dementia also placed them at greater risk of hospitalisation, but this finding was not statistically
significant (RR 1.24, 95% CI 0.58 to 2.64; p = 0.578).
Physical health factors Finally, Andrieu et al.179 reported that falls placed people with dementia at a
significantly higher risk of being hospitalised (RR 1.76, 95% CI 1.08 to 3.64; p = 0.028).
Discussion
This is the first review to systematically assess the physical and psychiatric risk factors for admission for
people with dementia. In particular, people with dementia were more likely to have either orthopaedic
(e.g. falls/fractures) or respiratory/urological (e.g. infections) precipitants of admission than those without
dementia. Most of the published work to date has focused on general hospital admissions, and the causes
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of psychiatric admission in people with dementia remain a relatively neglected area of study. Only two
studies180,185 specifically investigated the causes of psychiatric admission, of which one focused only on cases
of fronto-temporal dementia, whereas the other also included admissions to day hospital facilities.185
However, one study178 included admissions to a dementia-specific unit among its analysis of all admissions,
and three further studies167,179,184 included some analysis of the influence of psychiatric and behavioural
disturbances on admission to acute general hospitals. As expected, psychiatric and behavioural disturbance
was found to increase the risk of admission for people with dementia in relation to those without, and sleep
disturbance emerged as a particular risk factor for admission. Furthermore, the finding that disruption to the
social and environmental milieu often precipitated admission for people with dementia185 provides one of
several possible explanations for subsequent behavioural and psychological disturbances. The link between
acute physical illness and behavioural change in people with dementia has long been appreciated, and yet
psychiatric and general medical services are not always as well integrated as they might be to equip them to
deal with these problems.
People with dementia had higher risks of acute admission for respiratory and urological indications (likely to
include a high proportion of respiratory and urinary tract infections), and for all-cause infections. Potentially
preventable hospital admissions, such as those for urinary tract infections, were 78% more common in
people with dementia.186 There are several potential explanations for this finding. First, people with dementia
might be more prone to infection, secondary to factors such as reduced mobility, inadequate fluid intake and
the impaired performance of daily living tasks concerning personal hygiene. Second, people with dementia
might have reduced or delayed help-seeking behaviour, through either reduced recognition of symptoms or
impaired communication skills. Consequently, an acute infection might not be diagnosed in a person with
dementia until the physical symptoms become severe, or secondary behavioural or psychological symptoms
of delirium develop and, even then, carers or health-care staff might misattribute behavioural disturbance to
a direct effect of the dementia rather than seek an underlying physical health cause. Therefore, physical
health conditions that can be controlled in the general population through effective community management
and treatment, also known as ‘ambulatory care sensitive’ conditions, are more likely to result in acute
hospital admission for people with dementia. This highlights the importance of a more holistic approach to
providing community dementia care, encompassing the cognitive, behavioural, psychological and physical
needs of people with dementia and providing responsive care packages and health education to both people
with dementia and their carers.
The need for proper community assessment and supportive interventions for people with dementia is
further highlighted by the findings that they are at consistently higher risk than the general population of
sustaining falls and fractures necessitating acute hospital admission, and that they are more likely to have
significant difficulties with ADLs, including bathing, dressing, toileting and eating. In some cases, an acute
decline in ADL abilities might be the result of concomitant physical illness. However, physical health can
decline as a result of reduced mobility, poor nutritional intake or impaired personal hygiene. Furthermore,
patients with dementia may be admitted to acute hospitals as a result of their social circumstances, often
when they have been unable to care for themselves and without appropriate support. For example,
neglect and poor provision of care at home could lead to problems such as malnutrition, urinary tract
infections, chest infections, falls and fractures.
The UK National Audit Office187 reported how people with dementia receive poorer-quality care in acute
hospitals and how the lack of skill of acute hospital staff in caring for people with dementia can have
adverse effects on the symptoms of dementia. The National Audit of Dementia Care in General Hospitals188
found that two-thirds of hospital staff felt that they had received insufficient training in dementia care.
Given what we now know about the poor outcomes of hospital admission for people with dementia,
unnecessary acute hospital admissions must be avoided, and this requires the provision of early community
assessment, recognition of problems and appropriate interventions by multidisciplinary teams, including
medical staff, social workers, occupational therapists, nurses and trained care staff.
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One limitation of this review is that several risk factors could not be analysed using a meta-analysis either
owing to potential heterogeneity within risk factors (e.g. cardiovascular, psychiatric and neurological
disorders) or because there were insufficient studies for a meta-analysis of the identified risk factors
(e.g. social/environmental factors and ADLs). However, two studies166,178 concluded that people with
dementia were less likely than those without to be admitted for an acute cardiac syndrome. This might
reflect a lower recognition of acute angina or myocardial infarction in those with dementia, owing to
reduced reporting of specific symptoms or a tendency to interpret any accompanying confusion as part of
the established clinical syndrome of dementia.
Conclusion
Many acute hospital admissions for people with dementia are potentially preventable. Poor outcomes of
acute hospital admission for people with dementia have been widely documented; therefore, efforts need
to be focused on developing responsive and integrated community services. People with dementia are at
increased risk of hospitalisation owing to behavioural and psychological disturbances, and many older
people’s HTTs tend to focus on prevention and management of psychiatric crises and reducing psychiatric
admissions. This review highlights the need for recognition of the physical health risks in these patients,
including a high index of suspicion for conditions such as urinary tract and respiratory infections, and a low
threshold for early treatment in the community. This approach could potentially prevent acute admission to
general hospitals and reduce the associated risk of delirium, so that mental state and behaviour remain
more stable. This highlights the importance of integrated working between services for older people’s
mental health, primary care, social welfare, intermediate care and hospital liaison.
The effectiveness of crisis resolution/home treatment teams for older people with
mental health problems: a systematic review and scoping exercise
Aims
Our aim was to conduct a systematic review of evidence to evaluate the effectiveness of crisis resolution/
home treatment approaches to support older people with mental health problems at home compared with
other forms of treatment and to scope home treatment services for older people with mental health
problems, produce a typology of such services and review the typology in the context of policy and
research findings.
Methods: literature review
The method used was a literature review; controlled comparison studies, including RCTs, controlled
before-and-after studies and interrupted time series were eligible for inclusion in this review. Observational
studies, theoretical papers and government frameworks and policies were also reviewed.
Types of interventions
Experimental intervention
Any crisis resolution/home treatment intervention for older people with a diagnosed mental health problem.
Control
For controlled studies, control groups included TAU, standard community treatment and waiting list controls.
Types of participants
The inclusion criteria for participants in the studies included in the review were those aged ≥ 65 years,
diagnosed with a mental health condition and living in the community (excluding 24-hour care institutions).
Types of outcome measures
Primary outcomes included the following: number of admissions, length of hospital stay, maintenance of
community residence and patient quality of life. Secondary outcome measures included cognition, use of
medication, ADLs, patient/carer satisfaction, service use, health and social care costs and mortality.
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Search methods for identification of studies
Electronic searches: we searched the Specialised Register of the CDCIG, which included records from
The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL and LILACS, and many ongoing clinical trial
databases and grey literature sources. We also searched Web of Science and the Campbell Collaboration/
SORO database.
Data collection and analysis
Selection of papers: titles and abstracts of citations obtained from the search were examined and irrelevant
articles were discarded. The full texts of studies were obtained and assessed against our inclusion criteria.
Attempts were made to obtain additional information from the study authors when necessary. A second
reviewer independently reviewed the selected studies and agreement was reached on papers for inclusion.
Assessment of validity
The studies (primary research) were assigned a level of evidence according to the CEBM guidelines
(www.cebm.net/levels_of_evidence.asp#levels). Levels of evidence ranged from 1 to 5, with lower numbers
indicating higher quality. Studies rated between levels 1 and 4 were included in this review.
Procedure
Both reviewers assigned levels of evidence to each study independently and, in cases of disagreement,
discussed the studies until a conclusion was agreed. The outcomes across the studies were then assigned an
overall grade of evidence from A to D according to the CEBM criteria. Grade A represents consistent level 1
studies indicating the best evidence; grade B represents consistent level 2 or 3 studies; grade C represents
evidence from level 4 studies or extrapolations from level 2 or 3 studies; and grade D evidence is the lowest
level and represents level 5 evidence or troublingly inconsistent or inconclusive studies of any level.
Methods: scoping exercise
From consultations with colleagues, a review of policy and research literature, plus a scoping exercise we
sought to describe the diversity of models of HTTs identifying three principal models. Five crisis resolution
home treatment teams (CRHTTs) for older people across the UK were visited to identify what kinds of
crises take place, key attributes associated with crises, models of service provision, areas of need and key
themes to be included in a HTP. Recent case examples were discussed. The services had common aims:
to provide a rapid response to older adults presenting in mental health crisis, to offer assessment and
treatment at home as an alternative to hospital admission wherever possible and to facilitate timely
discharge from psychiatric inpatient units.
Results: literature review
There were 8222 references found, of which 8185 were excluded by reference to title and abstract alone
as they either did not cover crisis interventions or did not include people with mental health problems,
and 27 were excluded as they did not consider older people in the sample. Ten references were included:
three cohort studies,170,189,190 one descriptive study,27 one survey-related research study,191 two theoretical
papers192,193 and three government policy documents.23,194,195
Cohort studies and descriptive study
Three cohort studies and one descriptive study were included in the review (Table 45). All were assigned
level 4 evidence according to the CEBM guidelines. Dibben et al.190 studied the impact of a CRHTT
6 months before and 6 months after the service was implemented. Participants in this study were older
people with mental health problems. There were 65 participants in the pre-CRHTT (comparison) group and
102 in the post-CRHTT (intervention) group.
Ratna170 investigated the efficacy of a 24-hour community-orientated old age psychiatric crisis service in
North London, UK. The study concerned 142 older patients presenting in mental health crisis who had
been referred to the service over a 6-month period in 1976 and followed up for 2 years. The data were
compared with retrospective data from a study196 of two other psychiatric services, one a community
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service in Chichester (n = 216) and the other a hospital-centred service in Salisbury (n = 121), neither of
which provided a crisis service. For the purpose of this review, the data from the two services in the
Sainsbury et al.196 study were combined and included as one comparison group.
Doyle and Varian189 described a crisis intervention service operating between 9 a.m. and 5 p.m. on weekdays.
Participants in this study were 70 older people with mental health problems, followed up for 3 years from
referral (1989–92). The findings were compared with data from the Ratna170 study.
A prospective descriptive study27 described the activity and outcomes of an outreach support team based
in a day hospital for older people with mental illness. This service operated 12 hours per day, 7 days per
week. Routine clinical, demographic and service use information was described but no attempt was
made to draw a causal relationship between the activities of the outreach support team and subsequent
maintenance in the community. The participants were 40 older people with mental health problems.
There was no comparison group.
Primary outcomes
Number of admissions
There is grade C evidence of a reduction in number of hospital admissions when older people with mental
health problems are referred to crisis intervention services at a point when they would otherwise have
been admitted to hospital.
Dibben et al.190 found a statistically significant reduction in admissions 6 months after the introduction of
the CRHTT. Sixty-nine per cent of referrals (n = 70) were admitted in the intervention group, compared
with 100% (n = 65) in the comparison group (see Table 45). Ratna170 also found that a lower percentage
of patients were admitted to hospital on referral to the crisis service (29%; n = 41) than in the combined
comparison group (39%; n = 32). At 2-year follow-up, 34% (n = 48) of those in the crisis intervention
service had been admitted, compared with 60% (n = 1) in the merged comparison group. Doyle and
Varian189 found that, on referral, there was almost no difference in the percentage of the sample admitted
to hospital between the 9 a.m. and 5 p.m. service (31%; n = 22), and Ratna’s170 24-hours service group
(29%; n = 41) (see Table 45). Richman et al.27 found that 25% (n = 10) of patients referred to the crisis
service were admitted to hospital at the point of referral or within the 3 months’ follow-up.
Length of stay
There was grade D evidence to suggest that there may be a reduction in the length of hospital stay with a
crisis intervention service. Dibben et al.190 found no difference in length of hospital stay 6 months after the
introduction of the CRHTT, as the average length of stay was 53 days in the intervention group compared
with 49 days in the comparison group (see Table 45). Ratna170 found that, over 2 years’ follow-up, the
average length of stay in hospital was shorter for all patients referred to the crisis service (22 days) than for
those in the combined comparison group (101 days). The data in the Ratna170 paper were converted to
give the average length of stay for all participants in the cohorts, including those who were not admitted.
Doyle and Varian189 stated that the mean length of stay in hospital for patients admitted via the 9 a.m.–
5 p.m. crisis service was 49 days within the 3-year follow-up. The authors compared this with Ratna’s170
24-hour crisis service, where mean length of stay of only those admitted to hospital via the crisis service
was 91 days. However, Doyle and Varian189 did not state number of patients admitted to hospital over the
follow-up period and it was not, therefore, possible to compare average length of stay for all patients in
the cohort with Ratna’s intervention and combined comparison groups.
Maintenance of community residence
There was grade D evidence to suggest that crisis interventions help maintain community living for older
people with mental health problems. Ratna170 found that a higher percentage of people remained at home
after 2 years’ follow-up in the 24-hours crisis service group (49%; n = 69) than in the overall comparison
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group (35%; n = 42) (see Table 45). Doyle and Varian189 stated that 31% (n = 22) were living at home at
3 years’ follow-up (see Table 45).
Secondary outcomes
Mortality
There was grade D evidence for impact on mortality in older people with mental health problems referred
to a crisis intervention service. Ratna170 found, after 2 years’ follow-up, that mortality rates were lower for
patients in the crisis service group (29%) than for those in the overall comparison group (44%) (see Table 45),
and Doyle and Varian189 found a 30% mortality rate in their 9 a.m.–5 p.m. crisis service group after 3 years’
follow-up (see Table 45).
Use of services
There was grade D evidence for impact on use of services for older people with mental health problems
referred to a crisis intervention service. Doyle and Varian189 reported that 22% of patients received
domiciliary follow-up and 9% attended a day hospital/centre, and compared data with the Ratna170 study,
in which 61% of patients received domiciliary follow-up and 32% attended a day hospital/centre.
Service use costs
There was grade D evidence regarding service use costs in a crisis intervention service for older people with
mental health problems. Only one study considered this outcome. Richman et al.27 found that the cost per
patient per month in an outreach support team was £823, which was lower than the £1814 cost per
patient per month on an inpatient ward. However, these were staff costs only and did not reflect total
costs of the services. This cannot therefore be considered a detailed cost analysis.
Results: scoping exercise
We visited all five mental health home treatment services for older people identified across England in
2009 (Table 46). We compared and contrasted the three service models that these services followed
in practice.
Generic home treatment team
This team operated 24/7, offering immediate assessment (within 1 hour) to all patients meeting the referral
criteria, which included the need for immediate psychiatric admission in the absence of intensive home
treatment. The team performed a gatekeeping role for inpatient admissions, with all proposed admissions
being referred to the team first to see whether or not home treatment would be possible.
Specialist older adults home treatment team
This service was fully functional between 8 a.m. and 8 p.m. on weekdays and between 9 a.m. and 5 p.m.
at weekends and on bank holidays, and offered an overnight on-call telephone service to existing clients
but did not take new referrals or carry out new assessments overnight. This team considered itself a crisis
resolution team and the referral criteria included that a psychiatric inpatient admission would be immediately
warranted in the absence of intensive home treatment. The team performed a gatekeeping role for inpatient
admissions during its hours of full operation and carried out next-day assessments on the ward for all
patients admitted outside these hours to assess their suitability for home treatment.
Intermediate care
Three of the teams we visited could be described as intermediate care teams for older adults with mental
illness. These teams did not operate an overnight service but two operated extended hours on weekdays
and weekends. Consequently, none of these three teams provided a gatekeeping role for inpatient
admissions. Rather, they sought to avert the development of crises by encouraging early referral of patients
whose mental health was deteriorating, particularly where such deterioration would otherwise be likely to
result within days or weeks in either admission to a psychiatric hospital or a transition of care, especially
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involving a change of accommodation. The assessment of all new referrals took place as soon as possible
and, in any case, within 24 hours of receipt.
Night-time presentations
Overnight presentations requiring immediate psychiatric admission are rare in those aged > 65 years.
The generic HTT was the only service we visited that was fully operational on a 24/7 basis and saw an
average of just two older people presenting at night per month. Our own local audit of acute psychiatric
admissions found that fewer than 8% of older adults admitted over a 1-year period had presented in crisis
overnight (between 8 p.m. and 8 a.m.), and three-quarters of these night-time admissions were under the
Mental Health Act,197 suggesting that home treatment was probably inappropriate at that point in time.
TABLE 46 Comparison of three models of home treatment service for older people with mental health problems
Generic home
treatment
Specialist
home
treatment
Intermediate care
Team 1 Team 2 Team 3
Team composition Multidisciplinary
plus psychiatrist
sessions
Multidisciplinary Multidisciplinary Multidisciplinary Multidisciplinary
Specialist older
people’s staff
Lead nurse plus
three staff
All staff All staff All staff All staff
Dementia referrals Initially
excluded, now
accepted
Accepted Accepted Accepted (team is
dementia specific)
Accepted
Hours of operation
Monday–Friday
24/7 24/7 9 a.m.–7 p.m. 9 a.m.–5 p.m. 8 a.m.–6 p.m.
Hours of operation
bank holidays and
weekends
24/7 24/7 9 a.m.–5 p.m. Closed 9 a.m.–5 p.m.
New referrals
assessed at
weekends
Y Y Y N N
Telephone advice
overnight
Y Y (existing
clients only)
N N N
New referrals
accepted overnight
Y (A&E only) N N N N
Eligibility criteria Admission
imminent
Admission
imminent
Admission within
days/weeks
Admission within
days/weeks or
potential care
transition
Admission within
days/weeks or
potential care
transition
Assessment Within 1 hour Within 1 hour Within 24 hours Within 24 hours Within 24 hours
Gatekeeping role Y Y (except for
new referrals
overnight)
N N N
Focus Crisis
intervention
Crisis
intervention
Crisis prevention Crisis prevention Crisis prevention
Inpatient discharge
facilitated
Y Y Y Y Y
Local integrated
older people’s
CMHT
Y Y N (CPNs only) Y Y
A&E, accident and emergency; CPN, community psychiatric nurse; N, no; Y, yes.
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Discussion
This review found insufficient evidence for the efficacy of CRHTTs in supporting older people with mental
health problems to remain at home, as a result of a lack of properly designed research studies. Owing to
the lack of consistent and good-quality evidence, it is not possible to say whether or not crisis resolution
services for older people with mental health problems reduce length of stay in hospital from the three
studies which considered this outcome. In particular, we were not able to calculate the average length of
stay for the entire cohort in the Doyle and Varian189 study. The level of recommendation for maintenance
of community residence was grade D. Only two studies looked at this outcome.170,189 It is possible that the
24-hours crisis service can sustain people at home for longer, but this apparent finding might also have
arisen as a result of changes in service provision, such as the shift towards care/nursing home placements,
with long-term hospital beds becoming increasingly rare. The effects of crisis resolution services on mortality
rates, service use and service costs were all given an overall grade D of recommendation. This was due to
weakness in the study design, contrasting results, inappropriate comparison groups or lack of data.
From our scoping exercise of HTTs we were able to establish some key themes. Although we visited only five
teams across the UK, these services were representative of the three models found in the Cooper et al.191
UK survey. The home treatment services had varying definitions of crisis. Comparison of efficacy between
different models is made difficult by variations in aims and referral criteria between different services. In
addition, broad outcomes such as reduction in hospital admissions may be of limited utility in this instance,
as baseline admission threshold varies widely between geographical areas on the basis of availability of
inpatient and community resources and clinician preference, among other considerations.
Work package 2: development of a home treatment package
for people with dementia and their family caregivers
Development of the home treatment manual
This section reports the development of the home treatment manual and advisory protocol to support
people with dementia and their carers during crises to help avoid care home and hospital admissions.
Crises in dementia may be precipitated by a number of interacting factors that lead to a point at which the
individual and their carer cannot cope, or may arise from a single traumatic event. Contributing factors
include carer burden, behavioural and psychological characteristics, physical health problems, social factors
related to the person with dementia and their environment.27,181,198–205 We followed the MRC guidelines for
the development and evaluation of complex interventions30 using a systematic review of the literature and
the scoping exercise of HTTs.206
Focus groups
Aim
The aims of the focus groups were to identify factors precipitating crises and to identify interventions that
may help manage crises for people with dementia living at home and their carers.
Method
Design
Focus groups were selected as they provide an ideal method for exploring people’s own meaning and
understanding of a health-related problem through promoted discussion.207 Focus groups provide an
opportunity to observe the processes through which meaning is constructed and negotiated in the social
context of the group itself77,138 and allow the in-depth exploration of topics to provide rich data sources.75
Focus groups capture the participants’ views and perspectives and show them that their views are
important and taken seriously.73 The findings from these focus groups have been reported in accordance
with the Consolidated Criteria for Reporting Qualitative Research (COREQ) 32-item checklist.208
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Participants
Focus groups were conducted with the following stakeholder groups: people with dementia (three
groups), family carers (three groups) and staff from HTTs and older people’s CMHTs (three groups). These
three groups ensured that the views of relevant stakeholders were included in the development of the
home treatment advisory protocol. There were between four and eight participants in each focus group.
The groups were purposively sampled to ensure a rich and meaningful source of data so that there was
variation within our stakeholder groups in order to maximise the validity of findings. Key older people’s
HTT and CMHT staff were identified from NELFT and Kent and Medway NHS and Social Care Partnership
Trust. Eighteen people with mild-to-moderate dementia (female, n = 10, 56%; male, n = 8, 44%) living in
the community, and who were willing and able to consent, were recruited from two day hospitals and a
day centre within NELFT. Fifteen family carers (female, n = 9, 60%; male, n = 6, 40%) who lived locally
were recruited via voluntary sector organisations such as Dementia UK and local carer support groups.
We included both experienced carers (provided care for at least 2 years) and new carers (provided care for
< 1 year), and carers from a range of ethnicities and age groups. In addition, the carers we approached
had different types of relationships with their relatives including spouses, children and nieces/nephews.
The family carers were providing or had previously provided care for a minimum of 4 hours per week for a
relative with dementia. Nineteen health-care professionals (female, n = 11, 58%; male, n = 8, 42%) who
work with people with dementia at times of crisis, including occupational therapists, Admiral Nurses, day
hospital managers, HTT managers, psychologists and psychiatric nurses, were recruited into the groups.
The groups were of mixed sex whenever possible. Ethics and local R&D approvals were obtained (Research
Ethics Committee reference number 10/H0701/20). Informed consent was sought from all participants
who met the inclusion criteria.
Procedure
Three focus groups lasting 60–90 minutes were held for each of the three different stakeholder groups.
The sessions commenced with a brief presentation about the project overall. An explanation of the focus
group ‘ground rules’ was given and the participants were given the opportunity to ask questions before
being asked to focus on the topics for discussion. Each focus group was presented with the following
definition: ‘A crisis is defined as an urgent demand for immediate psychiatric intervention for a patient
living in the community’.170 The participants were asked their opinions on the definition and were then
asked to focus on causes of crisis involving people with dementia and their carers. Later, the participants
were asked to discuss which interventions and forms of support they thought would help during a crisis or
help to prevent a crisis. A framework was used to construct and develop the focus group discussions.
The participants were asked to express their opinions and discuss issues through using a series of open
questions. The questions included in the framework were:
(a) What sort of issues do you think could lead to a crisis situation? What about in the context of people
who are having memory problems? (Prompts from the evidence base provided if necessary.)
(b) What kind of support do you think would be helpful in a crisis?
(c) Do you think any of the following would be helpful in a crisis? (Interventions from the evidence base.)
Analyses
Two researchers conducted the focus groups. One acted as the moderator by facilitating the group, keeping
the discussion going and encouraging all group members to participate fully. The second researcher actively
listened, sought clarification and ensured the accuracy of content as needed during the interview,73 as well
as recording field notes during and immediately after the focus groups.74 Participants gave permission
for the focus groups to be audio tape-recorded and these were transcribed verbatim. The data were
qualitatively analysed to identify broad similarities and differences, using a data-driven inductive thematic
analysis76,209 and ‘long table’ approach to code and analyse information. Thematic analysis is useful for
summarising key features of a large body of data, as well as highlighting similarities and differences across
the data set.209 This can generate unanticipated insights, which is consistent with focus groups inquiry that
allows participants the freedom to provide information that does not necessarily fit with any expectation
going into the research. Inductive thematic analysis searches for themes that emerge directly from the data
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as being important to the description of the phenomenon.210 This approach complemented our research
questions, which were designed to be exploratory to extract descriptive data.
Two researchers independently analysed the focus group transcripts as a method of quality control and
validation. In addition, both researchers read the focus group transcripts twice to familiarise themselves
with the data. Initial codes were generated by coding interesting features within the transcripts in a
systematic and rigorous way across the entire data set, collating data relevant to each code. The codes
were then collated into potential themes, gathering all data relevant to each theme. The themes were
then applied to all of the transcripts again to assess the applicability, and were reviewed and refined as
necessary, generating a ‘thematic’ map of analysis. The themes were continually reviewed through
ongoing analysis, and clear definitions and names were finally applied to the agreed themes. A codebook
was produced, which highlighted the views of the three stakeholder groups, allowing us to assess the
similarities and differences between them.
Tables 47 and 48 present the themes derived from this study according to category and stakeholder
group for causes of crisis and interventions that could help to prevent or manage a crisis. The numbers of
counts illustrate the number of times the theme was discussed by participants in each stakeholder group.
There were five categories relating to themes for causes of crisis: (1) carer related; (2) environmental;
(3) vulnerability; (4) behavioural/psychological; and (5) physical health (see Table 47). There were four
categories relating to themes for interventions: (1) home environment; (2) carer related; (3) professional
health-care support; and (4) social and home care support (see Table 48).
Results
Causes of crisis
People with dementia thought that risks and hazards were the key factors in precipitating crises, including
hazards in daily living tasks in the home such as leaving the gas on or taps running, cooking and
fire hazards:
I thought I had forgotten to turn the fire off and you wouldn’t see how quickly I ran to get home.
Physical health-related factors were rarely mentioned by people with dementia, but falls were a serious
concern and physical hazards around the home could lead to a crisis:
[M]aybe living alone is a crisis and I end up dead . . . I fall everywhere! Bathroom, kitchen,
sitting room.
Outdoor safety was frequently mentioned, including road safety, forgetting keys and accidents in
the garden:
Being involved in an accident . . . on the roads . . . accident in the garden . . . At work!
People with dementia were concerned about their inability to identify potential risks, such as opening the
front door at night without knowing who was on the other side and letting strangers or burglars into
the home:
I shouldn’t have opened it [the front door]. You know it was about 11 o’clock . . . Without knowing
who is on the other side.
Carers were also worried about people with dementia’s inability to identify risks and hazards:
My dad will bring in anyone from the street . . . to our house, which is a bit of a worry.
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TABLE 47 Categories and themes for causes of crisis (number of times topic was discussed in each group)
Stakeholder
group
Carer-related
factors
Environmental
factors
Vulnerability
factors
Behavioural/
psychological
factors
Physical
health factors
People with
dementia
Family carer
absent (5)
Family carer
death (1)
Hazards relating to
daily living tasks in the
home (16)
Physical hazards
around the home (5)
Too much activity/
stimulus in the
home (2)
Outdoor safety (1)
Outdoor safety (6)
Inability to identify
potential risks (5)
Changes in
environment (3)
Social isolation (2)
Reluctance in calling
for/refusing to call for
help/assistance (2)
Person with dementia
is being abused (1)
Inability to manage
finances/bills (1)
Non-adherence to
medication routine (1)
Severity of memory
impairment (9)
Anxiety symptoms (2)
Depressive
symptoms (1)
Poor ability to
communicate
effectively (1)
Falls (5)
Carers Family carer
burden (16)
Family carer’s
mental health (14)
Limited family
carer awareness
and understanding
of dementia (6)
Family carer is
unable to access
support services (4)
Family carer
absent (4)
Family carer’s
physical health (2)
Family carer is
abusing person
with dementia (2)
Carer refusing help
or assistance (1)
Family carer is not
actively involved in
the care planning
process (1)
Poor inadequate
community services (8)
Hazards relating to
daily living tasks in the
home (5)
Physical hazards
around the home (4)
Lack of co-ordinated
health and social
support services (4)
Unable to access
essential amenities (2)
Outdoor safety (1)
Unplanned absence of
care staff (1)
Inability to identify
potential risks (7)
Reluctance or
refusing to access
help (3)
Refusing/forgetting to
take medication or
taking too many
medicines (1)
Non-adherence to
medication routine (1)
Declining support
services (1)
Severity of memory
impairment (8)
Wandering (8)
Physical aggression (5)
Verbal aggressions (2)
Poor inability to
communicate
effectively (2)
Sleep disturbances (2)
Hallucinations (1)
Depressive
symptoms (1)
Repetitive speech (1)
Incontinence (4)
Infections (4)
Falls (3)
Immobility/
difficulty in
walking (3)
Pain (1)
continued
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TABLE 47 Categories and themes for causes of crisis (number of times topic was discussed in each group)
(continued )
Stakeholder
group
Carer-related
factors
Environmental
factors
Vulnerability
factors
Behavioural/
psychological
factors
Physical
health factors
HCPs Family carer’s
mental health (9)
Limited family
carer awareness
(5)
Family carer
burden (3)
Family carer
absence (3)
Carers refusing
help (1)
Family carer is
abusing person
with dementia (1)
Family carer’s
physical health (1)
Poor/inadequate
community services
(17)
Changes in the home
environment (6)
Lack of co-ordinated
health and social
support services (6)
Unsuitably trained paid
care staff (5)
Changes in family and
relationships (4)
Hazards relating to
daily living tasks (3)
Lack of supportive
neighbours/friends in
the local area (3)
Unplanned absence of
paid care staff (3)
Lack of activities in the
home for person with
dementia (2)
Different types of
weather/seasons (1)
Living alone (1)
Reduced driving ability
(1)
Physical hazards
around the home (1)
Unable to access
essential amenities (1)
Very poor eating/
drinking (6)
Declining support
services (4)
Reluctance or
refusing to access
help (3)
Inability to identify
potential risks (3)
Person with dementia
is being abused (3)
Social isolation for
person with dementia
(2)
Non-adherence to
medication routine (2)
Inability to manage
finances/bills (2)
Severe neglect of
personal hygiene/
personal care (1)
Outdoor safety (1)
Severity of memory
impairment (6)
Wandering (4)
Verbal aggression (3)
Hallucinations (2)
Sleep disturbance/
excessive night-time
activity (2)
Depressive symptoms
(2)
Paranoia/suspicious
symptoms (1)
Poor ability to
communicate (1)
Disinhibition (1)
Physical aggression (1)
Immobility/
difficulty in
walking (3)
Incontinence (3)
Infections (3)
Falls (2)
Chronic
diseases (2)
Delirium (1)
Constipation (1)
Medication side
effects (1)
HCP, health-care professional.
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TABLE 48 Categories and themes for crisis interventions (number of times topic was discussed in each group)
Stakeholder
group Home environment Carer related
Professional
health-care support
Social and home care
support
People with
dementia
Supportive friends/
neighbours in local
area (11)
Communication
equipment (11)
Equipment/adapted
furniture/rails/ramps
around the home (9)
Prompts/cues/reminders
around the home (8)
Presence of a family
carer (8)
Maintaining a routine of
daily living tasks (4)
Administering/monitoring
medication (1)
Specialist assistive
technology (1)
Family carer
education (1)
Easy access to
A&E services in
hospital (4)
Specialist
assessments by a
MDT member of
staff (2)
Provision of home care
services (6)
Access to emergency
services (3)
Flexible provision of
services (1)
Carers Specialist assistive
technology (9)
Equipment/adapted
furniture/rails/ramps
around the home (7)
Engaging in purposeful
activities around the
home (3)
Communications
equipment (2)
Administering
medication (1)
Supportive friends/
neighbours in the local
area (1)
Family carer education
and training (10)
Involvement in family
carer support groups (4)
Direct payments (3)
Emergency access to
respite in the home (3)
Accessing the internet
for advice and
support (1)
Planning care and
support services with
the carer (1)
Counselling for family
carers (1)
Advice about financial/
legal matters (1)
Emergency access to
respite in a residential
care home (1)
One main point of
contact (5)
Admiral Nurse (5)
Implementation of a
co-ordinated care
plan (5)
Medication
reviews (4)
Access to HCPs
24 hours per day (4)
Telephone
helpline (2)
Support/specialist
training for HCPs (2)
Signposting (2)
Daily visits by HTT (2)
Easy access to a day
hospital (1)
Easier/better access
to GPs (1)
Referrals being made
earlier to support
services (1)
Provision of home care
services (9)
Specialist training for
home care staff (4)
Provision of day care/
centre services (3)
Centralised database (1)
Flexible provision of
services (1)
Immediate/emergency
provision of care (1)
Access to emergency
services (1)
continued
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TABLE 48 Categories and themes for crisis interventions (number of times topic was discussed in each group)
(continued )
Stakeholder
group Home environment Carer related
Professional
health-care support
Social and home care
support
HCPs Specialist assistive
technology (4)
Equipment/adapted
furniture/rails/ramps
around the home (1)
Communication
equipment (1)
Engaging in purposeful
activities around the
home (1)
Emergency access to
respite in the home (9)
Family carer education
and training (7)
Planning care and
support services with
the family carer (3)
Accessing internet for
advice and support (1)
Involvement with carer
support groups (1)
HCPs available for
longer hours (6)
Physical health
checks (5)
One main point of
contact (5)
Implementation of a
co-ordinated care
plan (5)
Specialist
assessments by
MDT (5)
Support/specialist
training for HCPs (4)
Easy access to GP (3)
Daily visits by HTT (3)
Signposting (3)
Telephone
helpline (2)
Access to Admiral
Nurse (2)
Referrals being made
earlier to support
services (2)
Access to specialist
safeguarding adult
teams (2)
Involving person with
dementia in planning
of their care (1)
Medication
review (1)
Provision of
stimulating activities
to person with
dementia (1)
Provision of home care
services (4)
Easy access to
emergency services (1)
Specialist training for
home care staff (1)
Provision of day care/
centre services (1)
Immediate/emergency
provision of care (1)
Centralised database (1)
A&E, accident and emergency; HCP, health-care professional; MDT, multidisciplinary team.
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Similarly, carers had concerns about household hazards, such as leaving on the electric cooker, leaving taps
running or leaving the gas on, and physical hazards leading to accidents in the shower or kitchen. Carers
thought that a key factor in causing crises was family carer burden due to excessive caring commitments
and their own mental health:
I live a little way away and I’ve got four children; and that’s hard in itself. I have to look after her as
well. Some days, I might be having a crisis before I have even seen her.
Male carers felt distressed and uncomfortable about taking on intimate tasks to which they were not
accustomed, such as looking after their wives’ personal hygiene, as illustrated by this quotation from a
discussion between two male carers:
. . . the crisis I had was with incontinence and being a man, I didn’t like the idea, even with your wife
this is a personal thing, especially to a woman it’s very important, even to my wife, married all
those years.
Some carers reported feeling very depressed. One carer, whose wife became very emotional and cried for
long periods of time when her memory was rapidly deteriorating, reported:
You say to yourself, I wish I was dead.
Staff also acknowledged that the family carer’s mental health could lead to a crisis. People with dementia,
on the other hand, rarely mentioned carer-related factors but were aware that the absence of a family
carer could potentially lead to a crisis, particularly for those who relied heavily on their carer in their
everyday lives.
People with dementia, carers and staff often thought that the severity of the person’s memory impairment
led to a crisis situation; one person with dementia stated:
[S]aying the wrong things at the wrong time . . . putting your foot right in it!
One carer described how their relative’s memory impairment led to significant problems:
. . . asking them [neighbours] to call the police to get this woman [person with dementia’s wife] out of
his house.
Behavioural problems, including wandering behaviour and physical aggression, were often a cause of great
concern to carers. One carer described their concerns about wandering behaviour:
[M]orning or night . . . she was missing and I woke up at 6 and she was right down the front at the
water’s edge.
Physical health-related factors were not mentioned as often in any of the groups, but incontinence, falls
and infections were discussed at length, and very often the ensuing crisis was quite intense and traumatic
for both the carer and the person with dementia. Staff reported that people with dementia with poor
eating/drinking patterns could find themselves in a crisis resulting in hospital admission:
. . . get admitted to hospital because it’s weight loss because they are refusing food.
Poor and inadequate community services, including poor continuity of care, was a leading cause of crisis
according to staff and carers. Staff reported that a crisis could often arise as a result of physical problems
not being fully investigated or health-care professionals not acting quickly enough or calling in support
services. Staff reported that:
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. . . a lot of the time GPs don’t act quickly enough on call, or in support services . . . social services are
quite slow to see people.
One carer described NHS continuing care services as:
[A] hospital ward with no staff. That’s what it feels like! You are on your own. There is nobody there!
Staff thought that the introduction of new home care staff could be confusing and upsetting for people
with dementia. One member of staff reported a recent example and added:
[T]here was an incident today. Home care staff changed and everything was chaotic.
Additionally, staff thought that unsuitably trained home care staff and people with dementia declining
support services often triggered a crisis. Staff mentioned that home environment changes (e.g. adaptations)
could cause confusion for people with dementia. Staff were concerned about changes in the family
(e.g. relatives getting married or having children), and the family carer having limited awareness about
dementia could lead to arguments between carers and people with dementia and, subsequently, to crises.
Interventions in a crisis
People with dementia thought that prompts/cues/reminders around the home, such as lists and notes,
could be very useful to help them to avoid various crisis situations. Communications equipment (people
with dementia), such as having a telephone, and equipment/adaptations (people with dementia and
carers) were thought to help prevent crises. People with dementia said:
You could use your phone if you had a bad fall. If you had a mobile you could take around with you
and:
I have a gas fire . . . so now I have had it disconnected. I’ve got my central heating, so I’ll be warm . . .
so I’m safer!
Family carers and staff highlighted the value of assistive technology such as gas detectors, personal safety
alarms, alerts/pagers and movement detectors. One carer said:
If you are worried about somebody getting out of bed, or getting out of a chair, like I was, they are
absolutely brilliant. It actually gave me a bit more freedom as well . . .
People with dementia primarily thought that having a network of supportive friends/neighbours in the
local area and having a family carer were most useful in helping to prevent a crisis and also during a time
of crisis:
My neighbour, she watches my lights go on and off, so she knows when I go to bed when it’s dark.
People with dementia, carers and staff all thought that home care services were a very useful intervention
during a time of crisis. As one carer said:
It’s been a great help to me, because my wife goes to the cinema and goes out walking. The home
care worker cooks, cleans and she is a real bubbly person . . . I know that I can go out and feel secure
that she is in good hands.
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Carers also highlighted the importance of providing home care staff who have specialist training in
working with people with dementia and their relatives. Staff also advocated emergency access to respite in
the home:
Instant home-based respite. Somebody sitting in the day and somebody overnight.
People with dementia highlighted some professional health-care support interventions that could help
them in a crisis, but their focus was on having easier access to accident and emergency services in hospital
and the emergency services. One carer described an out-of-hours doctor service:
I found that actually every time I rang them about myself or my wife, I got a response and they came
out to see me.
Staff also stated that there was a need for health-care professionals to be available for extended hours.
Staff also suggested regular physical health checks, stating that many crises were unrelated to a mental
health condition, whereas carers valued medication reviews. Staff thought multidisciplinary team
assessments were valuable in preventing and managing a crisis. Carers particularly valued having an
Admiral Nurse:
Thank God for the Admiral Nurses. They are the ones to tell you everything.
Carers and staff thought that the implementation of a care plan and having one main point of contact
(known to both the person with dementia and the carer) were helpful interventions in a crisis:
Someone you can rely on that you trust you can get hold of. I know not everybody is available
24 hours a day.
Staff said ‘with people with dementia it’s important to have some kind of continuity’ and stressed the
value of ‘familiarity and to know what that person needs’.
Staff and carers stressed the importance of providing family carers with education and training in
dementia. Carers wanted general courses on first aid, moving and handling, and information on coping
strategies to help prevent a crisis:
A first aid course . . . would teach me the basics what to do with a scald, what to do with a fire burn,
because they are the household things I am going to be dealing with.
Carers also valued having access to and attending family carer support groups to prevent crises.
Staff, on the other hand, stressed the importance of a more tailored approach:
Every client is different. Information that you give to that person, like individual care for the client or
carer, you need to gear it to the right level and their understanding.
Discussion
We explored the views of a diverse range of stakeholders involved in crises with people with dementia.
People with dementia worried about the risks and increased vulnerability associated with their declining
cognition but wanted support to allow them to remain at home safely. However, rather than expecting a
lot of input from professionals, they valued informal support such as local support from family, friends and
neighbours, notes and reminders, mobile phones, and aids and adaptations around the home to help
manage risks related to gas, electric, cooking and fire. Family carers also had concerns about vulnerability
and safety, and valued home adaptations and specialist assistive technology as being especially useful to
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them and their relative with dementia during times of crisis. Staff also mentioned that specialist assistive
technology should be more widely available for families in crisis.
Family carers had a broad understanding of the range of factors precipitating crises but their main
concerns related to increased carer burden, poor carer mental health and lack of support from other family
members or other services. Carers valued education and training as being useful to help prevent, and to
help them cope during, times of crisis.
Strengths and weaknesses of study
All groups found it easier to discuss causes of crisis than to identify interventions to help. The three key
stakeholder groups from a range of backgrounds, settings and disciplines allowed us to achieve theoretical
validity and theoretical saturation as well as a comprehensive and rich data set. However, some professional
groups were absent from our study, particularly those from outside mental health services such as GPs and
social services. People with dementia required more frequent prompts from the group facilitator than the
other stakeholder groups and, despite encouragement, some participants contributed little to the discussion.
Hearing impairment led to some difficulties but the research team had anticipated this and ensured that
there was additional staff support available when needed.
Clinical and policy implications
Crises faced by people with dementia and their families are complicated and distressing.192 Interventions
need to be flexible and tailored to both the individual person’s needs and their crisis situation.211
The findings from this study support the involvement of services users and carers in service planning.
Conclusion
People with dementia and family carers have much to offer in their understanding of the most important
causes and the most useful interventions in times of crisis. Although health-care professionals often
emphasised more costly and intensive interventions (such as extended-hours services and multidisciplinary
interventions), people with dementia often preferred support from family and friends, notes and
reminders, and home adaptations to reduce risks.
Identifying and managing crisis for people with dementia and their carers
Methods
Aim
Our aim was to conduct a consultation and consensus exercise with a stakeholder network, through
undertaking an online survey with academics, practitioners, voluntary sector and service users, to identify
the primary causes of crises, what interventions are most likely to be useful in a crisis (immediate) and
what are most likely to prevent a crisis (preventative) in dementia, and to provide the basis for
development of the home treatment manual.
Design
An online survey was used with a network of key stakeholders to identify the primary causes of crises
and interventions that are useful for managing or preventing a crisis for people with dementia and their
carers. The online survey was part of a modified Delphi process132,133 to develop a model of home treatment
for the SHIELD research programme. The online questionnaire was designed using results of a literature
review and analysis of focus groups that explored the causes of crisis in dementia.212 The results of the
survey were subsequently included in a manual of home treatment interventions. The effectiveness of using
the manual will be evaluated in a larger RCT.
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Participants
A network of key stakeholders included academic experts in the field of dementia, health and social care
practitioners, medical practitioners, emergency services, professional bodies, voluntary sector staff, home
care agency staff, people with dementia and family carers.
Procedure
Online survey
An online survey was designed using SurveyMonkey (Palo Alto, CA, USA; www.surveymonkey.com).
The respondents were asked to provide their opinions on the importance and frequency of the causes of
crisis, and the effectiveness and usefulness of identified interventions, and to suggest other factors that
they felt had not been covered.
Structure of the questionnaire
Causes of crisis The thematic analysis of the focus group transcripts led to the identification of five
categories of the causes of crisis: (1) behavioural/psychological; (2) physical health; (3) vulnerability;
(4) family carer; and (5) environment. Each category comprised a list of factors that could lead to a crisis
for people with dementia and their carers (Box 1). Participants were asked to choose the 50% from the
selection that they thought were most likely to result in a crisis. The questionnaire also allowed for
comments relating to causes that might not have been included.
Interventions in a crisis The thematic analysis of the focus group transcripts led to four categories of
interventions being identified: (1) professional health-care support; (2) social home care support; (3) family
carer support; and (4) home living environment. Each category comprised a list of interventions and
respondents were asked to indicate whether or not those interventions were likely to be useful in a crisis
and/or preventing a crisis.
Dissemination of the questionnaire
The questionnaire was available in both online and paper versions for completion between November
2010 and January 2011. Dissemination was via professional organisations, NHS trusts, DeNDRoNs (health-
care professionals), direct/personal e-mail correspondence with published academics, Dementia UK (carers),
participants of the focus groups (carers and health-care professionals) and day centres/hospitals through
one-to-one meetings with people with dementia following consultation with service managers.
Ethics considerations
Ethics approval for the research was obtained from the local ethics committee for the consultation and
consensus activities as part of the SHIELD home treatment programme (Research Ethics Committee reference
number 10/H0701/20). Prior to starting the questionnaire, respondents were asked to tick a box indicating
their understanding that they were completing the questionnaire as part of a research project and consenting
to their participation, and anonymised responses being used in the results. The research questionnaire was
anonymous and participants had the option to leave their contact details on an anonymously linked page to
be eligible for entry into a prize draw for a £150 shopping voucher. All questions were mandatory and the
questionnaire could be accessed online at www.surveymonkey.com/s/9THNMRW.
The participants attending the consensus conference all signed consent forms giving permission for their
participation and for their anonymised responses to be used in the results.
Statistical analysis
A chi-squared test was used to examine if there were differences in the response rates between the four
groups. As the respondents included some groups with frequency counts of fewer than five, Fisher’s exact
test was used in addition to the chi-squared test. When relevant, the Fisher’s exact p-value is quoted.
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BOX 1 List of the five domains of crisis and their associated factors
Behavioural and psychological
l Anxiety symptoms (e.g. constant worrying, irritability, agitation).
l Delusions (false beliefs).
l Depressive symptoms (e.g. suicidal thoughts, low mood).
l Disinhibition (e.g. overfamiliarity, inappropriate comments).
l Hallucinations (e.g. seeing and/or hearing things that are not there).
l Physical aggression (e.g. hitting out, throwing things).
l Poor ability to communicate effectively.
l Repetitive speech and actions.
l Severity of memory impairment (disorientation, forgetfulness).
l Sleep disturbance/excessive night-time activity.
l Sudden and unexplained changes in mood (e.g. crying).
l Suspicious/paranoid ideas (persecutory beliefs/accusatory thoughts).
l Verbal aggression (e.g. shouting, threatening and abusive comments).
l Wandering (e.g. wandering excessively around the home/outdoors, night-time walking).
Physical health
l Alcohol problems.
l Chronic diseases (e.g. heart conditions, chest problems, diabetes).
l Constipation.
l Delirium (confusional state – sudden onset).
l Falls.
l Immobility/difficulty walking.
l Incontinence.
l Infections (e.g. urinary tract infection, chest infection).
l Medication side effects.
l Pain.
Vulnerability
l Declining support services (e.g. care package).
l Inability to identify potential risks (e.g. leaving the front door open, bogus callers).
l Inability to manage finance/bills.
l Non-adherence to medication routine.
l Outdoor safety (road awareness, getting lost).
l Person with dementia/memory problems is being abused (e.g. physically, verbally, emotionally,
sexually, financially).
l Reluctance/refusal to call for help or assistance.
l Severe neglect of personal hygiene/personal care.
l Social isolation.
l Very poor eating/drinking.
Family carer
l Death of the family carer.
l Family carer burden (e.g. stress, workload).
l Family carer is abusing the person with dementia/memory problems.
l Family carer is being abused.
l Family carer is experiencing financial difficulties.
l Family carer is not actively involved in the care planning process.
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Results
Responses
A total of 719 respondents completed the questionnaire, comprising 20 academics (3%), 562 health sector
(78%), 54 family carers (8%), 23 social care sector (3%), 16 emergency services (2%), 12 voluntary sector
(2%), four people with dementia (1%) and 28 others (4%).
Of the respondents, 627 (87%) were female and 620 (86%) reported having been involved in a crisis
involving people with dementia and their carers. A total of 711 (99%) questionnaires were completed
online, whereas four (1%) were completed by hand and returned by post, and four (1%) were completed
by hand by the researcher through interviewing people with dementia.
The personal demographic information was used to group the types of participants into the following four
categories for analysis: 395 (55%) physical health practitioners, 227 (32%) mental health practitioners,
72 (10%) consumers (people with dementia, family carers and voluntary sector) and 25 (4%) academics.
Causes of crisis The top five causes of crisis, ranked by each of the four demographic groups, are listed in
Table 49. When a ranking of 1–5 is given, a low ranking indicates that the factor was selected most
frequently in that domain as being more likely to cause a crisis.
Behavioural/psychological factors There were significant differences in the top five rankings of crisis in
the behavioural/psychological factors domain. Wandering (p = 0.02) was the most commonly selected
factor across the four groups (84%). Although ‘wandering’ was ranked as their second choice, more
mental health practitioners (87%) chose it as a risk factor than consumers (71%), who ranked ‘wandering’
and ‘sleep disturbance’ equally in first place. Consumers (i.e. people with dementia, carers and the voluntary
l Family carer is unable to access support services (e.g. home care services, respite).
l Family carer mental health (depression, anxiety).
l Family carer refusing help or assistance.
l Family carer’s physical health.
l Limited family carer awareness and understanding of dementia/memory problems.
l Sudden absence of family carer (e.g. hospitalisation).
Environment
l Changes in family and relationships.
l Changes in the home environment.
l Hazards related to daily living tasks in the home.
l Lack of activities in the home for the person with dementia/memory problems.
l Lack of co-ordination between health and social support services.
l Lack of supportive neighbours/friends.
l Living alone.
l Physical hazards around the home.
l Poor/inadequate community services.
l Reduced driving ability.
l Too much activity/stimulus in the home.
l Unable to access essential amenities.
l Unsuitably trained paid care staff.
l Unplanned absence of paid care staff.
BOX 1 List of the five domains of crisis and their associated factors (continued)
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TABLE 49 Top five causes of crisis in dementia
Domain
Mental
health
(N= 227),
n (%)
Physical
health
(N= 395),
n (%)
Consumer
(N= 72),
n (%)
Academic
(N= 25),
n (%)
Total
(N= 719),
n (%) p-value
Behavioural/psychological
Wandering 198 (87)2 331 (84)1 51 (71)1 21 (84)3 601 (84)1 0.02
Physical aggression 206 (91)1 304 (77)2 46 (64)4 23 (92)1 579 (81)2 0.0001
Sleep disturbance 182 (80)3 281 (71)3 51 (71)1 20 (80)4 534 (74)3 0.07
Verbal aggression 170 (75)4 273 (69)4 45 (63)5 22 (88)2 510 (71)4 0.04
Suspicious/paranoid ideas 164 (72)5 234 (59)5 39 (54) 16 (64)5 453 (63)5 0.004
Anxiety symptoms 117 (52) 232 (59) 41 (57) 16 (64)5 406 (57) 0.3
Severity of memory
impairment
68 (30) 181 (46) 47 (65)3 7 (28) 303 (42) 0.0001
Physical health
Falls 205 (90)2 345 (87)1 62 (86)1 23 (92)1 635 (88)1 0.6
Infection 208 (92)1 321 (81)2 61 (85)2 21 (84)2 611 (85)2 0.004
Delirium 195 (86)3 281 (71)3 49 (68)3 18 (72)3 543 (76)3 0.0001
Immobility 102 (45)4 202 (51)4 30 (42)5 11 (44)5 345 (48)4 0.3
Incontinence 88 (39) 190 (48)5 44 (61)4 16 (64)4 335 (47)5 0.006
Medication side effects 93 (41)5 169 (43) 28 (39) 6 (24) 296 (41) 0.3
Alcohol problems 52 (23) 73 (18) 11 (15) 11 (44)5 147 (20) 0.02
Vulnerability
Inability to identify potential
risks
173 (76)1 298 (75)1 55 (76)1 20 (80)1 546 (76)1 1.0
Very poor eating and
drinking
170 (75)3 267 (68)2 43 (60)3 18 (60)3 495 (69)2 0.04
Person with dementia is
being abused
173 (76)1 245 (62)3 44 (61)2 14 (56)4 476 (66)3 0.001
Declining support services 140 (61)4 220 (56)4 41 (57)4 13 (52)5 414 (58)4 0.5
Outdoor safety 129 (57)5 188 (48) 35 (49)5 13 (52)5 365 (51)5 0.2
Severe neglect of personal
hygiene
120 (53) 194 (49)5 29 (40) 17 (68)2 360 (50) 0.1
Family carer
Family carer burden 182 (80)2 314 (80)1 62 (86)1 19 (76)2 577 (80)1 0.6
Sudden absence of family
carer
184 (81)1 296 (75)3 53 (74)2 20 (80)1 553 (77)2 0.3
Family carer’s physical health 165 (73)*3 301 (76)2 49 (68)3 18 (72)4 533 (74)3 0.4
Death of the family carer 160 (71)4 268 (68)4 43 (60) 17 (68)5 488 (68)4 0.4
Family carer mental health 146 (64)5 235 (60)5 46 (64)4 19 (76)2 446 (62)5 0.3
Family carer unable to access
services
110 (49) 207 (52) 46 (64)4 12 (48) 375 (52) 0.1
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sector) (64%) ranked ‘physical aggression’ (p < 0.0001) in fourth place, compared with 91% of mental
health practitioners and 92% of academics who ranked it first. Sixty-five per cent of consumers selected
‘severity of memory impairment’ (p = 0.004) as a top-five cause of crisis, compared with < 30% of academics
and mental health practitioners. In addition, more mental health practitioners (72%) chose ‘suspicious and
paranoid behaviour’ (p = 0.004) than consumers (54%), who did not rank it in their top five responses.
Physical health factors There were significant differences in the top five rankings of crisis in the physical
health factors domain. More mental health practitioners (86%) selected ‘delirium’ (p = 0.00009) than did
consumers (68%). In contrast, more consumers (61%) selected ‘incontinence’ (p = 0.006) than did mental
health practitioners (39%). Academics considered ‘alcohol problems’ (p = 0.02) a more significant cause of
crisis (44%), compared with the other three groups, particularly consumers (15%).
Vulnerability There were significant differences in the top five rankings of crisis in the vulnerability
domain. More mental health practitioners selected ‘very poor eating and drinking’ (p = 0.04) than did
consumers and academics (60%). In addition, 76% of mental health practitioners selected ‘person with
dementia is being abused’ (p = 0.001), compared with < 56% of academics and 61% of consumers.
Family carer There appeared more consensus across the four groups’ rankings of family carer factors that
could cause a crisis, with no significant differences observed. Interestingly, ‘death of family carer’ did not
feature in the top five rankings of consumers.
Environment There were significant differences in the top five rankings of crisis in the environment domain.
More physical health practitioners selected ‘physical hazards around the home’ (p = 0.005) as a top cause of
crisis than did consumers and academics. In addition, 76% of mental health practitioners considered ‘hazards
related to daily living tasks’ (p = 0.04) more likely to cause a crisis, compared with 61% of consumers.
Seventy-six per cent of consumers (76%) selected ‘living alone’ (p = 0.004) as a top five cause of crisis,
compared with 60% of mental health practitioners and 68% of academics.
TABLE 49 Top five causes of crisis in dementia (continued )
Domain
Mental
health
(N= 227),
n (%)
Physical
health
(N= 395),
n (%)
Consumer
(N= 72),
n (%)
Academic
(N= 25),
n (%)
Total
(N= 719),
n (%) p-value
Environment
Physical hazards around the
home
162 (71)3 315 (80)1 46 (64)4 16 (64) 539 (75)1 0.005
Hazards related to daily living
tasks
172 (76)1 264 (67)3 44 (61)5 18 (72)2 498 (69)2 0.04
Living alone 136 (60) 286 (72)2 55 (76)1 15 (60) 492 (68)3 0.004
Unable to access essential
amenities
164 (72)2 261 (66)4 43 (60) 18 (72)2 486 (68)4 0.2
Changes in the home
environment
161 (71)4 254 (64)5 48 (67)2 19 (76)1 482 (67)5 0.3
Inadequate community
services
138 (61) 238 (60) 44 (61)5 15 (60) 435 (61) 1.0
Unsuitably trained care staff 139 (61)5 230 (58) 45 (63) 18 (72)2 432 (60) 0.5
Lack of co-ordination
between health/social
services
108 (48) 248 (63) 48 (67)2 18 (72)2 422 (59) 0.0005
1–5 are the top five rankings for the cause of crisis in dementia; a low ranking indicates a high importance associated with
this factor.
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Crisis interventions The list of interventions for each of the four categories (professional health-care
support, social home care support, family carer support and home living environment) that all respondents
thought were most likely to be useful in a crisis and those most likely to prevent a crisis is shown in Table 50.
Where a ranking of 1–5 is given, a low ranking indicates the intervention was selected most frequently in
that category as being useful or preventative in a crisis.
Useful interventions
Professional health-care support There appeared to be more consensus across the four groups’ top five
rankings of professional health-care support factors that could useful in a crisis, with no significant
differences observed. Consumers ranked ‘easy access to accident and emergency services in a hospital’ top
of their selection, compared with mental health practitioners, who ranked it third.
Social home care There were significant differences in the rankings of the top five immediate
interventions in the social home care domain. More mental health practitioners (43%) selected ‘specialist
training for home care staff’ (p = 0.02) than did physical health practitioners (31%). Moreover, this factor
did not feature in the top five rankings of physical health practitioners.
Family carer There appeared to be more consensus across the four groups’ rankings of family carer
factors that could useful in a crisis, with no significant differences observed.
Home living environment There were significant differences in the rankings of the top five immediate
interventions in the home living environment domain. More mental health practitioners (76%) selected
‘communication equipment’ (p = 0.008) than did academics (44%). Similarly, fewer academics (12%)
selected ‘specialist assistive technology’ (p = 0.004) than mental health practitioners (40%), physical health
practitioners (29%) and consumers (28%). Moreover, 27% of mental health practitioners selected
‘administering/monitoring medication’ (p = 0.008), in comparison with lower numbers of physical health
practitioners (17%), consumers (15%) and academics (12%).
Preventative interventions
Professional health-care support There were significant differences in the top five rankings of
preventative interventions in the professional health-care support domain. ‘Referrals made earlier to
support services’ (p = 0.02) was the top-ranked factor across the four groups, although more physical
health practitioners (94%) selected this factor than consumers (86%). In addition, 86% of physical health
practitioners selected ‘specialist assessments by a member of the multidisciplinary team’ (p = 0.02) as a
preventative intervention, compared with 72% of academics.
Social home care There were significant differences in the top five rankings of preventative interventions
in the social home care domain. Fewer academics (80%) selected ‘specialist training for home care staff’
than the other three groups (> 93%).
Family carer There were significant differences in the top five rankings of preventative interventions in
the family carer domain. Fewer academics (80%) selected ‘family carers education/training’ (p = 0.05)
compared with the other three groups (94%). Similarly, fewer academics (76%) chose ‘planning care and
support services with the family carer’ (p = 0.02), compared with the other three groups (93%). Again,
academics’ (84%) views differed from those in the other three groups (> 93%). Academics’ (84%) views
also differed in their joint top ranking of ‘advice about financial/legal matters’ (p = 0.001) from those of
mental health practitioners (76%), who ranked it fifth.
Home living environment There were significant differences in the rankings of the top five preventative
interventions in the home living environment domain. More physical health practitioners (90%) selected
‘prompts/cues/reminders placed around the home’ (p = 0.0001) than did the other groups, particularly
consumers (72%).
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Discussion
This is the first quantitative study that has compared the views of people involved in the management of
crisis and dementia. The results suggest differences of opinion between professionals, consumers and
academics as to what can cause a crisis and what interventions can be useful and/or prevent a crisis for
people with dementia and their carers. Consumers’ rankings of the causes of crisis differed more frequently
than those of the other three groups. Academics’ views also differed, particularly regarding interventions
that could be useful in a crisis. These variances are important to recognise, particularly in the development of
policy and strategies aimed at avoiding crises and managing them effectively.
Consumers’ views differed in three of the five domains of crisis, which suggests that they may interpret
and manage crisis situations differently from health-care professionals. This divergence of opinion reflects
previous studies’ findings that people with dementia and family carers do not always hold similar views on
the provision of health-care services.213,214
There is increased policy emphasis on involving people with dementia and family carers in planning the
care that they receive, as nearly half report little or no involvement in the decisions and choices made about
the support services they receive.215 The results of this study suggest the need to listen more closely to the
views of people with dementia and their families about their needs and choices when planning care
interventions, particularly at times of crisis, as these may not reflect the priorities as assessed by health-care
professionals. The findings also highlight the importance of government policy and practice standards about
providing client-centred care that meets the needs and preferences of people with dementia.216
Government policies and guidelines highlight the need for health-care practitioners to work more
collaboratively in understanding and supporting people with dementia.217 Interestingly, the results from this
study suggest that there were no significant differences between mental and physical health practitioners’
views on the causes of crisis.
Conversely, the results also show that consumers may not always interpret or place significance on factors
associated with crisis, given their lower ranking of abuse, neglect and alcohol consumption, which in turn
has implications on safety and mortality. This could suggest the need for health-care professionals to
explore these issues with consumers and develop an educative role while recognising the sensitivities that
individuals may feel about disclosing this type of information.
The findings support the relevance and importance of family carer-related factors as a contributor to crisis.
In contrast, Toot et al.212 found that people with dementia did not consider issues such as family carer
burden or carer absence as significant, which suggests that people with dementia and family carers have
different views about family carer-related crisis.
The provision of timely and immediate interventions is critical in resolving crisis in dementia, which is often
complicated by comorbidity and safety issues. In comparison, the provision of preventative interventions is
important, as the degenerative and complex nature of dementia and its impact on families mean that the
support and care provided should offer stability and be sustainable in the longer term. The results of this
study demonstrate that interventions selected as being useful in a crisis were, in most cases, less frequently
selected as being useful to prevent a crisis, as illustrated by the significant differences between how the
interventions were ranked.
Overall, there was more consensus in how the groups ranked the top five interventions that could be useful
in a crisis. The results reflect the literature that identifies that people with dementia and their carers viewed
being able to access accident and emergency services in a crisis situation as important.212 Unfortunately,
people with dementia are more likely to experience negative outcomes following a hospital admission, such
as longer stays, increased confusion, infection and disorientation.217 Given that the number of avoidable
hospital admissions is rising,218 health-care practitioners could have an educative role in enabling consumers
to be aware of the range of primary and secondary care services available that were traditionally associated
with accident and emergency services in acute hospitals.
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The timing of when specialist assessments and opinions are sought from other professionals could indicate
differences in practice, with mental health practitioners considering this to be useful in a crisis and physical
health practitioners ranking it as being preventative. The implications for training all staff in the range of
potential services and assessments that could promote well-being and support for people with dementia
and their carers need to be considered.
The use of assistive technology in the management of dementia is widely reported in the literature;
however, different opinions regarding its efficacy as a useful and/or preventative intervention were
observed in the results. The disparity between mental health practitioners’ and academics’ views could
suggest a difference between the clinical and practical applications of assistive technology and the
published evidence supporting its use as an immediate or preventative intervention.
The findings also challenge the use of prompts and cues as an effective preventative intervention for
people with dementia, with consumers ranking this lower than the other three groups. This is of particular
interest when comparing advice published by charities and carer support groups of the importance of this
type of intervention. Equally, understanding the different views between people with dementia and family
carers about the use of prompts and cues could be important, especially if this is valued by people with
dementia and not by family carers.
The study has also shown the usefulness of using online surveys to obtain opinions from a wide range
of respondents and to reach a broad sample of participants. The use of online surveys is an affordable
and effective way of consulting with relevant stakeholders and has been shown to have no consistent
differences to postal surveys in response effects.219 Although the use of online surveys is advantageous in
offering accessibility and anonymity,220 there is a risk of attracting inappropriate or hoax respondents
owing to its ease of access. This risk was counteracted by sending the invitation and access to the survey
through known carer, organisational and professional networks.
Implications for practice
The results provide a useful insight into the perspectives of consumers and could further develop
assessment processes, for example robust risk assessments that also capture individuals’ unmet needs.
Risk and unmet needs assessments should explore carers’ perceptions about what they feel they could or
could not cope with, which in turn could influence carer education and support strategies as part of a
preventative care plan. Health-care professionals may also benefit from understanding a wider range of
consumer-related issues that could affect the cause and management of crisis, including understanding
perceptions about incontinence, and potentially low awareness of types of abuse, which could form part
of a risk management strategy. Supporting both carers and staff to understand how government policy is
reconfiguring services to provide support in the home and that accident and emergency is not the only
option in a crisis may also have quality-of-life benefits for the person with dementia. Equally, policy-makers
may wish to consider consumers’ views about accessing services in a crisis and that further education and
promotion of alternative routes to seeking support should be considered.
The findings could serve as a point of reference for practitioners and managers, supporting supervision
and decision-making tools around care planning and risk management. The findings also have potential
implications for the provision of interventions, particularly in situations in which consumers’ views differ;
therefore, practitioners may need to understand the different viewpoints and be equipped to negotiate
between parties.
The research shows differences and similarities between how groups of professional groups perceive and
interpret crisis situations. Developing a workforce education plan that increases the awareness of dementia
and the key issues related to crisis, interventions and the roles of the multidisciplinary teams in health,
social care and the voluntary sectors could increase competence and increase collaboration in practice.
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Plans have already been developed to progress the findings from this research into a manual of
interventions to support the common causes of crisis in dementia. It is anticipated that this resource will be
developed and used in practice to support practitioners, carers and people with dementia living at home.
Implications for research
The study demonstrates that differences of opinion exist between the stakeholders involved in the
management of crisis situations. The findings show that the needs of consumers differ at times from the
views of health-care professionals and academics.
Further research could be undertaken with a larger sample of people with dementia and carers, to gain a
greater understanding of their perspectives on crisis. This could also be supported by a qualitative study
to explore thoughts and feelings about crisis to enrich the research findings. Consideration could also be
given to exploring the different views held by people with dementia and carers in more detail, as this study
highlighted differences between the two groups in the literature which are not analysed in this research.
As academics are significant contributors to the evidence base on dementia, further research could be
undertaken with a larger sample of this group to gain a greater understanding of their perspectives on
crisis. A qualitative study could be used to explore their views on the use of alcohol as a cause of crisis,
in addition to preventative interventions such as family carer support and assistive technology.
Further research is required about the delivery of home interventions in a time of crisis and potential
challenges to their successful implementation. The use of care management as a method of preventing
and managing crisis situations could be explored further to assist in the development of best practice
treatment models.
Limitations
The use of online surveys may introduce bias owing to the non-representative nature of the internet
population.220 However, the large response received would indicate that an increasing number of people now
have access to the internet, including family carers. The option of completing paper versions of the survey was
taken by a small sample of people with dementia, with assistance from a researcher. There was a significantly
higher number of respondents in the physical health group than in the mental health group and this positively
reflects the increasing contribution of the physical health sector in caring for people with dementia, which has
been previously acknowledged.216 Future work could usefully explore further the perspectives of the relatively
under-represented groups in the present study, for example people with dementia.
Conclusion
The study aimed to compare stakeholders’ views of what causes a crisis for people with dementia and
their carers in addition to identifying the interventions that are preventative and useful in a managing
a crisis.
Views differed between the groups and could vary depending on the factors being presented. Consumers’
rankings of causes of crisis differed more frequently than those of other three groups. Academics’ views
also differed, particularly regarding interventions to support a crisis. These variances are important and
highlight the need for further research to understand the perspectives of others when planning and
managing support for people with dementia and their family carers.
This study identified the top five responses and could be extended to explore all the factors that were
presented. A larger sample of people with dementia and academics may provide more comparable data to
contribute to understanding crisis in dementia. Investigating the different views of people with dementia
and their carers would also be important.
This was a large-scale study that generated 99% of its responses online, demonstrating the potential of
using technology to generate opinions from a wide range of participants.
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Development of the home treatment protocol
Manual development
A manual of home treatment interventions was drafted, incorporating the results of the systematic reviews,
scoping visits to HTTs, focus groups with HTT and older persons’ mental health services staff, family caregivers
and people with dementia, and the results of the online questionnaires sent out to the stakeholder network.
The home treatment manual included a home treatment advisory protocol for assessing people with dementia
and their family carers at times of crises, and incorporates the Threshold Assessment Grid risk assessment, the
Camberwell Assessment of Need for the Elderly (CANE) and a care planning tool with case examples. From the
findings of the online questionnaire we were able to develop a table of interventions that were incorporated
into the home treatment manual (draft 1) and included the four categories of professional health care, home
living environment, social home care and family care support. In the table, the interventions were presented
in two distinct formats: a list of those interventions preventing a crisis and a list of those considered most
useful in a crisis.
Consensus conference
A consensus conference was organised for consultation on the home treatment manual (draft 1) and
the home treatment advisory protocol. Invitations were sent to 99 people from our database of key
stakeholders, which included service users (people with dementia and family carers), practitioners, voluntary
organisations, independent sector and professional bodies. The consensus conference consisted of a series
of short presentations on the development of the manual and a review of the existing evidence about crisis
interventions; a presentation on HTTs in Kent was also given. Participants were then divided up into small
working groups. Each working group was assigned one of the categories – behavioural/psychological,
physical health, vulnerability, family carer and environment – and asked to select the top five interventions
for all the factors in each of these categories. Participants selected the top five interventions that were most
likely to be useful in a crisis (immediate) and those most likely to prevent a crisis (preventative) from the
table of interventions generated through the online stakeholder survey.
Following the selection of the top five interventions, participants then applied the home treatment advisory
protocol to case vignettes and identified relevant interventions as part of the care planning process. Participants
had the choice of selecting interventions from the top five and the fuller table of interventions identified as
being most likely to be useful in a crisis (immediate) and those most likely to prevent a crisis (preventative),
or to identify additional interventions if these were thought to be more appropriate. The feedback from the
consensus conference was used to develop a glossary of interventions and was incorporated into a further
version of the home treatment manual (draft 2).
There were 23 participants who attended the consensus conference on 6 April 2011. Of these, there were
three (13.0%) service users (family carers), one (4.3%) voluntary organisation representative, 15 (65.2%)
practitioners, one (4.3%) representative from the independent sector and three (13.0%) representatives from
professional bodies, who were divided into five small working groups. In addition, e-mail consultation was
undertaken with 13 academics and clinicians on the stakeholder database. Each working group was assigned
one of the categories – behavioural/psychological, physical health, vulnerability, family carer, environment – and
selected five interventions that were most likely to be useful in a crisis (immediate) and most likely to prevent a
crisis (preventative) for each of the factors listed. These responses have been amalgamated into a glossary of
interventions, which was incorporated into the second draft of the home treatment manual. Following the
selection of the top five interventions, participants then applied the home treatment advisory protocol to case
vignettes and identified relevant interventions as part of the care planning process. Of the 10 case vignettes
that were completed, all of the care plans were completed using both immediate or preventative interventions
selected from either the top five interventions identified for that factor or the fuller list of interventions. The
feedback from the participants was unanimous in that the top five interventions selected were relevant and
appropriate for meeting the needs identified in the case vignettes.
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Case review workshops
To test the initial suitability and application of using the home treatment manual (version 2) and advisory
protocol, five case review workshops were held in Manchester, Hertfordshire and East London. There were
45 health-care practitioners who participated in these sessions aimed at reviewing the content of draft
version 2 of the home treatment manual and applying the advisory protocol to clinical situations that they
had managed. The workshops generated both individual and group feedback on the use of the home
treatment manual in addition to 40 completed cases using the home treatment advisory protocols. Feedback
and suggestions from the case review workshops were used to draft the home treatment manual (version 3).
Participants were generally positive about using the manual but had reservations about some aspects. This
included being unclear about the relationship between the need (CANE) and risk (Threshold Assessment
Grid) assessments, and how to interpret the scores and prioritise the unmet needs. It was agreed that needs
should be prioritised as immediate/high/moderate/low. Participants also had difficulty matching the unmet
need to the cause of crisis, so the bracketed examples were reintroduced, for example chronic diseases (e.g.
heart conditions, chest problems, diabetes) and inability to identify potential risks (e.g. leaving the front door
open, being unable to identify bogus callers). There was some sensitivity around wording, such as the use of
the term ‘wandering’ and the phrase ‘family carer is abusing the person with dementia/memory problems’,
and the term ‘abusing’ was replaced with neglecting. The care plan within the advisory protocol was
thought not to be detailed enough and this was renamed as a care planning tool. Navigating through the
manual was difficult for those unfamiliar with it and the introduction of tabs or colour coding was
suggested, which we adopted for the glossary in the manual.
Ratification and consensus on the home treatment manual
Consultation to validate and ratify the home treatment manual (version 3) was undertaken with 50 people
from our database of practitioners, family carers and experts in home treatment. All were sent a copy of
the manual. The participants were asked to focus attention on sections 1 and 2 of the home treatment
manual and to provide feedback on the relevance of the contents and its applicability to practice in
managing or preventing crisis situations in dementia. They could comment on the whole manual if they
preferred and were asked to test the practicality and applicability of using it by applying the home
treatment advisory protocol to one of the case vignettes in the manual.
The questions asked were:
1. Are you happy with the manual in its current form?
2. Was the manual easy to read and follow?
3. Was there anything you didn’t like about the manual?
4. Do you think anything is missing from the manual?
5. Is there anything you would change in the manual?
6. Any other comments?
Feedback received on the home treatment manual
In total there were 15 respondents, who consisted of one family carer, an occupational therapy practice
officer and 13 practitioners: nurses occupational therapists, a clinical psychologist, a service manager and
a consultant psychiatrist. About half of those consulted read the complete manual and three read the
manual and applied the vignettes. Although there were general concerns about the length of the home
treatment manual, there was consensus on the manual being informative, easy to read and use, relevant
to practice, comprehensive and suitable for use.
The following is a selection of comments obtained through validation of the home treatment manual:
The manual contains some valid points and offers excellent advice around crisis situations and
managing crisis situations.
Respondent 4
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I have worked in a crisis team for over 2 years and to see the ‘process’ formalised and based on
evidence is excellent.
Respondent 5
This manual will probably help in auditing the effectiveness of crisis teams, something which we found
quite difficult.
Respondent 6
. . . I think the manual is useful as it provides a very structured approach without being overly
prescriptive medicalised or complicated. I think it is a very practical manual but still very person
centred . . .
Respondent 11
I think this is an excellent piece of work and look forward to the next phase.
Respondent 10
What a fantastic piece of work this is, I can really see some benefit in how we could roll some of this
out within physical health care services, especially in our Community Inpatient Services, where we see
quite a bit of dementia . . .
Respondent 12
I like the document. It is a time-consuming read as it is detailed and at times complex . . . However,
it is relevant and supports good practice . . .
Respondent 13
Following the consultation, changes were made to the home treatment manual, which included reducing
its length, changing the wording when requested (e.g. psychiatric/mental health, vignettes/’case examples’
or scenario, wandering/purposeful walking) and adding in a quick access guide and a list of abbreviations
and acronyms. The manual was modified and version 4 of the home treatment manual was drafted.
Discussion
This study demonstrates the usefulness of involving a broad range of stakeholders in the shaping of care
approaches for dementia. From our consultation we have been able to determine what practitioners in
mental and physical health and services users consider to be the key causes of crisis in dementia, and what
interventions they judge as most helpful in managing or preventing the crisis situation. Our consultation
exercises during the consensus conference allowed us to build on the results of the online survey and link
the most relevant interventions to specific factors that cause crisis in dementia. Immediate interventions are
critical in resolving crises in dementia, which are often complicated and multifactorial situations owing to
comorbidity and safety issues, whereas preventative interventions are important as the degenerative and
complex nature of dementia and its impact on families mean that the support and care provided should offer
stability and be sustainable in the longer term. Overall there is a general agreement about what factors are most
likely to result in crisis and what is helpful in managing the situation. The involvement of service users (both
people with dementia and family carers) has been key in this process, as the relevance and appropriateness of
the interventions offered increase the likelihood of acceptance of and compliance with care planning.
The case review workshops and consensus work enabled the manual to be further improved to prepare it
to a level at which it was ready for field testing in clinical practice. Although there were concerns about
the manual’s length, and the additional work involved, it was regarded as easy to use and practical in
clinical situations.
Limitations
There was a lower number than expected of people who attended the consensus conference and this is
reflective of the demands on people’s time and commitments in the workplace. The NHS is currently
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undergoing significant change and the organisations and staff invited identified difficulties in finding the time
to attend, as shown by the numbers of requests to consult electronically. Nevertheless, those participants
who did attend offered a useful contribution and allowed us to complete the consultation exercises.
Implications for practice
Our study has led to the development of a glossary of interventions to help practitioners with care
planning and targeting interventions to meet the common causes of crisis in dementia. Developing a
systematic and structured approach to managing and preventing crisis in dementia has allowed us to
establish a model of good practice for home treatment interventions. The glossary of interventions has
been incorporated into our manual of home treatment interventions, which received a positive initial
response by the practitioners and service users involved in the consensus process and was judged relevant
and appropriate to clinical practice. Using the glossary may help practitioners by providing a systematic
approach to identifying appropriate interventions that can help to resolve the relevant issues contributing
to a crisis situation. The prompt and effective resolution of the problems contributing to crisis may, in turn,
lead to the avoidance of unnecessary or inappropriate hospital admissions and delays in care home
placement. Potential benefits are, therefore, indicated for people with dementia and family carers with the
wider implementation of the home treatment manual in practice.
Implications for research
Before the home treatment manual can be introduced into clinical practice, further feasibility testing of the
manual is needed. There is also a need to evaluate the effectiveness of implementing the home treatment
manual and the application of the glossary of interventions in practice, which should be undertaken in a
rigorous and robustly designed clinical trial. The study does show the positive advantage of using online
surveys to reach and consult with a wide range of stakeholders, and offers potential opportunities for
future research.
Conclusion
The inclusion of service users is vital in developing interventions in dementia that will be considered
relevant and preference based. Furthermore, the development of a glossary of interventions linked to the
main causes of crisis in dementia has the potential for improving patient outcomes. Further research is,
however, needed to show the effectiveness of applying the glossary of interventions in practice. Our use
of an online survey was effective in allowing us to consult with a broad range of stakeholders and is a
medium that should be explored further for use in research. The results of this study were used to further
develop the home treatment manual and produce the version for field testing.
Work package 3: feasibility study of using the home treatment manual
and advisory protocol in practice
Aim
The feasibility study was used to assess the practicality and applicability of using the home treatment
manual (version 4) and advisory protocol in practice to assess its potential for use in a large-scale
clinical trial.
Objectives
We tested aspects of feasibility, tolerability and efficacy of using the home treatment manual and advisory
protocol for people with dementia who are experiencing a crisis situation.
Our objectives were:
1. to assess if the home treatment manual and advisory protocol can be delivered as intended
2. to test the procedures for recruitment to and the retention and delivery of the intervention.
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Sample
We recruited 17 mental health keyworkers who support people with dementia either approaching or in
crisis situations who would use the home treatment manual with their clinical caseload. The practitioners
were recruited from HTTs and CMHTs in Lancashire Care Trust and NELFT. The home treatment advisory
protocol was applied to 21 clinical cases of people with dementia–caregiver dyads. The clinical cases were
either new referrals to the older person’s mental health service, or existing cases, who had been identified
as approaching or experiencing a crisis situation.
Intervention
The home treatment manual is intended for use for people with dementia and their family carer who
require home treatment interventions to avert or reduce the need for admission to hospital. It contains
guidance on assessment and the delivery of interventions to manage or reduce the risk of crisis in
dementia. A training day was provided on the use of the home treatment manual and advisory protocol,
and supervision structures were agreed before the feasibility study commenced. The clinical research staff
provided supervision to the teams through telephone and e-mail contact. The home treatment advisory
protocol was applied in accordance with the home treatment manual with 21 clinical cases of people with
dementia–caregiver dyads. The home treatment manual and advisory protocol were implemented on initial
assessment following referral to the service, or when the risk of hospital admission was identified for those
people with dementia who were known to the service.
Consent
Permission was obtained from the service managers for the clinical area and from the mental health
keyworkers for their participation in the study.
Data collected
We collected data from the home treatment advisory protocol, which were applied at two time points:
at initial assessment and on evaluation. The data included the following clinical outcomes for the person
with dementia: the number of unmet needs, the level of risk determined and the number of admissions to
hospital or to care homes. All of this information was collected from the completed advisory protocols.
All information was anonymised and used to evaluate practitioners’ ability to use the manual and advisory
protocol with clinical cases. These data included the following clinical outcomes for the person with
dementia: the number of unmet needs, the level of risk determined and any admissions to hospital or to
care homes. All of the information was available from the advisory protocol.
Feedback was collected from the mental health keyworkers about their use of the manual through
completion of the Adherence to Protocol Questionnaire and an individually completed questionnaire. This
included minimal demographic information about the mental health keyworker, such as their profession,
their place of work and the number of clinical cases in which they applied the advisory protocol. A group
discussion was also to be held with mental health keyworkers to explore their attitudes and opinions about
using the home treatment manual and advisory protocol.
Results
Of the 17 mental health keyworkers trained to implement the home treatment manual and advisory
protocol, only 10 practitioners from Lancashire Care used the home treatment manual and advisory
protocol; they were based in CMHTs (n = 3) and HTTs (n = 7). The reasons for the remaining seven
practitioners not using the home treatment manual and advisory protocol were change of role/promotion
(n = 2), did not care co-ordinate/admininstrate (n = 1), declined (n = 1), medium-/long-term sickness (n = 2)
and unknown (n = 1).
Of the 21 home treatment advisory protocols collected, there were completed forms for the Threshold
Assessment Grid, with 21 out of 21 completed with 100% accuracy; the CANE, with 21 out of 21
completed with 100% accuracy; the care planning tool, with 21 out of 21 completed with 100%
accuracy; and the discharge care planning tool, which had 16 out of 21 completed.
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Only 2 out of 10 practitioners completed the Adherence to Protocol Questionnaire and 8 out of 10
practitioners provided feedback using the questionnaire, two of whom completed the questionnaire jointly.
The comments are given in Table 51. The reasons for the remaining two practitioners not providing feedback
were sick leave (n= 1) and annual leave (n= 1). The group feedback discussion was unable to be held as,
despite three attempts to schedule these groups, a quorum of at least three participants could not be achieved.
Conclusion
In general, people found the manual and advisory protocol useful; however, most did state that they
found it a time-consuming process because it was novel and they were doing it in addition to their current
care planning procedures. Some participants were not able to complete the discharge care planning tool
and stated that this was because the service users were in their care for > 8 weeks, which was the time
frame for the feasibility study.
Recommendations to the manual were made and it was thought by some that the detailed description
of the development process at the front of the manual was not required. A number of participants stated
that they would like a smaller, more ‘simplified’ manual, with improved reference systems and a
‘step-by-step’ flow chart to guide them through the process.
The manual and advisory protocol were acknowledged as useful, especially for staff inexperienced in
working with people with dementia in crisis. However, it was felt that if this process was to be
implemented, an electronic or online format would be easier to use.
For more information on the SHIELD home treatment advisory protocol and guidance, please contact the
R&D office at NELFT or e-mail SHIELD@nelft.nhs.uk.
TABLE 51 Responses from the feedback questionnaire (seven forms)
Question Rating Comments
The home treatment manual
and advisory protocol are
suitable for purpose in their
current form
Strongly agree (n= 1)
Agree (n= 4)
Disagree (n= 2)
CANE useful (n= 2)
Time-consuming (n = 5)
Coding-related difficulties (n= 3)
The home treatment manual
is easy to read, follow and
apply
Agree (n= 6)
Don’t know (n= 1)
It is thorough and well thought out. It is good to have a tool to
use that is comprehensive and standardised – it reinforces our
current practice
Do you think anything is
missing from the manual?
No (n= 5)
Yes (n = 1)
Missing (n= 1)
The CANE doesn’t cover sleep problems, also needs a section for
‘other’
I found that the terminology relating to the codes was broad
enough to encompass all the identified actions on the care plan
Is there anything you would
change in the manual?
No (n= 1)
Yes (n = 5)
Missing (n= 1)
Manual is too long (n= 3)
Easier reference systems (n = 2)
Need an ‘idiot’s’ step-by-step guide to completing the
documents (n= 2)
Other comments
I can see the value of the manual and protocol for new
or inexperienced staff in order to standardise practice. However,
in order for it to be workable, it needs to be used regularly by
these practitioners so that it becomes second nature to use
For those professionals who are inexperienced with working
with people with dementia, then the manual provides a guide of
helpful interventions to consider
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Chapter 5 Conclusions and recommendations for
future research
Conclusions
There is an urgent need for useful and effective interventions to help to reduce the impact of dementia on
patients, carers and society. The aim of our research programme was to prevent excess disability, promote
social inclusion, improve health outcomes and enhance quality of life for people with dementia and their
carers. The aim was achieved by our rigorous 5-year programme of psychosocial research, which comprised
three projects: (1) MCST groups for people with dementia to improve their cognition and quality of life;
(2) an expert carer programme that trained ex-carers to help new carers of people with dementia and that
were undertaken alongside reminiscence groups for people with dementia and their carers to help maintain
quality of life and improve their relationships; and (3) developing intensive home support to help manage crises
at home and prevent admission to hospital for people with dementia. We used mixed-methods approaches, all
of which were carefully evaluated for their potential benefits to people with dementia and their carers.
The objectives for the project were achieved in that each of the three projects completed a number of
components of the pathway, through the development of theory, modelling, feasibility and evaluation to
dissemination and implementation, as illustrated in the MRC framework for complex interventions.30
We developed a strategy for user and carer involvement as part of the SHIELD research programme and
we have also produced training manuals, which will be made widely available to help other services
implement the same approaches.
We updated the Cochrane review on reality orientation/CST for dementia and developed a package for carer
supporters. Initial pilot studies were conducted for the MCST and the CSP to ensure that the detailed design,
methods and procedures were robust and fit for purpose. We then conducted definitive RCTs for MCST,
RYCT and the CSP, along with economic evaluations for the MCST and CSP/RYCT interventions. Continuing
MCST improved quality of life, improved cognition for those taking AChEIs and is cost-effective. Moreover,
our results support other work indicating that drug and psychosocial interventions may potentially work
better together than either intervention alone. Although the post-RCT surveillance observational study of
MCST in practice did not find a noticeable improvement in cognition or quality of life at follow-up 8 months
later, it is encouraging that neither declined over time. However, many participants in the observational
study had only mild cognitive impairment and, therefore, may have been too high functioning to benefit
cognitively from CST. The CSP/RYCT study did not find any particular benefits for family carers, although
quality of life expressed in terms of QALYs derived from the EQ-5D showed a limited but significant
reduction for people participating to RYCT. It could be the case that the structure of the RYCT programme
was putting an excessive strain on the carers’ side. However, both CSP and RYCT appeared to improve
quality of life for people with dementia. RYCT has the potential to be both effective and cost-effective in
maintaining the quality of life of people with dementia, but the cost per QALY would be far beyond the
NICE-accepted price window. Using a factorial design assumes that interventions are independent of each
other, but for people with dementia we found that there were significant interactions.
We carried out systematic reviews in the areas of home treatment for dementia to identify the most
promising interventions and components for an effective HTP for dementia. The finding that case
management for people with dementia reduces admission to long-term care is consistent with the related
literature. Case management also reduced behavioural problems in people with dementia. On the
evidence available it is not clear how it may affect overall health-care costs. People with dementia and
family carers have much to offer in their understanding of the causes and best interventions in times of
crisis. Staff suggested more costly and intensive interventions, whereas carers liked education and support,
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and people with dementia appreciated support from family, as well as home adaptations and technology
to reduce risks. The consensus methods and field testing enabled the production of an easy-to-use HTP
to help staff working in crisis teams prevent admissions for people with dementia. The HTP requires
evaluation in a full-scale multicentre trial.
The new wave of complex interventions shows great potential for benefit for people with dementia.
Alongside this research into psychosocial interventions, further advances in methodology will be required,
particularly in relation to process evaluations and implementation. Recent funding rounds by the NIHR and
Economic and Social Research Council should help the UK to remain at the forefront of dementia care
research with the potential to improve the lives of millions of people with dementia across the world.
Recommendations for future research
Maintenance cognitive stimulation therapy
l Cognitive stimulation therapy has the potential to improve cognition and well-being in many people
with dementia in addition to any potential benefits from antidementia medication. Future research and
practice need to investigate the use of CST delivered by family carers and for those in other cultural
and ethnic minority groups.
l Maintenance cognitive stimulation therapy, originally designed to be run twice weekly, was
implemented once weekly and this did not affect the cognition and quality-of-life scores. A future trial
would be useful to control the frequency of CST delivery, the time frame of completing the assessment
time points and the rigorousness of the inclusion criteria required to participate in the programme.
l Further research is required to look further at the mechanisms of change identified in both quantitative
and qualitative methods and relate this to CST and MCST to determine what is most important in
attempting to further understand and increase the benefits for the person with dementia.
Carer Supporter Yesterday, Caring Today
l The data collected in this trial include a comprehensive set of measures on coping and social support,
the secondary analysis of which will increase our understanding of the interplay of these variables.
l By collecting information from both family carers and people with dementia, we have the opportunity
to carry out analyses at the level of the dyad. This is something that has been long called for, but as yet
rarely executed, in the field of dementia care.
l Multilevel analyses are becoming increasingly popular in other fields in which interactions within the
dyad influence the outcomes of each member of that dyad. Future studies using a factorial design
should be adequately powered for an analysis of each intervention with TAU.
Home treatment programme
l Further research into crisis resolution interventions for older people with mental health problems should be
based on sound theory, so that a robust evidence base can be created to drive future policy development.
l Further research is required about the delivery of interventions at home during a time of crisis and
potential challenges to their successful implementation. The use of care management as a method of
preventing and managing crisis situations through a co-ordinated and planned response could be
explored further to assist in the development of best practice treatment models.
l Future research is needed to understand how carers make decisions when dealing with crises and how
these findings can be incorporated into providing appropriate and acceptable crisis interventions.
l Our use of an online survey was effective in allowing us to consult with a broad range of stakeholders
and is a medium that should be explored further for use in research.
l There is a need for a RCT to establish the efficacy of crisis resolution/home treatment services for older
people with mental health problems.
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